<?xml version="1.0" encoding="utf-8"?>
<documents>
  <document>
    <id>374911</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/content/15/1/9.short?rss=1]]&gt;</url>
    <title>"Hospital at home" care shows similar mortality and subsequent hospital admissions to hospital care for older patients with acutely decompensated chronic heart failure</title>
    <publicationDate>2010-02-22T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>RANDOMISED CONTROLLED TRIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Heart failure remains one of the most common reasons for emergency hospital admission, and readmission rates are high when post-discharge follow-up is poor or in frequent. There is good evidence that multidisciplinary programmes are effective at reducing the risk of readmission to hospital for patients recently discharged after treatment of acute decompensation, particularly where these programmes include frequent contact with the patient at home, either physically or by telephone1 or by remotely monitoring physiological data.2 Much less attention has been directed to avoiding hospital admission altogether for those experiencing the crisis of acute decompensation by providing greatly increased clinical support at home-the “hospital at home” concept.]]&gt;</body>
  </document>
  <document>
    <id>317309</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=397]]&gt;</url>
    <title>‘Pac Man’ enzyme eats Alzheimer’s plaques</title>
    <publicationDate>2009-04-22T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ American scientists have discovered chemicals that could speed up the destruction of proteins linked to Alzheimer’s disease.]]&gt;</body>
  </document>
  <document>
    <id>330001</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/10October/Pages/Drug-errors-in-care-homes.aspx]]&gt;</url>
    <title>06 October 2009 - Drug errors in care homes</title>
    <publicationDate>2009-10-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A study has found an “alarming” level of drug errors in care homes, according to &lt;EM&gt;The Guardian&lt;/EM&gt;. The study in question looked at 256 elderly people from 55 care homes in England. The mistakes included errors in dosage and how the drugs should be taken.]]&gt;</body>
  </document>
  <document>
    <id>260753</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://old.nimhe.csip.org.uk/silo/files/10-hics-for-mh--supplementary-guidance-for-opmh.pdf]]&gt;</url>
    <title>10 High Impact Changes for Mental Health Services: Supplementary guidance for Older Peoples' Mental Health Services.</title>
    <publicationDate>2007-04-20T00:00:00</publicationDate>
    <publisher>Care Services Improvement Partnership</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,MENTAL HEALTH,SCREENING,NSF FOR OLDER PEOPLE,OUTCOMES,ADULTS,MENTAL &amp; BEHAVIOURAL DISORDERS,OLDER PEOPLE,POPULATION BASED &amp; PREVENTATIVE SERVICES,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,SERVICES,2008-SEPTEMBER,MONTHLY ADDITIONS,GROUPS,POPULATIONS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>National Older People's Mental Health Programme.</description>
    <body>&lt;![CDATA[ &lt;P&gt;A 17-page&amp;nbsp;guide which has been created to support Older People's Mental Health services in implementing the 10 High Impact Changes for Mental Health Services. It advises what each High Impact Change might mean for Older People's Mental Health Services, and additional resources to support each of the High Impact Changes.&lt;/P&gt;
&lt;P&gt;It also identifies some of the benefits and measures of process or service redesign (relating to the 10 High Impact Changes).&lt;/P&gt;
&lt;P&gt;This supplementary guide should be utilised in conjunction with the main publications. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374915</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474442210700430/abstract?rss=yes#]]&gt;</url>
    <title>11C-PiB PET assessment of change in fibrillar amyloid-&amp;#946; load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study</title>
    <publicationDate>2010-03-15T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Carbon-11-labelled Pittsburgh compound B (11C-PiB) PET is a marker of cortical fibrillar amyloid-ß load in vivo. We used 11C-PiB PET to investigate whether bapineuzumab, a humanised anti-amyloid-ß monoclonal antibody, would reduce cortical fibrillar amyloid-ß load in patients with Alzheimer's disease.]]&gt;</body>
  </document>
  <document>
    <id>330002</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/10October/Pages/Jigsaws-and-dementia-diagnosis.aspx]]&gt;</url>
    <title>13 October 2009 - Jigsaws and dementia diagnosis</title>
    <publicationDate>2009-10-13T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "A failing memory may not be the first sign of Alzheimer's disease,” according to the BBC. It reported that a study has found that “spatial skills, such as reading a map or completing a jigsaw, seem to be the first to falter”. Researchers found that these skills appeared to decline sharply up to three years before the disease was diagnosed using current methods.]]&gt;</body>
  </document>
  <document>
    <id>330003</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/10October/Pages/Gout-chemical-and-Parkinsons.aspx]]&gt;</url>
    <title>14 October 2009 - Gout chemical 'may help' Parkinson's</title>
    <publicationDate>2009-10-04T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Researchers have concluded that urate, a naturally occurring chemical in the blood that is known to cause gout, “appears to slow the progression of Parkinson's disease”, BBC News has reported. Researchers claim that urate is a potent antioxidant and “counteracts oxygen-related cell damage thought to contribute to Parkinson's”. The news site said that trials are underway to find a safe way to raise urate levels as a therapy.]]&gt;</body>
  </document>
  <document>
    <id>313334</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=313334]]&gt;</url>
    <title>15 April 2009 - Brain bleeding 'caused by aspirin'</title>
    <publicationDate>2009-04-15T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Behind the headlines - Your guide to the science that makes the news.Created by NHS Choices</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;15 April 2009 - Brain bleeding 'caused by aspirin'&lt;/pageTitle&gt;&lt;pageBody&gt;"The ‘wonder drug’ aspirin may cause bleeding in the brain", the Daily Express has reported. The story comes from research looking at brain scans from more than a thousand people, finding that those taking aspirin had a 70% higher chance of having microscopic bleeding in their brains. This research looked at a range of antithrombosis drugs, including aspirin, which prevent blood from clotting within blood vessels.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>330004</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/10October/Pages/Health-after-retirement.aspx]]&gt;</url>
    <title>15 October 2009 - Health after retirement</title>
    <publicationDate>2009-10-15T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Work is good for you, especially after you've retired,” says the &lt;EM&gt;Daily Mail&lt;/EM&gt;. The newspaper and others report that workers who stop working suddenly&amp;nbsp;the moment they reach&amp;nbsp;retirement age are at greater risk of heart attacks, cancer and other major diseases than those who ease their way into old age by taking a part-time job.]]&gt;</body>
  </document>
  <document>
    <id>319600</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/06June/Pages/Elderlytakelisteriagamble.aspx]]&gt;</url>
    <title>17 June 2009 - Elderly take listeria 'gamble'</title>
    <publicationDate>2009-06-17T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Listeria poisonings are on the rise because the elderly are taking chances with use-by dates, newspapers reported. &lt;EM&gt;The Times&lt;/EM&gt; said that the 'waste not, want not' ethos of the post-war period could be responsible for the increase in the number of cases of food poisoning. The &lt;EM&gt;Daily Mail&lt;/EM&gt; said that rising food prices and fixed incomes mean that pensioners are keeping food for longer than they should.]]&gt;</body>
  </document>
  <document>
    <id>313336</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=313336]]&gt;</url>
    <title>2 April 2009 - Middle-aged sex risks Q&amp;A</title>
    <publicationDate>2009-04-02T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Behind the Headlines - your guide to the science that makes the news.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2 April 2009 - Middle-aged sex risks Q&amp;A&lt;/pageTitle&gt;&lt;pageBody&gt;Adults over 45 years old are taking chances with their sexual health and are at risk of contracting sexually transmitted infections (STIs) when starting new relationships, according to the Royal Pharmaceutical Society of Great Britain.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>316057</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/05May/Pages/BloodPressurePillsForAll.aspx]]&gt;</url>
    <title>21 May 2009 - 'Give heart drugs to all over 55'</title>
    <publicationDate>2009-05-21T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CARDIOVASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the headlines - your guide to the science that makes the news</description>
    <body>&lt;![CDATA[ “Blood pressure drugs should be given to everyone over 55 to reduce heart attacks and strokes”, the Daily Mail has reported. The newspaper said the medication should be prescribed even if blood pressure is normal, as new research estimates that common drugs reduce risk of heart attack by a quarter and stroke by a third.]]&gt;</body>
  </document>
  <document>
    <id>330005</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/10October/Pages/Sleep-deprivation-and-memory.aspx]]&gt;</url>
    <title>22 October 2009 - Sleep deprivation and memory</title>
    <publicationDate>2009-10-22T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“The forgetfulness brought on by insomnia may be countered with drugs,” says a report on BBC News today.&lt;/P&gt;
&lt;P&gt;Research in mice looked at a chemical pathway in the part of the brain&amp;nbsp;that deals&amp;nbsp;with memory. It showed that sleep deprivation increases levels of an enzyme called PDE4 and reduces levels of a molecule called cAMP. The researchers were able to manipulate these pathways with a drug called Rolipram,&amp;nbsp;which improved&amp;nbsp;some of the memory problems of the sleep-deprived mice.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319599</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/06June/Pages/Dietandlifespan.aspx]]&gt;</url>
    <title>24 June 2009 - Diet and lifespan</title>
    <publicationDate>2009-06-24T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Mediterranean diet is back in the news today, with &lt;EM&gt;The Daily Telegraph&lt;/EM&gt; suggesting that "wine, veg and little meat [are a] recipe for long life". The newspaper said that researchers had found that not all components of the Mediterranean diet had the same benefits. It said that while a diet with large amounts of fruit and vegetables, little red meat and a “glass or two” of red wine a day was a recipe for longer life, a seemingly healthy diet of low dairy and high amounts of fish and seafood did not prolong life.]]&gt;</body>
  </document>
  <document>
    <id>319598</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/06June/Pages/CouldBeingObeseBeGood.aspx]]&gt;</url>
    <title>25 June 2009 - Is extra weight good for you?</title>
    <publicationDate>2009-06-25T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;EM&gt;The Daily Telegraph&lt;/EM&gt; reported that “a few extra pounds helps you live longer.” According to the newspaper, new research shows that overweight people live longer than their slender peers. It said that results defy the common belief that staying slim is the secret to a long, healthy life.]]&gt;</body>
  </document>
  <document>
    <id>316058</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/05May/Pages/Middleagedspreadandmortality.aspx]]&gt;</url>
    <title>26 May 2009 - Middle-aged spread and mortality</title>
    <publicationDate>2009-05-26T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the headlines - your guide to the science that makes the news.</description>
    <body>&lt;![CDATA[ “People who are overweight or obese in middle-age run the risk of being frail in later life,” reported BBC News. It said a study found that men who put on weight in their 40s but lost it when they got older were at the highest risk of death in their 70s. It quoted the study leader as saying, “the unhealthy pattern of weight in their 40s was causing frailty in later life probably due to underlying cardiovascular problems, such as high blood pressure and early stages of diabetes”.]]&gt;</body>
  </document>
  <document>
    <id>316059</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/05May/Pages/QAonNiceguidanceforbackpain.aspx]]&gt;</url>
    <title>27 May 2009 - Q&amp;A on NICE guidance for back pain</title>
    <publicationDate>2009-05-27T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ MUSCULOSKELETAL,CONDITIONS,MAJOR NON-INFLAMMATORY,SPINAL PROBLEMS,LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the headlines - your guide to the science that makes the news.</description>
    <body>&lt;![CDATA[ Many newspapers have reported that the NHS is now to offer acupuncture for back pain. The Daily Telegraph said that people whose back pain has continued for more than six weeks but less than a year may be offered the option of 12 weeks of complementary therapy on the NHS, consisting of either exercise classes; manipulation sessions by a chiropractor, osteopath or physiotherapist; or acupuncture sessions. However, it warns that few people will have the choice of which of the three treatments they receive, due to a shortage of services.]]&gt;</body>
  </document>
  <document>
    <id>316062</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/05May/Pages/GlowingMonkeysForResearch.aspx]]&gt;</url>
    <title>28 May 2009 - Glowing monkeys 'milestone'</title>
    <publicationDate>2009-05-28T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the Headlines - your guide to the science the makes the news.</description>
    <body>&lt;![CDATA[ &lt;P&gt;“The world's first ‘glow in the dark’ monkeys could help in cure for diseases such as Parkinson's,” The Daily Telegraph has reported.&lt;/P&gt;
&lt;P&gt;The news comes from Japanese research into genetically modifying marmosets, a type of monkey that breeds rapidly. Monkey embryos were injected with a jellyfish gene that makes animals glow green under ultra-violet light, allowing scientists to tell easily whether the foreign gene successfully combined with the monkey DNA. A number of these embryos grew into monkeys that glowed under UV light, and these, in turn, were bred with regular monkeys. These offspring also carried the fluorescent gene. Theoretically, scientists could create and breed monkeys with genes for incurable human illnesses such as Parkinson’s disease. These monkeys could then be used in experiments as animal models of human disease.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319597</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/06June/Pages/HeatwaveHealthQandA.aspx]]&gt;</url>
    <title>29 June 2009 - Q&amp;A: heatwave health</title>
    <publicationDate>2009-06-29T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Today, several news sources reported the dangers of Britain’s soaring temperatures, which are set to hit 32°C later in the week. It has also been reported that thick clouds are likely to trap in the heat and humidity of the day, making temperatures uncomfortably high at night.]]&gt;</body>
  </document>
  <document>
    <id>87808</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11211722&amp;query_hl=7]]&gt;</url>
    <title>75  health assessments</title>
    <publicationDate>2001-05-06T00:00:00</publicationDate>
    <publisher>Australian Family Physician</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ BACKGROUND: The Enhanced Primary Care package (EPC) includes item numbers for annual health assessment of people aged 75 years and over. Nursing or allied health staff can perform these as home visits and save the general practitioner considerable time. OBJECTIVE: Explanatory notes for conducting these assessments are described with reference to the RACGP guidelines in print or on the internet. DISCUSSION: 75+ health assessments (75+ HA) represent an opportunity for GPs to improve the functional status of their elderly patients at the same time as building team work with nursing and allied health professionals.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>319604</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/06June/Pages/OilyFishSlowsEyeProblem.aspx]]&gt;</url>
    <title>9 June 2009 - Can diet slow sight loss in the elderly?</title>
    <publicationDate>2009-06-09T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,EYESIGHT,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Eating fish twice a week 'can help prevent eye disease',” &lt;EM&gt;The Daily Telegraph&lt;/EM&gt; has reported. It said a study has found that omega-3 fatty acids, found in oily fish&amp;nbsp;such as&amp;nbsp;salmon and tuna, could help prevent age-related macular degeneration (AMD), the main cause of blindness in elderly people.]]&gt;</body>
  </document>
  <document>
    <id>294228</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.snpearstesting.org/consensusfinal.pdf]]&gt;</url>
    <title>A collective responsibility to act now on ageing and mental health; a consensus statement</title>
    <publicationDate>2008-09-12T00:00:00</publicationDate>
    <publisher>CSIP Older People's Mental Health</publisher>
    <publicationType>CONSENSUS STATEMENT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,MENTAL HEALTH,DEMENTIA,ADULT CONDITIONS,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Issued by key organisations integral to the support, care, and treatment of mental health in later life</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;&amp;nbsp;CONTENTS&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Foreword&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Investing in Our Future&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Why a consensus statement? &lt;/LI&gt;
&lt;LI&gt;A consensus on areas for action&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;The Evidence&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Mental disorder in older people – the current situation &lt;/LI&gt;
&lt;LI&gt;Impact of socio-demographic change&lt;/LI&gt;
&lt;LI&gt;What is happening currently in healthcare? &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Appendix &lt;/LI&gt;
&lt;LI&gt;References &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>328760</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/reprint/361/13/1268.pdf]]&gt;</url>
    <title>A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease</title>
    <publicationDate>2009-09-24T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;A therapy that slows disease progression is the major unmet need in Parkinson's disease.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Methods:&lt;/STRONG&gt;&lt;BR&gt;In this double-blind trial, we examined the possibility that rasagiline has disease-modifying effects in Parkinson's disease. A total of 1176 subjects with untreated Parkinson's disease were randomly assigned to receive rasagiline (at a dose of either 1 mg or 2 mg per day) for 72 weeks (the early-start group) or placebo for 36 weeks followed by rasagiline (at a dose of either 1 mg or 2 mg per day) for 36 weeks (the delayed-start group). To determine a positive result with either dose, the early-start treatment group had to meet each of three hierarchical end points of the primary analysis based on the Unified Parkinson's Disease Rating Scale (UPDRS, a 176-point scale, with higher numbers indicating more severe disease): superiority to placebo in the rate of change in the UPDRS score between weeks 12 and 36, superiority to delayed-start treatment in the change in the score between baseline and week 72, and noninferiority to delayed-start treatment in the rate of change in the score between weeks 48 and 72.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Early-start treatment with rasagiline at a dose of 1 mg per day met all end points in the primary analysis: a smaller mean (±SE) increase (rate of worsening) in the UPDRS score between weeks 12 and 36 (0.09±0.02 points per week in the early-start group vs. 0.14±0.01 points per week in the placebo group, P=0.01), less worsening in the score between baseline and week 72 (2.82±0.53 points in the early-start group vs. 4.52±0.56 points in the delayed-start group, P=0.02), and noninferiority between the two groups with respect to the rate of change in the UPDRS score between weeks 48 and 72 (0.085±0.02 points per week in the early-start group vs. 0.085±0.02 points per week in the delayed-start group, P&amp;lt;0.001). All three end points were not met with rasagiline at a dose of 2 mg per day, since the change in the UPDRS score between baseline and week 72 was not significantly different in the two groups (3.47±0.50 points in the early-start group and 3.11±0.50 points in the delayed-start group, P=0.60).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;BR&gt;&lt;/STRONG&gt;Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease-modifying effect, but early treatment with rasagiline at a dose of 2 mg per day did not. Because the two doses were associated with different outcomes, the study results must be interpreted with caution. (ClinicalTrials.gov number, NCT00256204 [ClinicalTrials.gov] .)&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>270777</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csci.org.uk/PDF/fair_contract.pdf]]&gt;</url>
    <title>A fair contract for older people</title>
    <publicationDate>2007-10-18T00:00:00</publicationDate>
    <publisher>Commission for Social Care Inspection (CSCI)</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SECONDARY CARE,SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This report suggests that older people get a poor deal when finding a care home.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This report suggests that older people get a poor deal when finding a care home. Whilst care homes are improving the information they give to prospective residents, advertised fees for places in the same care home can vary hugely, sometimes from £650 to £1,500 a week, without a clear explanation of why some people pay more than others and what their money will buy. The report also showed that sometimes people paying for their own care can subsidise those people paid for by the local council, where councils negotiate lower rates.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87811</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7599249&amp;query_hl=11]]&gt;</url>
    <title>A geriatric assessment and intervention team for hospital inpatients awaiting transfer to a geriatric unit: a randomized trial</title>
    <publicationDate>1995-05-07T00:00:00</publicationDate>
    <publisher>Aging (Milano)</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,SECONDARY CARE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;The objective of this study, designed as a randomized controlled trial, was to decrease the length-of-stay (LOS) of hospitalized patients on a waiting list for admission to an inpatient geriatric assessment unit (GAU), and to optimize use of the GAU and other hospital services.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;We conclude that for Canadian hospitals in which extensive stays of frail elderly patients, "bed blockage", and thus access to unit-based geriatric services are common problems, the GAIT can efficiently decrease hospital LOS, increase home placement, and may improve outcomes. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95161</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4077016&amp;chk=rogWb9]]&gt;</url>
    <title>A guide to contracting for intermediate care services</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,NHS ACTIVITIES,LATER LIFE,INTERMEDIATE CARE,NHS STRUCTURES,COMMISSIONING,CONTRACTING,LEGAL AND TECHNICAL,COMMISSIONING PROCESS,THIRD SECTOR,INDEPENDENT SECTOR,OLDER PEOPLE,CONTRACTING AND PROCUREMENT,POPULATIONS SERVED,CONTRACT MANAGEMENT,CONTRACT LAW,COMMISSIONING,SERVICE SECTORS,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The purpose of this guide and its model contracts is to: 
&lt;DIV class=block100&gt;
&lt;DIV class=leftFloat100&gt;
&lt;UL&gt;
&lt;LI&gt;help establish clarity of roles and expectations between commissioners and providers; &lt;/LI&gt;
&lt;LI&gt;identify areas to be addressed in ensuring that patients/users receive a safe and appropriate service - with areas of risk addressed; and &lt;/LI&gt;
&lt;LI&gt;provide a sound contractual agreement, which delivers value for money.&lt;/LI&gt;&lt;/UL&gt;&lt;/DIV&gt;&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>319641</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.mwcscot.org.uk/web/FILES/Publications/Hospital_or_Home.pdf]]&gt;</url>
    <title>A hospital or a home? PDF</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>Mental Welfare commission for scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A report looking into whether it is best to be hospitalised or enter a care home during the later life stage.]]&gt;</body>
  </document>
  <document>
    <id>272040</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.counselandcare.org.uk/assets/library/documents/New_Carers_Strategy.pdf]]&gt;</url>
    <title>A New Strategy for Carers</title>
    <publicationDate>2007-10-30T00:00:00</publicationDate>
    <publisher>Counsel and Care</publisher>
    <publicationType>POLICY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,SECONDARY CARE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Counsel and Care's latest policy discussion paper on carers of older people.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Better support and recognition of carers of older people, particularly older carers, are crucial to proposed reform of social care, says Counsel and Care, the national charity getting the best care and support for older people, their families and carers, in its latest policy paper published today (30 October 2007). There are currently 1.5 million people over 60 providing unpaid care and 8,000 carers are aged 90 or over.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A New Strategy for Carers: better support for families and carers of older people, sets out recommendations for the Prime Minister’s review of the 1999 strategy for carers.&amp;nbsp; Critical to better supporting carers are radical improvements in social care services which will also be the subject of a green paper next year.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Included in Counsel and Care’s discussion paper’s recommendations are that government:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;addresses the needs of different types of carers, and recognises their diversity&amp;nbsp; 
&lt;LI&gt;reform the benefits system that currently penalises those carers who want to work, and further punishes them when they reach pensionable age by removing Carer’s Allowance 
&lt;LI&gt;increase carer’s premium for Income Support/Pension Credit, alongside an increase in Carer’s Allowance 
&lt;LI&gt;treat carers as equal stakeholders in the health and social care partnership 
&lt;LI&gt;make it easier for carers to work by better promoting the right to request flexible working and extending tax exemptions to care vouchers &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Referring to the recent report published by Carers UK showing that carers save the country £87 billion per year – more than the annual spend on the NHS&amp;nbsp; - Counsel and Care has supported Carers UK and other campaigners in demanding that carers are included as equals in the delivery of health and social care services.&amp;nbsp; Recent research from the University of Leeds for Carers UK has shown that:&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;41% of ‘new’ carers are caring for someone who does not receive any other services 
&lt;LI&gt;34% of ‘longer term’ carers struggle to make ends meet financially 
&lt;LI&gt;between 40% and 50% of working carers felt that there was little flexibility and sensitivity in service delivery, which hampered their efforts to get support.&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87825</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8955540&amp;query_hl=26]]&gt;</url>
    <title>A psychometric analysis of a short device for assessing depression in elderly people</title>
    <publicationDate>1996-05-05T00:00:00</publicationDate>
    <publisher>British Journal of Clinical Psychology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,DEPRESSION,MENTAL HEALTH,FOR REVIEW]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Schwab-Gilleard Depression Scale is a short self-report index for assessing depression in elderly people. The aim of this study is to investigate the psychometric properties of this device with particular reference to its reliability, criterion validity and ability to discriminate depression from dementia. The total sample comprised 166 elderly people living in Part III residential homes in south-west London. For 111 of these, the Schwab-Gilleard Depression Scale (SGDS), the Geriatric Depression Scale (GDS), the Short-Comprehensive Assessment and Referral Evaluation (CARE), and the Clifton Assessment Procedures for the Elderly (CAPE) were completed. The GDS and CAPE only were completed with the remaining 55 participants. Psychiatric diagnoses were available from the medical notes on each resident. In addition, a subsample of 49 had been assessed using the SGDS and CARE 14 months previously. These data were available for test-retest analyses. The self-rating SGDS was found to be a reliable and valid measure of depression and is recommended for use as a screening tool for depression in elderly people in residential homes.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>87827</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=536982&amp;query_hl=28]]&gt;</url>
    <title>A randomized controlled trial of geriatric screening and surveillance in general practice</title>
    <publicationDate>1979-05-06T00:00:00</publicationDate>
    <publisher>Journal of the Royal College of General Practitioners</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FOR REVIEW,SURVEILLANCE,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN style="mso-ansi-language: EN-US; mso-bidi-font-size: 10.0pt"&gt;Tulloch AJ,.Moore V. A randomized controlled trial of geriatric screening and surveillance in general practice. &lt;I&gt;Journal of the &lt;/I&gt;&lt;/SPAN&gt;&lt;I&gt;&lt;SPAN style="mso-ansi-language: EN-US; mso-bidi-font-size: 10.0pt"&gt;Royal&lt;/SPAN&gt;&lt;/I&gt;&lt;I&gt;&lt;SPAN style="mso-ansi-language: EN-US; mso-bidi-font-size: 10.0pt"&gt; &lt;/SPAN&gt;&lt;/I&gt;&lt;I&gt;&lt;SPAN style="mso-ansi-language: EN-US; mso-bidi-font-size: 10.0pt"&gt;College&lt;/SPAN&gt;&lt;/I&gt;&lt;I&gt;&lt;SPAN style="mso-ansi-language: EN-US; mso-bidi-font-size: 10.0pt"&gt; of General Practitioners&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style="mso-ansi-language: EN-US; mso-bidi-font-size: 10.0pt"&gt; 1979;&lt;B&gt;29&lt;/B&gt;:733-40.&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>87831</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9217619&amp;query_hl=33]]&gt;</url>
    <title>A randomized trial of office-based screening for common problems in older persons</title>
    <publicationDate>1997-05-04T00:00:00</publicationDate>
    <publisher>American Journal of Medicine</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ PURPOSE: To test the effectiveness of a 10-minute office-staff administered screen to evaluate malnutrition/weight loss, visual impairment, hearing loss, cognitive impairment, urinary incontinence, depression, physical limitations, and reduced leg mobility among older persons seen in office practice. This screen was coupled with clinical summaries to assist the physician in further evaluating and managing the screen-included problems. PATIENTS AND METHODS: Twenty-six community-based office practices of internists and family physicians in Los Angeles were randomized to intervention or control groups. Two hundred and sixty-one patients aged &amp;gt; or = 70 years and seeing these physicians for a new visit or a physical examination participated in the study. At the enrollment visit intervention group patients were administered the screening measure and their physicians were given the pertinent clinical summaries. Outcome measures were detection of, and intervention for conditions screened, and health status 6 months after the intervention. RESULTS: Hearing loss was both more commonly detected (40% intervention versus 28% control) and further evaluated (29% versus 16%) by physicians in the intervention group (P &amp;lt; 0.05). No other differences in the frequency of problem detection or intervention were noted between groups. Six months after the intervention no differences were noted in health status between groups. CONCLUSIONS: A brief measure to screen for common conditions in older persons was associated with more frequent detection and follow-up assessment of hearing loss. Although the measure was well accepted by physicians and their staffs, it did not appear to affect detection and intervention in regard to the other screen-included conditions, or health status at 6 months.]]&gt;</body>
  </document>
  <document>
    <id>328775</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://download.thelancet.com/pdfs/journals/laneur/PIIS147444220970225X.pdf]]&gt;</url>
    <title>A reassessment of risks and benefits of dopamine agonists in Parkinson's disease</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Neurologists have several choices of drugs that have been shown to be effective for the treatment of the symptoms of Parkinson's disease. Among the first options are the dopamine agonists, which are commonly used both as an early monotherapy and as an adjunct therapy to levodopa. However, before starting any treatment, the overall benefit-to-risk ratio to individual patients must be considered. For the dopamine agonists, the available evidence on their symptomatic efficacy, effect on long-term levodopa-related motor complications, putative effect on progression of disease, and adverse event profile must be taken into account. Recently, the ocurrence of adverse events such as leg oedema, daytime somnolence, impulse control disorders, and fibrosis have increasingly been recognised. The risks of these potentially serious adverse events must therefore be taken into account and treatment decisions should be based on considerations of risks versus benefits for individual patients.]]&gt;</body>
  </document>
  <document>
    <id>250685</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_065224]]&gt;</url>
    <title>A Recipe for Care – Not a Single Ingredient</title>
    <publicationDate></publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A Recipe for Care – Not a Single Ingredient
Clinical case for change: Report by Professor Ian Philp, National Director for Older People</description>
    <body>&lt;![CDATA[ This report outlines the case for reconfiguring older people's services to bring those services closer to their homes.]]&gt;</body>
  </document>
  <document>
    <id>328763</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/reprint/14/5/146]]&gt;</url>
    <title>A stepped-care prevention programme decreased depression and anxiety disorders in elderly patients</title>
    <publicationDate>2009-10-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;randomised controlled trial. ISRCTN26474556 [controlled-trials.com] .&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Blinding:&lt;BR&gt;&lt;/STRONG&gt;blinded (outcome assessors).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;primary care practices in the northwestern Netherlands.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Patients:&lt;/STRONG&gt;&lt;BR&gt;170 general practice patients &amp;gt;=75 years of age (mean age 81 y, 74% women) who had Center for Epidemiologic Studies Depression Scale (CES-D) scores &amp;gt;=16 and did not meet DSM-IV criteria for depressive or anxiety disorder in the previous 12 months as measured by the Mini International Neuropsychiatric Interview (MINI). Patients with serious cognitive decline were excluded. All patients completed 3 months of watchful waiting, after which they completed a second CES-D questionnaire. Patients with scores &amp;gt;=16 underwent a diagnostic MINI. Patients with CES-D scores &amp;gt;=16 but who did not have a depressive or anxiety disorder were randomized.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87839</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9419927&amp;query_hl=36]]&gt;</url>
    <title>A strategic supportive model for health prevention in the elderly: profile of a Puerto Rican geriatric population in a public health sector</title>
    <publicationDate>1997-05-04T00:00:00</publicationDate>
    <publisher>Bol Asoc Med P R</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SURVEILLANCE,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ OBJECTIVE: To introduce the ASSUME study with the presentation of a clinical, socio-demographic, preventive and psychological profile of a geriatric population of patients who receive their health care in the General Internal Medicine Ambulatory Sector of our institution. METHODS: The Assume study is a prospective, randomized trial which is directed at increasing the participation of patients in preventive health care strategies at a primary, secondary and tertiary level. In this paper we focus on the initial stage of the process which aims to define and synthesize predisposing risk factors in the geriatric patient which would be amenable to primary, secondary and tertiary preventive strategies. Through a process of patient interview profiles of a physical, social and psychological nature are have been constructed. With the availability of this profile a clearer definition of the potential benefit of preventive strategies could be established. In this paper we present the initial profile of patients of all patients randomized to the study as of Sept. 01, 1997. RESULTS: A total of 123 patients have been enrolled with 48(39%) males and 75(61%) females. The mean age of patients is 70 years with a median of 68 years. Cardiovascular disorders establish the leading disease events in our population of patients with Hypertension in 85%, Ischemic heart disease in 50%, Myocardial Infarction in 19% and 40% with a history of Congestive Heart failure. Diabetes and Heart Failure were seen in 40%. An average of 4.4 prescribed drugs per patient was documented. A minority of patients took more than 7 drugs and none took more than 9 medications. Most patients (67 or 55%) had not required hospitalizations in the preceding 12 months and none of the patients required more than 4 hospitalizations. The average LOS was 8.60 days. The Preventive Medicine profile reveals a large number of un-vaccinated adults. Regular cigarette smoking was seen in 12%. We have used the body mass index as a measure of adequacy of weight. We highlight the number of patients who have a BMI equivalent to an obese, severely obese or morbidly obese category (41%). The number of patients who follow a prescribed diet was found to be 54 patients for 44% of the study group. With regards to the interventions primarily designed for early cancer detecting, approximately half of the patients undergo the recommended annual screening interventions. The screening of visual accuracy was reported in 54%, dental screen (24%) and auditory screening (15%). Nearly a quarter of patients have severe depression. The CAPE testing reveal that in the information and orientation section most patients presented none or light dysfunction(87%). In the conductual phase marked or severe impairment was detected in 12% of patients. In the mental ability section 22% of patients presented marked or severe impairment. CONCLUSION: The geriatric population studied would benefit from modalities which would increment the modern modalities for primary and secondary prevention of disease. Follow-up studies will allow the evaluation of the effectiveness of the conceptual model proposed, which would increment the patient participation in these preventive modalities.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>93880</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11445104&amp;query_hl=32]]&gt;</url>
    <title>A three-item scale for the early prediction of stroke recovery</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Lancet</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ STROKE,NEUROLOGICAL CONDITIONS,REHABILITATION,LATER LIFE,STROKE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/diagnos/stroked.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"The combination of clinical and magnetic resonance diffusion-weighted imaging provided good preditcion of stroke recovery shortly after admission to hospital".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95055</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeopleArticle/fs/en?CONTENT_ID=4073597&amp;chk=4wRxm%2B]]&gt;</url>
    <title>About the NSF for older people</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE,ADULTS,POPULATION BASED &amp; PREVENTATIVE SERVICES,OLDER PEOPLE,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,SERVICES,HEALTHCARE &amp; HEALTH SERVICES,MONTHLY ADDITIONS,2008-SEPTEMBER,AGE GROUPS,POPULATIONS,GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The NSF for older people was published on 27 March 2001. It sets new national standards and service models of care across health and social services for all older people, whether they live at home, in residential care or are being looked after in hospital. 
&lt;DIV&gt;
&lt;P&gt;The NSF leads with plans to:&lt;/P&gt;&lt;/DIV&gt;
&lt;DIV class=block100&gt;
&lt;DIV class=leftFloat100&gt;
&lt;UL&gt;
&lt;LI&gt;tackle age discrimination to make it a thing of the past, and ensure older people are treated with respect and dignity 
&lt;LI&gt;ensure older people are supported by newly integrated services with a well co-ordinated, coherent and cohesive approach to assessing individual's needs and circumstances and for commission and providing services for them 
&lt;LI&gt;specifically address those conditions which are particularly significant for older people - stroke, falls and mental health problems associated with older age 
&lt;LI&gt;promote the health and well-being of older people through co-ordinated actions of the NHS and councils.&lt;/LI&gt;&lt;/UL&gt;&lt;/DIV&gt;&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>95414</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/SC87.asp]]&gt;</url>
    <title>Accommodation for older people with mental health problems</title>
    <publicationDate>1996-07-07T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A significant number of older people have a serious mental health problem which is not a form of dementia related to their age. Many are accommodated in long-stay psychiatric wards and homeless persons hostels. An exploratory study based in Edinburgh finds that few community care plans consider the special needs of this group or how they might be provided with more suitable housing.]]&gt;</body>
  </document>
  <document>
    <id>317410</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/content/full/NEJMp0903923?query=TOC]]&gt;</url>
    <title>Achieving health care reform - how physicans can help</title>
    <publicationDate>2009-06-11T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This year, we have the best chance in a generation of enacting&lt;SUP&gt; &lt;/SUP&gt;legislation worthy of being called health care reform and of&lt;SUP&gt; &lt;/SUP&gt;setting the United States on the path to high-quality, affordable&lt;SUP&gt; &lt;/SUP&gt;health care for all Americans. The recent commitment by several&lt;SUP&gt; &lt;/SUP&gt;major stakeholders — including the American Medical Association&lt;SUP&gt; &lt;/SUP&gt;— to slowing the growth of health care spending is a promising&lt;SUP&gt; &lt;/SUP&gt;development. But the controversy about whether the organizations&lt;SUP&gt; &lt;/SUP&gt;actually agreed to a 1.5-percentage-point reduction in annual&lt;SUP&gt; &lt;/SUP&gt;spending growth is just one indication that success is still&lt;SUP&gt; &lt;/SUP&gt;far from assured.&lt;SUP&gt; &lt;/SUP&gt;]]&gt;</body>
  </document>
  <document>
    <id>95183</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.bhfactive.org.uk/older-adults/publications.html#ALL]]&gt;</url>
    <title>Active for later life</title>
    <publicationDate></publicationDate>
    <publisher>British Heart Foundation</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NSF FOR OLDER PEOPLE,LATER LIFE,DEMENTIA,STROKE,CAUSES AND PRIMARY PREVENTION,FALLS,CAUSES AND PREVENTION,PREVENTION,SECONDARY PREVENTION,DETERMINANTS,ADULTS,OLDER PEOPLE,POPULATION BASED &amp; PREVENTATIVE SERVICES,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,INDIVIDUAL BEHAVIOUR,PHYSICAL ACTIVITY,SERVICES,2008-SEPTEMBER,MONTHLY ADDITIONS,POPULATIONS,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The Active for Later Life Resource aims to help all those involved in developing physical activity programmes for older people of all ages and abilities. It includes summaries of evidence and recommendations, policy and strategic connections, as well as a series of working papers and practical guidance documents and ideas on programming physical activity opportunities for older people. It has been designed for the wide range of national and local agencies with the potential to work with older people to promote physical activity.</description>
    <body>&lt;![CDATA[ The British Heart Foundation have produced a resource to assist in the promotion of physical activity with older people. The Active for Later Life Resource aims to help all those involved in developing physical activity programmes for older people of all ages and abilities. It includes summaries of evidence and recommendations, policy and strategic connections, as well as a series of working papers and practical guidance documents and ideas on programming physical activity opportunities for older people. It has been designed for the wide range of national and local agencies with the potential to work with older people to promote physical activity.]]&gt;</body>
  </document>
  <document>
    <id>313369</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rcplondon.ac.uk/pubs/brochure.aspx?e=267]]&gt;</url>
    <title>Advance Care Planning</title>
    <publicationDate>2009-02-28T00:00:00</publicationDate>
    <publisher>Royal College of Physicians</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN id=FormView1_summaryLabel&gt;
&lt;P&gt;&lt;STRONG&gt;Prepared by the British Geriatrics Society, Royal College of Physicians, Royal College of Nursing, Royal College of Psychiatrists, Royal College of General Practitioners, British Society of Rehabilitation Medicine, Alzheimer's Society, Help the Aged and the National Council for Palliative Care.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The aim of this guideline is to inform health and social care professionals on how best to manage advance care planning (ACP) in clinical practice.&lt;/P&gt;&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>319620</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk/eyes/page.aspx?pagename=AMDAEU2009]]&gt;</url>
    <title>Age Related Macular Degeneration Annual Evidence Update 2009</title>
    <publicationDate>2009-06-21T00:00:00</publicationDate>
    <publisher>NHS Evidence - eyes and vision</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This AEU is an update to the 2008 update and 2007 National Knowledge Week and so the same scope has been followed.&amp;nbsp;&amp;nbsp; The term age-related macular degeneration (AMD) is used to cover both wet and dry forms of AMD.&amp;nbsp; The dry form of the condition is also known as geographic atrophy and the wet form of the condition is also known as neovascular AMD.&amp;nbsp; Whilst an overview on early disease (which may not be visually impairing) is important to include for the epidemiology of this condition, the emphasis of this AEU is on sight-threatening or visually impairing forms.&amp;nbsp;&amp;nbsp; The developments in therapeutic and surgical interventions available for AMD that are featured in this update relate to the wet form of AMD.]]&gt;</body>
  </document>
  <document>
    <id>269038</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=269038]]&gt;</url>
    <title>Ageing Assets: Implications of population ageing for the South East region</title>
    <publicationDate>2005-10-03T00:00:00</publicationDate>
    <publisher>Social Inclusion Partnership South East (SIPSE)</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A report prepared by Population Ageing Associates for the Social Inclusion Partnership South East (SIPSE) Older People Action Group - October 2005.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Ageing Assets: Implications of population ageing for the South East region&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report has been commissioned by the Older People’s Action Group of the Social Inclusion Partnership South East. The aim is to inform regional and local planning by setting out key information and projections relating to the older population of the region over the&amp;nbsp; coming years. The report discusses the implications of ageing in the South East region and considers in particular the opportunities for action at regional level by regional organisations.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;It is well-known that the population of Britain is ageing. The South East region is no exception. People are living longer. The baby boom generation is getting older. And fertility is low – families are not&amp;nbsp; having enough children to reproduce themselves. The population of the region is growing faster than the UK average. An increase of around 12% is projected over the next 25 years, taking the population from 8.1 to 9.2 million. Most of the projected population growth is expected to be in the over 60 age group. Half the adult population are projected to be over the age of 50 by the early 2020s, which means that at that time half the voters are likely to be concerned with the matters discussed in this report.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This report addresses the issues arising from population ageing that are most relevant to the regional planning processes. The overall aim, it is suggested, should be to ensure that contributions and needs of both present and future generations of older people are consciously taken into account in the planning process. By thinking inclusively, future social exclusion will be minimised.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>330006</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/lancet/article/PIIS0140673609614604/abstract?rss=yes]]&gt;</url>
    <title>Ageing populations: the challenges ahead</title>
    <publicationDate>2009-10-01T00:00:00</publicationDate>
    <publisher>The Lancet</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ If the pace of increase in life expectancy in developed countries over the past two centuries continues through the 21st century, most babies born since 2000 in France, Germany, Italy, the UK, the USA, Canada, Japan, and other countries with long life expectancies will celebrate their 100th birthdays. Although trends differ between countries, populations of nearly all such countries are ageing as a result of low fertility, low immigration, and long lives. A key question is: are increases in life expectancy accompanied by a concurrent postponement of functional limitations and disability? The answer is still open, but research suggests that ageing processes are modifiable and that people are living longer without severe disability. This finding, together with technological and medical development and redistribution of work, will be important for our chances to meet the challenges of ageing populations.]]&gt;</body>
  </document>
  <document>
    <id>87886</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ageing.oupjournals.org/cgi/reprint/32/2/171]]&gt;</url>
    <title>Ageism in the management of lung cancer</title>
    <publicationDate>2003-05-04T00:00:00</publicationDate>
    <publisher>Age and Ageing</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ BACKGROUND: age-related differences in the treatment of lung cancer patients have been reported in the past, but most previous studies have not recorded case-mix factors, nor have they studied the impact of such ageism on survival. METHODS: a questionnaire-based study of diagnostic and case-mix factors was carried out across 48 hospital Trusts in the UK between 1997 and 1998. We identified 1,652 patients and followed through with regard to their treatment and survival for 6 months after diagnosis. RESULTS: the median age of the population was 69 years, and for this analysis, was divided into three age groups: under 65 years, 65-74 and 75 years and over. There were significant inverse correlations between age and histological diagnosis, any active treatment and survival, even when corrected for case-mix factors and non-cancer causes of death. For example, the surgical resection rate in patients with confirmed non-small cell lung cancer with good performance status, no chronic obstructive pulmonary disease and limited disease was 37% in the younger patients compared with 15% in those 75 and over. The overall mortality rates at 6 months ranged from 42% in patients under 65 to 58% in the over 75s. CONCLUSIONS: this national study of lung cancer care in the UK has shown large age-related differences in management and survival in patients with lung cancer, largely independent of case-mix factors. The reasons for this are complex but such under-treatment in the elderly may be one factor underlying the poor outcomes in lung cancer patients in the UK.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>284101</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/download.php?fileID=322]]&gt;</url>
    <title>Always a last resort: Inquiry into the prescription of antipsychotic drugs to people with dementia living in care homes</title>
    <publicationDate>2008-04-28T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,PATHOLOGY,DEFINITION AND TYPES,CAUSES AND PREVENTION,TREATMENT AND CARE,DEMENTIA,DIAGNOSIS,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Up to 105,000 people with dementia are given the drugs inappropriately, according to expert predictions in the new All-Party Parliamentary Group (APPG) on Dementia report, 'Always A Last Resort', published by the Alzheimer's Society.</description>
    <body>&lt;![CDATA[ &lt;P&gt;An influential group of MPs is calling on the Government to stop the dangerous over-prescribing of antipsychotic drugs to people with dementia.&lt;/P&gt;
&lt;P&gt;Up to 105,000 people with dementia are given the drugs inappropriately, according to expert predictions in the new All-Party Parliamentary Group (APPG) on Dementia report, 'Always A Last Resort'.&lt;/P&gt;
&lt;P&gt;Antipsychotics continue to be a first resort for dealing with challenging behaviour in people with dementia, such as aggression or agitation, despite causing devastating side effects, doubling risk of death and costing the UK over £60 million a year.&lt;/P&gt;
&lt;P&gt;'Always a Last Resort' identifies five vital steps to reduce antipsychotic use and reveals there is currently no audit or regulation of the issue. It urges the Government to use its new National Dementia Strategy to address the problem and the National Institute for Health and Clinical Excellence to conduct a thorough review.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374938</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/2/171?rss=1]]&gt;</url>
    <title>Alzheimer Disease-like Phenotype Associated With the c.154delA Mutation in Progranulin</title>
    <publicationDate>2010-02-08T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,PATHOLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ To characterize a kindred with a familial neurodegenerative disorder associated with a mutation in progranulin (PGRN), with emphasis on the unique clinical features in this kindred.]]&gt;</body>
  </document>
  <document>
    <id>317313</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=476]]&gt;</url>
    <title>Alzheimer’s society comment on benefits of weekly curry</title>
    <publicationDate>2009-06-03T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Professor Murali Doraiswamy, from the Duke University Medical Center in Carolina, has suggested that curcumin, found in the popular curry ingredient tumeric, could help prevent the onset of dementia.]]&gt;</body>
  </document>
  <document>
    <id>317314</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=470]]&gt;</url>
    <title>Alzheimer’s society comment on new data observing the cost effectiveness of Aricept (donepezil)</title>
    <publicationDate>2009-05-21T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ New research suggests that prescribing Aricept on diagnosis of either mild or moderate Alzheimer's disease would save the NHS money.]]&gt;</body>
  </document>
  <document>
    <id>317316</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=466]]&gt;</url>
    <title>Alzheimer’s society comment on new research into heart rhythm disorder as a risk factor for dementia</title>
    <publicationDate>2009-05-15T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Researchers at the Intermountain Medical Center have conducted research into the link between atrial fibrillation, a fairly common heart rhythm disorder, and dementia.]]&gt;</body>
  </document>
  <document>
    <id>317315</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=469]]&gt;</url>
    <title>Alzheimer’s society comment on research into impact of vitamin D on brain performance</title>
    <publicationDate>2009-05-20T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A study of 3,133 men from a variety of test centres across Europe has shown that lower 25 (OH) D levels (vitamin D levels) were associated with poorer brain performance (in middle aged and older men).]]&gt;</body>
  </document>
  <document>
    <id>389428</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/guidance/index.jsp?action=folder&amp;o=51044]]&gt;</url>
    <title>Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): Appraisal consultation</title>
    <publicationDate>2010-10-07T00:00:00</publicationDate>
    <publisher>National Institute for Clinical Excellence (NICE)</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,TREATMENT AND CARE,DEMENTIA,NEUROLOGICAL CONDITIONS,RECENT ADDITIONS,ALZHEIMER'S DISEASE,DEMENTIA,CONDITIONS,OCTOBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using donepezil, galantamine, rivastigmine and memantine in the NHS in England and Wales. This is a review of technology appraisal guidance 111. The Appraisal Committee has considered the evidence submitted and the views of non-manufacturer consultees and commentators, and clinical specialists and patient experts.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Publication information:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Appraisal consultation documents&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>293480</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=293480]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: 1. Definitions, Diagnosis and Screening</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ DEFINITION AND TYPES,DEMENTIA,LATER LIFE,DIAGNOSIS,OUTCOMES,DEMENTIA,MENTAL &amp; BEHAVIOURAL DISORDERS,PUBLIC HEALTH,DIAGNOSIS,METHODS,MONTHLY ADDITIONS,2008-SEPTEMBER,ANALYSIS &amp; RESEARCH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A summary of new evidence from systematic reviews published between August 2007 and July 2008.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;2&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Annual Evidence Update 2008: 1. Diagnosis and Screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;A summary of the recent evidence by Dr Amitava Banerjee.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID293480/nelhImp_0001_faces_140x140.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update (AEU) is aimed at clinicians in primary care or general medicine.&amp;nbsp; It covers the following topics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Definitions&lt;/LI&gt;
&lt;LI&gt;Diagnosis&lt;/LI&gt;
&lt;LI&gt;Diagnostic criteria for Alzheimer's Disease, Frontotemporal dementia, Lewy Body dementia, Vascular dementia&lt;/LI&gt;
&lt;LI&gt;Further investigations&lt;/LI&gt;
&lt;LI&gt;Screening&lt;/LI&gt;
&lt;LI&gt;References&lt;/LI&gt;&lt;/UL&gt;
&lt;H3&gt;Definitions&lt;/H3&gt;
&lt;P&gt;There is heterogeneity in the literature in how dementia and Alzheimer's Disease are characterised in patient populations. We recommend that clinicians review both topics as ruling one out may exclude important evidence.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dementia&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Dementia affects 17–25 million people worldwide, with an estimated four million in the US and an estimated 800,000 people in the UK. The majority of research and guidelines in the field of dementia has concerned Alzheimer’s disease (AD), which accounts for about 50% of dementia. However, the other subtypes of dementia also make up a significant disease burden.&lt;/P&gt;
&lt;P&gt;The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) states, "The essential feature of dementia is impairment in short-and long-term memory, associated with impairment in abstract thinking, impaired judgment, other disturbances of higher cortical function, or personality change. The disturbance is severe enough to interfere significantly with work or usual social activities or relationships with others. The diagnosis of dementia is not made if these symptoms occur ... in delirium." (DSM-IV, Feldman 2008, Chertkow 2008).&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Delirium&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Delirium is a syndrome characterised by the rapid onset of variable and fluctuating changes in mental status caused by physiologic consequences of a medical disturbance. DSM-IV states, "The essential feature of a delirium is a disturbance in consciousness that is accompanied by a change in cognition that cannot be better accounted for by a pre-existing or evolving dementia." (DSM-IV).&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Mild cognitive impairment&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;The grey zone between normality and dementia is characterised as "mild cognitive impairment” (MCI). The initial criteria for mild cognitive impairment require a subjective report of cognitive decline from a former level, gradual in onset, and present for at least 6 months. “If the memory loss is severe and accompanied by significant functional impairment and other cognitive impairments, the patient meets the clinical criteria for dementia, not mild cognitive impairment” (Chertkow 2008).&lt;/P&gt;
&lt;H3&gt;Diagnosis&lt;/H3&gt;
&lt;P&gt;The diagnosis of dementia is based on history, family interview, physical examination and brief cognitive testing. A number of core laboratory tests are also recommended. Structural neuro-imaging is advised in selected cases. Other diagnostic approaches are not yet recommended for routine use in diagnosis of dementia.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Patient history&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Focus on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;the onset and course of the illness (gradual and insidious in Alzheimer disease, stepwise in vascular dementia) &lt;/LI&gt;
&lt;LI&gt;past vascular history and risk factors&lt;/LI&gt;
&lt;LI&gt;alcohol abuse&lt;/LI&gt;
&lt;LI&gt;renal failure&lt;/LI&gt;
&lt;LI&gt;previous head trauma.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Family interview&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Focus on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Personality&lt;/LI&gt;
&lt;LI&gt;Behaviour&lt;/LI&gt;
&lt;LI&gt;Functional impairment&lt;/LI&gt;
&lt;LI&gt;Family support systems and the social setting.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Physical examination&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Focus on potential signs of stroke. &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Brief cognitive tests&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Brief cognitive tests serve to determine the presence and overall severity of memory and cognitive deficits. Brief cognitive tests have a lower sensitivity and specificity than does a full neuropsychological evaluation, but they are far faster and more accessible than specialised testing. &lt;/P&gt;
&lt;P&gt;The Mini-Mental State Examination (MMSE) is the most widely used instrument. Patients with mild dementia usually have a score of 18–26 out of 30, those with moderate dementia a score of 10–18, and those with severe dementia a score of less than 10. &lt;/P&gt;
&lt;P&gt;A number of newer tests have been developed to provide improved sensitivity, e.g. the Montréal Cognitive Assessment, DemTect, the 7-Minute Screen, the General Practitioner Assessment of Cognition and the Behavioural Neurology Assessment short form. &lt;/P&gt;
&lt;P&gt;All of these tests have been shown to be more accurate than the MMSE in discriminating between dementia and normal cognition, particularly in mild dementia. No brief cognitive test can differentiate between subtypes of dementia (Feldman 2008).&lt;/P&gt;
&lt;P&gt;At this point in the evaluation, the physician has accumulated sufficient information to decide whether the patient meets clinical criteria for dementia. On the basis of consensus clinical criteria, the specific type of dementia can be determined.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Diagnostic criteria for Alzheimer’s disease&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Dementia&lt;/LI&gt;
&lt;LI&gt;Progressive worsening of memory and other cognitive functions&lt;/LI&gt;
&lt;LI&gt;No disturbance of consciousness&lt;/LI&gt;
&lt;LI&gt;Absence of systemic disorders or other brain diseases that could account for the progressive cognitive decline&lt;/LI&gt;
&lt;LI&gt;Supportive features include:&lt;BR&gt;&amp;nbsp; -Altered behavioural patterns&lt;BR&gt;&amp;nbsp; -Family history of similar disorders, particularly if confirmed neuropathologically&lt;/LI&gt;
&lt;LI&gt;Features that make a diagnosis of Alzeimer’s disease unlikely include:&lt;BR&gt;&amp;nbsp; - Sudden onset&lt;BR&gt;&amp;nbsp; -Focal neurological findings, including hemiparesis, sensory loss, visual field deficits, incoordination&lt;BR&gt;&amp;nbsp; -Early presence of a gait disorder or seizure.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Frontotemporal dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Younger age of onset than AD&lt;/LI&gt;
&lt;LI&gt;Prominent behavioural changes (e.g. social conduct dysregulation, disinhibition, perseveration, emotional blunting) OR&lt;/LI&gt;
&lt;LI&gt;Prominent language impairment (e.g. progressive nonfluent aphasia or semantic problems, with&amp;nbsp; breakdown of word meaning and knowledge).&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Dementia associated with Lewy bodies or with Parkinson disease&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Clinical features of these 2 conditions overlap considerably&lt;/LI&gt;
&lt;LI&gt;Dementia associated with Parkinson disease begins with idiopathic Parkinson disease for =1 year before onset of dementia, whereas Lew body dementia begins with cognitive and behavioural disorder that can have concurrent parkinsonian features &lt;/LI&gt;
&lt;LI&gt;Neuropsychiatric features including visual hallucinations and fluctuations in disease course. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Vascular dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Typically stepwise progression&lt;/LI&gt;
&lt;LI&gt;Hallmark cognitive feature of a dysexecutive syndrome&lt;/LI&gt;
&lt;LI&gt;Focal neurological findings often found early in the disease course.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Further investigations&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The purpose of laboratory investigations and structural neuro-imaging is to exclude a treatable disorder presenting as memory loss, e.g. renal failure, brain tumour, normal pressure hydrocephalus and subdural hemorrhages, which account for less than 1% of dementia cases. &lt;/P&gt;
&lt;P&gt;All patients should have tests for full blood count, thyroid stimulating hormone, serum calcium, electrolytes, vitamin B12 and fasting glucose. Selective testing of serum and folate levels, syphilis screening, and HIV antibodies is recommended. &lt;/P&gt;
&lt;P&gt;The selective use of either CT or MRI is recommended, but there is currently insufficient evidence to recommend use of functional neuro-imaging, such as PET scanning in the routine evaluation of dementia (Feldman 2008). &lt;/P&gt;
&lt;P&gt;Neuropsychological testing provides detailed, standardized assessment across a wide range of cognitive domains, and is particularly helpful in MCI and mild dementia, but it is much more time-consuming and much more expensive than brief cognitive tests (Feldman 2008, Laws 2007, Hutchinson 2007). &lt;/P&gt;
&lt;P&gt;There is no ideal biomarker for dementia that is currently available. The leading candidates include cerebrospinal fluid levels of ß-amyloid1–42, total tau, and phospho-tau (p-tau) proteins, but these are currently the domain of specialist research institutions and not in routine clinical practice (Diniz 2008, Petzold 2007). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Screening&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Although there is currently insufficient data to suggest population-wide genetic screening for dementia, a strong family history of dementia should trigger further investigation and referral to a specialist for consultation. &lt;/P&gt;
&lt;P&gt;A recent review recommended that clinicians should select one primary tool for dementia screening based on (1) the population receiving care; (2) an awareness of the effects of educational level, race, and age on scoring; and (3) consideration of adding 1 or 2 other tools for special situations as needed (Holsinger 2007). Such tools should take into account both cognitive and functional capacity (e.g. IADL-instrumental activities of daily living) (Castilla-Rilo 2007). &lt;/P&gt;
&lt;P&gt;Certain dementia screening tools are available of self-administration (e.g. the Concord Informant Dementia Scale (CIDS) and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), but they have not yet been validated for use. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Algase DL, Moore DH, Vandeweerd C, Gavin-Dreschnack DJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18074256" target="_blank"&gt;Mapping the maze of terms and definitions in dementia-related wandering&lt;/A&gt;. Aging &amp;amp; Mental Health 2007; 11(6):686-99.&lt;/LI&gt;
&lt;LI&gt;Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=17192785" target="_blank"&gt;Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database&lt;/A&gt;. Nat Genet 2007; 39(1):17-23.&lt;/LI&gt;
&lt;LI&gt;Castilla-Rilo J, Lopez-Arrieta J, Bermejo-Pareja F, Ruiz M, Sanchez-Sanchez F, Trincado R. &lt;A href="http://www3.interscience.wiley.com/journal/114078432/abstract" target="_blank"&gt;Instrumental activities of daily living in the screening of dementia in population studies: a systematic review and meta-analysis&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(9):829-36. &lt;/LI&gt;
&lt;LI&gt;Cherbuin N, Leach LS, Christensen H, Anstey KJ. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=000109150&amp;amp;Ausgabe=233780&amp;amp;ProduktNr=224226&amp;amp;filename=000109150.pdf" target="_blank"&gt;Neuroimaging and APOE genotype: a systematic qualitative review&lt;/A&gt;. Dement Geriatr Cogn Disord 2007; 24(5):348-62. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Cherbuin N., Anstey K.J., Lipnicki D.M. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18289452" target="_blank"&gt;Screening for dementia: A review of self- and informant-assessment instruments&lt;/A&gt;. Int Psychogeriatr 2008; 20(3):431-58.&lt;/LI&gt;
&lt;LI&gt;Chertkow H, Massoud F, Nasreddine Z et al. &lt;A href="http://www.cmaj.ca/cgi/content/full/178/10/1273" target="_blank"&gt;Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia&lt;/A&gt;. CMAJ 2008; 178(10):1273-85. 18458258 (Link to full-text on webpage).&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://allpsych.com/disorders/dsm.html" target="_blank"&gt;Diagnostic and Statistical Manual of Mental Disorders&lt;/A&gt;. 4th ed. Washington, DC: American Psychiatric Association; 1994:124-133.&lt;/LI&gt;
&lt;LI&gt;Diniz B.S.O., Pinto Jr. J.A., Forlenza O.V. &lt;A href="http://www.informaworld.com/smpp/content~content=a781983183~db=all~order=page" target="_blank"&gt;Do CSF total tau, phosphorylated tau, and b-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature.&lt;/A&gt; World Journal of Biological Psychiatry 2008; 9(3):172-82.&lt;/LI&gt;
&lt;LI&gt;Dong MJ, Peng B, Lin XT, Zhao J, Zhou YR, Wang RH. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17965036" target="_blank"&gt;The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies.&lt;/A&gt; Age Ageing 2007; 36(6):619-24. &lt;/LI&gt;
&lt;LI&gt;Feldman H.H., Jacova C., Robillard A. et al. &lt;A href="http://www.cmaj.ca/cgi/content/full/178/7/825" target="_blank"&gt;Diagnosis and treatment of dementia: 2. Diagnosis&lt;/A&gt;. Can Med Assoc J 2008; 178(7):825-36. (Link to full-text on webpage)&lt;/LI&gt;
&lt;LI&gt;Green C. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17803333" target="_blank"&gt;Modelling disease progression in Alzheimer's disease: A review of modelling methods used for cost-effectiveness analysis&lt;/A&gt;. Pharmacoeconomics 2007; 25(9):735-50. &lt;/LI&gt;
&lt;LI&gt;Holsinger T, Deveau J, Boustani M, Williams JW Jr. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17551132" target="_blank"&gt;Does this patient have dementia?&lt;/A&gt; JAMA 2007; 297(21):2391-404.&lt;/LI&gt;
&lt;LI&gt;Hutchinson AD, Mathias JL. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17371908" target="_blank"&gt;Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review&lt;/A&gt;. J Neurol Neurosurg Psychiatry 2007; 78(9):917-28. &lt;/LI&gt;
&lt;LI&gt;Laws KR, Adlington RL, Gale TM, Moreno-Martinez FJ, Sartori G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17499818" target="_blank"&gt;A meta-analytic review of category naming in Alzheimer's disease&lt;/A&gt;. Neuropsychologia 2007; 45(12):2674-82. &lt;/LI&gt;
&lt;LI&gt;Patterson C., Feightner J.W., Garcia A., Hsiung G.-Y.R., MacKnight C., Sadovnick A.D. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18299540" target="_blank"&gt;Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease&lt;/A&gt;. Can Med Assoc J 2008; 178(5):548-56. (Link to full-text on webpage)&lt;/LI&gt;
&lt;LI&gt;Petzold A., Keir G., Warren J., Fox N., Rossor M.N. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;amp;ArtikelNr=000101843&amp;amp;Ausgabe=233078&amp;amp;ProduktNr=229093" target="_blank"&gt;A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia&lt;/A&gt;. Neurodegenerative Diseases 2007; 4(2-3):185-94..&lt;/LI&gt;
&lt;LI&gt;Setter SM, Neumiller JJ, Johnson M, Borson S, Scanlan JM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18198975" target="_blank"&gt;The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' use&lt;/A&gt;. Consult Pharm 2007; 22(10):855-61. &lt;/LI&gt;
&lt;LI&gt;Verkaik R, Nuyen J, Schellevis F, Francke A. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17457960" target="_blank"&gt;The relationship between severity of Alzheimer's disease and prevalence of comorbid depressive symptoms and depression: A systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(11):1063-86.&lt;/LI&gt;
&lt;LI&gt;Von Gunten A., Alnawaqil A.-M., Abderhalden C., Needham I., Schupbach B. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18272010" target="_blank"&gt;Vocally disruptive behavior in the elderly: A systematic review&lt;/A&gt;. Int Psychogeriatr 2008; 20(4):653-72.&lt;/LI&gt;
&lt;LI&gt;Waldemar G., Dubois B., Emre M. et al. &lt;A href="http://www3.interscience.wiley.com/journal/117979709/abstract" target="_blank"&gt;Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline&lt;/A&gt;. Eur J Neurol 2007; 14(1):e1-e26.&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;
&lt;P&gt;&lt;STRONG&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;2&lt;/pageID&gt;&lt;pageSequence&gt;3&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia: Guidelines, systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Chertkow H, Massoud F, Nasreddine Z et al. &lt;A href="http://www.cmaj.ca/cgi/content/full/178/10/1273" target="_blank"&gt;Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia&lt;/A&gt;. CMAJ 2008; 178(10):1273-85. 18458258 (Link to full-text on webpage)&lt;/LI&gt;
&lt;LI&gt;Feldman HH, Jacova C, Robillard A et al. &lt;A href="http://www.cmaj.ca/cgi/content/full/178/7/825" target="_blank"&gt;Diagnosis and treatment of dementia: 2. Diagnosis&lt;/A&gt;. CMAJ 2008; 178(7):825-36. (Link to full-text on webpage)&lt;/LI&gt;
&lt;LI&gt;Patterson C., Feightner J.W., Garcia A., Hsiung G.-Y.R., MacKnight C., Sadovnick A.D. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18299540" target="_blank"&gt;Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease&lt;/A&gt;. Can Med Assoc J 2008; 178(5):548-56. (Link to full-text on webpage)&lt;/LI&gt;
&lt;LI&gt;Waldemar G., Dubois B., Emre M. et al. &lt;A href="http://www3.interscience.wiley.com/journal/117979709/abstract?CRETRY=1&amp;amp;SRETRY=0" target="_blank"&gt;Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline&lt;/A&gt;. Eur J Neurol 2007; 14(1):e1-e26.&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Algase DL, Moore DH, Vandeweerd C, Gavin-Dreschnack DJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18074256" target="_blank"&gt;Mapping the maze of terms and definitions in dementia-related wandering&lt;/A&gt;. Aging &amp;amp; Mental Health 2007; 11(6):686-99.&lt;/LI&gt;
&lt;LI&gt;Castilla-Rilo J, Lopez-Arrieta J, Bermejo-Pareja F, Ruiz M, Sanchez-Sanchez F, Trincado R. &lt;A href="http://www3.interscience.wiley.com/journal/114078432/abstract" target="_blank"&gt;Instrumental activities of daily living in the screening of dementia in population studies: a systematic review and meta-analysis&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(9):829-36. &lt;/LI&gt;
&lt;LI&gt;Cherbuin N., Anstey K.J., Lipnicki D.M. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18289452" target="_blank"&gt;Screening for dementia: A review of self- and informant-assessment instruments&lt;/A&gt;. Int Psychogeriatr 2008; 20(3):431-58.&lt;/LI&gt;
&lt;LI&gt;Dong MJ, Peng B, Lin XT, Zhao J, Zhou YR, Wang RH. The &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17965036" target="_blank"&gt;prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies&lt;/A&gt;. Age Ageing 2007; 36(6):619-24. &lt;/LI&gt;
&lt;LI&gt;Holsinger T, Deveau J, Boustani M, Williams JW Jr. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17551132" target="_blank"&gt;Does this patient have dementia?&lt;/A&gt; JAMA 2007; 297(21):2391-404. &lt;/LI&gt;
&lt;LI&gt;Petzold A., Keir G., Warren J., Fox N., Rossor M.N. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;amp;ArtikelNr=000101843&amp;amp;Ausgabe=233078&amp;amp;ProduktNr=229093" target="_blank"&gt;A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia.&lt;/A&gt; Neurodegenerative Diseases 2007; 4(2-3):185-94.&lt;/LI&gt;
&lt;LI&gt;Setter SM, Neumiller JJ, Johnson M, Borson S, Scanlan JM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18198975" target="_blank"&gt;The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' use&lt;/A&gt;. Consult Pharm 2007; 22(10):855-61. &lt;/LI&gt;
&lt;LI&gt;Von Gunten A., Alnawaqil A.-M., Abderhalden C., Needham I., Schupbach B. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18272010" target="_blank"&gt;Vocally disruptive behavior in the elderly: A systematic review&lt;/A&gt;. Int Psychogeriatr 2008; 20(4):653-72.&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Apostolova LG, Cummings JL. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18087152" target="_blank"&gt;Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature&lt;/A&gt;. Dement Geriatr Cogn Disord 2008; 25(2):115-26. &lt;/LI&gt;
&lt;LI&gt;Emre M, Aarsland D, Brown R et al. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17542011" target="_blank"&gt;Clinical diagnostic criteria for dementia associated with Parkinson's disease&lt;/A&gt;. Mov Disord 2007; 22(12):1689-707; quiz 1837. &lt;/LI&gt;
&lt;LI&gt;Fratiglioni L, Wang H-X. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17851191" target="_blank"&gt;Brain reserve hypothesis in dementia&lt;/A&gt;. Journal of Alzheimer's Disease 2007; 12(1):11-22.&lt;/LI&gt;
&lt;LI&gt;Liepelt I, Maetzler W, Blaicher H, Gasser T, Berg D. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=000101337&amp;amp;Ausgabe=233037&amp;amp;ProduktNr=224226&amp;amp;filename=000101337.pdf" target="_blank"&gt;Treatment of dementia in Parkinsonian syndromes with cholinesterase inhibitors&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2007; 23(6):351-68. (Link to article in full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Mariani E., Monastero R., Mecocci P. &lt;A href="http://www.cicaline.com/_Profile_Base/Picture/_e2/e290c5be371f47157fbf413e0080dc5d/9fb72daa-2e9c-4851-804a-c6d1c91f89f7.pdf" target="_blank"&gt;Mild cognitive impairment: A systematic review&lt;/A&gt;. Journal of Alzheimer's Disease 2007; 12(1):23-35. (Link to article in full-text PDF)&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;3&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease: Guidelines and systematic reviews&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Guideline&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Waldemar G., Dubois B., Emre M. et al. &lt;A href="http://www3.interscience.wiley.com/journal/117979709/abstract" target="_blank"&gt;Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline&lt;/A&gt;. Eur J Neurol 2007; 14(1):e1-e26.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=17192785" target="_blank"&gt;Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database&lt;/A&gt;. Nat Genet 2007; 39(1):17-23.&lt;/LI&gt;
&lt;LI&gt;Cherbuin N, Leach LS, Christensen H, Anstey KJ. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=000109150&amp;amp;Ausgabe=233780&amp;amp;ProduktNr=224226&amp;amp;filename=000109150.pdf" target="_blank"&gt;Neuroimaging and APOE genotype: a systematic qualitative review&lt;/A&gt;. Dement Geriatr Cogn Disord 2007; 24(5):348-62. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Diniz B.S.O., Pinto Jr. J.A., Forlenza O.V. &lt;A href="http://www.informaworld.com/smpp/content~content=a781983183~db=all~order=page" target="_blank"&gt;Do CSF total tau, phosphorylated tau, and b-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature&lt;/A&gt;. World Journal of Biological Psychiatry 2008; 9(3):172-82.&lt;/LI&gt;
&lt;LI&gt;Green C. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17803333" target="_blank"&gt;Modelling disease progression in Alzheimer's disease: A review of modelling methods used for cost-effectiveness analysis&lt;/A&gt;. Pharmacoeconomics 2007; 25(9):735-50.&lt;/LI&gt;
&lt;LI&gt;Hutchinson AD, Mathias JL. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17371908" target="_blank"&gt;Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.&lt;/A&gt; J Neurol Neurosurg Psychiatry 2007; 78(9):917-28. &lt;/LI&gt;
&lt;LI&gt;Laws KR, Adlington RL, Gale TM, Moreno-Martinez FJ, Sartori G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17499818" target="_blank"&gt;A meta-analytic review of category naming in Alzheimer's disease&lt;/A&gt;. Neuropsychologia 2007; 45(12):2674-82. &lt;/LI&gt;
&lt;LI&gt;Verkaik R, Nuyen J, Schellevis F, Francke A. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17457960" target="_blank"&gt;The relationship between severity of Alzheimer's disease and prevalence of comorbid depressive symptoms and depression: A systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(11):1063-86.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>293477</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=293477]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: 2. Risk factors and aetiology</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION,ENVIRONMENTAL,RISK FACTORS,OUTCOMES,DETERMINANTS,MENTAL &amp; BEHAVIOURAL DISORDERS,DEMENTIA,PUBLIC HEALTH,2008-SEPTEMBER,MONTHLY ADDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A summary of new evidence from systematic reviews published between August 2007 and July 2008.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;2&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Annual Evidence Update 2008: Risk factors and aetiology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Summary of the evidence by Dr Amitava Banerjee.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID293477/nelhImp_0000_hands_140x140.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update (AEU) is aimed at clinicians in primary care or general medicine.&amp;nbsp; It covers the following topics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Smoking&lt;/LI&gt;
&lt;LI&gt;Obesity&lt;/LI&gt;
&lt;LI&gt;Vascular and lifestyle factors&lt;/LI&gt;
&lt;LI&gt;ApoE and Genetics of Alzheimer's Disease&lt;/LI&gt;
&lt;LI&gt;Hormone Replacement Therapy (HRT)&lt;/LI&gt;
&lt;LI&gt;Occupational exposure&lt;/LI&gt;
&lt;LI&gt;Mild cognitive impairment&lt;/LI&gt;&lt;/UL&gt;
&lt;H3&gt;Smoking&lt;/H3&gt;
&lt;P&gt;Current smokers have a 40-80% greater risk of dementia and cognitive decline compared to never smokers (Anstey 2007), and this risk is particularly manifest among older adults. In a systematic review, former smokers were at significantly lower risk of Alzheimer’s disease (AD) and yearly cognitive decline than current smokers, but there was no difference in risk of vascular dementia and any dementia between the current and former smokers (Anstey 2007). &lt;/P&gt;
&lt;P&gt;The associations between smoking and dementia may be explained by associations between lifestyle factors (e.g. nutrition, alcohol intake and physical activity) and dementia, via effects on cardiovascular disease or its intermediate risk factors or interactions with genetic factors (e.g. apolipoprotein E genotype, ApoE).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Obesity&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A meta-analysis showed a significant U-shaped association between BMI (body mass index) and dementia (P = 0.034), with dementia risk increased for obesity (OR 1.42) and underweight (OR 1.36), but not for overweight (OR 0.88) (Beydoun 2008). The association between obesity and dementia remained for both incident AD and vascular dementia (ORs of 1.80 and 1.73 respectively). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Vascular and lifestyle factors&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The roles of hypertension and hyperlipidaemia in the development of dementia are not clear. Although systolic hypertension and hyperlipidaemia have been associated with increased risk of both AD and all-cause dementia, randomized trials have failed to show consistent benefit in the treatment of blood pressure or cholesterol on future risk of dementia (Patterson 2008). &lt;/P&gt;
&lt;P&gt;Both total dietary fat intake and reduced levels of omega 3 fatty acids are associated with increased risk of dementia and a Mediterranean-style diet and fish consumption may be associated with decreased risk of AD (Patterson 2008). &lt;/P&gt;
&lt;P&gt;A recent systematic review found that the validity of previous associations between low blood concentrations of vitamins B6 and B12, and folate and increased risk of dementia was poor due to significant heterogeneity of existing studies (Raman 2007). Without randomized controlled trial evidence, the role of diet in primary prevention of dementia is still unclear. &lt;/P&gt;
&lt;P&gt;“Brain reserve” refers to the ability to tolerate age-related changes and disease related pathology in the brain without developing clear clinical symptoms or signs (Fratiglioni 2007). High education, adult-life occupational work complexity, as well as a mentally and socially integrated lifestyle in late life could postpone the onset of clinical dementia and AD. &lt;/P&gt;
&lt;P&gt;Increased levels of physical activity have been linked to a reduced risk of subsequent dementia (relative risk, RR=0.50) in the Canadian Study of Health and Ageing (Patterson 2008). Daily mental activities and cognitive training have been shown to reduce the risk of all-cause dementia, and may delay cognitive decline. &lt;/P&gt;
&lt;P&gt;Activities with physical, mental and social components probably have the most benefit. &lt;/P&gt;
&lt;P&gt;A moderate consumption of wine (1 glass per day), compared with an intake of more or less than this amount, is associated with a reduced risk of subsequent all-cause dementia (RR 0.56) and of&amp;nbsp; AD(RR 0.53), but advice about alcohol consumption should be tempered by the known risks of excessive use in other organ systems (Patterson 2008). &lt;/P&gt;
&lt;P&gt;There is no association between the severity of AD and the prevalence of depression, so prevention and intervention strategies for comorbid depression in AD should be aimed at all patients irrespective their disease severity (Verkaik 2007).&lt;/P&gt;
&lt;P&gt;The role of head injury in subsequent development of dementia is unclear.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;ApoE and genetics of Alzheimer's Disease (AD)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Early-onset AD is generally defined as occurring before 60 years of age and accounts for only 6%–7% of all cases of AD. To date, all 3 causative gene mutations (amyloid precursor protein gene, located on chromosome 21; presenilin-1, located on chromosome 14; and presenilin-2, located on chromosome 1) lead to the early-onset form, with autosomal dominant inheritance.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Several genes have been implicated as risk factors in late-onset AD. Currently, only ApoE has been confirmed as a genetic risk factor in multiple large, population-based studies, particularly the association with the e4 allele. This association is stronger in women than in men, and is stronger below the age of 65 years, probably due to increasing risk of AD with age, whether or not the e4 allele is present. A recent review showed that structural brain change is associated with the ApoE genotype and that this is more prominent below the age of 65 years (Cherbuin 2007).&lt;/P&gt;
&lt;P&gt;The sortilin-related receptor gene (SORL1) has been associated with late-onset Alzheimer's disease in several populations of different ethnic backgrounds in the United States. SORL1 is also involved in amyloid precursor protein processing, further supporting the role of the amyloid cascade in the pathogenesis of AD. &lt;/P&gt;
&lt;P&gt;A recent meta-analysis concluded that “the impact on AD risk of genetic variants of these genes involved in Aß production, aggregation or degradation is rather limited; and therefore, attention should be given to meta-analysis of other different genes involved in these metabolic pathways” (Llorca 2008). &lt;/P&gt;
&lt;P&gt;Although there is currently insufficient data to suggest screening for dementia, a strong family history of dementia should trigger further investigation and referral to a specialist for consultation. &lt;/P&gt;
&lt;P&gt;Genetic testing has no significant impact on psychological outcomes, little effect on behaviour, and does not change perceived risk, and so may well be used to identify patients at risk for functional decline in the future. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;HRT&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Neither oestrogen-alone nor combined hormone replacement (HRT) prevent cognitive decline in older postmenopausal women when given as short term or longer term (up to 5 years) therapy (Lethaby 2008). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Occupational exposure&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Although meta-analyses have implicated aluminium toxicity, pesticides and extremely low frequency electromagnetic frequency radiation (ELF-EMF) in dementia, there is insufficient data to suggest a role in causation for any of these agents (Ferreira 2008, Garcia 2008, Santibanez 2007). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Mild cognitive impairment&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Mild cognitive impairment (MCI) represents a condition with multiple sources of heterogeneity, including clinical presentation, aetiology and prognosis, and may represent a “predementia” state. More research is required in order to develop more reliable methods to determine its progression or improvement. A systematic review found no benefit from cholinesterase inhibitors (ChEIs) in MCI in the delay of the onset of AD or dementia (Raschetti 2007, Mariani 2007). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Anstey KJ, von Sanden C, Salim A, O'Kearney R. &lt;A href="http://aje.oxfordjournals.org/cgi/content/full/166/4/367" target="_blank"&gt;Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.&lt;/A&gt; Am J Epidemiol 2007; 166(4):367-78. (link to full-text)&lt;/LI&gt;
&lt;LI&gt;Beydoun MA, Beydoun HA, Wang Y. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18331422?ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis&lt;/A&gt;. Obes Rev 2008; 9(3):204-18. &lt;/LI&gt;
&lt;LI&gt;Chang CL. &lt;A href="http://www.highbeam.com/doc/1G1-177018913.html" target="_blank"&gt;Obesity and Alzheimer's disease&lt;/A&gt;. Hong Kong Journal of Psychiatry 2008; 18(1):28-36.&lt;/LI&gt;
&lt;LI&gt;Cherbuin N, Leach LS, Christensen H, Anstey KJ. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=109150&amp;amp;Ausgabe=233780&amp;amp;ProduktNr=224226&amp;amp;filename=109150.pdf" target="_blank"&gt;Neuroimaging and APOE genotype: a systematic qualitative review&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2007; 24(5):348-63. (Link to article in full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Ferreira PC, Piai Kde A, Takayanagui AM, Segura-Munoz SI. &lt;A href="http://www.scielo.br/pdf/rlae/v16n1/22.pdf" target="_blank"&gt;Aluminum as a risk factor for Alzheimer's disease&lt;/A&gt;. Rev Lat Am Enfermagem 2008; 16(1):151-7. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Fratiglioni L., Wang H.-X. &lt;A href="http://iospress.metapress.com/content/q7k8100685505261/" target="_blank"&gt;Brain reserve hypothesis in dementia.&lt;/A&gt; Journal of Alzheimer's Disease 2007; 12(1):11-22.&lt;/LI&gt;
&lt;LI&gt;Garcia AM, Sisternas A, Hoyos SP. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18245151?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis&lt;/A&gt;. Int J Epidemiol 2008; 37(2):329-40. &lt;/LI&gt;
&lt;LI&gt;Gorospe E.C., Dave J.K. &lt;A href="http://ageing.oxfordjournals.org/cgi/reprint/36/1/23" target="_blank"&gt;The risk of dementia with increased body mass index&lt;/A&gt;. Age Ageing 2007; 36(1):23-9. (Link to article in full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18197053?ordinalpos=35&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;A systematic review of perceived risks, psychological and behavioral impacts of genetic testing&lt;/A&gt;. Genet Med 2008; 10(1):19-32. &lt;/LI&gt;
&lt;LI&gt;Hoogerduijn JG, Schuurmans MJ, Duijnstee MSh, de Rooij SE, Grypdonck MF. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17181666" target="_blank"&gt;A systematic review of predictors and screening instruments to identify older hospitalized patients at risk for functional decline&lt;/A&gt;. J Clin Nurs 2007; 16(1):46-58.&lt;/LI&gt;
&lt;LI&gt;Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003122/frame.html" target="_blank"&gt;Hormone replacement therapy for cognitive function in postmenopausal women&lt;/A&gt;. Cochrane Database of Systematic Reviews 2008; (1):CD003122-NaN. (Link to Cochrane Review)&lt;/LI&gt;
&lt;LI&gt;Llorca J, Rodriguez-Rodriguez E, Dierssen-Sotos T, Delgado-Rodriguez M, Berciano J, Combarros O. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17854420?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Meta-analysis of genetic variability in the beta-amyloid production, aggregation&amp;nbsp; and degradation metabolic pathways and the risk of Alzheimer's disease.&lt;/A&gt; Acta Neurol Scand 2008; 117(1):1-14. &lt;/LI&gt;
&lt;LI&gt;Mariani E, Monastero R, Mecocci P. &lt;A href="http://iospress.metapress.com/content/8v0r0p1g7u656632/" target="_blank"&gt;Mild cognitive impairment: a systematic review&lt;/A&gt;. J Alzheimers Dis 2007; 12(1):23-35. &lt;/LI&gt;
&lt;LI&gt;Meyer-Baron M, Schaper M, Knapp G, van Thriel C. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17692380?ordinalpos=35&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Occupational aluminum exposure: evidence in support of its neurobehavioral impact&lt;/A&gt;. Neurotoxicology 2007; 28(6):1068-78.&lt;/LI&gt;
&lt;LI&gt;Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18299540" target="_blank"&gt;Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease&lt;/A&gt;. CMAJ 2008; 178(5):548-56. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Raman G., Tatsioni A., Chung M. et al. &lt;A href="http://jn.nutrition.org/cgi/content/full/137/7/1789" target="_blank"&gt;Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function&lt;/A&gt;. J Nutr 2007; 137(7):1789-94. (Link to full-text webpage)&lt;/LI&gt;
&lt;LI&gt;Raschetti R, Albanese E, Vanacore N, Maggini M. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18044984" target="_blank"&gt;Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials&lt;/A&gt;. PLoS Med 2007; 4(11):e338. (Link to full-text webpage)&lt;/LI&gt;
&lt;LI&gt;Santibanez M, Bolumar F, Garcia AM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17525096?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies&lt;/A&gt;. Occup Environ Med 2007; 64(11):723-32. &lt;/LI&gt;
&lt;LI&gt;Verkaik R., Nuyen J., Schellevis F., Francke A. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17457960" target="_blank"&gt;The relationship between severity of Alzheimer's disease and prevalence of comorbid depressive symtoms and depression: A systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(11):1063-86.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;2&lt;/pageID&gt;&lt;pageSequence&gt;3&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia: Systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Anstey KJ, von Sanden C, Salim A, O'Kearney R. &lt;A href="http://aje.oxfordjournals.org/cgi/content/full/166/4/367" target="_blank"&gt;Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies&lt;/A&gt;. Am J Epidemiol 2007; 166(4):367-78. (link to full-text)&lt;/LI&gt;
&lt;LI&gt;Beydoun MA, Beydoun HA, Wang Y. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18331422?ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis&lt;/A&gt;. Obes Rev 2008; 9(3):204-18. &lt;/LI&gt;
&lt;LI&gt;Chang CL. &lt;A href="http://www.highbeam.com/doc/1G1-177018913.html" target="_blank"&gt;Obesity and Alzheimer's disease&lt;/A&gt;. Hong Kong Journal of Psychiatry 2008; 18(1):28-36.&lt;/LI&gt;
&lt;LI&gt;Cherbuin N, Leach LS, Christensen H, Anstey KJ. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=109150&amp;amp;Ausgabe=233780&amp;amp;ProduktNr=224226&amp;amp;filename=109150.pdf" target="_blank"&gt;Neuroimaging and APOE genotype: a systematic qualitative review&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2007; 24(5):348-63. (Link to article in full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Fratiglioni L., Wang H.-X. &lt;A href="http://iospress.metapress.com/content/q7k8100685505261/" target="_blank"&gt;Brain reserve hypothesis in dementia.&lt;/A&gt; Journal of Alzheimer's Disease 2007; 12(1):11-22.&lt;/LI&gt;
&lt;LI&gt;Gorospe E.C., Dave J.K. &lt;A href="http://ageing.oxfordjournals.org/cgi/reprint/36/1/23" target="_blank"&gt;The risk of dementia with increased body mass index&lt;/A&gt;. Age Ageing 2007; 36(1):23-9. (Link to article in full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18197053?ordinalpos=35&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.&lt;/A&gt; Genet Med 2008; 10(1):19-32. &lt;/LI&gt;
&lt;LI&gt;Hoogerduijn JG, Schuurmans MJ, Duijnstee MSh, de Rooij SE, Grypdonck MF. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17181666" target="_blank"&gt;A systematic review of predictors and screening instruments to identify older hospitalized patients at risk for functional decline&lt;/A&gt;. J Clin Nurs 2007; 16(1):46-58.&lt;/LI&gt;
&lt;LI&gt;Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003122/frame.html" target="_blank"&gt;Hormone replacement therapy for cognitive function in postmenopausal women&lt;/A&gt;. Cochrane Database of Systematic Reviews 2008; (1):CD003122-NaN. (Link to Cochrane Review)&lt;/LI&gt;
&lt;LI&gt;Meyer-Baron M, Schaper M, Knapp G, van Thriel C. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17692380?ordinalpos=35&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Occupational aluminum exposure: evidence in support of its neurobehavioral impact&lt;/A&gt;. Neurotoxicology 2007; 28(6):1068-78. &lt;/LI&gt;
&lt;LI&gt;Raman G., Tatsioni A., Chung M. et al. &lt;A href="http://jn.nutrition.org/cgi/content/full/137/7/1789" target="_blank"&gt;Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function&lt;/A&gt;. J Nutr 2007; 137(7):1789-94. (Link to full-text webpage)&lt;/LI&gt;
&lt;LI&gt;Raschetti R, Albanese E, Vanacore N, Maggini M. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18044984" target="_blank"&gt;Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials&lt;/A&gt;. PLoS Med 2007; 4(11):e338. (Link to full-text webpage)&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Apostolova L.G., Cummings J.L. &lt;A href="http://content.karger.com/produktedb/produkte.asp?typ=fulltext&amp;amp;file=000112509" target="_blank"&gt;Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature&lt;/A&gt;. Dement Geriatr Cogn Disord 2008; 25(2):115-26.&lt;/LI&gt;
&lt;LI&gt;Farlow MR, Cummings J. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=119104&amp;amp;Ausgabe=235811&amp;amp;ProduktNr=224226&amp;amp;filename=119104.pdf" target="_blank"&gt;A modern hypothesis: the distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2008; 25(4):301-9. (Link to article in full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Hoogerduijn JG, Schuurmans MJ, Duijnstee MSH, de Rooij SE, Grypdonck MFH. &lt;A href="http://www.ingentaconnect.com/content/bsc/jcn/2007/00000016/00000001/art00006;jsessionid=23q5abmhf4xb3.alexandra?format=print" target="_blank"&gt;A systematic review of predictors and screening instruments to identify older hospitalized patients at risk for functional decline&lt;/A&gt;. J Clin Nurs 2007; 16(1):46-57.&lt;/LI&gt;
&lt;LI&gt;Patterson C., Feightner J., Garcia A., MacKnight C. &lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7W6D-4PPWMP4-2&amp;amp;_user=10&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=066478ef67f585f6b130523436ce344a" target="_blank"&gt;General risk factors for dementia: A systematic evidence review&lt;/A&gt;. Alzheimer's and Dementia 2007; 3(4):341-7.&lt;/LI&gt;
&lt;LI&gt;Patterson C, Feightner J, Garcia A, MacKnight C. &lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7W6D-4PW5NCT-9&amp;amp;_user=10&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=db76b65e417a787515ab999f0c4ed4e3" target="_blank"&gt;Primary prevention of dementia&lt;/A&gt;. Alzheimer's &amp;amp; Dementia 2007; 3(4):348-54.&lt;/LI&gt;
&lt;LI&gt;van Herk R, van Dijk M, Baar FPM, Tibboel D, de Wit R. &lt;A href="http://cat.inist.fr/?aModele=afficheN&amp;amp;cpsidt=18392199" target="_blank"&gt;Observation scales for pain assessment in older adults with cognitive impairments or communication difficulties&lt;/A&gt;. Nurs Res 2007; 56(1):34-44.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;3&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease: Systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Cherbuin N, Leach LS, Christensen H, Anstey KJ. &lt;A href="http://content.karger.com/produktedb/produkte.asp?typ=fulltext&amp;amp;file=000109150" target="_blank"&gt;Neuroimaging and APOE genotype: a systematic qualitative review&lt;/A&gt;. Dement Geriatr Cogn Disord 2007; 24(5):348-62. (Link to full-text webpage)&lt;/LI&gt;
&lt;LI&gt;Ferreira PC, Piai Kde A, Takayanagui AM, Segura-Munoz SI. &lt;A href="http://www.scielo.br/pdf/rlae/v16n1/22.pdf" target="_blank"&gt;Aluminum as a risk factor for Alzheimer's disease&lt;/A&gt;. Rev Lat Am Enfermagem 2008; 16(1):151-7. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Garcia AM, Sisternas A, Hoyos SP. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18245151?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis&lt;/A&gt;. Int J Epidemiol 2008; 37(2):329-40. &lt;/LI&gt;
&lt;LI&gt;Llorca J, Rodriguez-Rodriguez E, Dierssen-Sotos T, Delgado-Rodriguez M, Berciano J, Combarros O. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17854420?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Meta-analysis of genetic variability in the beta-amyloid production, aggregation&amp;nbsp; and degradation metabolic pathways and the risk of Alzheimer's disease&lt;/A&gt;. Acta Neurol Scand 2008; 117(1):1-14. &lt;/LI&gt;
&lt;LI&gt;Mariani E, Monastero R, Mecocci P. &lt;A href="http://iospress.metapress.com/content/8v0r0p1g7u656632/" target="_blank"&gt;Mild cognitive impairment: a systematic review&lt;/A&gt;. J Alzheimers Dis 2007; 12(1):23-35. &lt;/LI&gt;
&lt;LI&gt;Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=18299540" target="_blank"&gt;Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease&lt;/A&gt;. CMAJ 2008; 178(5):548-56. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Santibanez M, Bolumar F, Garcia AM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17525096?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies&lt;/A&gt;. Occup Environ Med 2007; 64(11):723-32. &lt;/LI&gt;
&lt;LI&gt;Verkaik R., Nuyen J., Schellevis F., Francke A. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17457960" target="_blank"&gt;The relationship between severity of Alzheimer's disease and prevalence of comorbid depressive symtoms and depression: A systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(11):1063-86.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Review&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Hernan M.A., Alonso A., Logroscino G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18414087?ordinalpos=7&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Cigarette smoking and dementia: Potential selection bias in the elderly&lt;/A&gt;. Epidemiology 2008; 19(3):448-50.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>293506</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=293506]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: 3. Pharmacological treatments</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A summary of new evidence from systematic reviews published between August 2007 and July 2008.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;2&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Annual Evidence Update 2008: Pharmacological treatments&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Summary of the evidence by Dr Amitava Banerjee&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID293506/nelhImp_0000_kissing_140x140.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update (AEU) is aimed at clinicians in primary care or general medicine. It covers:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Cholinesterase inhibitors (ChEIs)&lt;/LI&gt;
&lt;LI&gt;Memantine&lt;/LI&gt;
&lt;LI&gt;Other therapies&lt;/LI&gt;
&lt;LI&gt;Treatment of neuropsychiatric and behavioural symptoms&lt;/LI&gt;&lt;/UL&gt;
&lt;H3&gt;Pharmacological treatments: Dementia&lt;/H3&gt;
&lt;P&gt;At present, there is no cure for dementia, regardless of aetiology. Current pharmacological interventions attempt to delay progression of the syndrome and improve its symptoms. &lt;/P&gt;
&lt;P&gt;Several consensus guidelines have been produced to guide drug therapy in Alzheimer’s disease and other dementias (Qaseem 2008, Waldemar 2007, NICE 2007). A recent statement by the International Psychogeriatric Association recommended clear, pre-defined diagnostic and severity criteria and outcome measures, which include functional and executive capacity, in treatment trials for dementia. &lt;/P&gt;
&lt;P&gt;In the context of ageing populations and demographic transition worldwide, it also emphasised the need for new cost-effectiveness analyses which take into account up-to-date, country-specific data using relevant outcome measures (Katona 2007).&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;American College of Physicians and the American Academy of Family Physicians Recommendations (Qaseem 2008)&lt;/EM&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;EM&gt;Clinicians should base the decision to initiate a trial of therapy with a cholinesterase inhibitor or memantine on individualized assessment. (Grade: weak recommendation, moderate-quality evidence.)&lt;/EM&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;EM&gt;Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. The evidence is insufficient to compare the effectiveness of different pharmacologic agents for the treatment of dementia. (Grade: weak recommendation, low-quality evidence.) &lt;/EM&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;EM&gt;There is an urgent need for further research on the clinical effectiveness of pharmacologic management of dementia (particularly combination therapy).&lt;/EM&gt; &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;There is an important distinction between the statistical significance of changes in scale scores reported in trials and the clinically important improvement which patients with dementia, caregivers, and clinicians are more concerned with. As an example, for the mini-mental state examination (MMSE), a change of 3 points or more is considered clinically important (Qaseem 2008).&lt;/P&gt;
&lt;H3&gt;Cholinesterase inhibitors (ChEIs)&lt;/H3&gt;
&lt;P&gt;The most commonly used cholinesterase inhibitors (ChEIs) are donepezil, galantamine, rivastigmine and tacrine. Most studies have found statistically significant improvements on global assessments, but the clinical importance of these changes is uncertain, and none of the trials have studied the long-term effects of ChEIs (Qaseem 2008, Waldemar 2007, Landmark 2008). &lt;/P&gt;
&lt;P&gt;Adjusted indirect comparison of placebo-controlled data did not find statistically significant differences among drugs with regard to cognition, but found the relative risk of global response to be better with donepezil and rivastigmine compared with galantamine (relative risk = 1.63 and 1.42, respectively) (Hansen 2008). &lt;/P&gt;
&lt;P&gt;The evidence for clinical benefit is weakest for tacrine, which also has serious side effects, including liver damage. The incidence of adverse events was generally lowest for donepezil and highest for rivastigmine.&lt;/P&gt;
&lt;P&gt;In one study, Huperzine A (a new ChEI) had some beneficial effects on general cognitive function, global clinical status, behavioral disturbance and functional performance, with no obvious serious adverse events for patients with AD, but there is inadequate evidence to make any recommendation about its use (Li 2008). &lt;/P&gt;
&lt;P&gt;The use of ChEIs in mild cognitive impairment (MCI) has not been associated with any delay in the onset of AD or dementia (Raschetti 2007).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Memantine&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Memantine is an non-competitive NMDA receptor antagonist which has been shown to give statistically significant, but not clinically important, improvement in cognition scores for moderate to severe Alzheimer disease, as well as all levels of severity for Alzheimer disease and vascular dementia, comparable to existing ChEIs (Smith Doody 2007, Qaseem 2008).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other therapies&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;AD may be caused by the formation of extracellular senile beta-amyloid (Aß) plaques. In vitro and mouse model studies have demonstrated that metal protein attenuating compounds (MPACs) promote the solubilisation and clearance of Aß. A recent Cochrane review found that there is currently no evidence to recommend use of clioquinol (PBT1), which is a MPAC (Sampson 2008).&lt;/P&gt;
&lt;P&gt;Although hyperlipidaemia has been associated with increased risk of both AD and all-cause dementia, statin use did not show a beneficial effect on the risk of dementia or Alzheimer's disease (Zhou 2007).&lt;/P&gt;
&lt;P&gt;A systematic review of the use of SSRIs (selective serotonin reuptake inhibitors) showed no evidence to support positive outcomes in dementia, but this was largely due to omissions in clinical trial design, as opposed to reporting of negative outcomes (Chow 2007). &lt;/P&gt;
&lt;P&gt;There is no evidence of an effect of vitamin B6 or B12 or folic acid supplementation, alone or in combination, on cognitive function testing in people with either normal or impaired cognitive function (Balk 2007). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Neuropsychiatric and behavioural symptoms&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Although there have been numerous well-designed studies of the pharmacotherapy of neuropsychiatric symptoms in AD, safer and more effective treatments are urgently needed (Herrmann 2007). &lt;/P&gt;
&lt;P&gt;The atypical antipsychotics (risperidone and olanzapine) are more effective than placebo in the setting of severe agitation, aggression, and psychosis, but this is counterbalanced by safety concerns that including risk of stroke and death. &lt;/P&gt;
&lt;P&gt;ChEIs and memantine have modest benefits for patients with mildly to moderately severe symptoms. &lt;/P&gt;
&lt;P&gt;Although antidepressants are effective for treating depression in AD, the efficacy of trazodone and citalopram in treatment of agitation and aggression is unknown. Carbamazepine is effective but its side effect profile and drug interactions limit its use. Benzodiazepines should only be used for short-term, as-needed use. There are inadequate data on other pharmacologic interventions, such as beta blockers, valproate, buspirone, and oestrogen preparations (Herrmann 2007). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Balk E.M., Raman G., Tatsioni A., Chung M., Lau J., Rosenberg I.H. &lt;A href="http://www.cababstractsplus.org/google/abstract.asp?AcNo=20073015381" target="_blank"&gt;Vitamin B&lt;SUB&gt;6&lt;/SUB&gt;, B&lt;SUB&gt;12&lt;/SUB&gt;, and folic acid supplementation and cognitive function: A systematic review of randomized trials&lt;/A&gt;. Arch Intern Med 2007; 167(1):21-30. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Chow T.W., Pollock B.G., Milgram N.W. &lt;A href="http://www.dovepress.com/articles.php?article_id=937" target="_blank"&gt;Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.&lt;/A&gt; Neuropsychiatric Disease and Treatment 2007; 3(5):627-36.&lt;/LI&gt;
&lt;LI&gt;Egert S, Wagenpfeil S, Forstl H. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17520505" target="_blank"&gt;Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies&lt;/A&gt;]. Dtsch Med Wochenschr 2007; 132(22):1207-13.&lt;/LI&gt;
&lt;LI&gt;Hansen R.A., Gartlehner G., Lohr K.N., Kaufer D.I. &lt;A href="http://aging.adisonline.com/pt/re/dra/abstract.00002512-200724020-00007.htm;jsessionid=L2lJtwbpHFsd1shhL6L1RQQMvVsJ2Px6yzVvGy8M4nQsxqJS4mZK%21-1004083789%21181195629%218091%21-1" target="_blank"&gt;Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis&lt;/A&gt;. Drugs Aging 2007; 24(2):155-67.&lt;/LI&gt;
&lt;LI&gt;Hansen R.A., Gartlehner G., Webb A.P., Morgan L.C., Moore C.G., Jonas D.E. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18686744?dopt=Citation" target="_blank"&gt;Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis&lt;/A&gt;. Clinical Interventions in Aging 2008; 3(2):211-25.&lt;/LI&gt;
&lt;LI&gt;Herrmann N, Lanctot KL. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18020111" target="_blank"&gt;Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease&lt;/A&gt;. Can J Psychiatry 2007; 52(10):630-46. &lt;/LI&gt;
&lt;LI&gt;Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. &lt;A href="http://journals.cambridge.org/action/displayAbstract?fromPage=online&amp;amp;aid=1002336" target="_blank"&gt;International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia&lt;/A&gt;. Int Psychogeriatr 2007; 19(3):345-54.&lt;/LI&gt;
&lt;LI&gt;Landmark K, Reikvam A. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18264153" target="_blank"&gt;Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?&lt;/A&gt;]. Tidsskr Nor Laegeforen 2008; 128(3):294-7.&lt;/LI&gt;
&lt;LI&gt;Li J, Wu HM, Zhou RL, Liu GJ, Dong BR. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005592/frame.html" target="_blank"&gt;Huperzine A for Alzheimer's disease&lt;/A&gt;. Cochrane Database Syst Rev 2008; (2):CD005592. (Link to full text in the Cochrane Library)&lt;/LI&gt;
&lt;LI&gt;Maidment I.D., Fox C.G., Boustani M., Rodriguez J., Brown R.C., Katona C.L. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18056833" target="_blank"&gt;Efficacy of memantine on behavioral and psychological symptoms related to dementia: A systematic meta-analysis&lt;/A&gt;. Ann Pharmacother 2008; 42(1):32-8.&lt;/LI&gt;
&lt;LI&gt;Miller LJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18198970" target="_blank"&gt;The use of cognitive enhancers in behavioral disturbances of Alzheimer's disease&lt;/A&gt;. Consult Pharm 2007; 22(9):754-62.&lt;/LI&gt;
&lt;LI&gt;NICE guideline (26 Sept 2007). &lt;A href="http://www.nice.org.uk/nicemedia/pdf/TA111fullversionamendedSept07.pdf" target="_blank"&gt;Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease&lt;/A&gt;. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Qaseem A, Snow V, Cross JT Jr et al. &lt;A href="http://www.annals.org/cgi/content/full/148/5/370" target="_blank"&gt;Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians&lt;/A&gt;. Ann Intern Med 2008; 148(5):370-8. &lt;/LI&gt;
&lt;LI&gt;Raina P, Santaguida P, Ismaila A et al. &lt;A href="http://www.annals.org/cgi/content/full/148/5/379" target="_blank"&gt;Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.&lt;/A&gt; Ann Intern Med 2008; 148(5):379-97. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Raschetti R., Albanese E., Vanacore N., Maggini M. &lt;A href="http://medicine.plosjournals.org/archive/1549-1676/4/11/pdf/10.1371_journal.pmed.0040338-S.pdf" target="_blank"&gt;Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials&lt;/A&gt;. PLoS Medicine 2007; 4(11):1818-28. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Sampson E, Jenagaratnam L, McShane R. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005380/frame.html" target="_blank"&gt;Metal protein attenuating compounds for the treatment of Alzheimer's disease.&lt;/A&gt; Cochrane Database Syst Rev 2008; (1):CD005380. (Link to full text in the Cochrane Library)&lt;/LI&gt;
&lt;LI&gt;Smith Doody R, Tariot P N, Pfeiffer E, Olin J T, Graham S M. &lt;A href="http://www.library.nhs.uk/LaterLife/ViewResource.aspx?resID=277925&amp;amp;tabID=289&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE&amp;amp;catID=6469" target="_blank"&gt;Meta-analysis of six-month memantine trials in Alzheimer's disease&lt;/A&gt;. Alzheimer's and Dementia, 2007; 3(1): 7-17 (Link to DARE record in LLSL).&lt;/LI&gt;
&lt;LI&gt;Waldemar G., Dubois B., Emre M. et al. &lt;A href="http://www3.interscience.wiley.com/journal/117979709/abstract?CRETRY=1&amp;amp;SRETRY=0" target="_blank"&gt;Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline&lt;/A&gt;. Eur J Neurol 2007; 14(1):e1-e26.&lt;/LI&gt;
&lt;LI&gt;Zhou B, Teramukai S, Fukushima M. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;amp;ArtikelNr=000099037&amp;amp;Ausgabe=232755&amp;amp;ProduktNr=224226" target="_blank"&gt;Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2007; 23(3):194-202.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;
&lt;P&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;/P&gt;
&lt;P&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;2&lt;/pageID&gt;&lt;pageSequence&gt;3&lt;/pageSequence&gt;&lt;pageTitle&gt;Guidelines, systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Guidelines&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. &lt;A href="http://journals.cambridge.org/action/displayAbstract?fromPage=online&amp;amp;aid=1002336" target="_blank"&gt;International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia&lt;/A&gt;. Int Psychogeriatr 2007; 19(3):345-54. &lt;/LI&gt;
&lt;LI&gt;Qaseem A, Snow V, Cross JT Jr et al. &lt;A href="http://www.annals.org/cgi/content/full/148/5/370" target="_blank"&gt;Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.&lt;/A&gt; Ann Intern Med 2008; 148(5):370-8. (Link to full-text on webpage) &lt;BR&gt;Notes: CORPORATE NAME: American College of Physicians/American Academy of Family Physicians Panel on Dementia &lt;/LI&gt;
&lt;LI&gt;Waldemar G., Dubois B., Emre M. et al. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17222085" target="_blank"&gt;Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline&lt;/A&gt;. Eur J Neurol 2007; 14(1):e1-e26.&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Balk E.M., Raman G., Tatsioni A., Chung M., Lau J., Rosenberg I.H. &lt;A href="http://archinte.ama-assn.org/cgi/content/full/167/1/21" target="_blank"&gt;Vitamin B&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt;, B&amp;lt;sub&amp;gt;12&amp;lt;/sub&amp;gt;, and folic acid supplementation and cognitive function: A systematic review of randomized trials&lt;/A&gt;. Arch Intern Med 2007; 167(1):21-30. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Landmark K, Reikvam A. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18264153" target="_blank"&gt;Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?&lt;/A&gt;]. Tidsskr Nor Laegeforen 2008; 128(3):294-7. &lt;/LI&gt;
&lt;LI&gt;Maidment I.D., Fox C.G., Boustani M., Rodriguez J., Brown R.C., Katona C.L. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18056833" target="_blank"&gt;Efficacy of memantine on behavioral and psychological symptoms related to dementia: A systematic meta-analysis&lt;/A&gt;. Ann Pharmacother 2008; 42(1):32-8.&lt;/LI&gt;
&lt;LI&gt;Raina P, Santaguida P, Ismaila A et al. &lt;A href="http://www.annals.org/cgi/content/full/148/5/379" target="_blank"&gt;Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.&lt;/A&gt; Ann Intern Med 2008; 148(5):379-97. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Raschetti R., Albanese E., Vanacore N., Maggini M. &lt;A href="http://medicine.plosjournals.org/archive/1549-1676/4/11/pdf/10.1371_journal.pmed.0040338-S.pdf" target="_blank"&gt;Cholinesterase inhibitors in mild cognitive impairment: A systematic review of randomised trials&lt;/A&gt;. PLoS Medicine 2007; 4(11):1818-28. (Link to full-text PDF)&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;McGuinness B, Todd S, Passmore AP, Bullock R. &lt;A href="http://jnnp.bmj.com/cgi/content/extract/79/1/4" target="_blank"&gt;Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia&lt;/A&gt;. Journal of Neurology, Neurosurgery &amp;amp; Psychiatry 2008; 79(1):4-5.&lt;/LI&gt;
&lt;LI&gt;Saddichha S, Pandey V. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18332476" target="_blank"&gt;Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies&lt;/A&gt;. Am J Alzheimers Dis Other Demen 2008; 23(2):150-61.&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;3&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's disease: Guidelines, systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Guideline&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Waldemar G., Dubois B., Emre M. et al. &lt;A href="http://www3.interscience.wiley.com/journal/117979709/abstract?CRETRY=1&amp;amp;SRETRY=0" target="_blank"&gt;Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline&lt;/A&gt;. Eur J Neurol 2007; 14(1):e1-e26.&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.nice.org.uk/nicemedia/pdf/TA111fullversionamendedSept07.pdf" target="_blank"&gt;Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease&lt;/A&gt;. NICE guideline (26 Sept 2007). (Link to full-text PDF)&lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;&lt;BR&gt;Systematic Reviews&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Chow T.W., Pollock B.G., Milgram N.W. &lt;A href="http://www.dovepress.com/articles.php?article_id=937" target="_blank"&gt;Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease&lt;/A&gt;. Neuropsychiatric Disease and Treatment 2007; 3(5):627-36.&lt;/LI&gt;
&lt;LI&gt;Egert S, Wagenpfeil S, Forstl H. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17520505" target="_blank"&gt;Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies&lt;/A&gt;]. Dtsch Med Wochenschr 2007; 132(22):1207-13. &lt;/LI&gt;
&lt;LI&gt;Hansen R.A., Gartlehner G., Lohr K.N., Kaufer D.I. &lt;A href="http://aging.adisonline.com/pt/re/dra/abstract.00002512-200724020-00007.htm;jsessionid=L2lJtwbpHFsd1shhL6L1RQQMvVsJ2Px6yzVvGy8M4nQsxqJS4mZK!-1004083789!181195629!8091!-1" target="_blank"&gt;Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis&lt;/A&gt;. Drugs Aging 2007; 24(2):155-67.&lt;/LI&gt;
&lt;LI&gt;Hansen R.A., Gartlehner G., Webb A.P., Morgan L.C., Moore C.G., Jonas D.E. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18686744?dopt=Citation" target="_blank"&gt;Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis&lt;/A&gt;. Clinical Interventions in Aging 2008; 3(2):211-25.&lt;/LI&gt;
&lt;LI&gt;Herrmann N, Lanctot KL. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18020111" target="_blank"&gt;Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease&lt;/A&gt;. Can J Psychiatry 2007; 52(10):630-46. &lt;/LI&gt;
&lt;LI&gt;Isaac MGEKN, Quinn R, Tabet N. &lt;A href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002854/frame.html" target="_blank"&gt;Vitamin E for Alzheimer's disease and mild cognitive impairment&lt;/A&gt;. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD002854. DOI: 10.1002/14651858.CD002854.pub2.&lt;/LI&gt;
&lt;LI&gt;Li J, Wu HM, Zhou RL, Liu GJ, Dong BR. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005592/frame.html" target="_blank"&gt;Huperzine A for Alzheimer's disease&lt;/A&gt;. Cochrane Database Syst Rev 2008; (2):CD005592. (Link to full text in the Cochrane Library)&lt;/LI&gt;
&lt;LI&gt;Miller LJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18198970" target="_blank"&gt;The use of cognitive enhancers in behavioral disturbances of Alzheimer's disease&lt;/A&gt;. Consult Pharm 2007; 22(9):754-62. &lt;/LI&gt;
&lt;LI&gt;Sampson E, Jenagaratnam L, McShane R. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005380/frame.html" target="_blank"&gt;Metal protein attenuating compounds for the treatment of Alzheimer's disease&lt;/A&gt;. Cochrane Database Syst Rev 2008; (1):CD005380. (Link to full text in the Cochrane Library)&lt;/LI&gt;
&lt;LI&gt;Smith Doody R, Tariot P N, Pfeiffer E, Olin J T, Graham S M. &lt;A href="http://www.library.nhs.uk/LaterLife/ViewResource.aspx?resID=277925&amp;amp;tabID=289&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE&amp;amp;catID=6469" target="_blank"&gt;Meta-analysis of six-month memantine trials in Alzheimer's disease&lt;/A&gt;. Alzheimer's and Dementia, 2007; 3(1): 7-17 (Link to DARE record in LLSL). &lt;/LI&gt;
&lt;LI&gt;Zhou B, Teramukai S, Fukushima M. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;amp;ArtikelNr=000099037&amp;amp;Ausgabe=232755&amp;amp;ProduktNr=224226" target="_blank"&gt;Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2007; 23(3):194-202.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;Reviews&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Gauthier S, Loft H, Cummings J. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18058838/" target="_blank"&gt;Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis&lt;/A&gt;. Int J Geriatr Psychiatry 2008; 23(5):537-46.&lt;/LI&gt;
&lt;LI&gt;Oremus M. &lt;A href="http://www.expert-reviews.com/doi/abs/10.1586/14737167.8.3.273" target="_blank"&gt;Systematic review of economic evaluations of Alzheimer's disease medications&lt;/A&gt;. Expert Review of Pharmacoeconomics and Outcomes Research 2008; 8(3):273-89.&lt;/LI&gt;
&lt;LI&gt;Seow D, Gauthier S. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18020110" target="_blank"&gt;Pharmacotherapy of Alzheimer disease&lt;/A&gt;. Can J Psychiatry 2007; 52(10):620-9. &lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>293525</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=293525]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: 4. Non-pharmacological treatments</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE,COMPLEMENTARY AND ALTERNATIVE MEDICINE,ACUPUNCTURE,AROMATHERAPY,DIETARY AND NUTRITIONAL THERAPIES,HERBAL MEDICINE,OTHER THERAPIES OR MEDICAL SYSTEMS,CONDITIONS A-Z,DEMENTIA,ART THERAPY,CONDITIONS A-B,CONDITIONS D-E,ALZHEIMER'S DISEASE,DATE ADDED,NUTRITIONAL SUPPLEMENTS,SEPTEMBER 2008]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A summary of new evidence from systematic reviews published between August 2007 and July 2008.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;2&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Annual Evidence Update 2008: Non-pharmacological treatments&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Summary of the evidence by Dr Amitava Banerjee.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID293525/nelhImp_0000_faces_140x140.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update (AEU) is aimed at clinicians in primary care or general medicine.&amp;nbsp; It covers:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Psychological interventions&lt;/LI&gt;
&lt;LI&gt;Motor interventions&lt;/LI&gt;
&lt;LI&gt;Nutritional supplements&lt;/LI&gt;
&lt;LI&gt;Herbal medicine&lt;/LI&gt;
&lt;LI&gt;Acupuncture&lt;/LI&gt;
&lt;LI&gt;Aromatherapy&lt;/LI&gt;
&lt;LI&gt;Creative therapy&lt;/LI&gt;&lt;/UL&gt;
&lt;H3&gt;Non-Pharmacological treatments for&amp;nbsp;Dementia&lt;/H3&gt;
&lt;P&gt;The institutionalised care of patients with dementia is one of the three most expensive areas of health care in both Europe and the USA (Spijker 2008). &lt;/P&gt;
&lt;P&gt;A meta-analysis of 13 non-pharmacological support programmes showed that such programmes can “significantly decrease the odds of institutionalisation and significantly increase the time to institutionalisation” for patients with dementia. &lt;/P&gt;
&lt;P&gt;Effective programmes were characterized by counseling, personal assistance with problem solving, and various support strategies and services for caregivers (Spijker 2008). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Psychological interventions&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is weak evidence that behaviour problem-solving therapies and individualized, progressive, lowered stress interventions in combination with problem solving and environmental modification can be beneficial in the treatment of behavioural disturbances in dementia. However, the existing studies are small, have inadequate follow-up, and have questionable validity and reliability (Logsdon 2007).&lt;/P&gt;
&lt;P&gt;Wandering occurs in 15–60% of people with dementia, and psychosocial interventions rather than pharmacological methods are often recommended. There is currently inadequate evidence to recommend the use of any non-pharmacological intervention to reduce wandering in dementia (Hermans 2007).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Motor interventions&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Motor interventions (physiotherapy, occupational therapy, physical education, motor approach, exercise, and physical activity) can help to minimise physical and cognitive decline in dementia (Christofoletti 2007).&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Nutritional supplements&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A recent systematic review found that “B vitamins and antioxidant vitamins used in the trials were unlikely to have clinically important effects on global cognitive function”, even in the patients with cognitive impairment or dementia, who had low vitamin B status. The reviewers found insufficient evidence to evaluate the effect of omega-3 fatty acids on dementia. Their review studied nutritional supplements in isolation and in combination, and concluded that the lack of benefit of supplementation is unlikely to be due to inadequate dosage (Jia 2008). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Herbal medicine&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Ginkgo biloba appears to be safe in use with no excess side effects compared with placebo. A recent meta-analysis concluded that there is inconsistent and unconvincing evidence that Ginkgo has a clinically significant benefit for people with dementia or cognitive impairment (Birks 2007). A systematic review showed 2 herbs (Melissa officinalis and Salvia officinalis) and 2 formulations (Yi-Gan San and BDW) were useful for cognitive impairment in AD. M. officinalis and Yi-Gan San are also useful in agitation, for their sedative effects (Man 2008, Dos Santos 2006). &lt;/P&gt;
&lt;P&gt;Large scale, prospective studies with adequate duration of follow-up are required to further evaluate the effectiveness these herbs fully. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Acupuncture&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A Chinese meta-analysis found that acupuncture therapy is effective on dementia (Guo 2008), but a Cochrane review of its use in vascular dementia found no relevant RCTs and no evidence supporting use of acupuncture (Peng 2008). Therefore, randomised double-blind placebo controlled trials are needed before the use of acupuncture can be recommended. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Aromatherapy&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A review found very poor quality data regarding the efficacy of aromatherapy in dementia and highlighted the need for prospective, randomised trials (Nguyen 2008).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Creative therapy&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Creative therapies, such as art and drama, ‘aim at activating the creative potential of the patients in the sense of acceptance, orientation and coping with their illness "dementia" and at improving their quality of life’ (Schmitt 2007). &lt;/P&gt;
&lt;P&gt;A review concluded that creative therapy led to positive effects like the improvement of interaction skills, and supported its use in order to help patients accept dementia as their illness and finally to cope with it. The reviewers recommended that new tools are required to allow the quantitative evaluation of parameters such as agility and interaction skills (Schmitt 2007).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Birks J, Grimley EJ. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003120/frame.html" target="_blank"&gt;Ginkgo biloba for cognitive impairment and dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (2):CD003120-NaN. &lt;/LI&gt;
&lt;LI&gt;Christofoletti G, Oliani MM, Gobbi S, Stella F. &lt;A href="http://pt.wkhealth.com/pt/re/tgr/abstract.00013614-200704000-00006.htm;jsessionid=L2TZcdWrlSTTV3BkndPyPvdqqGphRMBBd7hwM4nqYjMhQ4hjXysf%21-1004083789%21181195629%218091%21-1" target="_blank"&gt;Effects of motor intervention in elderly patients with dementia: an analysis of randomized controlled trials&lt;/A&gt;. Topics in Geriatric Rehabilitation 2007; 23(2):149-55.&lt;/LI&gt;
&lt;LI&gt;Dos Santos-Neto LL, de Vilhena Toledo MA, Medeiros-Souza P, de Souza GA. &lt;A href="http://ecam.oxfordjournals.org/cgi/content/full/3/4/441" target="_blank"&gt;The use of herbal medicine in Alzheimer's disease-a systematic review&lt;/A&gt;. Evid Based Complement Alternat Med. 2006 Dec;3(4):441-5. Epub 2006 Oct 23. &lt;/LI&gt;
&lt;LI&gt;Guo XX, Jin HS, Huo L, Zheng J, Zhou XM. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18405161" target="_blank"&gt;Meta-analysis on acupuncture for treatment of dementia&lt;/A&gt;]. Zhongguo Zhen Jiu 2008; 28(2):140-4. 18405161&lt;/LI&gt;
&lt;LI&gt;Hermans DG, Htay U Hla, McShane R. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005994/frame.html" target="_blank"&gt;Non-pharmacological interventions for wandering of people with dementia in the domestic setting&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (1):CD005994-NaN.&lt;/LI&gt;
&lt;LI&gt;Jia X., McNeill G., Avenell A. &lt;A href="http://www.ingentaconnect.com/content/bsc/jhnd/2008/00000021/00000004/art00003;jsessionid=1jnjrm63load3.alexandra?format=print" target="_blank"&gt;Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials&lt;/A&gt;. Journal of Human Nutrition and Dietetics 2008; 21(4):317-36.&lt;/LI&gt;
&lt;LI&gt;Logsdon R G, McCurry S M, Teri L. &lt;A href="http://www.library.nhs.uk/LaterLife/ViewResource.aspx?resID=278869&amp;amp;tabID=289&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE&amp;amp;catID=6469" target="_blank"&gt;Evidence-based psychological treatments for disruptive behaviors in individuals with dementia&lt;/A&gt;. Psychology and Aging, 2007; 22(1): 28-36. (Link to the DARE abstract in the LLSL)&lt;/LI&gt;
&lt;LI&gt;Man SC, Durairajan SSK, Kum WF&amp;nbsp; et al. &lt;A href="http://iospress.metapress.com/content/7562057t6l46wgw5/" target="_blank"&gt;Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease&lt;/A&gt;. Journal of Alzheimer's Disease 2008; 14(2):209-23. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Nguyen Q, Paton C. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17918182" target="_blank"&gt;The use of aromatherapy to treat behavioural problems in dementia&lt;/A&gt;. Int J Geriatr Psychiatry 2008; 23(4):337-47.&lt;/LI&gt;
&lt;LI&gt;Peng WN, Zhao H, Liu ZS, Wang S. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004987/frame.html" target="_blank"&gt;Acupuncture for vascular dementia&lt;/A&gt;. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004987.&lt;/LI&gt;
&lt;LI&gt;Robinson L., Hutchings D., Dickinson H.O. et al. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17096455?ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: A systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(1):9-22.&lt;/LI&gt;
&lt;LI&gt;Schmitt B, Frolich L. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17443437" target="_blank"&gt;Creative therapy options for patients with dementia--A systematic review&lt;/A&gt;. Fortschr Neurol Psychiatr 2007; 75(12):699-707.&lt;/LI&gt;
&lt;LI&gt;Spijker A., Vernooij-Dassen M., Vasse E. et al. &lt;A href="http://lib.bioinfo.pl/pmid:18410323" target="_blank"&gt;Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: A meta-analysis&lt;/A&gt;. J Am Geriatr Soc 2008; 56(6):1116-28.&lt;/LI&gt;
&lt;LI&gt;Zientz J., Rackley A., Chapman S.B., Hopper T., Mahendra N., Cleary S. &lt;A href="http://goliath.ecnext.com/coms2/gi_0199-7000524/Evidence-based-practice-recommendations-caregiver.html" target="_blank"&gt;Evidence-based practice recommendations: Caregiver-administered active cognitive stimulation for individuals with Alzheimer's disease&lt;/A&gt;. Journal of Medical Speech-Language Pathology 2007; 15(3):xxvii-xxxiv.&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;
&lt;H2&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;/H2&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;3&lt;/pageID&gt;&lt;pageSequence&gt;3&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia: Systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Systematic Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Birks J, Grimley EJ. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003120/frame.html" target="_blank"&gt;Ginkgo biloba for cognitive impairment and dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (2):CD003120-NaN. &lt;/LI&gt;
&lt;LI&gt;Christofoletti G, Oliani MM, Gobbi S, Stella F. &lt;A href="http://pt.wkhealth.com/pt/re/tgr/abstract.00013614-200704000-00006.htm;jsessionid=L2TZcdWrlSTTV3BkndPyPvdqqGphRMBBd7hwM4nqYjMhQ4hjXysf%21-1004083789%21181195629%218091%21-1" target="_blank"&gt;Effects of motor intervention in elderly patients with dementia: an analysis of randomized controlled trials&lt;/A&gt;. Topics in Geriatric Rehabilitation 2007; 23(2):149-55.&lt;/LI&gt;
&lt;LI&gt;Forbes D, Forbes S, Morgan DG, Markle-Reid M, Wood J, Culum I. &lt;A href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006489/frame.html" target="_blank"&gt;Physical activity programs for persons with dementia.&lt;/A&gt; Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006489. DOI: 10.1002/14651858.CD006489.pub2.&lt;/LI&gt;
&lt;LI&gt;Guo XX, Jin HS, Huo L, Zheng J, Zhou XM. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18405161" target="_blank"&gt;Meta-analysis on acupuncture for treatment of dementia&lt;/A&gt;]. Zhongguo Zhen Jiu 2008; 28(2):140-4. 18405161&lt;/LI&gt;
&lt;LI&gt;Hermans DG, Htay U Hla, McShane R. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005994/frame.html" target="_blank"&gt;Non-pharmacological interventions for wandering of people with dementia in the domestic setting&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (1):CD005994-NaN.&lt;/LI&gt;
&lt;LI&gt;Jia X., McNeill G., Avenell A. &lt;A href="http://www.ingentaconnect.com/content/bsc/jhnd/2008/00000021/00000004/art00003;jsessionid=1jnjrm63load3.alexandra?format=print" target="_blank"&gt;Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials&lt;/A&gt;. Journal of Human Nutrition and Dietetics 2008; 21(4):317-36.&lt;/LI&gt;
&lt;LI&gt;Logsdon R G, McCurry S M, Teri L. &lt;A href="http://www.library.nhs.uk/LaterLife/ViewResource.aspx?resID=278869&amp;amp;tabID=289&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE&amp;amp;catID=6469" target="_blank"&gt;Evidence-based psychological treatments for disruptive behaviors in individuals with dementia&lt;/A&gt;. Psychology and Aging, 2007; 22(1): 28-36. (Link to the DARE abstract in the LLSL)&lt;/LI&gt;
&lt;LI&gt;Nguyen Q, Paton C. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17918182" target="_blank"&gt;The use of aromatherapy to treat behavioural problems in dementia&lt;/A&gt;. Int J Geriatr Psychiatry 2008; 23(4):337-47.&lt;/LI&gt;
&lt;LI&gt;Robinson L., Hutchings D., Dickinson H.O. et al. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17096455?ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: A systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(1):9-22.&lt;/LI&gt;
&lt;LI&gt;Schmitt B, Frolich L. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17443437" target="_blank"&gt;Creative therapy options for patients with dementia--A systematic review&lt;/A&gt;. Fortschr Neurol Psychiatr 2007; 75(12):699-707.&lt;/LI&gt;
&lt;LI&gt;Spijker A., Vernooij-Dassen M., Vasse E. et al. &lt;A href="http://lib.bioinfo.pl/pmid:18410323" target="_blank"&gt;Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: A meta-analysis&lt;/A&gt;. J Am Geriatr Soc 2008; 56(6):1116-28.&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Heidler M. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18247268" target="_blank"&gt;Effects of multisensory stimulation interventions in brain-damaged patients &lt;/A&gt;[German]. Rehabilitation (Stuttg) 2008; 47(1):23-31.&lt;/LI&gt;
&lt;LI&gt;Saddichha S, Pandey V. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18332476" target="_blank"&gt;Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies&lt;/A&gt;. Am J Alzheimers Dis Other Demen 2008; 23(2):150-61. &lt;/LI&gt;
&lt;LI&gt;Zientz J., Rackley A., Chapman S.B., Hopper T., Mahendra N., Cleary S. &lt;A href="http://goliath.ecnext.com/coms2/gi_0199-7000524/Evidence-based-practice-recommendations-caregiver.html" target="_blank"&gt;Evidence-based practice recommendations: Caregiver-administered active cognitive stimulation for individuals with Alzheimer's disease&lt;/A&gt;. Journal of Medical Speech-Language Pathology 2007; 15(3):xxvii-xxxiv.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;2&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease: Guidelines, systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Systematic reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Man SC, Durairajan SSK, Kum WF&amp;nbsp; et al. &lt;A href="http://iospress.metapress.com/content/7562057t6l46wgw5/" target="_blank"&gt;Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease&lt;/A&gt;. Journal of Alzheimer's Disease 2008; 14(2):209-23. &lt;/LI&gt;
&lt;LI&gt;Zientz J., Rackley A., Chapman S.B., Hopper T., Mahendra N., Cleary S. &lt;A href="http://goliath.ecnext.com/coms2/gi_0199-7000524/Evidence-based-practice-recommendations-caregiver.html" target="_blank"&gt;Evidence-based practice recommendations: Caregiver-administered active cognitive stimulation for individuals with Alzheimer's disease&lt;/A&gt;. Journal of Medical Speech-Language Pathology 2007; 15(3):xxvii-xxxiv.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Review&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Burgener SC, Buettner L, Coen Buckwalter K et al. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18165840" target="_blank"&gt;Evidence supporting nutritional interventions for persons in early stage Alzheimer's disease (AD)&lt;/A&gt;. J Nutr Health Aging 2008; 12(1):18-21.&amp;nbsp;&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>293531</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=293531]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: 5. Rehabilitation, practice and care standards</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A summary of new evidence from systematic reviews published between August 2007 and July 2008.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;2&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Annual Evidence Update 2008: Rehabilitation, practice and care standards&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/LaterLife/Page.aspx?pagename=DEMENTAEU" target="_blank"&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Summary of the evidence by Dr Gail Hayward&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID293531/nelhImp_0000_hands_140x140.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update (AEU) is aimed at clinicians in primary care or general medicine.&amp;nbsp; It covers:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Improving the burden on caregivers&lt;/LI&gt;
&lt;LI&gt;Driving in dementia&lt;/LI&gt;
&lt;LI&gt;Wandering in dementia. &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Interventions to improve mental health and burden in caregivers of patients with dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;It is estimated that 63.5% of people with late onset (onset &amp;gt;65 years) dementia live in private households rather than care homes (Dementia UK report 2007). Therefore an important consequence of dementia is its impact upon the health of the caregivers of the patient. A quarter of caregivers are estimated to suffer from anxiety (Cooper at al 2007a). &lt;/P&gt;
&lt;P&gt;Caring for patients with dementia has also been consistently linked with increased caregiver burden and depression (Pinquart and Sorenson 2003).&lt;/P&gt;
&lt;P&gt;Recently the efficacy of interventions to improve both mental health and burden in caregivers have been examined. In a review of the efficacy of psychological interventions, good evidence was demonstrated for a benefit of individual behaviour management techniques lasting for 6 sessions or more on depression in caregivers (Selwood et al 2007). &lt;/P&gt;
&lt;P&gt;Three RCTs (randomised controlled trials) demonstrated significant improvement in depression rating scales compared to controls. Interestingly, group behaviour management interventions did not result in an improvement in depression ratings, which may be because the benefit came from discussing solutions to the specific problems faced by the carer, rather than learning general principles of behaviour management.&lt;/P&gt;
&lt;P&gt;A broader analysis of information and support interventions for caregivers, including technological interventions such as specialised computer and telephone networks and individual and group training or education programmes provides somewhat contradictory evidence to that described above. &lt;/P&gt;
&lt;P&gt;Thompson et al (2007) found that group based psychoeducational interventions were significantly beneficial to caregivers mental health in a meta-analysis of 5 studies (-0.71 95% CI -0.95 - -0.46), but that there was no evidence for effectiveness of any other intervention, including individual interventions, on a range of physical and psychological outcomes. &lt;/P&gt;
&lt;P&gt;However, these studies did not specifically examine behaviour management techniques but rather encompassed a wide variety of different interventions.&lt;/P&gt;
&lt;P&gt;There is least evidence for interventions addressing anxiety in caregivers. A recent systematic review (Cooper et al 2007b) discovered only 1 RCT directly examining this. This study demonstrated a significant reduction in caregiver anxiety levels following an intervention involving relaxation and cognitive behavioural therapy.&lt;/P&gt;
&lt;P&gt;Combined interventions, which involve both the caregiver and the care receiver in appropriate support or rehabilitation activities, have previously been suggested to be more effective for caregivers (Brodaty et al 2003). However, in a review of the effects of combined interventions, Smits et al (2007) found only a modest effect on the mental health of the caregivers, with only 2 of 7 studies showing significant improvement in depression but 3 of 4 studies showing significant improvement at some point after the intervention in general / psychosomatic and psychological complaints. Just under half of the interventions benefited both the carereceiver and caregiver in some way. The main benefit to the patient of such interventions was increased time to institutionalisation, found in 8 out of the 12 studies which examined this.&lt;/P&gt;
&lt;P&gt;This last finding does seem to generalise to other interventions. Non-pharmacological support programmes have been shown to significantly reduce the odds of institutionalisation in patients with dementia, as demonstrated in a meta-analysis of 13 different support programmes (OR 0.66 95% CI 0.43 – 0.99) (Spijker et al (2008).&lt;/P&gt;
&lt;H3&gt;Managing dementia – updates to research into driving and wandering in dementia &lt;/H3&gt;
&lt;P&gt;&lt;EM&gt;Driving&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;A diagnosis of dementia does not automatically exclude patients from driving in the UK, although as the disease progresses the DVLA may seek information from medical records and / or driving assessment to suggest that a licence is revoked. &lt;/P&gt;
&lt;P&gt;A recent attempt has been made to establish the extent to which patients with dementia are at greater driving risk (Man-Son-Hing et al 2007). Studies examining driver performance in road evaluations or simulations, or those which used caregiver crash reports, reveal patients with dementia to perform significantly worse than control subjects. &lt;/P&gt;
&lt;P&gt;Interestingly, only 1 of 3 studies using state driving crash records as an outcome measure found that drivers with dementia crashed more than controls, which may be due to the poor detection of minor crashes and out-of-state accidents. &lt;/P&gt;
&lt;P&gt;The authors found an overall increased risk of crashing of between 2 and 8&amp;nbsp;times using caregiver crash reports. They were unable to quantify the driving risk related to the degree of cognitive impairment, and further found no evidence based options for compensatory strategies to enhance the driving capabilities of persons with dementia.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Wandering&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Wandering in dementia is a behaviour which can be associated with physical harm, early institutionalisation and emotional distress. It is commonly managed with physical barriers or restraints, which can pose ethical concerns, or drugs, which can produce harmful side effects. &lt;/P&gt;
&lt;P&gt;A systematic review (Robinson et al 2007) of the literature on non-pharmacological interventions to reduce wandering revealed only exercise therapy, examined in a single RCT, to be of significant benefit. However, this paper failed to report its data fully, casting doubt on the strength of this result. &lt;/P&gt;
&lt;P&gt;Of other interventions examined, therapeutic touch was effective at reducing pacing but not wandering, there were heterogenous results of the use of essential oils and a meta-analysis of the use of multisensory environments revealed an insignificant benefit.&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;References&lt;/H3&gt;
&lt;OL&gt;
&lt;LI&gt;Brodaty, H, Green, A, Koschera, A (2003) &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/12752841" target="_blank"&gt;Meta-analysis of psychosocial interventions for caregivers of people with dementia&lt;/A&gt;. JAGS 51: 657-664 &lt;/LI&gt;
&lt;LI&gt;Cooper C., Balamurali T.B.S., Livingston G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17005068" target="_blank"&gt;A systematic review of the prevalence and covariates of anxiety in caregivers of people with dementia&lt;/A&gt;. Int Psychogeriatr 2007a; 19(2):175-95.&lt;/LI&gt;
&lt;LI&gt;Cooper C, Balamurali TBS, Selwood A, Livingston G. &lt;A href="http://www3.interscience.wiley.com/journal/113374369/abstract" target="_blank"&gt;A systematic review of intervention studies about anxiety in caregivers of people with dementia&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(3):181-8.&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.alzheimers.org.uk/downloads/Dementia_UK_Full_Report.pdf" target="_blank"&gt;Dementia UK Report&lt;/A&gt;. (2007) commissioned and published by the Alzheimers Society&lt;/LI&gt;
&lt;LI&gt;Man-Son-Hing M, Marshall SC, Molnar FJ, Wilson KG. &lt;A href="http://www.ingentaconnect.com/content/bsc/jgs/2007/00000055/00000006/art00010;jsessionid=293ao2c849nt0.alice?format=print" target="_blank"&gt;Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia&lt;/A&gt;. J Am Geriatr Soc 2007; 55(6):878-84.&lt;/LI&gt;
&lt;LI&gt;Pinquart and Sorenson 2003 &lt;A href="http://cat.inist.fr/?aModele=afficheN&amp;amp;cpsidt=14888824" target="_blank"&gt;Differences between caregivers and non-caregivers in psychological health and physical health,: a meta-analysis&lt;/A&gt;. Psychol. Aging 18 250 – 267 (&lt;A href="http://ebmh.bmj.com/cgi/reprint/7/1/28.pdf" target="_blank"&gt;Link to EBMH commentary on this article here&lt;/A&gt;&amp;nbsp;in Full-text PDF).&lt;/LI&gt;
&lt;LI&gt;Robinson L, Hutchings D, Dickinson HO et al. &lt;A href="http://cat.inist.fr/?aModele=afficheN&amp;amp;cpsidt=18381734" target="_blank"&gt;Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007 22 9 - 22&lt;/LI&gt;
&lt;LI&gt;Selwood A, Johnston K, Katona C, Lyketsos C, Livingston G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17173977" target="_blank"&gt;Systematic review of the effect of psychological interventions on family caregivers of people with dementia&lt;/A&gt;. J Affect Disord 2007; 101(1-3):75-89. 17173977&lt;/LI&gt;
&lt;LI&gt;Smits CH, de Lange J, Droes RM, Meiland F, Vernooij-Dassen M, Pot AM. &lt;A href="http://www3.interscience.wiley.com/journal/114219405/abstract" target="_blank"&gt;Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(12):1181-93. 17457793&lt;/LI&gt;
&lt;LI&gt;Spijker A, Vernooij-Dassen M, Vasse E et al. &lt;A href="http://lancashirecare.wordpress.com/2008/08/04/dementia-effectiveness-of-nonpharmacological-interventions-in-delaying-the-institutionalization-of-patients-with-dementia-a-meta-analysis/" target="_blank"&gt;Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis&lt;/A&gt;. J Am Geriatr Soc 2008; 56(6):1116-28. 18410323&lt;/LI&gt;
&lt;LI&gt;Thompson C.A., Spilsbury K., Hall J., Birks Y., Barnes C., Adamson J. &lt;A href="http://www.biomedcentral.com/content/pdf/1471-2318-7-18.pdf" target="_blank"&gt;Systematic review of information and support interventions for caregivers of people with dementia&lt;/A&gt;. BMC Geriatrics 2007; 7. (Link to full-text PDF)&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;BR&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;BR&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;2&lt;/pageID&gt;&lt;pageSequence&gt;3&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia: Systematic reviews and other evidence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Links are to abstracts unless specified&lt;/EM&gt;&lt;/STRONG&gt;&lt;STRONG&gt;&lt;EM&gt;&amp;nbsp;otherwise.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Bryon E, de Casterle BD, Gastmans C. &lt;A href="http://jme.bmj.com/cgi/content/abstract/34/6/431" target="_blank"&gt;Nurses' attitudes towards artificial food or fluid administration in patients with dementia and in terminally ill patients: A review of the literature&lt;/A&gt;. J Med Ethics 2008; 34(6):431-6.&lt;/LI&gt;
&lt;LI&gt;Cooper C., Balamurali T.B.S., Livingston G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17005068" target="_blank"&gt;A systematic review of the prevalence and covariates of anxiety in caregivers of people with dementia.&lt;/A&gt; Int Psychogeriatr 2007; 19(2):175-95.&lt;/LI&gt;
&lt;LI&gt;Cooper C, Selwood A, Livingston G. &lt;A href="http://ageing.oxfordjournals.org/cgi/content/abstract/37/2/151" target="_blank"&gt;The prevalence of elder abuse and neglect: a systematic review&lt;/A&gt;. Age Ageing 2008; 37(2):151-60. 18349012&lt;/LI&gt;
&lt;LI&gt;Cooper C, Balamurali TBS, Selwood A, Livingston G. &lt;A href="http://www3.interscience.wiley.com/journal/113374369/abstract" target="_blank"&gt;A systematic review of intervention studies about anxiety in caregivers of people with dementia&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(3):181-8.&lt;/LI&gt;
&lt;LI&gt;Daykin N., Byrne E., Soteriou T., O'Connor S. &lt;A href="http://rsh.sagepub.com/cgi/content/abstract/128/2/85" target="_blank"&gt;The impact of art, design and environment in mental healthcare: A systematic review of the literature&lt;/A&gt;. Journal of The Royal Society for the Promotion of Health 2008; 128(2):85-94.&lt;/LI&gt;
&lt;LI&gt;Ehlhardt L.A., Sohlberg M.M., Kennedy M. et al. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18569746" target="_blank"&gt;Evidence-based practice guidelines for instructing individuals with neurogenic memory impairments: What have we learned in the past 20 years?&lt;/A&gt; Neuropsychological Rehabilitation 2008; 18(3):300-42.&lt;/LI&gt;
&lt;LI&gt;Gaugler JE, Duval S, Anderson KA, Kane RL. &lt;A href="http://www.biomedcentral.com/1471-2318/7/13" target="_blank"&gt;Predicting nursing home admission in the U.S: a meta-analysis&lt;/A&gt;. BMC Geriatr 2007; 7:13. (Link to full-text article on webpage)&lt;/LI&gt;
&lt;LI&gt;Man-Son-Hing M, Marshall SC, Molnar FJ, Wilson KG. &lt;A href="http://www.ingentaconnect.com/content/bsc/jgs/2007/00000055/00000006/art00010;jsessionid=293ao2c849nt0.alice?format=print" target="_blank"&gt;Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia&lt;/A&gt;. J Am Geriatr Soc 2007; 55(6):878-84.&lt;/LI&gt;
&lt;LI&gt;Mason A, Weatherly H, Spilsbury K et al. &lt;A href="http://www.hta.ac.uk/execsumm/summ1115.htm" target="_blank"&gt;A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carers&lt;/A&gt;. Health Technol Assess 2007; 11(15):iii-NaN.&lt;/LI&gt;
&lt;LI&gt;Moniz-Cook E, Vernooij-Dassen M, Woods R et al. &lt;A href="http://www.informaworld.com/smpp/content~content=a790802368~db=all~jumptype=rss" target="_blank"&gt;A European consensus on outcome measures for psychosocial intervention research in dementia care.&lt;/A&gt; Aging Ment Health 2008; 12(1):14-29. 18297476&lt;BR&gt;Notes: CORPORATE NAME: INTERDEM group&lt;/LI&gt;
&lt;LI&gt;Oliver D., Connelly J.B., Victor C.R. et al. &lt;A href="http://www.bmj.com/cgi/content/abstract/334/7584/82" target="_blank"&gt;Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: Systematic review and meta-analyses&lt;/A&gt;. Br Med J 2007; 334(7584):82-5.&lt;/LI&gt;
&lt;LI&gt;Robinson L, Hutchings D, Corner L et al. &lt;A href="http://www.informaworld.com/smpp/content~content=a783055773~db=all~tab=content~order=page" target="_blank"&gt;Balancing rights and risks: Conflicting perspectives in the management of wandering in dementia&lt;/A&gt;. Health, Risk &amp;amp; Society 2007; 9(4):389-406.&lt;/LI&gt;
&lt;LI&gt;Scholzel-Dorenbos C.J.M., Van Der Steen M.J.M.M., Engels L.K., Olde Rikkert M.G.M. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;amp;uid=17545745&amp;amp;cmd=showdetailview&amp;amp;indexed=google" target="_blank"&gt;Assessment of quality of life as outcome in dementia and MCI intervention trials: A systematic review&lt;/A&gt;. Alzheimer Dis Assoc Disord 2007; 21(2):172-8.&lt;/LI&gt;
&lt;LI&gt;Selwood A, Johnston K, Katona C, Lyketsos C, Livingston G. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17173977" target="_blank"&gt;Systematic review of the effect of psychological interventions on family caregivers of people with dementia&lt;/A&gt;. J Affect Disord 2007; 101(1-3):75-89. 17173977&lt;/LI&gt;
&lt;LI&gt;Smits CH, de Lange J, Droes RM, Meiland F, Vernooij-Dassen M, Pot AM. &lt;A href="http://www3.interscience.wiley.com/journal/114219405/abstract" target="_blank"&gt;Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review&lt;/A&gt;. Int J Geriatr Psychiatry 2007; 22(12):1181-93. 17457793&lt;/LI&gt;
&lt;LI&gt;Spijker A, Vernooij-Dassen M, Vasse E et al. &lt;A href="http://lancashirecare.wordpress.com/2008/08/04/dementia-effectiveness-of-nonpharmacological-interventions-in-delaying-the-institutionalization-of-patients-with-dementia-a-meta-analysis/" target="_blank"&gt;Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis&lt;/A&gt;. J Am Geriatr Soc 2008; 56(6):1116-28. 18410323&lt;/LI&gt;
&lt;LI&gt;Thompson C.A., Spilsbury K., Hall J., Birks Y., Barnes C., Adamson J. &lt;A href="http://www.biomedcentral.com/content/pdf/1471-2318-7-18.pdf" target="_blank"&gt;Systematic review of information and support interventions for caregivers of people with dementia&lt;/A&gt;. BMC Geriatrics 2007; 7. (Link to full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Thompson P, Lang L, Annells M. &lt;A href="http://www.ingentaconnect.com/content/bsc/jcn/2008/00000017/00000011/art00004;jsessionid=fs8hjcdlsaj3r.alexandra?format=print" target="_blank"&gt;A systematic review of the effectiveness of in-home community nurse led interventions for the mental health of older persons&lt;/A&gt;. J Clin Nurs 2008; 17(11):1419-27.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Birch D, Draper J. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18416791" target="_blank"&gt;A critical literature review exploring the challenges of delivering effective palliative care to older people with dementia&lt;/A&gt;. J Clin Nurs 2008; 17(9):1144-64.&lt;/LI&gt;
&lt;LI&gt;Harlein J, Scheffel E, Heinze C, Dassen T. Fall &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17565436" target="_blank"&gt;prevention in people with dementia: Do experiences from long-term-care offer new methods of resolution?&lt;/A&gt; Z Gerontol Geriatr 2007; 40(3):185-91.&lt;/LI&gt;
&lt;LI&gt;Harumi K. Concept analysis of "sleep promotion" in nursing -- as a base of conceptual model of sleep promotion to dementia elderly -- [sic] [Japanese]. Journal of St. Luke's Society for Nursing Research 2007; 11(1):29-38.&lt;/LI&gt;
&lt;LI&gt;Kuske B., Hanns S., Luck T., Angermeyer M.C., Behrens J., Riedel-Heller S.G. &lt;A href="http://cat.inist.fr/?aModele=afficheN&amp;amp;cpsidt=19049658" target="_blank"&gt;Nursing home staff training in dementia care: A systematic review of evaluated programs&lt;/A&gt;. Int Psychogeriatr 2007; 19(5):818-41.&lt;/LI&gt;
&lt;LI&gt;Locca J.-F., Zumbach S., Bula C., Bugnon O. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18072600" target="_blank"&gt;Management of elderly patients with delirium or dementia in Swiss nursing homes.&lt;/A&gt; Revue Medicale Suisse 2007; 3(132):2519-30.&lt;/LI&gt;
&lt;LI&gt;Mier N. &lt;A href="http://www.aarpinternational.org/news/news_show.htm?doc_id=670243" target="_blank"&gt;The caregiving experience among Hispanic caregivers of dementia patients&lt;/A&gt;. J Cult Divers 2007; 14(1):12-9. (Link to full-text webpage)&lt;/LI&gt;
&lt;LI&gt;Moniz-Cook E, Vernooij-Dassen M, Woods R et al. &lt;A href="http://www.informaworld.com/smpp/content~content=a790802368~db=all~jumptype=rss" target="_blank"&gt;A European consensus on outcome measures for psychosocial intervention research in dementia care.&lt;/A&gt; Aging &amp;amp; Mental Health 2008; 12(1):14-29.&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;3&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease: Systematic review&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;The link is to an abstract.&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic Review&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Zientz J., Rackley A., Chapman S.B. et al. &lt;A href="http://findarticles.com/p/articles/mi_hb1397/is_200703/ai_n18942996" target="_blank"&gt;Evidence-based practice recommendations for dementia: Educating caregivers on Alzheimer's disease and training communication strategies&lt;/A&gt;. Journal of Medical Speech-Language Pathology 2007; 15(1):liii-lxiv.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>293534</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=293534]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: 6. Evidence on other Dementias</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES,CAUSES AND PREVENTION,PATHOLOGY,TREATMENT AND CARE,DIAGNOSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A summary of new evidence from systematic reviews published between August 2007 and July 2008.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;2&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Annual Evidence Update 2008: Evidence on other Dementias&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/LaterLife/Page.aspx?pagename=DEMENTAEU" target="_blank"&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Summary of the evidence by Dr Amitava Banerjee&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID293534/nelhImp_0000_kissing_140x140.jpg"&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update (AEU) is aimed at clinicians in primary care or general medicine. It covers:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Frontotemporal dementia &lt;/LI&gt;
&lt;LI&gt;Vascular dementia&lt;/LI&gt;&lt;/UL&gt;
&lt;H3&gt;Frontotemporal dementia (FTD) &lt;/H3&gt;
&lt;P&gt;&lt;EM&gt;(See also: AEU 1) &lt;A href="nelh:293480:0" name=internalLink&gt;Diagnosis and Screening&lt;/A&gt;)&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;FTD is associated with the following behaviors: apathy-abulia; disinhibition-impulsivity; loss of insight and self-referential behavior; decreased emotion and empathy; violation of social and moral norms; changes in dietary or eating behavior; and repetitive behaviors. It is less frequently associated with anxiety and mood disorders, which may be a prodrome or risk factor, and rarely presents with delusions or hallucinations (Mendez 2007).&lt;/P&gt;
&lt;P&gt;Studies of FTD in the context of cognitive neuropsychiatry have revealed impairment of the frontomedian network in particular, as well as the right anterior insula and medial thalamus. Therefore, FTD affects neural networks enabling self-monitoring, theory of mind capabilities, processing/evaluation of internal mental states, perception of pain and emotions, and sustaining personality and self (Peng 2008). &lt;/P&gt;
&lt;P&gt;One systematic review revealed specific neural networks for each of the three clinically defined subtypes of frontotemporal lobar degeneration, namely frontotemporal dementia, semantic dementia, and progressive non-fluent aphasia (Schroeter 2007).&lt;/P&gt;
&lt;P&gt;The most discriminating cognitive tests between AD and FTD were measures of orientation, memory, language, visuo-motor function and general cognitive ability. &lt;/P&gt;
&lt;P&gt;However, given the large overlap in the test performance of persons diagnosed with AD and FTD, cognitive tests should be used with caution and in conjunction with a medical history, behavioural observations, imaging and information from relatives when making differential diagnoses of dementia (Hutchinson 2007).&lt;/P&gt;
&lt;H3&gt;Vascular dementia&lt;/H3&gt;
&lt;P&gt;Vascular dementia is caused by cerebrovascular disease. There is currently insufficient data to support the use of cholinesterase inhibitors (donepezil, galantamine and rivastigmine) and memantine in vascular dementia. Individual patient analyses are needed to identify subgroups of patients with vascular dementia who might benefit (Kavirajan 2007).&lt;/P&gt;
&lt;P&gt;'Yizhi capsule' is a Chinese traditional medicine which has been used in the treatment of vascular dementia for improving cognitive function. However, a recent review found no randomised placebo-controlled trials that considered 'Yizhi capsule' for patients with vascular dementia and so could not recommend its use in vascular dementia (Wu 2007).&lt;/P&gt;
&lt;H3&gt;References&lt;/H3&gt;
&lt;OL&gt;
&lt;LI&gt;Hutchinson AD, Mathias JL. &lt;A href="http://jnnp.bmj.com/cgi/content/abstract/78/9/917" target="_blank"&gt;Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review&lt;/A&gt;. J Neurol Neurosurg Psychiatry 2007; 78(9):917-28.&lt;/LI&gt;
&lt;LI&gt;Kavirajan H, Schneider LS. &lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6X3F-4PBG1J0-2&amp;amp;_user=10&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=067821357fa7800a71024f5065f022ea" target="_blank"&gt;Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials&lt;/A&gt;. Lancet Neurol 2007; 6(9):782-92. &lt;/LI&gt;
&lt;LI&gt;Mendez MF, Lauterbach EC, Sampson SM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18451185" target="_blank"&gt;An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research&lt;/A&gt;. J Neuropsychiatry Clin Neurosci 2008; 20(2):130-49.&lt;BR&gt;Notes: CORPORATE NAME: ANPA Committee on Research &lt;/LI&gt;
&lt;LI&gt;Peng WN, Zhao H, Liu ZS, Wang S. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004987/frame.html" target="_blank"&gt;Acupuncture for vascular dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (2):CD004987-NaN.&lt;/LI&gt;
&lt;LI&gt;Schroeter M.L., Raczka K., Neumann J., von Cramon D.Y. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17140704" target="_blank"&gt;Neural networks in frontotemporal dementia-A meta-analysis&lt;/A&gt;. Neurobiol Aging 2008; 29(3):418-26.&lt;/LI&gt;
&lt;LI&gt;Schroeter ML, Raczka K, Neumann J, Yves von Cramon D. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17478101" target="_blank"&gt;Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects&lt;/A&gt;. Neuroimage 2007; 36(3):497-510.&lt;/LI&gt;
&lt;LI&gt;Wu TX, Li QP, Yuan ZY. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005382/frame.html" target="_blank"&gt;Yizhi capsule for vascular dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (2):CD005382-NaN.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;2&lt;/pageID&gt;&lt;pageSequence&gt;3&lt;/pageSequence&gt;&lt;pageTitle&gt;Diagnosis and Screening: Dementia with Lewy Bodies&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Aarsland D, Kurz M, Beyer M, Bronnick K, Piepenstock Nore S, Ballard C. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=000113417&amp;amp;Ausgabe=234530&amp;amp;ProduktNr=224226&amp;amp;filename=000113417.pdf" target="_blank"&gt;Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers&lt;/A&gt;. Dement Geriatr Cogn Disord 2008; 25(3):195-205. (Link to article as full-text PDF)&lt;/LI&gt;
&lt;LI&gt;Fischer C, Bozanovic R, Atkins JH, Rourke S. &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=94975&amp;amp;Ausgabe=232122&amp;amp;ProduktNr=224226&amp;amp;filename=94975.pdf" target="_blank"&gt;Treatment of delusions in dementia with Lewy bodies -- response to pharmacotherapy&lt;/A&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2007; 23(5):307-12. (Link to article in full-text PDF)&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;3&lt;/pageID&gt;&lt;pageSequence&gt;4&lt;/pageSequence&gt;&lt;pageTitle&gt;Diagnosis and Screening: Frontotemporal dementia&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Hutchinson AD, Mathias JL. &lt;A href="http://jnnp.bmj.com/cgi/content/abstract/78/9/917" target="_blank"&gt;Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review&lt;/A&gt;. J Neurol Neurosurg Psychiatry 2007; 78(9):917-28.&lt;/LI&gt;
&lt;LI&gt;Mendez MF, Lauterbach EC, Sampson SM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18451185" target="_blank"&gt;An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research&lt;/A&gt;. J Neuropsychiatry Clin Neurosci 2008; 20(2):130-49.&lt;BR&gt;Notes: CORPORATE NAME: ANPA Committee on Research &lt;/LI&gt;
&lt;LI&gt;Schroeter M.L., Raczka K., Neumann J., von Cramon D.Y. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17140704" target="_blank"&gt;Neural networks in frontotemporal dementia-A meta-analysis&lt;/A&gt;. Neurobiol Aging 2008; 29(3):418-26.&lt;/LI&gt;
&lt;LI&gt;Schroeter ML, Raczka K, Neumann J, Yves von Cramon D. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17478101" target="_blank"&gt;Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects&lt;/A&gt;. Neuroimage 2007; 36(3):497-510. &lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;4&lt;/pageID&gt;&lt;pageSequence&gt;5&lt;/pageSequence&gt;&lt;pageTitle&gt;Pharmacological treatments: Vascular dementia&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic review&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Kavirajan H, Schneider LS. &lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6X3F-4PBG1J0-2&amp;amp;_user=10&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;view=c&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=067821357fa7800a71024f5065f022ea" target="_blank"&gt;Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials&lt;/A&gt;. Lancet Neurol 2007; 6(9):782-92. &lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Demaerschalk B.M., Wingerchuk D.M. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17215726" target="_blank"&gt;Treatment of vascular dementia and vascular cognitive impairment&lt;/A&gt;. Neurologist 2007; 13(1):37-41.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;page&gt;&lt;pageID&gt;5&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Non-pharmacological treatments: Vascular dementia&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to 2008 Contents page&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Links are to abstracts unless specified otherwise.&lt;/EM&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Systematic Reviews&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Peng WN, Zhao H, Liu ZS, Wang S. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004987/frame.html" target="_blank"&gt;Acupuncture for vascular dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (2):CD004987-NaN.&lt;/LI&gt;
&lt;LI&gt;Wu TX, Li QP, Yuan ZY. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005382/frame.html" target="_blank"&gt;Yizhi capsule for vascular dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2007; (2):CD005382-NaN.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>294277</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=294277]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: Contents</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES,CAUSES AND PREVENTION,PATHOLOGY,TREATMENT AND CARE,DIAGNOSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The Later Life Specialist Library's Alzheimer's Disease and Dementia Annual Evidence Update aims to provide healthcare professionals with a clear path to the most important recent evidence surrounding the five major types of dementias: Alzheimers; Vascular dementia; Dementia with lewy bodies; Frontotemporal dementia; and mixed dementias.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2008: Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;/P&gt;
&lt;P style="FLOAT: right"&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID294277/nelhImp_0000_kissing_140x140.jpg"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P align=left&gt;
&lt;H1&gt;&lt;STRONG&gt;Alzheimer's Disease and Dementia&lt;/STRONG&gt;&lt;/H1&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P align=left&gt;
&lt;H1&gt;&lt;STRONG&gt;Annual Evidence Update 2008&lt;/STRONG&gt;&lt;/H1&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;The Later Life Specialist Library’s Alzheimer's Disease and Dementia Annual Evidence Update aims to provide healthcare professionals with a clear path to the most important recent evidence surrounding the five major types of dementias: Alzheimer’s; Vascular dementia; Dementia with lewy bodies; Frontotemporal dementia; and mixed dementias.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Dementia AEU provides bibliographies and clinical commentary on secondary research (systematic reviews, meta analyses and guidelines) from the last 14 months for the following topics:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;A href="nelh:293480:0" name=internalLink&gt;Definitions, Diagnosis and screening&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:293477:0" name=internalLink&gt;Risk factors and aetiology&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:293506:0" name=internalLink&gt;Pharmacological treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:293525:0" name=internalLink&gt;Non-pharmacological treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:293531:0" name=internalLink&gt;Rehabilitation, practice and care standards&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:293534:0" name=internalLink&gt;Evidence on other Dementias&lt;/A&gt;. &lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;You can read and download the methodology &lt;A href="nelh:294194:0" name=internalLink&gt;here&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;Please send us your feedback &lt;A href="http://www.library.nhs.uk/LaterLife/ContactUs.aspx" target="_blank"&gt;here&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;Link to Dementia Knowledge Week 2007: Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>294194</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=294194]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2008: Methodology</title>
    <publicationDate>2008-09-15T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The Later Life Specialist Library Alzheimer's Disease and Dementia Annual Evidence Update 2008 presents the results of extensive literature searches carried out to identify guidelines, systematic reviews and meta-analyses relating to dementia.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2008: Methodology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:294277:0" name=internalLink&gt;Link to the Alzheimer's Disease and Dementia Annual Evidence Update 2008: Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Alzheimer’s Disease and Dementia &lt;BR&gt;Annual Evidence Update 2008: Methodology&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;a.&amp;nbsp;Inclusion criteria&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;References are included if they are identified as guidelines, systematic reviews, meta-analyses, or publication types further down the evidence hierarchy which are relevant to the subject scope and have been reviewed by the clinical lead and a team of referees. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;b.&amp;nbsp;Exclusion criteria&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;We excluded references about types of dementia or cognitive disorders which are not commonly found in older people, such as: Pick’s disease, Huntington’s disease, Creutzfeldt Jakob Syndrome, Kluver Bucy Syndrome, Wernicke Encephalopathy, and Korsakoff’s Syndrome. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;c.&amp;nbsp;Publication types&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic reviews and meta-analyses are the highest level of evidence to inform clinical practice, in line with the Centre for Evidence Based Medicine’s ‘Levels of Evidence’ document (May 2001).&amp;nbsp; Our criteria for classifying a reference as a definite systematic review was based on NLH Specialist Libraries guidance on identifying systematic reviews , in combination with the definition of a systematic review from the Glossary of Cochrane Collaboration Terms on the Cochrane Collaboration website. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;d.&amp;nbsp;Sources to search&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;We searched the following databases using NLH Search 2.0 Healthcare databases advanced search:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Cinahl&lt;/LI&gt;
&lt;LI&gt;Embase&lt;/LI&gt;
&lt;LI&gt;Psycinfo&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;We also searched PubMed, the Cochrane Library and the Later Life Specialist Library. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;e.&amp;nbsp;Search period&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;We searched by Publication Year 2007-2008 in the Healthcare databases advanced search, and more specifically in PubMed (01 June 2007 – 01 August 2008). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;f.&amp;nbsp;Search strategy&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;We based the search strategy on the Cochrane Dementia and Cognitive Improvement Group’s Medline (1966 to 2008/02) search string: &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;((prevent$ or delay$ or reduc$) and (dement$ or alzheimer$ or (cognit$ adj5 impair$))).ti,ab&lt;/LI&gt;
&lt;LI&gt;((cognit$ or memory$ or mental$ or cerebral or "mild cognitive function" or mci or "brain activity") and (improv$ or enhanc$ or perform$ or process$)).ti,ab&lt;/LI&gt;
&lt;LI&gt;((prevent$ adj5 los$) or (prevent$ adj5 deteriorat$)).ti,ab&lt;/LI&gt;
&lt;LI&gt;((cognit$ adj5 declin$) or (cognit$ adj5 deficit$)).ti,ab&lt;/LI&gt;
&lt;LI&gt;3 and 4&lt;/LI&gt;
&lt;LI&gt;1 or 2 or 5&lt;/LI&gt;
&lt;LI&gt;dement$.ti,ab&lt;/LI&gt;
&lt;LI&gt;alzheimer$.ti,ab&lt;/LI&gt;
&lt;LI&gt;(lewy$ and bod$).ti,ab&lt;/LI&gt;
&lt;LI&gt;deliri$.ti,ab &lt;/LI&gt;
&lt;LI&gt;((cognit$ or memory$ or mental$) and (declin$ or impair$ or los$ or deteriorat$)).ti,ab&lt;/LI&gt;
&lt;LI&gt;(chronic and cerebrovascular) .ti,ab&lt;/LI&gt;
&lt;LI&gt;("organic brain disease" or "organic brain syndrome").ti,ab&lt;/LI&gt;
&lt;LI&gt;"supra nuclear palsy".ti,ab &lt;/LI&gt;
&lt;LI&gt;("normal pressure hydrocephalus" and shunt$).ti,ab &lt;/LI&gt;
&lt;LI&gt;"benign senescent forgetfulness".ti,ab&lt;/LI&gt;
&lt;LI&gt;(cerebr$ and deteriorat$).ti,ab&lt;/LI&gt;
&lt;LI&gt;(cerebr$ and insufficien$).ti,ab&lt;/LI&gt;
&lt;LI&gt;(confusion$ or confused) .ti,ab&lt;/LI&gt;
&lt;LI&gt;binswanger$.ti,ab &lt;/LI&gt;
&lt;LI&gt;"alzheimer disease"/&lt;/LI&gt;
&lt;LI&gt;exp "dementia vascular"/&lt;/LI&gt;
&lt;LI&gt;"lewy body disease"/&lt;/LI&gt;
&lt;LI&gt;"delirium"/&lt;/LI&gt;
&lt;LI&gt;7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24&lt;/LI&gt;
&lt;LI&gt;6 or 25&lt;/LI&gt;
&lt;LI&gt;hiv$.ti,ab&lt;/LI&gt;
&lt;LI&gt;26 not 27&lt;/LI&gt;
&lt;LI&gt;aids.ti,ab&lt;/LI&gt;
&lt;LI&gt;28 not 29&lt;/LI&gt;
&lt;LI&gt;stroke.ti,ab&lt;/LI&gt;
&lt;LI&gt;30 not 31&lt;/LI&gt;
&lt;LI&gt;diabet$.ti,ab&lt;/LI&gt;
&lt;LI&gt;32 not 33&lt;/LI&gt;
&lt;LI&gt;heart.ti,ab&lt;/LI&gt;
&lt;LI&gt;34 not 35&lt;/LI&gt;
&lt;LI&gt;epilep$.ti,ab&lt;/LI&gt;
&lt;LI&gt;36 not 37&lt;/LI&gt;
&lt;LI&gt;schizophre$.ti,ab&lt;/LI&gt;
&lt;LI&gt;38 not 39&lt;/LI&gt;
&lt;LI&gt;child$.ti,ab&lt;/LI&gt;
&lt;LI&gt;40 not 41&lt;/LI&gt;
&lt;LI&gt;systematic.ti.ab.&lt;/LI&gt;
&lt;LI&gt;42 and 43&lt;/LI&gt;
&lt;LI&gt;44 [Limit to: Publication Year 2007-2008]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;g.&amp;nbsp;Sifting and selection&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;All citations found in the searches were sifted by the Later Life Specialist Library information scientist. The references were then sent to two reviewers, Drs Amitava Banerjee and Gail Hayward, who summarised the evidence in six commentaries on the following subjects:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Definitions, Diagnosis and screening&lt;/LI&gt;
&lt;LI&gt;Risk factors and aetiology&lt;/LI&gt;
&lt;LI&gt;Pharmacological treatments&lt;/LI&gt;
&lt;LI&gt;Non-pharmacological treatments&lt;/LI&gt;
&lt;LI&gt;Rehabilitation, practice and care standards&lt;/LI&gt;
&lt;LI&gt;Evidence on other Dementias.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;h.&amp;nbsp;Results&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;BR&gt;We also included two Cochrane systematic reviews which were published after the search period:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Isaac MGEKN, Quinn R, Tabet N. &lt;A href="nelh:237409:0" name=internalLink&gt;Vitamin E for Alzheimer's disease and mild cognitive impairment&lt;/A&gt;. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD002854. DOI: 10.1002/14651858.CD002854.pub2.&lt;/LI&gt;
&lt;LI&gt;Forbes D, Forbes S, Morgan DG, Markle-Reid M, Wood J, Culum I. &lt;A href="nelh:293651:0" name=internalLink&gt;Physical activity programs for persons with dementia&lt;/A&gt;. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006489. DOI: 10.1002/14651858.CD006489.pub2.&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319931</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319931]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Contents</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;NHS Evidence - later life's&amp;nbsp;Alzheimer's Disease and Dementia Annual Evidence Update 2009 aims to provide healthcare professionals with a clear path to the most important recent evidence surrounding the five major types of dementia: Alzheimer’s; Vascular dementia; Dementia with Lewy bodies; Frontotemporal dementia; and Mixed dementias.&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319931/nelhImp_0001_old-lady-1---contents-page.jpg"&gt;&lt;/P&gt;
&lt;P&gt;The Dementia AEU provides bibliographies on secondary research (systematic reviews, meta analyses and guidelines) from the last 18 months for the following topics:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;A href="nelh:319933:1" name=internalLink&gt;Definitions, Diagnosis and Screening&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:319934:1" name=internalLink&gt;Risk Factors and Aetiology&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:319935:1" name=internalLink&gt;Pharmacological Treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:319937:1" name=internalLink&gt;Non-Pharmacological Treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:319939:1" name=internalLink&gt;Rehabilitation, Practice and Care Standards&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:319942:1" name=internalLink&gt;Evidence on Other Dementias&lt;/A&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Our bibliographies are presented in three sections:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews&lt;/STRONG&gt;&lt;BR&gt;Systematic reviews that have been published or updated in the last year.&amp;nbsp; Systematic reviews aim to find, assess and summarise all of the research that has been conducted on a specific topic.&amp;nbsp; We identify systematic reviews by checking the abstract for the key sections of a systematic review:&amp;nbsp; inclusion criteria, search strategy, study selection and evaluation, data extraction and statistical analysis.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews&lt;/STRONG&gt;&lt;BR&gt;This sub-section contains relevant reviews whose abstracts do not contain all of the key sections of a systematic review.&amp;nbsp; As such, some of these documents will be genuine systematic reviews, whilst others will be less rigorous overviews of the topic.&amp;nbsp; You should check the methods section to see if these reviews made sufficient efforts to find and include all of the relevant evidence.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other important evidence&lt;/STRONG&gt;&lt;BR&gt;We use this category as a “catch-all” for studies, such as critical appraisals of individual trials, that are relevant but do not fit into either of the above two categories.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Recent 2008-2009 Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:306183:1" name=internalLink&gt;Living well with dementia: a National Dementia Strategy&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:317635:1" name=internalLink&gt;Living well with dementia: the National Dementia Strategy joint commissioning framework for dementia&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:321654:1" name=internalLink&gt;Living well with dementia: a National Dementia Strategy Implementation Plan&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:298275:1" name=internalLink&gt;Guidance on nominating a consultee for research involving adults who lack capacity to consent&lt;/A&gt;. 2008&lt;/LI&gt;
&lt;LI&gt;Royal College of Physicians. &lt;A href="nelh:324665:1" name=internalLink&gt;Long-term neurological conditions: management at the interface between neurology, rehabilitation and pallative care&lt;/A&gt;. 2008.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;&amp;nbsp;Other Important Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:272715:1" name=internalLink&gt;Alzheimer's disease - drug treatments&lt;/A&gt;. 2007.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:277529:1" name=internalLink&gt;Commissioning Guides: Memory assessment service for the early identification and care of people with dementia&lt;/A&gt;. 2007.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:212221:1" name=internalLink&gt;Dementia: supporting people with dementia and their carers in health and social care&lt;/A&gt;. 2006.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:212247:1" name=internalLink&gt;Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease&lt;/A&gt;. 2007.&lt;/LI&gt;
&lt;LI&gt;Royal College of Psychiatrists. &lt;A href="nelh:35755:1" name=internalLink&gt;Copying clinical letters to patients: guidelines for old age psychiatrists&lt;/A&gt;. 2004.&lt;/LI&gt;
&lt;LI&gt;Royal College of Psychiatrists. &lt;A href="nelh:30175:1" name=internalLink&gt;Forgetful but not forgotten: assessment and aspects of treatment of people with dementia by a specialist old age psychiatry service&lt;/A&gt;. 2005.&lt;/LI&gt;
&lt;LI&gt;Royal College of Speech and Language Therapists. &lt;A href="nelh:300745:1" name=internalLink&gt;Position Paper: speech and language therapy provision for people with dementia&lt;/A&gt;. 2005. &lt;/LI&gt;
&lt;LI&gt;SIGN. &lt;A href="nelh:29883:1" name=internalLink&gt;Management of patients with dementia: a national clinical guideline&lt;/A&gt;. 2006.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;International Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;American College of Physicians. &lt;A href="http://www.guideline.gov/summary/summary.aspx?doc_id=12290&amp;amp;nbr=6365&amp;amp;ss=6&amp;amp;xl=999" target="_blank"&gt;Current pharmacological treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians&lt;/A&gt;. 2008.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;You can read and download the following documents below:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=319931" target="_blank"&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009 Methodology PDF&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=324874" target="_blank"&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009 Publicity Poster PDF&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=324875" target="_blank"&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009 Press Release PDF&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Please send us your feedback &lt;A href="http://www.library.nhs.uk/LaterLife/ContactUs.aspx" target="_blank"&gt;here&lt;/A&gt;.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319933</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319933]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Definitions, Diagnosis and Screening</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,LATER LIFE,DEMENTIA,OLD AGE,NOT ROUTINELY OFFERED,ALZHEIMER'S DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Definitions, Diagnosis and Screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;A href="nelh:319931:1" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:319931:0" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update&amp;nbsp;Contents Page&lt;/A&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319933/nelhImp_0001_Well-dressed-senior-couple.jpg"&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia Assessment&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This section of the AEU explores research evidence in the definition and measurement of dementia and cognitive impairment, diagnostic tests and screening instruments.&lt;/P&gt;
&lt;P&gt;The evidence includes validation studies of specific tests such as the Mini-Mental State Examination, and reviews of specific clinical symptoms and biomarkers for Alzheimer’s Disease and dementia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Adelman. S, Blanchard. M, Livingston. G. A systematic review of the prevalence and covariates of dementia or relative cognitive impairment in the older African-Caribbean population in Britain. Int J Geriatr Psychiatry 2009; 24(7):657-65.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19235788" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Carrillo-Alcala. M.E, Bermejo-Paraja. F. Dementia in nonagenarians. Systematic review of population-based studies with Spanish data. Rev Neurol 2008; 47(7):347-54.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18841545" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Martin. A.J. Driving assessment for maintaining mobility and safety in drivers with dementia. Cochrane Database of Systematic Reviews 2009; 1.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160270" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Oremus. M, Tarride. J. A systematic review of the use of contingent valuation in Alzheimer's disease research. Dementia (14713012) 2008; 7(4):461-81.&lt;BR&gt;[&lt;A href="http://dem.sagepub.com/cgi/content/abstract/7/4/461" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Von Gunten. A. Vocally disruptive behavior in the elderly: a systematic review. Int Psychogeriatr 2008; 20(4):653-72.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18272010" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Abdulrab. K, Heun. R. Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria.&amp;nbsp; European Psychiatry: the Journal of the Association of European Psychiatrists 2008; 23(5):321-30.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18434102" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Apostolova. L.G, Cummings. J.L. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. [Review] [50 refs]. Dementia &amp;amp; Geriatric Cognitive Disorders 2008; 25(2):115-26.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18087152" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bouwens. S.F. Review of goal attainment scaling as a useful outcome measure in psychogeriatric patients with cognitive disorders.&amp;nbsp; Dementia &amp;amp; Geriatric Cognitive Disorders 2008; 26(6):528-40.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19052453" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Busch. R, M, Chapin. J.S. Review of normative data for common screening measures used to evaluate cognitive functioning in elderly individuals. Clinical Neuropsychologist, 2008; 22(4):620-650.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17853152" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Carpenter. C.R.&amp;nbsp; Does This Patient Have Dementia? Ann Emerg Med, 2008; 52(5):554-6.&lt;BR&gt;[&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6WB0-4RJSHW9-5&amp;amp;_user=10&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_searchStrId=1008341614&amp;amp;_rerunOrigin=google&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=79d8d2d46d3281cb3d2298d1fc3b2e4a" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Chertkow. H, Massoud. F, Nasreddine. Z et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. [Review] [127 refs]. CMAJ Canadian Medical Association Journal 2008; 178(10):1273-85.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18458258" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Crane. P.K, Narasimhalu. K, Gibbons. L.E et al. Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. [Review] [44 refs]. J Clin Epidemiol 2008; 61(10):1018-27.e9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18455909" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gispen-De Wied. C.C, Kritsidima. M,&amp;nbsp; Elferink. A.J.A. The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES). Journal of Nutrition, Health and Aging 2009; 13(4):376-87.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19300886" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Heshka. J.T. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. [Review] [48 refs]. Genetics in Medicine 2008; 10(1):19-32.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18197053" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McLellan. T, Johnston. L, Dalrymple-Alford. J, Porter. R. The recognition of facial expressions of emotion in Alzheimer's disease: A review of findings. Acta Neuropsychiatrica 2008; 20(5):236-50.&lt;BR&gt;[&lt;A href="http://www3.interscience.wiley.com/journal/121451520/abstract?CRETRY=1&amp;amp;SRETRY=0" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mitchell. A.J. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res 2009; 43(4):411-31.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18579155" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mitchell. A.J. The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta-analysis. Int J Geriatr Psychiatry 2008; 23(11):1191-203.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18500688" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ressner. P, Hort. J, Rektorova. I. et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia. Ceska a Slovenska Neurologie a Neurochirurgie 2008; 71(4):494-501.&lt;BR&gt;[&lt;A href="http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;amp;SrcAuth=Alerting&amp;amp;SrcApp=Alerting&amp;amp;DestApp=WOS&amp;amp;DestLinkType=FullRecord&amp;amp;KeyUT=000259079900018" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schillaci. O,&amp;nbsp; Travascio. L,&amp;nbsp; Bruni. C. et al. Molecular imaging and magnetic resonance imaging in early diagnosis of alzheimer's disease. A literature review. Neuroradiology Journal 2008; 21(6):755-771. &lt;BR&gt;[&lt;A href="http://www.centauro.it/theneuroradiologyjournal/indice_21_06_december_2008.htm" target="_blank"&gt;Full text print only&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schwindt. G.C, Black. S.E. Functional imaging studies of episodic memory in Alzheimer's disease: a quantitative meta-analysis. Neuroimage 2009; 45(1):181-90.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19103293" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tranel. D, Rudrauf. D, Vianna. E.P, Damasio. H. Does the Clock Drawing Test have focal neuroanatomical correlates? Neuropsychology 2008; 22 (5):553-62.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18763875" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wiederkehr. S, Simard. M, Fortin. C, Van Reekum. R. Comparability of the clinical diagnostic criteria for vascular dementia: A critical review. Part I. Journal of Neuropsychiatry and Clinical Neurosciences 2008; 20(2):150-161. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18451186" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Xiong. C. Evaluating the quality of longitudinal statistical applications in original publications on Alzheimer's disease. Neuroepidemiology 2008; 30(2):112-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18334827" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Yuan. Y. Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol 2009; 30(2):404-10.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19001534" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other important evidence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;De Santi. S, Pirraglia. E, Barr. W. et al. Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology 2008; 22(4):469-84.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18590359" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jagger. C. The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS). Age &amp;amp; Ageing 2009; 38(3):319-25; discussion 251.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19258397" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/A&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319942</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319942]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Evidence on Other Dementia's</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Evidence on Other Dementia's&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:319931:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2009 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia3.html" target="_blank"&gt;NHS Choices&amp;nbsp;Map of Medicine - Dementia - Vascular Dementia&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia4.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia with Lewy Bodies (DLB)&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319942/nelhImp_0000_Elderly-Man-smiling.jpg"&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This section contains all of the reviews we found that focused specifically on non-Alzheimer’s Disease dementias:&amp;nbsp; Vascular dementia, Dementia with Lewy Bodies, Frontotemporal dementia and Mixed dementias.&lt;/P&gt;
&lt;P&gt;The material encompasses aetiology, risk factors, symptoms, diagnosis and treatment.&lt;/P&gt;
&lt;P&gt;You should also consult the material in other sections, as some of the reviews may be applicable to other dementias.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Ding. J. Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. [Review] [53 refs]. Br J Ophthalmol 2008; 92(8):1017-25.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18614569" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hao. Z, Liu. M, Liu. Z, Lv. D. Huperzine A for vascular dementia. Cochrane Database of Systematic Reviews 2009; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007365/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jirong. Y, Yang. X, Wu. T, Defen. S, Dong. B. Zhiling Decoction for vascular dementia. Cochrane Database of Systematic Reviews 2004; 4. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004670/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;López Arrieta. J, Birks. J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database of Systematic Reviews 2002; 3. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000147/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGuinness. B, Craig. D, Bullock. R, Passmore. P. Statins for the prevention of dementia. Cochrane Database of Systematic Reviews 2009; 2. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003160/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Uthman. O.A. Adjunctive therapies for AIDS dementia complex. Cochrane Database of Systematic Reviews 2008.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006496/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wild. R, Pettit. T.A.C.L, Burns. A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database of Systematic Reviews 2003; 3.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003672/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wu. T, Qingpu. L, Zhenyong. Y. Yizhi capsule for vascular dementia. Cochrane Database of Systematic Reviews 2007; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005382/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Bornhoft. G, Maxion-Bergemann. S, Matthiessen. P.F. External validity of clinical trials for treatment of dementia with ginkgo biloba extracts. Z Gerontol Geriatr 2008; 41(4):298-312.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18327688" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Farrall. A.J. Blood-brain barrier: Ageing and microvascular disease - systematic review and meta-analysis. Neurobiol Aging 2009; 30(3):337-52.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17869382" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Feldman. H.H, Pirttila. T, Dartigues. J.F et al. Analyses of mortality risk in patients with dementia treated with galantamine. Acta Neurol Scand 2009; 119(1):22-31.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18518863" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Liu. H, Liu. M, Li. W et al. Association of ACE I/D gene polymorphism with vascular dementia: a meta-analysis. [Review] [62 refs]. Journal of Geriatric Psychiatry &amp;amp; Neurology 2009; 22(1):10-22.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19073835" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mendez. M.F, Lauterbach. E.C, Sampson. S.M. ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. [Review] [192 refs]. Journal of Neurology and Psychiatry 2008; 20(2):130-49.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18451185" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schroeter. M.L. Neural networks in frontotemporal dementia--a meta-analysis. Neurobiol Aging 2008; 29(3):418-26.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17140704" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wiederkehr. S, Simard. M, Fortin. C, Van-Reekum. R. Comparability of the clinical diagnostic criteria for vascular dementia: A critical review. Part I. Journal of Neuropsychiatry and Clinical Neurosciences 2008; 20(2):150-161.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18451186" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other relevant evidence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Gareri. P. The safety of clozapine in the elderly.&amp;nbsp; Expert Opinion on Drug Safety 2008; 7(5):525-38.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18759705" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hallam. B.J. Clinical presentation of prodromal frontotemporal dementia. American Journal of Alzheimer's Disease and Other Dementias 2008; 22(6):456-67.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18166605" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mendez. M, F,&amp;nbsp; Shapira.J et al. Psychotic symptoms in frontotemporal dementia: Prevalence and review. Dementia and Geriatric Cognitive Disorders 2008; 25(3):206-211.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18204254" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319937</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319937]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Non-pharmacological Treatments</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,COMPLEMENTARY AND ALTERNATIVE MEDICINE,ACUPUNCTURE,AROMATHERAPY,HERBAL MEDICINE,CONDITIONS A-Z,DEMENTIA,CONDITIONS A-B,CONDITIONS D-E,ALZHEIMER'S DISEASE,SEPTEMBER 2009]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Non-pharmacological Treatments&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:319931:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2009 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319937/nelhImp_0001_Aged-Mother-and-Mature-Daug.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This section contains recent evidence on non-drug interventions for dementia and Alzheimer’s Disease.&lt;/P&gt;
&lt;P&gt;We included research on the use of psychological interventions to prevent cognitive decline, exercise regimens for people with dementia and other interventions such as occupational therapy (cost effectiveness analysis), dog-assisted therapy, simulated presence therapy and snoezelen.&lt;/P&gt;
&lt;P&gt;This section also contains research on complementary and alternative medicines (CAM) including acupuncture and aromatherapy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Chung. J.C.C, Lai. C.K.Y. Snoezelen for dementia. Cochrane Database of Systematic Reviews 2002; 4. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003152/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Forbes. D, Forbes. S, Morgan. D.G, Markle-Reid. M, Wood. J, Culum. I. Physical activity programs for persons with dementia. Cochrane Database of Systematic Reviews 2008; 3.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006489/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lee. M.S. Acupuncture for Alzheimer's disease: A systematic review. Int J Clin Pract 2009; 63(6):874-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19490197" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;May. B.H. Herbal medicine for dementia: a systematic review. [Review] [60 refs]. Phytother Res 2009; 23(4):447-59.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19086008" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McCarney. R.W, Warner. J, Fisher. P, van Haselen. R. Homeopathy for dementia. Cochrane Database of Systematic Reviews 2003; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003803/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Nguyen. Q.A P.C . The use of aromatherapy to treat behavioural problems in dementia.&amp;nbsp; Int J Geriatr Psychiatry 2008; 23(4):337-46.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17918182" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;O'Connor. D.W. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. Int Psychogeriatr 2009; 21(2):241-51.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19138459" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ozkan. B. Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature. [Review] [74 refs]. American Journal of Alzheimer's Disease &amp;amp; Other Dementias 2008; 23(4):344-54.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18509106" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Spijker. A V-. Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis. [Review] [33 refs]. J Am Geriatr Soc 2008; 56(6):1116-28.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18410323" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zetteler. J.&amp;nbsp;&amp;nbsp; Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis. [Review] [43 refs]. Aging &amp;amp; Mental Health 2008; 12(6):779-85.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19023729" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Beuscher. L, Beck. C. A literature review of spirituality in coping with early-stage Alzheimer's disease. Journal of Nursing &amp;amp; Healthcare of Chronic Illnesses 2008; 17(5A):88-98.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18298759" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Buettner. L, Richeson. N.E, Yu. F, et al. Evidence supporting exercise interventions for persons in early-stage Alzheimer's disease. American Journal of Recreation Therapy 2008; 7(1):17-25.&lt;BR&gt;[&lt;A href="http://en.scientificcommons.org/45683850" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cummings. J, L, Mackell. J, Kaufer. D. Behavioral effects of current Alzheimer's disease treatments: A descriptive review. Alzheimer's and Dementia 2008; 4(1):49-60.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18631950" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fischer-Terworth. C. Psychological interventions in dementia: An evaluative review. Zeitschrift Fur Psychiatrie, Psychologie Und Psychotherapie 2009; 57(3):195-206.&lt;/LI&gt;
&lt;LI&gt;Guo. X.X, Jin. H.S, Huo. L, Zheng. J,&amp;nbsp; Zhou. X.M. Meta-analysis on acupuncture for treatment of dementia. [Chinese]. Zhongguo Zhenjiu 2008; 28(2):140-4.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18405161" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Herrmann. N, Gauthier. S. Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. [Review] [72 refs]. CMAJ Canadian Medical Association Journal 2008; 179(12):1279-87.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19047609" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Heyn. P.C, Johnson. K.E, Kramer. A.F. Endurance and strength training outcomes on cognitively impaired and cognitively intact older adults: a meta-analysis. Journal of Nutrition, Health &amp;amp; Aging; 2008, 12(6):401-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18548179" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hogan. D, B, Bailey. P, et al. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Canadian Medical Association Journal 2008; 179(8):787-793.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18838454" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Man. S.C. Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease. [Review] [117 refs]. Journal of Alzheimer's Disease 2008; 14(2):209-23.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18560132" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Perkins. J, Bartlett. H, Travers. C, Rand. J. Dog-assisted therapy for older people with dementia: a review. Australasian Journal on Ageing 2008; 27(4):177-83.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19032618" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Saddichha. S, Pandey. V. Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies. [Review] [105 refs]. American Journal of Alzheimer's Disease &amp;amp; Other Dementias 2008; 23(2):150-61.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18332476" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Witzke. J, Rhone. R.A, Backhaus. D, Shaver. N.A. How sweet the sound: research evidence for the use of music in Alzheimer's dementia. J Gerontol Nurs 2008; 34(10):45-53.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18942539" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Yu. F. Cognitive training for early-stage Alzheimer's disease and dementia. [Review] [35 refs]. J Gerontol Nurs 2009; 35(3):23-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19326826" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other relevant evidence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Draper B. Occupational therapy is cost-effective for older people with dementia and their caregivers.&amp;nbsp; Evidence-Based Mental Health 2008; 11:83.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/11/3/83" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Farlow. M, R, Miller. M, L, Pejovic. V. Treatment options in Alzheimer's disease: Maximizing benefit, managing expectations. Dementia and Geriatric Cognitive Disorders 2008; 25(5):408-422. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18391487" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Moniz-Cook. E, Vernooij-Dassen. M, Woods. R. et al. A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging &amp;amp; Mental Health 2008; 12(1):14-30.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18297476" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319935</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319935]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Pharmacological Treatments</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Pharmacological Treatments&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:319931:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2009 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia Alzheimer's Disease&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;BR&gt;This section contains recent evidence on drug treatments for the treatment of Alzheimer’s Disease and dementia.&amp;nbsp; Within this category we have included treatments for specific symptoms, such as cognitive function and behaviour, the use of supplements, herbal and traditional medicines, homeopathy and the potential risks and side effects of treatments.&lt;/P&gt;
&lt;P&gt;Note also the guidelines published in the Canadian Medical Association Journal&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319935/nelhImp_0000_Elderly-woman-with-bible.jpg"&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Ashford. J,&amp;nbsp; McCabe. D,&amp;nbsp; Wheeler-Hegland. K et al.&amp;nbsp; Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part III - Impact of dysphagia treatments on populations with neurological disorders. J Rehabil Res Dev 2009; 46(2):195-204.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19533533" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birks. J, Flicker. L. Selegiline for Alzheimer's disease. Cochrane Database of Systematic Reviews 2003; 1. (published 2003, updated 2008?)&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000442/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birks. J, Grimley Evans. J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews 2009; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003120/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birks. J, Grimley-Evans. J, Iakovidou. V, Tsolaki. M. Rivastigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2009; 2. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001191/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birks. J, Wilcock. G.K. Velnacrine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2004; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004748/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bornhoft. G, Maxion-Bergemann. S, Matthiessen. P.F. External validity of clinical trials for treatment of dementia with ginkgo biloba extracts. Z Gerontol Geriatr 2008; 41(4):298-312.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18327688" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Campbell. N, Ayub. A, Boustani. M.A. et al. Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis. Clinical Interventions In Aging 2008; 3(4):719-28.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19281064" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Chow. T.W. Insufficient evidence on Huperzine A for Alzheimer’s. Evidence-Based Mental Health 2008; (11):112&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18952961" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Coelho Filho JMJMC, Birks. J. Physostigmine for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews 2001; 2.&amp;nbsp;&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/3512944" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Figiel. G, Sadowsky. C. A. Systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders. [Review] [62 refs]. Current Medical Research &amp;amp; Opinion 2008; 24(1):157-66.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18036286" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fioravanti. M, Yanagi. M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews 2005; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000269/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Flicker. L, Grimley-Evans. J. Piracetam for dementia or cognitive impairment. Cochrane Database of Systematic Reviews 2004; 1. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001011/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Frampton. M.A, Harvey. R.J, Kirchner. V. Propentofylline for dementia. Cochrane Database of Systematic Reviews 2003; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002853/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Grimley-Evans. J, Malouf. R, Huppert. F.A.H, Van Niekerk. J.K. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database of Systematic Reviews 2006; 4.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006221/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hansen. R.A. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. [Review] [65 refs]. Clinical Interventions In Aging 2008; 3(2):211-25.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18686744" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hao. Z, Liu. M, Liu. Z, Lv. D. Huperzine A for vascular dementia. Cochrane Database of Systematic Reviews 2009; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007365/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hoffmann F. Cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia. Evidence-Based Mental Health 2008; (11):113.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/11/4/113" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hogervorst. E, Yaffe. K, Richards. M, Huppert. F.A.H. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database of Systematic Reviews 2009; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003799/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jansen. S.L, Forbes. D, Duncan. V, Morgan. D.G. Melatonin for cognitive impairment. Cochrane Database of Systematic Reviews 2006; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003802/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jones. R, Laake. K, Øksengård. A.R. D-cycloserine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2002; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003153/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kirchner. V, Kelly. C.A, Harvey. R.J. Thioridazine for dementia. Cochrane Database of Systematic Reviews 2001; 4.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000464/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Klugman. A, Sauer. J, Tabet. N, Howard. R. Alpha lipoic acid for dementia. Cochrane Database of Systematic Reviews 2004; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004244/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Konovalov. S. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. [Review] [57 refs]. Int Psychogeriatr 2008; 20(2):293-308.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18047764" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Krishnan. S, Cairns. R, Howard. R. Cannabinoids for the treatment of dementia. Cochrane Database of Systematic Reviews 2009; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007204/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lethaby. A. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database of Systematic Reviews 2008; 1.&lt;BR&gt;[&lt;A href="http://www.cochrane.org/reviews/en/ab003122.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Li. J, Wu. H.M, Zhou. R.L, Liu. G.J, Dong. B.R. Huperzine A for Alzheimer's disease. Cochrane Database of Systematic Reviews 2008; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003122/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lonergan. E, Luxenberg. J, Colford. J.M, Birks. J. Haloperidol for agitation in dementia. Cochrane Database of Systematic Reviews 2002; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002852/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lonergan. E, Luxenberg. J. Valproate preparations for agitation in dementia. Cochrane Database of Systematic Reviews 2009; 3.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003945/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;López-Arrieta. J, Sanz. FJFJS. Nicotine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2001; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001749/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;López-Arrieta. J, Schneider. L. Metrifonate for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003155/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Maidment. I.D. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis. Ann Pharmacother 2008; 42(1):32-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18056833" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Martinón-Torres. G, Fioravanti. M, Grimley-Evans. J. Trazodone for agitation in dementia. Cochrane Database of Systematic Reviews 2004; 3.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004990/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mohan. M. Memantine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews 2009; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007657/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Molnar. F.J. Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. J Am Geriatr Soc 2009; 57(3):536-47.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19187414" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Oremus. M. Systematic review of economic evaluations of Alzheimer's disease medications. Expert Review of Pharmacoeconomics and Outcomes Research 2008; 8(3):273-89.&lt;BR&gt;[&lt;A href="http://www.ingentaconnect.com/content/ftd/erp/2008/00000008/00000003/art00008" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Overshott. R. Cholinesterase inhibitors for delirium.&amp;nbsp; Cochrane Database of Systematic Reviews 2008; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005317/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ozkan. B. Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature. [Review] [74 refs]. American Journal of Alzheimer's Disease &amp;amp; Other Dementias 2008; 23(4):344-54.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18509106" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Rands. G, Orrell. M, Spector. A.E. Aspirin for vascular dementia. Cochrane Database of Systematic Reviews 2000; 4.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001296/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Rodríguez. J.L, Qizilbash. N, López-Arrieta. J. Thiamine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2001; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001498/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sampson. E.L. Metal protein attenuating compounds for the treatment of Alzheimer's disease. Cochrane Database of Systematic Reviews 2008; 1.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005380/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schneider. L, Olin. J.T, Novit. A, Luczak. S. Hydergine for dementia. Cochrane Database of Systematic Reviews 2000; 3.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000359/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Szatmári. S, Bereczki. D. Procaine treatments for cognition and dementia. Cochrane Database of Systematic Reviews 2008; 4.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005993/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tabet. N, Feldman. H. Ibuprofen for Alzheimer's disease. Cochrane Database of Systematic Reviews; 2003, (2).&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004031/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tabet. N, Feldman. H. Indomethacin for Alzheimer's disease. Cochrane Database of Systematic Reviews 2002; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003673/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Van Dam. F. Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch Gerontol Geriatr 2009;&amp;nbsp; 48(3):425-30.&lt;BR&gt;[&lt;A href="http://www.journals.elsevierhealth.com/periodicals/agg/article/PIIS016749430800071X/abstract" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wild. R, Pettit. T.A.C.L, Burns. A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database of Systematic Reviews 2003; 3.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003672/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wu. T, Qingpu. L, Zhenyong. Y. Yizhi capsule for vascular dementia. Cochrane Database of Systematic Reviews 2007; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005382/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Astrup. A, Meier. D.H, Mikkelsen. B.O, Villumsen. J.S, Larsen TM. Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease. Obesity 2008; 16(6):1363-9.&lt;BR&gt;[&lt;A href="http://www.nature.com/oby/journal/v16/n6/full/oby200856a.html" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ballard. C, Day. S, Sharp. S, Wing. G, Sorensen. S. Neuropsychiatric symptoms in dementia: importance and treatment considerations. [Review] [85 refs]. International Review of Psychiatry 2008; 20(4):396-404.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18925489" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bernardo. C.G, Singh. V, Thompson. P.M. Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders. [Review] [85 refs]. Expert Opinion on Drug Safety 2008; 7(4):435-45.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18613807" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cummings. J, L, Mackell. J,&amp;nbsp; Kaufer. D. Behavioral effects of current Alzheimer's disease treatments: A descriptive review. Alzheimer's and Dementia 2008; 4(1):49-60.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18631950" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Deberdt. W.G, Siegal. A, Ahl. J, Meyers. A.L, Landbloom. R. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis. Int J Geriatr Psychiatry 2008; 23(4):364-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17708584" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Desilets. A.R, Gickas. J.J, Dunican. K.C. Role of huperzine a in the treatment of Alzheimer's disease.&amp;nbsp; Ann Pharmacother 2009; 43(3):514-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19240260" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Diniz. B, Pinto. Jr. J, Gonzaga. M. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2009; 259(4):248-56.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19224111" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Emre. M, Mecocci. P, Stender. K. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease. Journal of Alzheimer's Disease 2008; 14(2):193-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18560130" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Farlow. M, R,&amp;nbsp; Miller. M, L,&amp;nbsp; Pejovic. V. Treatment options in Alzheimer's disease: Maximizing benefit, managing expectations. Dementia and Geriatric Cognitive Disorders 2008; 25(5):408-422.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18391487" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Feldman. H.H, Pirttila. T, Dartigues. J.F. et al. Analyses of mortality risk in patients with dementia treated with galantamine. Acta Neurol Scand 2009; 119(1):22-31.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18518863" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gauthier. S, Loft. H, Cummings. J. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry, 2008; 23(5):537-45.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18058838" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Grossberg. G.T. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease. Dementia &amp;amp; Geriatric Cognitive Disorders, 2009; 27(2):164-72.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19194105" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Guay. D.R.&amp;nbsp; Rivastigmine transdermal patch: role in the management of Alzheimer's disease.&amp;nbsp; Consultant Pharmacist 2008; 23(8):598-609.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19032006" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Herrmann. N, Gauthier. S. Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. [Review] [72 refs]. CMAJ Canadian Medical Association Journal 2008; 179(12):1279-87.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19047609" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hogan. D, B,&amp;nbsp; Bailey. P, et al. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Canadian Medical Association Journal 2008; 179(8):787-793.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18838454" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jacobson. S, A, Sabbagh. M, N. Donepezil: Potential neuroprotective and disease-modifying effects. Expert Opinion on Drug Metabolism and Toxicology 2008; 4(10):1363-1369.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18798705" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kavirajan. H. Memantine: a comprehensive review of safety and efficacy. Expert Opinion on Drug Safety 2009; 8(1):89-109.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18798705" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kim. Y. Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. Drugs &amp;amp; Aging 2008; 25(3):187-96.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18331071" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lanctot. K, L, Rajaram. R, D, Herrmann. N. Therapy for Alzheimer's disease: How effective are current treatments? Therapeutic Advances in Neurological Disorders 2009; 2(3):163-180.&lt;BR&gt;[&lt;A href="http://tan.sagepub.com/cgi/content/abstract/2/3/163" target="_blank"&gt;SAGE abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Locca. J.F, Bula. C.J, Zumbach. S, Bugnon. O. Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: development of practice recommendations in a Swiss canton. [Review] [50 refs]. Journal of the American Medical Directors Association 2008; 9(6):439-48.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18585647" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Madhusoodanan. S, Shah. P. Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole. Clinical Interventions In Aging 2008; 3(3):491-501.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18982919" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mazzucco. S, Cipriani. A, Barbui. C, Monaco. S. Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review. [Review] [38 refs]. Mini-Reviews in Medicinal Chemistry; 2008, 8(8):776-83.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18673133" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McNeal. K, M, Meyer. R, et al. Using risperidone for Alzheimer's dementia-associated psychosis. Expert Opinion on Pharmacotherapy 2008; 9(14):2537.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18778191" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Nieoullon. A. Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine.&amp;nbsp; Current Medical Research &amp;amp; Opinion 2008; 24(12):3357-67.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19032118" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Raina. P, Santaguida. P, Ismaila. A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008; 148(5):379-97.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18316756" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Saddichha. S, Pandey. V. Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies. [Review] [105 refs]. American Journal of Alzheimer's Disease &amp;amp; Other Dementias 2008; 23(2):150-61.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18332476" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wang. B.S, Wang. H, Wei. Z.H, Song. Y.Y, Zhang. L, Chen. H.Z. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. J Neural Transm 2009; 116(4):457-65.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19221692" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other relevant evidence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Arlt. S, Lindner. R, Rosler. A , Von Renteln-Kruse. W. Adherence to medication in patients with dementia: Predictors and strategies for improvement. Drugs Aging 2008; 25(12):1033-47.v&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19021302" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ballard C. Atypical antipsychotics fail to improve functioning or quality of life in people with Alzheimer’s disease. Evidence-Based Mental Health 2009; (12):20.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/12/1/20" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ballard. C, Lana. M, Theodoulou. M, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Medicine / Public Library of Science 2008; 5(4):e76.&lt;BR&gt;[&lt;A href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0050076" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ballard. C, Hanney. M.L, Theodoulou. M et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.&amp;nbsp; Lancet Neurology 2009; 8 (2):151-7.&lt;BR&gt;[&lt;A href="http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(08)70295-3/abstract" target="_blank"&gt;Full text requiures payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Esposito. E. Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia.&amp;nbsp; Evidence-Based Mental Health 2009; (12):23.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/12/1/23" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kales. H.C. New use of antipsychotic drugs in elderly people with dementia may increase the mortality risk.&amp;nbsp; Evidence-Based Mental Health 2008; (11):54.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/11/2/54" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Liperoti. R. Starting a conventional antipsychotic increases risk of death more than an atypical antipsychotic in elderly people with dementia. Evidence-Based Mental Health 2009; (12):58.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/12/2/58" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Pelosi. A. Donepezil is no more effective than placebo for agitation in people with Alzheimer’s disease.&amp;nbsp; Evidence-Based Mental Health 2008; (11):84.&lt;BR&gt;[&lt;A href="http://ebmh.bmj.com/cgi/content/extract/11/3/84" target="_blank"&gt;EBMH abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319939</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319939]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Rehabilitation, Practice and Care Standards</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Rehabilitation, Practice and Care Standards&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:319931:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2009 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319939/nelhImp_0002_Caring-for-husband.jpg"&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This section contains important new evidence about all aspects of caring for people with dementia or Alzheimer’s Disease.&lt;/P&gt;
&lt;P&gt;The scope includes feeding, predictors of nursing home admissions, risk factors for falls in people with dementia, telehealth and other new technologies, quality of life research&lt;/P&gt;
&lt;P&gt;There is a substantial amount of evidence about supporting caregivers, including providing information, respite care, telehealth and psychological interventions.&lt;/P&gt;
&lt;P&gt;The evidence also encompasses broader social issues, such as housing, and research about different settings of care:&amp;nbsp; acute care, the role of general practitioners and palliative care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;STRONG&gt;Systematic reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Chang. C.C. Feeding difficulty in older adults with dementia. J Clin Nurs 2008; 17(17):2266-74.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18705703" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Dassen. T. Fall risk factors in older people with dementia or cognitive impairment: a systematic review. J Adv Nurs 2009; 65(5):922-34.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19291191" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Department of Health. Joint commissioning framework for dementia 2009; 72 pgs. &lt;BR&gt;[&lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_100835" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Docherty. A. Knowledge and information needs of informal caregivers in palliative care: A qualitative systematic review. Palliat Med 2009; 22(2):153-71.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18372380" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gaugler. J.E. Predictors of nursing home admission for persons with dementia.&amp;nbsp; Med Care 2009; 47(2):191-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19169120" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hall. S. Interventions for improving palliative care for older people living in nursing care homes. Cochrane Database of Systematic Reviews 2008; 2.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007132/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Huss. A, Stuck. A.E, et al. Multidimensional preventive home visit programs for community-dwelling older adults: A systematic review and meta-analysis of randomized controlled trials. J Gerontol A Biol Sci Med Sci 2008; 63(3):298-307.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/cldare/articles/DARE-12008103944/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lee. H, Cameron. M.H. Respite care for people with dementia and their carers. Cochrane Database of Systematic Reviews 2004; 1.&amp;nbsp;&amp;nbsp;&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004396/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&amp;nbsp; &lt;/LI&gt;
&lt;LI&gt;Lorenz. K.A. Clinical guidelines. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med 2008; 148(2):147-60.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18195339" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Martin. S. Smart home technologies for health and social care support.&amp;nbsp; Cochrane Database of Systematic Reviews 2008; 4.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006412/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McAuliffe. L. Pain assessment in older people with dementia: literature review. J Adv Nurs 2009; 65(1):2-10.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19016920" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Powell. J. A systematic review of networked technologies supporting carers of people with dementia. [Review] [15 refs]. Journal of Telemedicine &amp;amp; Telecare 2008; 14(3):154-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18430288" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Quinn. C. The impact of the quality of relationship on the experiences and wellbeing of caregivers of people with dementia: a systematic review. Aging &amp;amp; Mental Health 2009; 13(2):143-55.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19347681" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sampson. E.L, Candy. B, Jones. L. Enteral tube feeding for older people with advanced dementia. Cochrane Database of Systematic Reviews 2009; 2. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007209/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Warner. J. Psychological interventions for caregivers of people with dementia.&amp;nbsp; Evidence-Based Mental Health 2008; (11):53.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18441142" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Young. J, Lambley. R, Langhorne. P. Medical day hospital care for the elderly versus alternative forms of care. Cochrane Database of Systematic Reviews 2008; 4.&lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001730/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Arlt. S, Lindner. R, Rosler. A, Von Renteln-Kruse. W. Adherence to medication in patients with dementia: Predictors and strategies for improvement. Drugs Aging 2008; 25(12):1033-47.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19021302" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Baker. K.L, Robertson. N. Coping with caring for someone with dementia: reviewing the literature about men. Aging &amp;amp; Mental Health 2008; 12(4):413-23.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18791888" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Banerjee. S, Samsi. K, Petrie. C.D&amp;nbsp; et al. What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia. Int J Geriatr Psychiatry, 2009; 24(1):15-25.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18727132" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birch. D, Draper. J. A critical literature review exploring the challenges of delivering effective palliative care to older people with dementia. J Clin Nurs 2008; 17(9):1144-64.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18416791" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Botsis. T, Hartvigsen. G. Current status and future perspectives in telecare for elderly people suffering from chronic diseases. [Review] [65 refs]. Journal of Telemedicine &amp;amp; Telecare 2008; 14(4):195-203.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18534954" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bryon. E, De Casterl. B, Gastmans. C. Nurses' attitudes towards artificial food or fluid administration in patients with dementia and in terminally ill patients: a review of the literature. J Med Ethics 2008; 34(6):431-7.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18511614" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cox. K. Improving the quality of rural nursing care. Annu Rev Nurs Res 2008; (26):175-95.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18709750" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Herrmann. N, Gauthier. S. Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. [Review] [72 refs]. CMAJ Canadian Medical Association Journal 2008; 179(12):1279-87.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19047609" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hogan. D.B, Bailey. P, et al. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Canadian Medical Association Journal 2008; 179(8):787-793.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18838454" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hogan. D.B, Bailey. P, Black. S et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. [Review] [62 refs]. CMAJ Canadian Medical Association Journal 2008; 179(10):1019-26.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18981443" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Konno. R. Assisting caregivers to support people with dementia living in the community. J Adv Nurs 2009; 65(4):773-774.&lt;BR&gt;[&lt;A href="http://pt.wkhealth.com/pt/re/janu/abstract.00004471-200904000-00006.htm;jsessionid=KqSBv073hQtwd0LGqpW58GBjTTyyRdvSLqtHyC3BXTSYQN10W7JB!783167578!181195629!8091!-1" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mason. B.J, Harrison. B.E. Telephone interventions for family caregivers of patients with dementia: what are best nursing practices? Holist Nurs Pract 2008; 22(6):348-55.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18981815" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Moyle. W. Best practice for the management of older people with dementia in the acute care setting: a review of the literature. International Journal of Older People Nursing 2008; 3(2):121-31.&lt;BR&gt;[&lt;A href="http://www.ingentaconnect.com/content/bpl/opn/2008/00000003/00000002/art00007" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Murray. L.M, Boyd. S. Protecting personhood and achieving quality of life for older adults with dementia in the U.S. Health care system. J Aging Health 2009; 21(2):350-375.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19114609" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;NHS End of Life Care Programme. NHS End of Life Care Programme. National End of Life Care Programme.&lt;BR&gt;[&lt;A href="http://www.dh.gov.uk/en/Healthcare/IntegratedCare/Endoflifecare/DH_086083" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Parker. D. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review. International Journal of Evidence-Based Healthcare 2008; 6(2):137-73.&lt;BR&gt;[&lt;A href="http://www3.interscience.wiley.com/journal/120089995/abstract" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ryan. T. End-of-life care for people with dementia: A thematic review of familial involvement, practices and beliefs. International Journal on Disability and Human Development 2009 8(1):15-20. &lt;BR&gt;[Print only]&lt;/LI&gt;
&lt;LI&gt;Ryan. T, Ingleton. C. Commentary on Birch D and Draper J (2008) A critical literature review exploring the challenges of delivering effective palliative care to older people with dementia.&amp;nbsp; J Clin Nurs 2009; 18(1):150-152.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19120741" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schoenmakers. B, Buntinx. F, Delepeleire. J. What is the role of the general practitioner towards the family caregiver of a community-dwelling demented relative? A systematic literature review. [Review] [42 refs]. Scand J Prim Health Care 2009; 27(1):31-40.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19040191" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sikkes. S. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. [Review] [56 refs]. Journal of Neurology, Neurosurgery &amp;amp; Psychiatry 2009; 80(1):7-12.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19091706" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Smith. D.A. Treatment of Alzheimer's disease in the long-term-care setting. Am J Health Syst Pharm 2009; 66(10):899-908.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19420308" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tilly. J, Reed. P. Falls, wandering, and physical restraints: a review of interventions for individuals with dementia in assisted living and nursing homes. Alzheimer's Care Today 2008; 9(1):45-51.&lt;BR&gt;[&lt;A href="https://www.nursingcenter.com/library/JournalArticle.asp?Article_ID=772640" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tilly. J, Reed. P. Literature review: intervention research on caring for people with dementia in assisted living and nursing homes. Alzheimer's Care Today 2008; 9(1):24-33.&lt;BR&gt;[&lt;A href="https://www.nursingcenter.com/library/JournalArticle.asp?Article_ID=772632" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Topo. P. Technology studies to meet the needs of people with dementia and their caregivers: a literature review. J Appl Gerontol 2009; 28(1):5-38.&lt;BR&gt;[&lt;A href="http://jag.sagepub.com/cgi/content/abstract/28/1/5" target="_blank"&gt;SAGE abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Verbeek. H. Small, homelike care environments for older people with dementia: a literature review. Int Psychogeriatr 2009; 21(2):252-64. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19102801" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other relevant evidence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Chappell. N.L.&amp;nbsp; Carers of people with dementia: no benefit of adding befriending initiative to usual care.&amp;nbsp; Evidence-Based Mental Health 2008; (11):121.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18952970" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kim. Y, Schulz. R. Family caregivers' strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving. Journal of Aging &amp;amp; Health 2008; 20(5):483-503.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18420838" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lecouturier. J,&amp;nbsp; Bamford. C,&amp;nbsp; Hughes. J, et al. Appropriate disclosure of a diagnosis of dementia: Identifying the key behaviours of 'best practice'. BMC Health Services Research 2008; 95(8).&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18452594" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tobias. M, Yeh. L.C, Johnson. E. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031. Australian &amp;amp; New Zealand Journal of Psychiatry 2008; 42(9):828-36.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18696288" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>319934</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=319934]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2009: Risk Factors and Aetiology</title>
    <publicationDate>2009-09-14T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2009: Risk Factors and Aetiology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=384150&amp;amp;pgID=1" target="_blank"&gt;Link to 2010 Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:319931:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2009 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This section contains material about risk factors for dementia and cognitive decline.&amp;nbsp; The evidence explores links with cardiovascular risk factors such as blood pressure, glucose intolerance, interactions with other drug treatments and links with obesity, smoking and alcohol use.&amp;nbsp; Prognostic reviews, reporting the likely progression of disease, are also included.&lt;BR&gt;&amp;nbsp;&lt;BR&gt;We also include material about prevention, such as Vitamin B6 supplementation, statins and blood pressure lowering.&amp;nbsp;&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319934/nelhImp_0000_elderly-man.jpg"&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Anstey. K.J, et al. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008; 16(5):343-54.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18448847" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cechetto. D.F, Hachinski. V, Whitehead. S.N. Vascular risk factors and Alzheimer's disease. [Review] [101 refs]. Expert Review of Neurotherapeutics 2008; 8(5):743-50.&lt;BR&gt;[&lt;A href="http://www.ingentaconnect.com/content/ftd/ern/2008/00000008/00000005/art00008" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Di Bona. D, et al. Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. [Review] [34 refs]. Brain Research Reviews 2008; 59(1):155-63.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18675847" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ferreira. P.C. Aluminum as a risk factor for Alzheimer's disease. Revista Latino-Americana De Enfermagem (RLAE) 2008, 16(1):151-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18392545" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fischer. C.E. Functional outcome in delusional Alzheimer disease patients: a systematic review. Dementia &amp;amp; Geriatric Cognitive Disorders 2009; 27(2):105-11.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19169029" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Garcia. A.M, Sisternas. A, Hoyos. S.P. Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis. Int J Epidemiol 2008; 37(2):329-40.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18245151" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lamport. D.J, Lawton. C, et al. Impairments in glucose tolerance can have a negative impact on cognitive function: A systematic research review. Neuroscience and Biobehavioral Reviews 2009; 33(3):394-413.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19026680" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lu. F.P. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. [Review] [82 refs]. PLoS ONE [Electronic Resource] 2009; 4(1):e4144.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19127292" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Malouf. R, Grimley-Evans. J. Vitamin B6 for cognition. Cochrane Database of Systematic Reviews 2003; 4. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004393/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGuinness. B, Craig. D, Bullock. R, Passmore. P. Statins for the prevention of dementia. Cochrane Database of Systematic Reviews 2009; 2. &lt;BR&gt;[&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003160/frame.html" target="_blank"&gt;Wiley abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGuinness. B. Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. [Review] [3 refs]. Journal of Neurology,Neurosurgery &amp;amp; Psychiatry 2008; 79(1):4-5.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18079296" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Papp. K.V. Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directions. [Review] [47 refs]. Alzheimer's &amp;amp; Dementia 2009; 5(1):50-60.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19118809" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Paradise. M. Systematic review of the effect of education on survival in Alzheimer's disease. Int Psychogeriatr 2009; 21(1):25-33.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19026089" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Peters. R. Alcohol, dementia and cognitive decline in the elderly: a systematic review.[see comment]. [Review] [52 refs]. Age &amp;amp; Ageing 2008; 37(5):505-12.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18487267" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Peters. R. Haemoglobin, anaemia, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatrics 2008; 8(18).&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18691409" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Purnell. C. Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. [Review] [70 refs]. Alzheimer Disease &amp;amp; Associated Disorders 2009; 23(1):1-10.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18703981" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Barrosl. A, C,&amp;nbsp; Lucatelli. J, et al. Genetic influence on late onset Alzeimer's disease. Revista De Psiquiatria Clinica 2009; 36(1):16-24. [Spanish]&lt;BR&gt;[&lt;A href="http://www.scielo.br/scielo.php?pid=S0101-60832009000100004&amp;amp;script=sci_abstract" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bertram. L, Tanzi. R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. [Review] [110 refs]. Nature Reviews Neuroscience 2008; 9(10):768-78.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18802446" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Beydoun. M.A. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. [erratum appears in Obes Rev. 2008 May;9(3):267]. Obesity Reviews 2008; 9(3):204-18.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18331422" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birns. J. Cognitive function and hypertension. J Hum Hypertens 2009; 23(2):86-96.&lt;BR&gt;[&lt;A href="http://www.nature.com/jhh/journal/v23/n2/abs/jhh200880a.html" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bourbonnais. A, Ducharme. F. Screaming in elderly persons with dementia. Dementia (14713012) 2008; 7(2):205-26.&lt;BR&gt;[&lt;A href="http://dem.sagepub.com/cgi/content/abstract/7/2/205" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Chang. C.L. Obesity and Alzheimer's disease. Hong Kong Journal of Psychiatry 2008; 18(1):28-36.&lt;BR&gt;[&lt;A href="http://findarticles.com/p/articles/mi_6882/is_1_18/ai_n28506007/?tag=content;col1" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Duron. E, Hanon. O. Hypertension, cognitive decline and dementia. [Review] [62 refs]. Archives of Cardiovascular Diseases 2008; 101(3):181-9.&lt;BR&gt;[&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B8JH0-4SSRK65-9&amp;amp;_user=10&amp;amp;_rdoc=1&amp;amp;_fmt=&amp;amp;_orig=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_searchStrId=1004499554&amp;amp;_rerunOrigin=google&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=3c8848dae9d3113e7f55ddc131fc99bc" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hernan. M.A. Cigarette smoking and dementia: potential selection bias in the elderly.[Review] [19 refs]. Epidemiology 2008; 19(3):448-50.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18414087" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Huang. T. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pacific Journal of Clinical Nutrition 2008; 17(1):8-16.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18364320" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Huang. T.L. Weight loss occurs over a decade prior to dementia diagnosis: comment on meta-analysis of obesity as a risk factor for dementia and its subtypes. Obesity Reviews 2008; 9(6):631-2; author reply 633-4.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18801008" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jagger. C. The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS). Age &amp;amp; Ageing 2009; 38(3):319-25; discussion 251.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19258397" target="_blank"&gt;Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;Kamat. C, D, Gadal. S, et al. Antioxidants in central nervous system diseases: Preclinical promise and translational challenges. Journal of Alzheimer's Disease 2008; 15(3):473-493&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18997301" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kavvoura. F.K, McQueen. M.B, Khoury. M.J, Tanzi. R.E, Bertram. L, Ioannidis. J.P. Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease. Am J Epidemiol 2008; 168(8):855-65.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18779388" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Llorca. J, Rodriguez-Rodriguez. E, Dierssen-Sotos. T, Delgado-Rodriguez. M, Berciano. J, Combarros. O. Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease. Acta Neurol Scand 2008; 117(1):1-14.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17854420" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lucatelli. J, F,&amp;nbsp; BAGenetic influence on early onset Alzeimer's disease. Revista De Psiquiatria Clinica 2009; 36(1):25-30&lt;BR&gt;[&lt;A href="http://www.openj-gate.org/browse/ArticleList.aspx?issue_id=1005625&amp;amp;Journal_id=120321" target="_blank"&gt;Abstract only&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Michelsen. K, The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease. Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance. Progress in Brain Research 2008; 172:233-64.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18772036" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Luppa. M, Luck. T, Brunhler. E , Kunig. H, Riedel-Heller. S.G. Prediction of institutionalisation in dementia. A systematic review. Dementia &amp;amp; Geriatric Cognitive Disorders 2008; 26(1):65-79.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18617737" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mitchell. A, J,&amp;nbsp; Shiri-Feshki. M. Rate of progression of mild cognitive impairment to dementia - Meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica 2009; 119(4):252-265&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19236314" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mitchell. A, J,&amp;nbsp; Shiri-Feshki. M. Temporal trends in the long term risk of progression of mild cognitive impairment: A pooled analysis. Journal of Neurology, Neurosurgery and Psychiatry 2008; 79(12):1386-1391&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19010949" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Poon. I. O. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy 2008; 28(3):366-375&lt;BR&gt;[&lt;A href="http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.28.3.366?cookieSet=1&amp;amp;journalCode=phco" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schaeffer. E.L. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.&amp;nbsp; Psychopharmacology (Berl) 2008; 198(1):1-27.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18392810" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sotiropoulos. I, Cerqueira. J.J, Catania. C, Takashima. A, Sousa. N, Almeida. O.F. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. [Review] [206 refs]. Neuroscience &amp;amp; Biobehavioral Reviews 2008; 32(6):1161-73.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18573532" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Strachan. M.W. The relationship between type 2 diabetes and dementia. Br Med Bull 2008; 88(1):131-46.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19029150" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other relevant evidence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Esposito. E. Short term use of antipsychotics increases the risk of serious adverse events in elderly people with dementia. Evidence-Based Mental Health 2009; (12):23.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19176782" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wilson. R.S. Elderly women with larger social networks are less likely to develop dementia. Evidence-Based Mental Health 2009; (12):22.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19176781" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384150</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384150]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Contents</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,PATHOLOGY,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;NHS Evidence - later life's&amp;nbsp;Alzheimer's Disease and Dementia AEU 2010 aims to provide healthcare professionals with a clear path to the most important recent evidence surrounding the five major types of dementia: Alzheimer’s; Vascular dementia; Dementia with Lewy bodies; Frontotemporal dementia; and Mixed dementias.&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319931/nelhImp_0001_old-lady-1---contents-page.jpg"&gt;&lt;/P&gt;
&lt;P&gt;The Dementia AEU provides bibliographies on secondary research (systematic reviews, meta analyses and guidelines) from the last 18 months for the following topics:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;A href="nelh:384152:1" name=internalLink&gt;Definitions, Diagnosis, Screening&amp;nbsp;and Prevention&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:384158:1" name=internalLink&gt;Risk Factors and Aetiology&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:384156:1" name=internalLink&gt;Pharmacological Treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:384154:1" name=internalLink&gt;Non-Pharmocological Treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:384157:1" name=internalLink&gt;Models of Dementia Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:384153:1" name=internalLink&gt;Evidence on Other Dementias&lt;/A&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Recent Guidelines (2009 - 2010):&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Department of Health. &lt;A href="http://www.library.nhs.uk/LaterLife/ViewResource.aspx?resID=291261&amp;amp;tabID=288" target="_blank"&gt;End of Life Care Strategy: Second Annual Report&lt;/A&gt;. 2010.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:379753:1" name=internalLink&gt;Quality standard for dementia&lt;/A&gt;. 2010.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:381863:1" name=internalLink&gt;Delirium: diagnosis, prevention and management&lt;/A&gt;. 2010.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:338938:1" name=internalLink&gt;Improving care and saving money: learning the lessons on prevention and early intervention for older people&lt;/A&gt;. 2010.&lt;/LI&gt;
&lt;LI&gt;Royal College of Psychiatrists. &lt;A href="nelh:331030:1" name=internalLink&gt;Dementia and people with learning disabilities&lt;/A&gt;. 2009&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:306183:1" name=internalLink&gt;Living well with dementia: a National Dementia Strategy&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:317635:1" name=internalLink&gt;Living well with dementia: the National Dementia Strategy joint commissioning framework for dementia&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:321654:1" name=internalLink&gt;Living well with dementia: a National Dementia Strategy Implementation Plan&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Royal College of Physicians. &lt;A href="nelh:324665:1" name=internalLink&gt;Long-term neurological conditions: management at the interface between neurology, rehabilitation and pallative care&lt;/A&gt;. 2008.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other important Guidelines &amp;amp; Publications:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;College of Optometrists. &lt;A href="nelh:328519:1" name=internalLink&gt;Code of ethics and guidelines for professional conduct C4: examining a patient with dementia&lt;/A&gt;. 2010.&lt;/LI&gt;
&lt;LI&gt;General Medical Council. &lt;A href="nelh:61418:1" name=internalLink&gt;Treatment and care towards the end of life: good practice in decision making&lt;/A&gt;. 2010.&lt;/LI&gt;
&lt;LI&gt;Department of Health. &lt;A href="nelh:329921:1" name=internalLink&gt;Report on the prescribing of anti-psychotic drugs to people with dementia&lt;/A&gt;. 2009&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:258475:1" name=internalLink&gt;Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;Alzheimer's Society. &lt;A href="nelh:311980:1" name=internalLink&gt;Dementia: What every commissioner needs to know&lt;/A&gt;. 2009&lt;/LI&gt;
&lt;LI&gt;NHS End of Life Care. &lt;A href="nelh:304177:1" name=internalLink&gt;Commissioning End of Life Care&lt;/A&gt;. 2009.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:277529:1" name=internalLink&gt;Commissioning Guide: Memory assessment service for the early identification and care of people with dementia&lt;/A&gt;. 2007.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:272715:1" name=internalLink&gt;Alzheimer's disease - drug treatments&lt;/A&gt;. 2007.&lt;/LI&gt;
&lt;LI&gt;NICE. &lt;A href="nelh:212221:1" name=internalLink&gt;Dementia: supporting people with dementia and their carers in health and social care&lt;/A&gt;. 2006.&lt;/LI&gt;
&lt;LI&gt;SIGN. &lt;A href="nelh:29883:1" name=internalLink&gt;Management of patients with dementia: a national clinical guideline&lt;/A&gt;. 2006.&lt;/LI&gt;
&lt;LI&gt;Royal College of Psychiatrists. &lt;A href="nelh:30175:1" name=internalLink&gt;Forgetful but not forgotten: assessment and aspects of treatment of people with dementia by a specialist old age psychiatry service&lt;/A&gt;. 2005.&lt;/LI&gt;
&lt;LI&gt;Royal College of Speech and Language Therapists. &lt;A href="nelh:387846:1" name=internalLink&gt;&lt;A href="nelh:387846:1" name=internalLink&gt;Position Paper: speech and language therapy provision for people with dementia&lt;/A&gt;&lt;/A&gt;. 2005. &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Other important publications:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;House of Commons Public Accounts Committee. &lt;A href="nelh:347198:1" name=internalLink&gt;Improving dementia services&amp;nbsp; in England - an interim report: Nineteenth report of session 2009-2010&lt;/A&gt;. 2010.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;International Guidelines:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;American College of Physicians. &lt;A href="http://www.guideline.gov/summary/summary.aspx?doc_id=12290&amp;amp;nbr=6365&amp;amp;ss=6&amp;amp;xl=999" target="_blank"&gt;Current pharmacological treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians&lt;/A&gt;. 2008.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;You can read and download the following documents below:&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=384150" target="_blank"&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010 Methodology PDF&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=387159" target="_blank"&gt;&lt;/A&gt;&lt;/P&gt;Please send us your feedback &lt;A href="http://www.library.nhs.uk/LaterLife/ContactUs.aspx" target="_blank"&gt;here&lt;/A&gt;. 
&lt;P&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384152</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384152]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Definitions, Diagnosis, Screening and Prevention</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Definitions, Diagnosis, Screening and Prevention&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:384150:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia Assessment&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia - Management&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319933/nelhImp_0001_Well-dressed-senior-couple.jpg"&gt;The category of definitions contains evidence relating to how we define and understand dementia. This includes: reviews of experimental models, practitioner roles, prevalence studies and social, personal and economic impact of dementia.&lt;/P&gt;
&lt;P&gt;We have grouped the evidence into the following subtopics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Definitions&lt;/LI&gt;
&lt;LI&gt;Diagnosis&lt;/LI&gt;
&lt;LI&gt;Screening&lt;/LI&gt;
&lt;LI&gt;Prevention&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Definitions:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This sub-topic contains important new evidence about the prevalence, nature and definition of dementia.&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Aselage M.B, et al. &lt;STRONG&gt;Ethical issues in conducting research with persons with dementia&lt;/STRONG&gt;. Southern Online Journal of Nursing Research 2009; 9:4.&lt;BR&gt;[&lt;A href="http://snrs.org/publications/SOJNR_articles2/Vol09Num04Art04.pdf" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Caddell L et al. &lt;STRONG&gt;The impact of dementia on self and identity: A systematic review&lt;/STRONG&gt;. Clinical Psychology Review 2010;30(1):113-126. &lt;BR&gt;[&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6VB8-4XG3SG1-2&amp;amp;_user=10&amp;amp;_coverDate=02%2F28%2F2010&amp;amp;_rdoc=1&amp;amp;_fmt=high&amp;amp;_orig=search&amp;amp;_origin=search&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_searchStrId=1449844040&amp;amp;_rerunOrigin=google&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=99b975daef79d4f988e41b91a5796bd5&amp;amp;searchtype=a" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;de Pedro-Cuesta J, et al. &lt;STRONG&gt;Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys 1990-2008&lt;/STRONG&gt;. BMC Neurology 2009;9:55. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed?term=prevalence%20of%20dementia%20and%20major%20dementia%20subtypes%20in%20spanish%20populations%20a%20reanalysis%20of%20dementia%20prevalence%20survey,1990-2008.&amp;amp;cmd=correctspelling" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Garcia S, et al. &lt;STRONG&gt;Alzheimer's disease: An outlook from its first description toward a molecular perspective&lt;/STRONG&gt;. Medicina Interna De Mexico 2009;25(4):300-312. &lt;BR&gt;[&lt;A href="http://www.imbiomed.com/1/1/articulos.php?method=showDetail&amp;amp;id_articulo=58628&amp;amp;id_seccion=1480&amp;amp;id_ejemplar=5932&amp;amp;id_revista=47" target="_blank"&gt;Abstract in Spanish&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Keage H, et al. &lt;STRONG&gt;Population studies of sporadic cerebral amyloid angiopathy and dementia: A systematic review&lt;/STRONG&gt;. BMC Neurology 2009;3(9):3. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19144113" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Manzano S, et al. &lt;STRONG&gt;Experimental models in Alzheimer's disease&lt;/STRONG&gt;. Neurologia 2009;24(4):255-262. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19603296" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Villars H, et al. &lt;STRONG&gt;The primary care physician and Alzheimer's disease: an international position paper&lt;/STRONG&gt;. The Journal of Nutrition, Heallth &amp;amp; Aging 2010. 14(2):110-120. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20126959" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Aldelman S, et al. &lt;STRONG&gt;A systematic review of the prevalence and covariates of dementia or relative impairment in the older African-Caribbean population in Britain&lt;/STRONG&gt;. Internations Journal of Geriatric Psychiatry 2009; 24(7):657-665.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19235788" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kopf D, et al. &lt;STRONG&gt;Risk of incident Alzheimer's disease in diabetic patients: A systematic review of prospective trials&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009; 16(4):677-685. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19387104" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Luck T, et al. &lt;STRONG&gt;Incidence of mild cognitive impairment: A systematic review&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders 2010; 22(2):164-175. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20150735" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cooper C, et al. &lt;STRONG&gt;A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care and research&lt;/STRONG&gt;. The American Journal of Geriatric Psychiatry 2010;18(3):193-203.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20224516" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ito K, et al. &lt;STRONG&gt;Disease progression meta-analysis model in Alzheimer's disease&lt;/STRONG&gt;. Alzheimer's and Dementia 2010;6(1):39-53. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19592311" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schaeffer E, et al. &lt;STRONG&gt;Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-satge Alzheimer disease&lt;/STRONG&gt; 2009;202(1-3):37-51.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18853146" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Quentin W, et al. &lt;STRONG&gt;Cost-of-illness studies of dementia: A systematic review focusing on stage dependency of costs&lt;/STRONG&gt;. Acta Psychiatrica Scandinavica 2010;121(4):243-259. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19694634" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Diagnosis:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This sub-category contains evidence about the diagnosis and prognosis of dementia. It includes evidence on: assessment of symptoms, outcome measure validation studies and validations of specific diagnostic tests:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Barnes J, et al. &lt;STRONG&gt;A meta-analysis of hippocampal atrophy rates in Alzheimer's disease&lt;/STRONG&gt;. Neurobiology of Ageing 2009;30(11):1711-1723. &lt;BR&gt;[&lt;A href="http://www.neurobiologyofaging.org/article/S0197-4580%2808%2900026-2/abstract" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bradford A, et al. &lt;STRONG&gt;Missed and delayed diagnosis of dementia in primary care: Prevalence and contributing factors&lt;/STRONG&gt;. Alzheimer's Disease and Associated Disorders 2009;23(4):306-314.&lt;BR&gt;[&lt;A href="http://journals.lww.com/alzheimerjournal/Abstract/2009/10000/Missed_and_Delayed_Diagnosis_of_Dementia_in.2.aspx" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Durand-Martel P, et al. &lt;STRONG&gt;Autopsy as gold standard in FDG-PET studies in dementia&lt;/STRONG&gt;. Canadian Journal of Neurological Sciences 2010;37(3):336-342. &lt;BR&gt;[&lt;A href="http://translate.google.co.uk/translate?hl=en&amp;amp;sl=fr&amp;amp;u=http://cat.inist.fr/%3FaModele%3DafficheN%26cpsidt%3D22751764&amp;amp;ei=VpxSTNKcLoH60wSq_4W4Cw&amp;amp;sa=X&amp;amp;oi=translate&amp;amp;ct=result&amp;amp;resnum=2&amp;amp;ved=0CB0Q7gEwAQ&amp;amp;prev=/search%3Fq%3DAutopsy%2Bas%2Bgold%2Bstandard%2Bin%2BFDG-PET%2Bstudies%2Bin%2Bdementia.%2BCanadian%2BJournal%2Bof%2BNeurological%2BSciences.%2B%2B37%283%29%2B%28Pp%2B336-342%29,%2B2010.%2BDate%2Bof%2BPublication:%2B01%2BMay%2B2010.%26hl%3Den" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fischer C, et al. &lt;STRONG&gt;Functional outcome in delusional Alzheimer's disease patients: A systematic review&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders 2009;27(2):105-110. &lt;BR&gt;[&lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&amp;amp;ArtikelNr=194659&amp;amp;Ausgabe=244213&amp;amp;ProduktNr=224226&amp;amp;filename=194659.pdf" target="_blank"&gt;Link to full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gaugler J.E, et al. &lt;STRONG&gt;Predictors of nursing home admission for persons with dementia&lt;/STRONG&gt;. Medical Care 2009;47(2):191-198.&lt;BR&gt;[&lt;A href="http://journals.lww.com/lww-medicalcare/Abstract/2009/02000/Predictors_of_Nursing_Home_Admission_for_Persons.9.aspx" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Huntley J.D, et al. &lt;STRONG&gt;Working memory in early Alzheimer's disease: A neuropsychological review&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2010;25(2):121-132. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19672843" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Iiiffe S, et al, &lt;STRONG&gt;Primary care and dementia: 1. Diagnosis, screening and disclosure&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2009;24(9):895-901. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19226529" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Iverson D, et al. &lt;STRONG&gt;Practice parameter update: Evaluation and management of driving risk in dementia: Report of the quality standards subcommittee of the American academy of neurology&lt;/STRONG&gt;. Neurology 2010;74(16):1316-1324.&lt;BR&gt;[&lt;A href="http://www.neurology.org/cgi/content/abstract/74/16/1316" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jahn K, et al. &lt;STRONG&gt;Gait disturbances in old age - Classification, diagnosis and treatment from a neurological perspecive&lt;/STRONG&gt;. Deutsches Arzteblatt 2010;107(17):306-316.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20490346" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Laws K.R, et al. &lt;STRONG&gt;'Normal' semantic-phonemic fluency discrepancy in Alzheimer's disease? A meta-analytic study&lt;/STRONG&gt;. Cortex 2010;46(5):595-601.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19560132" target="_blank"&gt;Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;Lee M, et al. &lt;STRONG&gt;Dementia and Life Expectancy: What Do We Know?&lt;/STRONG&gt; Journal of the American Medical Directors Association 2009;10(7):466-471. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19716062" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Low L, et al. &lt;STRONG&gt;Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review&lt;/STRONG&gt;. Neuroscience and Biobehavioral Reviews 2009;34(3):408-437.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19720080" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Luppa M, et al. &lt;STRONG&gt;Prediction of institutionalization in the elderly. A systematic review&lt;/STRONG&gt;. Age and Ageing 2010;39(1):31-38.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19934075" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McAuliffe L, et al. &lt;STRONG&gt;Pain assessment in older people with dementia: Literature review&lt;/STRONG&gt;.&amp;nbsp;Journal of Advanced Nursing 2009;65(1):2-10.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19016920" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mitchell A, et al. &lt;STRONG&gt;Rate of progression of mild cognitive impairment to dementia - Meta-analysis of 41 robust inception cohort studies&lt;/STRONG&gt;. Acta Psychiatrica Scandinavica 2009;119(4):252-265.&lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2008.01326.x/abstract" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Monastero R, et al. &lt;STRONG&gt;A systematic review of neuropsychiatric symptoms in mild cognitive impairment&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009;18(1):11-30.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19542627" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Monge-Argiles J, A,&amp;nbsp; et al. &lt;STRONG&gt;Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer's disease&lt;/STRONG&gt;. Revista De Neurologia 2010;50(4):193-200.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20198590" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Shub D, et al. &lt;STRONG&gt;The link between psychosis and aggression in persons with dementia: A systematic review&lt;/STRONG&gt;. Psychiatric Quarterly 2010;81(2):97-110.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20058077" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sikkes S, et al. &lt;STRONG&gt;A systematic review of Instrumental Activities of Daily Living scales in dementia: Room for improvement&lt;/STRONG&gt;. Journal of Neurology, Neurosurgery and Psychiatry 2009;80(1):7-12. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19091706" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Stein J, et al. &lt;STRONG&gt;The assessment of changes in cognitive functioning: Reliable change indices for neuropsychological instruments in the elderly - A systematic review&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders 2010;29(3):275-286.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20375509" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Thomas H. &lt;STRONG&gt;Attitudes of primary care team to diagnosing dementia&lt;/STRONG&gt;. Nursing Older People 2010;22(3):23-27. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20432783" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Yuan Y, et al. &lt;STRONG&gt;Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to alzheimer disease in patients with mild cognitive impairment: A meta-analysis&lt;/STRONG&gt;. American Journal of Neuroradiology 2009;30(2): 404-410. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19001534" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zhou B, et al. &lt;STRONG&gt;Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009;18(1):89-102. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19542628" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Screening:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This section contains important new evidence from reviews about screening for dementia.&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Ehreke L, et al. &lt;STRONG&gt;Is the clock drawing test a screening tool for the diagnosis of mild cognitive impairment? A systematic review&lt;/STRONG&gt;. International Psychogeriatrics 2010;22(1):56-63. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19691908" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Iliffe S, et al. &lt;STRONG&gt;Primary care and dementia: 1. Diagnosis, screening and disclosure&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2009;24(9):895-901.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19226529" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lonie J, A, et al. &lt;STRONG&gt;Screening for mild cognitive impairment: A systematic review&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2009;24(9):902-915.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19226524" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Pinto E, et al. &lt;STRONG&gt;Literature review of the Clock Drawing Test as a tool for cognitive screening&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders 2009;27(3): 201-213. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19225234" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Prevention:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This section contains review evidence on possible approaches to the prevention of dementia.&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Aarsland D, et al. &lt;STRONG&gt;Is physical activity a potential preventive factor for vascular dementia? A systematic review&lt;/STRONG&gt;. Aging &amp;amp; Mental Health 2010; 14(4). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20455113" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Andrieu S, et al. &lt;STRONG&gt;Methodological issues in primary prevention trials for neurodegenerative dementia&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009;16(2):235-270. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19221415" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Conti A, et al. &lt;STRONG&gt;The potential role of leisure in the prevention of dementia&lt;/STRONG&gt;. Annual in Therapeutic Recreation. 2009. &lt;BR&gt;[&lt;A href="http://www.atra-online.com/" target="_blank"&gt;Abstract requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;George D, et al. &lt;STRONG&gt;The role of nutrients in the prevention and treatment of Alzheimer's disease: Methodology for a systematic review&lt;/STRONG&gt;. European Journal of Neurology 2009;16(1):8-11) &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19703214" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGuinness B, &lt;STRONG&gt;Statins for the prevention of dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;2. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20687089" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGuinness B, et al. &lt;STRONG&gt;Blood pressure lowering in patients without priot cerebrovascular disease for prevention of cognitive impairment and dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;4. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19821318" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Muangpaisan W,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Systematic review of statins for the prevention of vascular dementia or dementia&lt;/STRONG&gt;. Geriatrics &amp;amp; Gerontology International 2010; 10(2). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20100290" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Purandare N. &lt;STRONG&gt;Preventing dementia: Role of vascular risk factors and cerebral emboli&lt;/STRONG&gt;. British Medical Bulletin 2009;91(1):49-59. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19515691" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Stern C, et al. &lt;STRONG&gt;Physical leisure activities and their role in preventing dementia: A systematic review&lt;/STRONG&gt;. International Journal of Evidence-Based Healthcare 2009;7(4):270-282.&lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/doi/10.1111/j.1744-1609.2009.00144.x/abstract" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Stern C,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Cognitive leisure activities and their role in preventing dementia: A systematic review&lt;/STRONG&gt;. International Journal of Evidence-Based Healthcare 2010;8(1):2-17. &lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/doi/10.1111/j.1744-1609.2010.00150.x/pdf" target="_blank"&gt;Link to full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Thompson H, et al. &lt;STRONG&gt;Health-and disease-related biomarkers in aging research&lt;/STRONG&gt;. Research in Gerontological Nursing 2009;2(2):137-148. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20077975" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Travers C, et al. &lt;STRONG&gt;Barriers and enablers of health promotion, prevention and early intervention in primary care: Evidence to inform the Australian national dementia strategy&lt;/STRONG&gt;. Australasian Journal on Ageing 2009;28(2):51-57. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19566797" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Valenzuela M, et al. &lt;STRONG&gt;Can cognitive exercise prevent the onset of dementia? systematic review of randomized clinical trials with longitudinal follow-up&lt;/STRONG&gt;. American Journal of Geriatric Psychiatry 2009;17(3):179-187. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19225276" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Van Dam F, et al. &lt;STRONG&gt;Hyperhomocysteinemia and Alzheimer's disease: A systematic review&lt;/STRONG&gt;. Archives of Gerontology and Geriatrics 2009;48(3):425-430. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18479766" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Harlein J, et al. &lt;STRONG&gt;Fall risk factors in older people with dementia or cognitive impairment: A systematic review&lt;/STRONG&gt;. Journal of Advanced Nursing 2009;65(5):922-933. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19291191" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Price J D, et al. &lt;STRONG&gt;Subjective barriers to prevent wandering of cognitively impaired people&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;3. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384153</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384153]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Evidence on Other Dementias</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Evidence on Other Dementias&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:384150:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2010 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices&amp;nbsp;Map of Medicine - Dementia - Assessment&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia - Management&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319942/nelhImp_0000_Elderly-Man-smiling.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This section contains important new evidence from reviews about vascular dementia. &lt;/P&gt;
&lt;P&gt;We have grouped the evidence into the following subtopics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Diagnosis, symptoms and prevalence&lt;/LI&gt;
&lt;LI&gt;Risk factors&lt;/LI&gt;
&lt;LI&gt;Treatment&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Diagnosis, symptoms and prevalence:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Aarsland D,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Is physical activity a potential preventive factor for vascular dementia? A systematic review&lt;/STRONG&gt;. Aging &amp;amp; Mental Health 2010;14:(4). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20455113" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bodden M, et al. &lt;STRONG&gt;Theory of mind in Parkinson's disease and related basal ganglia disorders: A systematic review&lt;/STRONG&gt;. Movement Disorders 2010;25(1):13-27. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19908307" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mathias J.L, et al. &lt;STRONG&gt;Cognitive Functioning in Alzheimer's and Vascular Dementia: A Meta-Analysis&lt;/STRONG&gt;. Neuropsychology 2009;23(4):411-423.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19586206" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Muangpaisan W, et al. &lt;STRONG&gt;Systematic review of statins for the prevention of vascular dementia or dementia&lt;/STRONG&gt;. Geriatrics &amp;amp; Gerontology International 2010;10(2):199-208. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20100290" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Shub D, et al. &lt;STRONG&gt;Comparison of behavioral and psychological symptoms in persons with vascular dementia and Alzheimer's disease: A review&lt;/STRONG&gt;. Minerva Psichiatrica 2010;51(1):27-36. &lt;BR&gt;[&lt;A href="http://www.minervamedica.it/en/journals/minerva-psichiatrica/article.php?cod=R17Y2010N01A0027" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Risk factors:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Liu H, et al. &lt;STRONG&gt;Association of ACE I/D gene polymorphism with vascular dementia: A meta-analysis&lt;/STRONG&gt;. Journal of Geriatric Psychiatry and Neurology 2009;22(1):10-22. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19073835" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Liu H, et al. &lt;STRONG&gt;The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis&lt;/STRONG&gt;. Journal of the Neurological Sciences 2010;294(1-2):74-80.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20441995" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Pinkston J.B, et al.&amp;nbsp;&lt;STRONG&gt;Stroke and dementia&lt;/STRONG&gt;. Neurological Research 2009;31(8):824-831.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19723451" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Savva G.M et al. &lt;STRONG&gt;Epidemiological studies of the effect of stroke on incident dementia: A systematic review&lt;/STRONG&gt;. Stroke 2010;41(1):E41-E46. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19910553" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Treatment:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Birks J, et al. &lt;STRONG&gt;Nimodipine for primary degenerative, mixed and vascular dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2010,(3). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab000147.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;De Paula V, et al. &lt;STRONG&gt;The role of TAU protein in the pathophysiology of frontotemporal dementia&lt;/STRONG&gt;. Revista De Psiquiatria Clinica 2009;36(5):212-217. &lt;BR&gt;[&lt;A href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;amp;pid=S0101-60832009000500004&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hao Z, et al. &lt;STRONG&gt;Huperzine A for vascular dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(2). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19370686" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kavirajan H, et al. &lt;STRONG&gt;Memantine: a comprehensive review of safety and efficacy&lt;/STRONG&gt;. Expert Opinion on Drug Safety 2009;8(1):89-109. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19236221" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wong C.L, et al. &lt;STRONG&gt;Cost-Effectiveness: Cholinesterase inhibitors and memantine in vascular dementia&lt;/STRONG&gt;. Canadian Journal of Neurological Sciences 2009;36(6):735-739. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19960752" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wu T, et al. &lt;STRONG&gt;Yizhi capsule for vascular dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;2. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17443586" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384157</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384157]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Models of Dementia Care</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Models of Dementia Care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:384150:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2010 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices&amp;nbsp;Map of Medicine - Dementia - Assessment&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia - Management&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319939/nelhImp_0002_Caring-for-husband.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This section contains important new evidence from reviews about models of dementia care.&lt;/P&gt;
&lt;P&gt;We have grouped the&amp;nbsp;evidence into the following subtopics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Evaluations of models of care&lt;/LI&gt;
&lt;LI&gt;Management of nutrition, sleeping and incontinence&lt;/LI&gt;
&lt;LI&gt;Person-centred care&lt;/LI&gt;
&lt;LI&gt;Care support&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Evaluations of models of care:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Ablitt A,&amp;nbsp;et al. &lt;STRONG&gt;Living with dementia: A systematic review of the influence of relationship factors&lt;/STRONG&gt;. Aging and Mental Health 2009;13(4):497-511. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19629774" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Adams T. &lt;STRONG&gt;The applicability of a recovery approach to nursing people with dementia&lt;/STRONG&gt;. International Journal of Nursing Studies 2010;47(5):626-634. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20197187" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Chenoweth L, et al.&amp;nbsp;&lt;STRONG&gt;A systematic review of what factors attract and retain nurses in aged and dementia care&lt;/STRONG&gt;. Journal of Clinical Nursing 2010;19(1-2):156-167. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20500254" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Collet J, et al. &lt;STRONG&gt;Efficacy of integrated interventions combining psychiatric care and nursing home care for nursing home residents: a review of the literature&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2010;25(1):3-13.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19513988" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Comondore V.R, et al. &lt;STRONG&gt;Quality of care in for-profit and not-for-profit nursing homes: Systematic review and meta-analysis&lt;/STRONG&gt;. BMJ 2009;339(7717):381-384.&amp;nbsp;&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19654184" target="_blank"&gt;Pubmed abstract&lt;/A&gt;] &lt;/LI&gt;
&lt;LI&gt;Cooper C,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research&lt;/STRONG&gt;. The American Journal of Geriatric Psychiatry 2010;18(3):2010:193-203. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20224516" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Courtenay K, et al. &lt;STRONG&gt;Caregiving and adults with intellectual disabilities affected by dementia&lt;/STRONG&gt;. Journal of Policy and Practice in Intellectual Disabilities 2010;7(1):26-33. &lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/doi/10.1111/j.1741-1130.2010.00244.x/pdf" target="_blank"&gt;Link to full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gaugler J, et al. &lt;STRONG&gt;Predictors of nursing home admission for persons with dementia&lt;/STRONG&gt;. Medical Care 2009;47(2):191-198. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19169120" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lai C.K, et al. &lt;STRONG&gt;Special care units for dementia individuals with behavioural problems&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;4. &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab006470.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]]&lt;/LI&gt;
&lt;LI&gt;Luppa M, et al. &lt;STRONG&gt;Gender differences in predictors of nursing home placement in the elderly: A systematic review&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(6):1015-1025 &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19589192" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Luppa M, et al. &lt;STRONG&gt;Prediction of institutionalization in the elderly. A systematic review&lt;/STRONG&gt;. Age and Ageing 2010;39(1):31-38. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19934075" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGilton K.S, et al. &lt;STRONG&gt;A systematic review of the effectiveness of communication interventions for health care providers caring for patients in residential care settings&lt;/STRONG&gt;. Worldviews on Evidence-Based Nursing 2009;6(3):149-159. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19523033" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Oeseburg B, et al. &lt;STRONG&gt;Effects of case management for frail older people or those with chronic illness: a systematic review&lt;/STRONG&gt;. Nursing Research 2009;58(3):201-210. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19448524" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Rampatige R, et al &lt;STRONG&gt;The effect of continuing professional education on health care outcomes: Lessons for dementia care&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(1):S34-S43. &lt;BR&gt;[&lt;A href="http://journals.cambridge.org/action/displayAbstract?fromPage=online&amp;amp;aid=5218216" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Robinson L, et al. &lt;STRONG&gt;Primary care and dementia: 2. Long-term care at home: Psychosocial interventions, information provision, carer support and case management&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2010;25(7):657-664.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19946862" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schoenmakers B, et al. &lt;STRONG&gt;Factors determining the impact of care-giving on caregivers of elderly patients with dementia. A systematic literature review&lt;/STRONG&gt;. Maturitas 2010;66(2):191-200.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20307942" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Shaw C, et al. &lt;STRONG&gt;Systematic review of respite care in the frail elderly&lt;/STRONG&gt;. Health Technology Assessment 2009;13(20):1-224. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19393135" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Vasse E, et al. &lt;STRONG&gt;A systematic review of communication strategies for people with dementia in residential and nursing homes&lt;/STRONG&gt;. International Psychogeriatrics 2010;22(2):189-200.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19638257" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Verbeek H, et al. &lt;STRONG&gt;Small, homelike care environments for older people with dementia: A literature review&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(2):252-264. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19102801" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wu Y-H,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Information and communication technology interventions supporting carers of people with Alzheimer's disease: A literature review&lt;/STRONG&gt;. Psychologie &amp;amp; NeuroPsychiatrie Du Vieillissement 2009;7(3):185-192. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19720579" target="_blank"&gt;Pubmed abstract&lt;/A&gt; - Article in French]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Management of nutrition, sleeping and incontinence&lt;/STRONG&gt;&lt;STRONG&gt;:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Aselage M.B, &lt;STRONG&gt;An evolutionary analysis of mealtime difficulties in older adults with dementia&lt;/STRONG&gt;. Journal Clinical Nursing 2010;19(1-2):33-41. &lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20500242" target="_blank"&gt;[Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Aselage M.B, &lt;STRONG&gt;Measuring mealtime difficulties: Eating, feeding and meal behaviours in older adults with dementia&lt;/STRONG&gt;. Journal of Clinical Nursing 2010;19(5-6):621-631 &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20500303" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Beaulieu-Bonneau S,&amp;nbsp;et al. &lt;STRONG&gt;Sleep disturbances in older adults with mild cognitive impairment&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(4):654-666. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19426575" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Begum M.N, et al. &lt;STRONG&gt;A review of the literature on dehydration in the institutionalized elderly&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2010;5(1):E47-E53. &lt;BR&gt;[&lt;A href="http://www.journals.elsevierhealth.com/periodicals/yeclnm/article/S1751-4991%2809%2900093-6/abstract" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hagglund D.&amp;nbsp; &lt;STRONG&gt;A systematic literature review of incontinence care for persons with dementia: The research evidence&lt;/STRONG&gt;. Journal of Clinical Nursing 2010;19(3-4):303-312. &lt;BR&gt;[&lt;A href="http://www.ingentaconnect.com/content/bsc/jcn/2010/00000019/F0020003/art00002" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Offermans M.P, et al. &lt;STRONG&gt;Prevalence of urinary incontinence and associated risk factors in nursing home residents: A systematic review&lt;/STRONG&gt;. Neurourology and Urodynamics 2009;28(4):288-294. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19191259" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Young J, et al. &lt;STRONG&gt;Sleep in hospitalized medical patients, Part 2: Behavioral and pharmacological management of sleep disturbances&lt;/STRONG&gt;. Journal of Hospital Medicine 2009;4(1):50-59.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19140196" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Person-centred care:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Exley C, et al. &lt;STRONG&gt;Advance care planning: An opportunity for person-centred care for people living with dementia&lt;/STRONG&gt;. Dementia: The International Journal of Social Research and Practice 2009;8(3):419-424. &lt;BR&gt;[&lt;A href="http://dem.sagepub.com/content/8/3/419.short" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Carer support:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Almeida K.S, et al. &lt;STRONG&gt;Alzheimer's family caregivers: literature review&lt;/STRONG&gt;. Revista Eletrnica De Enfermagem 2009; 11(2). &lt;BR&gt;[No abstract available]&lt;/LI&gt;
&lt;LI&gt;Bouman A,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Effects of intensive home visiting programs for older people with poor health status: a systematic review&lt;/STRONG&gt;. BMC Health Services Research 2008; 8:74.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364620/" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Konno R. &lt;STRONG&gt;Assisting caregivers to support people with dementia living in the community&lt;/STRONG&gt;. Journal of Advanced Nursing 2009;65(4):773-774. &lt;BR&gt;[No abstract available]&lt;/LI&gt;
&lt;LI&gt;Lavela S.L, et al. &lt;STRONG&gt;Psychological health in older adult spousal caregivers of older adults&lt;/STRONG&gt;. Chronic Lllness 2010;6(1):67-80. &lt;BR&gt;[&lt;A href="http://chi.sagepub.com/content/6/1/67.abstract?rss=1" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Quinn C, et al. &lt;STRONG&gt;The impact of the quality of relationship on the experiences and wellbeing of caregivers of people with dementia: A systematic review&lt;/STRONG&gt;. Aging and Mental Health 2009;13(2):143-154. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19347681" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Quinn C, et al. &lt;STRONG&gt;The impact of motivations and meanings on the wellbeing of caregivers of people with dementia: A systematic review&lt;/STRONG&gt;. International Psychogeriatrics 2010;22(1):43-55.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19772684" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schoenmakers B, et al. &lt;STRONG&gt;Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver?&lt;/STRONG&gt; Family Practice 2009;26(4):279-286.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19423698" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schoenmakers B, et al. &lt;STRONG&gt;Supporting the dementia family caregiver: the effect of home care intervention on general well-being&lt;/STRONG&gt;. Aging &amp;amp; Mental Health 2010;14(1):44-56. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20155520" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schoenmakers B, et al. &lt;STRONG&gt;What is the role of the general practitioner towards the family caregiver of a community-dwelling demented relative? A systematic literature review&lt;/STRONG&gt;. Scandinavian Journal of Primary Health Care 2009;27(1):31-40.&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19040191" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wilson E, et al. &lt;STRONG&gt;Befriending carers of people with dementia: a cost utility analysis&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2009;24(6):610-623. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19101921" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384154</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384154]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Non-pharmacological Treatments</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE,COMPLEMENTARY AND ALTERNATIVE MEDICINE,ACUPUNCTURE,HERBAL MEDICINE,OTHER THERAPIES OR MEDICAL SYSTEMS,CONDITIONS A-Z,DEMENTIA,MUSIC THERAPY,CONDITIONS A-B,CONDITIONS D-E,TRADITIONAL CHINESE MEDICINE (TCM),ALZHEIMER'S DISEASE,SEPTEMBER 2010]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Non-pharmacological Treatments&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:384150:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2010 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices&amp;nbsp;Map of Medicine - Dementia - Assessment&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia - Management&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319937/nelhImp_0001_Aged-Mother-and-Mature-Daug.jpg"&gt;&lt;/P&gt;
&lt;P&gt;This section contains evidence on the effectiveness of non-drug treatments for dementia.&amp;nbsp;This includes evidence for the management of specific symptoms, such as dysphagia.&lt;/P&gt;
&lt;P&gt;We have grouped it into the following subtopics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Psychological interventions&lt;/LI&gt;
&lt;LI&gt;Physiotherapy and related interventions&lt;/LI&gt;
&lt;LI&gt;Complementary and alternative medicine&lt;/LI&gt;
&lt;LI&gt;Interventions for management of symptoms&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Psychological interventions:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Fischer-Terworth C,&amp;nbsp;et al. &lt;STRONG&gt;Psychological interventions in dementia: An evaluative review&lt;/STRONG&gt;. Zeitschrift Fur Psychiatrie, Psychologie Und Psychotherapie 2009;57(3):195-206. &lt;BR&gt;[&lt;A href="http://www.psycontent.com/content/nn7713128g578848/?p=cecda52f42fd4141bdbf99c57da84977&amp;amp;pi=5" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;O'Connor D, et al. &lt;STRONG&gt;Psychosocial treatments of behavior symptoms in dementia: A systematic review of reports meeting quality standards&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(2):225-240. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18814806" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Physiotherapy and related interventions:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Coelho F, et al. &lt;STRONG&gt;Systematized physical activity and cognitive performance in elderly with Alzheimer's dementia: A systematic review&lt;/STRONG&gt;. Revista Brasileira De Psiquiatria 2009;31(2):163-170. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19578690" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Forbes D,&amp;nbsp; et al. &lt;STRONG&gt;Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009; (4). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab003946.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hermans, D. &lt;STRONG&gt;Non-pharmacological interventions for wandering of people with dementia in the domestic setting&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(4).&amp;nbsp;&lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab005994.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hulme C, et al. &lt;STRONG&gt;Non-pharmacological approaches for dementia that informal carers might try or access: A systematic review&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2010;25(7):756-763. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19946870" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;George D, et al. &lt;STRONG&gt;The role of nutrients in the prevention and treatment of Alzheimer's disease: Methodology for a systematic review&lt;/STRONG&gt;. European Journal of Neurology 2009;16:8-11. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19703214" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Iwamoto J, et al. &lt;STRONG&gt;Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease&lt;/STRONG&gt;. Aging - Clinical and Experimental Research 2009;21(4-5):277-281. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19959915" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kong E, et al. &lt;STRONG&gt;Nonpharmocological intervention for agitation in dementia: A systematic review and meta-analysis&lt;/STRONG&gt;. Aging and Mental Health 2009;13(4):512-520. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19629775" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Papp K.V, et al. &lt;STRONG&gt;Immediate and delayed effects of cognitive interventions in healthy elderly: A review of current literature and future directions&lt;/STRONG&gt;.&amp;nbsp;Alzheimer's &amp;amp; Dementia 2009;5(1):50-60. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19118809" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Price J.D,&amp;nbsp;et al. &lt;STRONG&gt;Subjective barriers to prevent wandering of cognitively impaired people&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009(3). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab001932.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Skingley A, et al. &lt;STRONG&gt;Therapeutic effects of music and singing for older people&lt;/STRONG&gt;. Nursing Standard 2010;24(19):35-41. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20175359" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Stern C, et al. &lt;STRONG&gt;Physical leisure activities and their role in preventing dementia: A systematic review&lt;/STRONG&gt;. International Journal of Evidence-Based Healthcare 2009;7(4):270-282. &lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/doi/10.1111/j.1744-1609.2009.00144.x/abstract" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Streiner D, L. &lt;STRONG&gt;The effects of exercise programs on cognition in older adults: A review&lt;/STRONG&gt;. Clinical Journal of Sport Medicine 2009; 19(5):438. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19001882" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Valenzuela M, et al. &lt;STRONG&gt;Can cognitive exercise prevent the onset of dementia? systematic review of randomized clinical trials with longitudinal follow-up.&lt;/STRONG&gt; American Journal of Geriatric Psychiatry 2009;17(3):179-187. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19225276" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Vital T, et al. &lt;STRONG&gt;Systematized physical activity and depressive symptoms in Alzheimer's dementia: A systematic review&lt;/STRONG&gt;. Jornal Brasileiro De Psiquiatria 2010;59(1):58-64. &lt;BR&gt;[&lt;A href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;amp;pid=S0047-20852010000100009&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wall M,&amp;nbsp; et al. &lt;STRONG&gt;The effects of music therapy for older people with dementia&lt;/STRONG&gt;. British Journal of Nursing 2010;19(2):108-113.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20220649" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zetteller, J. &lt;STRONG&gt;Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis&lt;/STRONG&gt;. Ageing Mental Health 2010;12(6):779-785. &amp;nbsp;&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19023729" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Complementary and Alternative Medicine:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Birks J,&amp;nbsp;et al. &lt;STRONG&gt;Ginkgo biloba for cognitive impairment and dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009:(1). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab003120.html" target="_blank"&gt;Link to article&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ernst E. &lt;STRONG&gt;Homeopathy: What does the "best" evidence tell us?&lt;/STRONG&gt; Medical Journal of Australia 2010;192(8):458-460. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20402610" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Geng J, et al. &lt;STRONG&gt;Ginseng for cognition&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(2). &lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD007769/frame.html" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kaschel R. &lt;STRONG&gt;Ginkgo biloba: specificity of neuropsychological improvement--a selective review in search of differential effects&lt;/STRONG&gt;. Human Psychopharmacology 2009;24(5):345-370. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19551805" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kasper S, et al. &lt;STRONG&gt;Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability&lt;/STRONG&gt;.&amp;nbsp; Fortschr Neurol Psychiatr 2009;77(9):494-506. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19621278" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lee M, et al &lt;STRONG&gt;Acupuncture for Alzheimer's disease: A systematic review&lt;/STRONG&gt;. International Journal of Clinical Practice 2009;63(6):874-879. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19490197" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lee M, et al. &lt;STRONG&gt;Ginseng for cognitive function in alzheimer's disease: A systematic review&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009;18(2):339-344. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19584437" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Manheimer E, et al. &lt;STRONG&gt;Evidence from the cochrane collaboration for traditional chinese medicine therapies&lt;/STRONG&gt;. Journal of Alternative and Complementary Medicine 2009;15(9):1001-1014. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19757977" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;May B, et al. &lt;STRONG&gt;Herbal medicine for dementia: A systematic review&lt;/STRONG&gt;. Phytotherapy Research 2009;23(4):447-459. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19086008" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Taixiang W, et al. &lt;STRONG&gt;Yizhi capsule for vascular dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(2). &lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005382/frame.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Vandervaart S, et al. &lt;STRONG&gt;A systematic review of the therapeutic effects of Reiki&lt;/STRONG&gt;. Journal of Alternative and Complementary Medicine 2009;15(11):1157-1169. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19922247" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wang H, et al. &lt;STRONG&gt;Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: A bivariate random effect meta-analysis&lt;/STRONG&gt;. Pharmacopsychiatry 2010;43(3):86-91. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20104449" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Interventions for management of symptoms:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Ashford J, et al. &lt;STRONG&gt;Evidence-based systematic review: Oropharyngeal dysphagia behavioral treatments. Part III - Impact of dysphagia treatments on populations with neurological disorders&lt;/STRONG&gt;. Journal of Rehabilitation Research and Development 2009;46(2):195-204. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19533534" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bereczki D,&amp;nbsp;et al. &lt;STRONG&gt;Treatment of dementia and cognitive impairment: What can we learn from the Cochrane Library&lt;/STRONG&gt;. Journal of the Neurological Sciences. 2009;283(1-2):207-210.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19268303" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kverno K, et al. &lt;STRONG&gt;Research on treating neuropsychiatric symptoms of advanced dementia with non-pharmacological strategies, 19982008: A systematic literature review&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(5):825-843. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19586562" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lane-Brown A, et al. &lt;STRONG&gt;Apathy after acquired brain impairment: A systematic review of non-pharmacological interventions&lt;/STRONG&gt;. Neuropsychological Rehabilitation 2009;19(4):481-516.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19533496" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Martin AJ, et al. &lt;STRONG&gt;Driving assessment for maintaining mobility and safety in drivers with dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(1).&amp;nbsp;&lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab006222.html" target="_blank"&gt;Link to article&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;McGilton K.S, et al. &lt;STRONG&gt;A systematic review of the effectiveness of communication interventions for health care providers caring for patients in residential care settings&lt;/STRONG&gt;. Worldviews Evidence Based Nursing 2009;6(3):149-159. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19523033" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schaeffer E, L. &lt;STRONG&gt;Environmental enrichment as strategy to promote neurogenesis in Alzheimer disease: Possible participation of phospholipase A2&lt;/STRONG&gt;. Revista De Psiquiatria Clinica 2010;37(2):81-88. &lt;BR&gt;[&lt;A href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;amp;pid=S0101-60832010000200008&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Yu F, et al. &lt;STRONG&gt;Cognitive training for early-stage Alzheimer's disease and dementia&lt;/STRONG&gt;. Journal Gerontology Nursing 2009;35(3):23-29. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19326826" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384156</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384156]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Pharmacological Treatments</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Pharmacological Treatments&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:384150:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2010 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia - Management&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices&amp;nbsp;Map of Medicine - Dementia - Assessment&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;This section contains important new evidence from reviews about pharmacological treatments for dementia.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;We&amp;nbsp;have grouped the evidence into the following subtopics:&lt;/P&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage2 name=nelh_tempImage2 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319935/nelhImp_0000_Elderly-woman-with-bible.jpg"&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Treatment of mild cognitive impairment, and delay of progression to Alzheimer's Disease&lt;/LI&gt;
&lt;LI&gt;Treatment of symptoms of Alzheimer's Disease&lt;/LI&gt;
&lt;LI&gt;Prevention of falls in patients with Alzheimer's Disease&lt;/LI&gt;
&lt;LI&gt;Reviews of adverse events and possible complications among patients with Alzheimer's Disease&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Treatment of mild cognitive impairment:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Barnard K, et al. &lt;STRONG&gt;Extraskeletal effects of vitamin D in older adults: Cardiovascular disease, mortality, mood, and cognition&lt;/STRONG&gt;. American Journal Geriatric Pharmacotherapy 2010;8(1)4-33. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/11279679" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Beri A, et al. &lt;STRONG&gt;Non-atheroprotective effects of statins: A systematic review&lt;/STRONG&gt;. American Journal of Cardiovascular Drugs; 9(6):361-370). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19929034" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birks J, &lt;STRONG&gt;Donepezil for mild cognitive impairment&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews;(4). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab006104.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Diniz B.S, et al. &lt;STRONG&gt;To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease&lt;/STRONG&gt;. European Archives of Psychiatry and Clinical Neuroscience 2009;259(4): 248-256. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19224111" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fioravanti M, et al. &lt;STRONG&gt;Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews1;(1). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15846601" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hogervorst E, et al. &lt;STRONG&gt;Hormone replacement therapy to maintain cognitive function in women with dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(1).&amp;nbsp; &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab003799.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lopez-Bastida J, et al. &lt;STRONG&gt;Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009;16(2):399-407.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19221429" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Maki P.M, et al. &lt;STRONG&gt;Hormone therapy and cognitive function&lt;/STRONG&gt;. Human Reproduction Update 2009:15(6):667-681. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19468050" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Szatmári S, et al. &lt;STRONG&gt;Procaine treatments for cognition and dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2010;(7). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab005993.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Treatment of symptoms of Alzheimer's Disease:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Birks J, et al. &lt;STRONG&gt;Nimodipine for primary degenerative, mixed and vascular dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009(3). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19929034" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Birks J, et al. &lt;STRONG&gt;Rivastigmine for Alzheimer's disease&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(2). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab001191.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Campbell N, et al.&amp;nbsp;&lt;STRONG&gt;Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis&lt;/STRONG&gt;. Clinical Interventions In Aging 2008; 3(4):719-728. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19281064" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Desilets A, et al. &lt;STRONG&gt;Role of huperzine A in the treatment of alzheimer's disease&lt;/STRONG&gt;. Annals of Pharmacotherapy 2009;43(3):514-518. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19240260" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Drijgers R, et al. &lt;STRONG&gt;Pharmacological treatment of apathy in neurodegenerative diseases: A systematic review&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders 2009;28(1):13-22.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19609082" target="_blank"&gt;Pubmed abstract&lt;/A&gt;] &lt;/LI&gt;
&lt;LI&gt;Grossberg G.T, et al. &lt;STRONG&gt;Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders. 2009;27(2):164-172). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19194105" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Grossberg G, et al. &lt;STRONG&gt;Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease&lt;/STRONG&gt;. International Journal of Clinical Practice 2010;64(5):651-660. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20102418" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Hao Z, et al. &lt;STRONG&gt;Huperzine A for vascular dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(2). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab007365.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kirchner V, et al. &lt;STRONG&gt;Thioridazine for dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2001;(4). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab000464.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Krishnan S, et al. &lt;STRONG&gt;Cannabinoids for the treatment of dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews2009;(2). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab007204.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lonergan E, et al. &lt;STRONG&gt;Haloperidol for agitation in dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(2). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab002852.html" target="_blank"&gt;Link to article&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lonergan E, et al. &lt;STRONG&gt;Valproate preparations for agitation in dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(3). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab003945.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;López-Arrieta J,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Nicotine for Alzheimer's disease&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2010;(7). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab001749.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;McGuinness, B et al. &lt;STRONG&gt;Statins for the treatment of dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2010;(8).&lt;BR&gt;[&lt;A href="http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD007514/frame.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Mohan M, et al. &lt;STRONG&gt;Galantamine for dementia in people with Down syndrome&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(1). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab007656.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mohan M, et al. &lt;STRONG&gt;Rivastigmine for dementia in people with Down syndrome&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(1). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab007658.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Molnar F, et al. &lt;STRONG&gt;Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia: Drugs and pharmacology&lt;/STRONG&gt;. Journal of the American Geriatrics Society 2009;57(3):536-546. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19187414" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Muangpaisan W, et al. &lt;STRONG&gt;Systematic review of statins for the prevention of vascular dementia or dementia&lt;/STRONG&gt;. Geriatrics &amp;amp; Gerontology International 2010;10(2):109-208. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20100290" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Rodda J,&amp;nbsp;et al.&amp;nbsp;&lt;STRONG&gt;Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine&lt;/STRONG&gt;. Int Psychogeriatr 2009;21(5):813-824. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19616185" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sabbagh M, N. &lt;STRONG&gt;Drug development for Alzheimer's disease: Where are we now and where are we headed?&lt;/STRONG&gt; American Journal Geriatric Pharmacotherapy 2009;7(3):167-185. &lt;BR&gt;[&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7CWH-4WS92W3-4&amp;amp;_user=10&amp;amp;_coverDate=06%2F30%2F2009&amp;amp;_alid=1434470061&amp;amp;_rdoc=1&amp;amp;_fmt=high&amp;amp;_orig=search&amp;amp;_cdi=18107&amp;amp;_sort=r&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=1&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=d1ca74b1bc2072f51fed993419bb3075" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schneider L, et al. &lt;STRONG&gt;Hydergine for dementia&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2009;(3). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab000359.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schoenmakers B, et al. &lt;STRONG&gt;Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver?&lt;/STRONG&gt; Family Practice 2009;26(4):279-286. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19423698" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tabet N, et al. &lt;STRONG&gt;Indomethacin for Alzheimer's disease&lt;/STRONG&gt;. Cochrane Database of Systematic Reviews 2010;(1). &lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab003673.html" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Prevention of falls in patients with Alzheimer's Disease:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Iwamoto J, et al. &lt;STRONG&gt;Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease&lt;/STRONG&gt;. Aging - Clinical and Experimental Research 2009;(21):277-281. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19959915" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Adverse events &amp;amp; complications:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Bishara D. &lt;STRONG&gt;Using antipsychotics in dementia patients creates a clinical and ethical dilemma&lt;/STRONG&gt;. Pharmacy in Practice 2009;19(2):55-58. &lt;BR&gt;[&lt;A href="http://pharmacyinpractice.com/past-issues/2009-volume-19-issue-2/5-PIP-Mental-health-special-section-MarApr09.pdf" target="_blank"&gt;Link to full text&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Darreh-Shori T,&amp;nbsp;et al. &lt;STRONG&gt;Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia&lt;/STRONG&gt;. Expert Opinion on Drug Safety 2010;9(1):167-176). &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20021294" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jones R.W, et al. &lt;STRONG&gt;A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors&lt;/STRONG&gt;. International Journal of Geriatric Psychiatry 2010;25(6):547-553. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20049770" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kavirajan H, et al. &lt;STRONG&gt;A comprehensive review of safety and efficacy&lt;/STRONG&gt;. Expert Opinion on Drug Safety 2009;8(1):89-109.&lt;BR&gt;[&lt;A href="http://informahealthcare.com/doi/abs/10.1517/14740330802528420" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Lockhart I.A, et al. &lt;STRONG&gt;Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence&lt;/STRONG&gt;. Dementia &amp;amp; Geriatric Cognitive Disorders 2009;28(5):389-403.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19893314" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Repantis D, &lt;STRONG&gt;Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review&lt;/STRONG&gt;. Pharmacological Research 2010;61(6):473-481.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20193764" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sacchetti E, et al. &lt;STRONG&gt;Cerebrovascular accidents in elderly people treated with antipsychotic drugs: A systematic review&lt;/STRONG&gt;. Drug Safety 2010;33(4):273-288. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20297860" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Shah K, et al. &lt;STRONG&gt;Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review&lt;/STRONG&gt;. American Journal Geriatric Pharmacotherapy 2009;7(5):250-261. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19948301" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Smith H. &lt;STRONG&gt;Implications of opioid analgesia for medically complicated patients&lt;/STRONG&gt;. Drugs and Aging 2010;27(5):417-433.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20450239" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384158</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=384158]]&gt;</url>
    <title>Alzheimer's Disease and Dementia Annual Evidence Update 2010: Risk Factors and Aetiology</title>
    <publicationDate>2010-09-13T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Alzheimer's Disease and Dementia Annual Evidence Update 2010: Risk Factors and Aetiology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:384150:1" name=internalLink&gt;Back to Alzheimer's Disease and Dementia Annual Evidence Update 2010 Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia1.html" target="_blank"&gt;NHS Choices&amp;nbsp;Map of Medicine - Dementia - Assessment&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://healthguides.mapofmedicine.com/choices/map/dementia2.html" target="_blank"&gt;NHS Choices Map of Medicine - Dementia - Management&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;This section contains contains important new evidence from reviews of the risk factors, causation and aetiology of dementia.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We have grouped the evidence&amp;nbsp;into the following subtopics: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Risk factors&lt;/LI&gt;
&lt;LI&gt;Pathophysiology&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID319934/nelhImp_0000_elderly-man.jpg"&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&lt;STRONG&gt;Risk factors:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Anstey K, et al. &lt;STRONG&gt;Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies&lt;/STRONG&gt;. American Journal of Geriatric Psychiatry 2009;17(7):542-555.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19546653" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Bona D, et al. &lt;STRONG&gt;Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease&lt;/STRONG&gt;. Brain Research Reviews 2009;61(2):60-68. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19445962" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cataldo J, et al. &lt;STRONG&gt;Cigarette smoking is a risk factor for Alzheimer's disease: An analysis controlling for tobacco industry affiliation&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2010;19(2):465-480.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20110594" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;DeMichele-Sweet M A,et al. &lt;STRONG&gt;Genetics of psychosis in Alzheimer's disease: A review&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2010;19(3):761-780.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20157235" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Dome P, et al. &lt;STRONG&gt;Smoking, nicotine and neuropsychiatric disorders&lt;/STRONG&gt;. Neuroscience and Biobehavioral Reviews 2010;34(3):295-342. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19665479" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Farrall A, et al. &lt;STRONG&gt;Blood-brain barrier: Ageing and microvascular disease - systematic review and meta-analysis&lt;/STRONG&gt;. Neurobiology of Aging 2009;30(3):337-352.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17869382" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fotuhi M, et al. &lt;STRONG&gt;Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: A complex association&lt;/STRONG&gt;. Nature Clinical Practice Neurology 2009;5(3):140-152. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19262590" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hamer M, et al. &lt;STRONG&gt;Physical activity and risk of neurodegenerative disease: A systematic review of prospective evidence&lt;/STRONG&gt;. Psychological Medicine 2009;39(1):3-11.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18570697" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Harlein J, et al. &lt;STRONG&gt;Fall risk factors in older people with dementia or cognitive impairment: A systematic review&lt;/STRONG&gt;. Journal of Advanced Nursing 2009;65(5):922-933.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19291191" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kopf D, et al. &lt;STRONG&gt;Risk of incident Alzheimer's disease in diabetic patients: A systematic review of prospective trials&lt;/STRONG&gt;. Journal of Alzheimer's Disease 2009;16(4):677-685.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19387104" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lee Y et al. &lt;STRONG&gt;Systematic review of health behavioral risks and cognitive health in older adults&lt;/STRONG&gt;. International Psychogeriatrics 2010;22(2):174-187.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19883522" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Liu H, et al. &lt;STRONG&gt;The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis&lt;/STRONG&gt;. Journal of the Neurological Sciences 2010;294(1-2):74-80.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20441995" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Low L, et al. &lt;STRONG&gt;Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review&lt;/STRONG&gt;. Neuroscience and Biobehavioral Reviews 2010;34(3):408-437.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19720080" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Paradise M, et al. &lt;STRONG&gt;Systematic review of the effect of education on survival in Alzheimer's disease&lt;/STRONG&gt;. International Psychogeriatrics 2009;21(1):25-32.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19026089" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Profenno L, et al. &lt;STRONG&gt;Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders&lt;/STRONG&gt;. Biological Psychiatry 2010;67(6):505-512.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19358976" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Purnell C, et al. &lt;STRONG&gt;Cardiovascular risk factors and incident alzheimer disease: A systematic review of the literature&lt;/STRONG&gt;. Alzheimer Disease and Associated Disorders 2009;23(1):1-10.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18703981" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Savva G M, et al. &lt;STRONG&gt;Epidemiological studies of the effect of stroke on incident dementia: A systematic review&lt;/STRONG&gt;. Stroke 2010;41(1):E41-E46.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19910553" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Van Dam F, et al. &lt;STRONG&gt;Hyperhomocysteinemia and Alzheimer's disease: A systematic review&lt;/STRONG&gt;. Archives of Gerontology and Geriatrics 2009;48(3):425-430.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18479766" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Weih M, et al. &lt;STRONG&gt;Physical activity and Alzheimer's disease: A meta-analysis of cohort studies&lt;/STRONG&gt;. GeroPsych: The Journal of Gerontopsychology and Geriatric Psychiatry 2010;23(1):17-20.&lt;BR&gt;[&lt;A href="http://www.psycontent.com/content/n63137k885433134/?p=d68b09182f994f63be2f5c1bf2bbd9e6&amp;amp;pi=2" target="_blank"&gt;Full text requires payment&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ventura A, et al. &lt;STRONG&gt;Colinergic system: Revisiting receptors, regulation and the relationship with Alzheimer disease, schizophrenia, epilepsy and smoking&lt;/STRONG&gt;. Revista De Psiquiatria Clinica 2010;37(2):74-80.&lt;BR&gt;[&lt;A href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;amp;pid=S0101-60832010000200007&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en" target="_blank"&gt;Link to abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Williams J.W, et al. &lt;STRONG&gt;Alzheimer's Disease and Cognitive Decline, Structured Abstract&lt;/STRONG&gt;. Agency for Healthcare Research and Quality 2010. &lt;BR&gt;[&lt;A href="http://www.ahrq.gov/clinic/tp/alzcogtp.htm" target="_blank"&gt;Link to full text&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;STRONG&gt;Pathophysiology:&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Abellan van Kan G, et al. &lt;STRONG&gt;Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) task force&lt;/STRONG&gt;. Journal of Nutrition, Health and Aging 2009;13(10):881-889. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19924348" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Annweiler C, et al. &lt;STRONG&gt;Vitamin D and cognitive performance in adults: A systematic review&lt;/STRONG&gt;. European Journal of Neurology 2009;16(10):1083-1089. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19659751" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Beecham G W, et al.&amp;nbsp;&lt;STRONG&gt;APOE is not associated with Alzheimer disease: a cautionary tale of genotype imputation&lt;/STRONG&gt;. Annals of Human Genetics 2010;74(3):189-94. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20529013" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;De Paula V, et al. &lt;STRONG&gt;The role of TAU protein in the pathophysiology of frontotemporal dementia&lt;/STRONG&gt;. Revista De Psiquiatria Clinica 2009;36(5):197-202.&lt;BR&gt;[&lt;A href="http://www.scielo.br/scielo.php?script=sci_abstract&amp;amp;pid=S0101-60832009000500004&amp;amp;lng=en&amp;amp;nrm=iso&amp;amp;tlng=en" target="_blank"&gt;Full text not available in English&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Roberts J, et al. &lt;STRONG&gt;Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: A systematic review&lt;/STRONG&gt;. Dementia and Geriatric Cognitive Disorders 2009;28(2):95-109.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19684399" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Schroeter M L, et al. &lt;STRONG&gt;Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients&lt;/STRONG&gt;. Neuroimage 2009;47(4):1196-206. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19463961" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Shi F, et al. &lt;STRONG&gt;Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies.&lt;/STRONG&gt; Hippocampus 2009;19(11):1055-64.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19309039" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Vogel T, et al. &lt;STRONG&gt;Homocysteine, vitamin B12, folate and cognitive functions: A systematic and critical review of the literature&lt;/STRONG&gt;. International Journal of Clinical Practice 2009;63(7):1061-1067.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19570123" target="_blank"&gt;Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346411</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/03March/Pages/purpose-in-life-Alzheimers.aspx]]&gt;</url>
    <title>Alzheimer's risk linked to outlook</title>
    <publicationDate>2010-03-02T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Elderly people with a strong sense of purpose in life face a reduced risk of developing Alzheimer's disease,” &lt;EM&gt;The Daily Telegraph&lt;/EM&gt; reports. The finding comes from research that assessed the outlook on life in 900 elderly people, following them for several years to see which of them developed cognitive problems.]]&gt;</body>
  </document>
  <document>
    <id>374922</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/5/536?rss=1]]&gt;</url>
    <title>An Inherited Variable Poly-T Repeat Genotype in TOMM40 in Alzheimer Disease</title>
    <publicationDate>2010-05-10T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ I coauthored a recently published research article describing a variable length, poly-T polymorphism in the TOMM40 gene, adjacent to apolipoprotein E (APOE) on chromosome 19, that accounts for the age at onset distribution for a complex disease, late-onset Alzheimer disease. These new data explain the mean age at disease onset for patients with the APOE4/4 genotype and differentiate 2 forms of TOMM40 poly-T polymorphisms linked to APOE, with each form associated with a different age at disease onset distribution. When linked to APOE3 (encoding the {varepsilon}3 isoform of APOE), the longer TOMM40 poly-T repeats (19-39 nucleotides) at the rs10524523 (hereafter, 523) locus are associated with earlier age at onset and the shorter TOMM40 523 alleles (11-16 nucleotides) are associated with later age at onset. The data suggest that the poly-T alleles are codominant, with the age at onset phenotype determined by the 2 inherited 523 alleles, but with variable expressivity. Additional data will further refine the relationship between the length of the poly-T alleles and age at disease onset and determine if the relationship is linear.]]&gt;</body>
  </document>
  <document>
    <id>101900</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8201149&amp;query_hl=6]]&gt;</url>
    <title>An in-home preventive assessment program for independent older adults: a randomized controlled trial</title>
    <publicationDate>1994-08-07T00:00:00</publicationDate>
    <publisher>Journal of the American Geriatrics Society</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEART DISEASE,CANCER,SCREENING,SCREENING AND SURVEILLANCE,OSTEOPOROSIS,CARDIOVASCULAR RISK,MENTAL HEALTH,RISK OF FALLS,HEARING,THYROID DISEASE,DIABETES,EYESIGHT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To evaluate the effectiveness of in-home geriatric assessments as a means of providing preventive health care and improving health and functional status of community-living elderly veterans.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;A brief geriatric screening assessment performed in the home can detect unrecognized and treatable problems, even among relatively healthy older adults. The use of trained volunteers is a feasible strategy for providing health education and follow-up contacts. These results support the concept that preventive gerontological approaches can help maintain important aspects of health and function.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94109</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11589255&amp;query_hl=137]]&gt;</url>
    <title>Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Clinical Therapeutics</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,SECONDARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;systematic review&amp;nbsp;has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000278133" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Differences in the aspirin and dipyridamole doses and the methodology used may explain why the addition of dipyridamole to aspirin has only recently been demonstrated to provide benefit in the secondary prevention of stroke. Further studies are needed to confirm the long-term benefit.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;The authors' conclusions are supported by the review but are rather too general given the available data".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101901</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8037981&amp;query_hl=8]]&gt;</url>
    <title>Annual assessment of patients aged 75 years and over: general practitioners' and practice nurses' views and experiences</title>
    <publicationDate>1994-08-07T00:00:00</publicationDate>
    <publisher>British Journal of General Practice</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SURVEILLANCE,SCREENING AND SURVEILLANCE,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;A study was undertaken to collect details of practice organization of these assessments, general practitioners' and practice nurses' experience of assessments, and their views of the value of such assessments. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;The findings suggest that the experiences of the first two years of this activity had convinced some general practitioners that routine assessment of elderly patients is worthwhile. However the increased demand for other services must obviously be met by an increase in resources if the effectiveness of these assessments is not to be undermined. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101903</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8671100&amp;query_hl=10]]&gt;</url>
    <title>Annual visits to patients over the age of 75--who is missed?</title>
    <publicationDate>1996-08-04T00:00:00</publicationDate>
    <publisher>Family Practice</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To describe the characteristics of elderly people who declined the offer of an annual home visit. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;There appears little evidence in this population that elderly people who decline a home visit are necessarily part of an 'iceberg' of unmet need. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93875</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/cgi/reprint/131/7/492.pdf]]&gt;</url>
    <title>Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>Ann Intern Med</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This meta analysis has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band70/b70-2.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"This is a review written by people involved in some of the main trials in this area, and with a view to examining benefit and harm. The reviews will also be available separately on the Cochrane Library in early 2000. &lt;BR&gt;&lt;BR&gt;The authors modelled the effects of treatment - the benefit in terms of reductions in all-cause strokes, and the harm in terms of major extracranial bleeds. The effects based on cohorts of 1000 patients over one year, at various baseline risk of stroke and for primary and secondary prevention are shown in &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band70/b70-2.html#Heading16" target="_blank"&gt;Table 2&lt;/A&gt; . Benefit outweighs harm. &lt;BR&gt;&lt;BR&gt;Given that atrial fibrillation is often aggressively treated in primary care, and is relatively common (three million warfarin prescriptions in primary care in England in 1998), this conclusion is comforting. The review did not deal with people with structural heart disease, in whom the risk of stroke may be higher. It is a worthwhile read".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321711</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/7/888]]&gt;</url>
    <title>Apathy symptom profile and behavioural associations in frontotemporal dementia vs dementia of Alzheimer type</title>
    <publicationDate>2009-07-07T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;Apathy is a common and significant problem in patients with dementia, regardless of its cause. Observations about frontosubcortical circuit syndromes indicate that apathy may have affective, behavioral, or cognitive manifestations.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objectives:&lt;/STRONG&gt;&lt;BR&gt;To explore whether the apathy manifested in frontotemporal dementia (FTD), with its predominantly anterior brain neuropathologic features, differs from the apathy in dementia of Alzheimer type (DAT), with its predominantly hippocampal- and temporoparietal-based neuropathologic features, and to determine whether other behavioral disturbances reported in frontosubcortical circuit syndromes correlate with apathy.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Analyses included individual items within Neuropsychiatric Inventory subscale items. Items of the apathy/indifference subscale were designated by consensus as affective (lacking in emotions), behavioral (inactive, chores abandoned), or cognitive (no interest in the activities of others). Proportions of correlated nonapathy Neuropsychiatric Inventory items were calculated.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;Several neurology specialty clinics contributed to our data set.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;A total of 92 participants with FTD and 457 with DAT.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;/STRONG&gt;&lt;BR&gt;The Neuropsychiatric Inventory was analyzed.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Apathy was more prevalent in patients with FTD than in those with DAT, but when present, the specific apathy symptoms associated with both types of dementia were rarely restricted to 1 of the 3 domains of apathy. Dysphoria concurrent with apathy was unique to the DAT group and negatively correlated in the FTD group. Participants with affective apathy more frequently copresented with an orbital frontosubcortical syndrome in FTD (impulsivity and compulsions). Affective apathy also copresented with uncooperative agitation, anger, and physical agitation in both types of dementia.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;Apathy is common in patients with FTD and DAT, although it is more common in those with FTD. When present, it usually involves changes in affect, behavior, and cognition. It is associated with behaviors that have previously been shown to affect patient safety, independence, and quality of life.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374942</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/93?rss=1]]&gt;</url>
    <title>APOE {varepsilon}4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,PATHOLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objective&amp;nbsp; To study differences in longitudinal changes in regional cerebral blood flow (rCBF) between apolipoprotein E (APOE) {varepsilon}4 carriers and noncarriers in nondemented older adults from the Baltimore Longitudinal Study of Aging using positron emission tomography in order to determine whether there are regionally specific longitudinal changes in rCBF in APOE {varepsilon}4 carriers that might be related to its well-established role as a genetic risk factor for Alzheimer disease.]]&gt;</body>
  </document>
  <document>
    <id>93865</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/band89/b89-6.html]]&gt;</url>
    <title>Assessing the evidence of effectiveness of acupuncture for stroke rehabilitation: stepped assessment of likelihood of bias</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a commentary on a systematic review conducted by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/alternat/ACstroke.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;Conclusion&lt;/P&gt;
&lt;P&gt;Sensitivity analysis for known sources of bias is important where "vote-counting" replaces data pooling. There were no high quality trials of acupuncture for stroke that showed that it was beneficial. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101910</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2341684&amp;query_hl=13]]&gt;</url>
    <title>Assessment of hearing loss in elderly people: the feasibility of a nurse administered screening test</title>
    <publicationDate>1990-08-05T00:00:00</publicationDate>
    <publisher>Journal of Advanced Nursing</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEARING,SCREENING AND SURVEILLANCE,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This paper examines the findings and implications of an exploratory study which was designed to determine the feasibility of a nurse administered hearing screen test for elderly patients. Theoretical and practical considerations which influenced the design of the hearing assessment test (HAT) and the method of the study are discussed. A sample of 27 elderly hospital inpatients, with a mean age of 81 years, participated in the study. The results of the new HAT were validated by comparison with audiometric assessment results. Analysis using the Generalized Linear Model showed a significant (P less than or equal to 0.01) relationship between the total HAT score and the audiometric measures, with the exception of the audiometric classification of hearing loss which was significant at P less than or equal to 0.05. The results demonstrate that the HAT is a potentially useful tool for nurses to use, but that refinement of the scale and further validity and reliability testing is required before it can be adopted as part of the nursing assessment of elderly people. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101921</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1393077&amp;query_hl=15]]&gt;</url>
    <title>Assessment of patients aged over 75 in general practice</title>
    <publicationDate>1992-08-02T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To evaluate the assessment scheme for people aged 75, to establish doctors' and nurses' views on the value of the assessment scheme, and to seek patients' opinions on elderly assessments. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Doctors see no merit in the scheme; most undertake assessments opportunistically and pick up few new problems. Nurses who see it as important require further training to fit them to do home visits confidently. Patients who were assessed found it worth while. The case for developing a specialist community nurse for elderly people should be investigated. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>346417</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/reprint/303/8/763]]&gt;</url>
    <title>Association between acute care and critical illness hospitalization and cognitive function in older adults</title>
    <publicationDate>2010-02-24T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Context&amp;nbsp;&lt;/B&gt; Studies suggest that many survivors of critical&lt;SUP&gt; &lt;/SUP&gt;illness experience long-term cognitive impairment but have not&lt;SUP&gt; &lt;/SUP&gt;included premorbid measures of cognitive functioning and have&lt;SUP&gt; &lt;/SUP&gt;not evaluated risk for dementia associated with critical illness.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Objectives&amp;nbsp;&lt;/B&gt; To determine whether decline in cognitive function&lt;SUP&gt; &lt;/SUP&gt;was greater among older individuals who experienced acute care&lt;SUP&gt; &lt;/SUP&gt;or critical illness hospitalizations relative to those not hospitalized&lt;SUP&gt; &lt;/SUP&gt;and to determine whether the risk for incident dementia differed&lt;SUP&gt; &lt;/SUP&gt;by these exposures.&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93862</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10819950&amp;query_hl=21]]&gt;</url>
    <title>Association of coffee and caffeine intake with the risk of Parkinson disease</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE,MOVEMENT DISORDERS,PARKINSON'S DISEASE,NEUROLOGICAL CONDITIONS,CONDITIONS,PARKINSON'S DISEASE &amp; AKINETIC RIGID SYNDROMES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band78/b78-6.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;This is the first time, apparently, that this inverse relationship between coffee intake and Parkinson's disease has been demonstrated conclusively. Is there a reason for this? Obviously there must be a reason, and there are many candidates, but right now we don't know what it is. The authors of the paper discuss possible mechanisms in great detail, and it is an interesting read. &lt;BR&gt;&lt;BR&gt;Whether the message can be generalised to 'Drink coffee and avoid Parkinson's disease' is at least moot. Coffee addicts, though, will take some comfort from this report".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374943</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/87?rss=1]]&gt;</url>
    <title>Association of C-Reactive Protein With Cognitive Impairment</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ High-sensitivity C-reactive protein (hsCRP) is a biomarker of cardiovascular risk that is suggested to be a biomarker for cognitive impairment.]]&gt;</body>
  </document>
  <document>
    <id>93838</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15169702&amp;query_hl=11]]&gt;</url>
    <title>Atypical antipsychotics and risk of cerebrovascular accidents</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>American Journal of Psychiatry</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,STROKE,TREATMENT AND CARE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This cohort study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/neurol/atypdement.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"Evidence from randomised trials shows a small increased risk of stroke in patients with dementia and agitation treated with atypical antipsychotics risperidone and olanzapine, but based on a small number of events. A large observational study failed to find any increased risk, and probably limits the size of the effect to no more than two extra strokes per 1000 person years of treatment". &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313519</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nao.org.uk/publications/0809/audit_of_assumptions_for_2009.aspx]]&gt;</url>
    <title>Audit of Assumptions for Budget 2009</title>
    <publicationDate>2009-04-22T00:00:00</publicationDate>
    <publisher>National Audit Office</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Audit of Assumptions for Budget 2009. Helping the nation spend wisely.]]&gt;</body>
  </document>
  <document>
    <id>95926</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4082904]]&gt;</url>
    <title>Avoiding and diverting admissions to hospital: a good practice guide</title>
    <publicationDate>2004-08-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Avoiding and diverting admissions to hospital: a good practice guide&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This publication sets out some suggested approaches to avoid and divert admissions to hospital. It is aimed at managers and clinicians who commission or run emergency, intermediate and community services and long-term care.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>101922</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9196465&amp;query_hl=17]]&gt;</url>
    <title>Balance screening of an inner city older adult population</title>
    <publicationDate>1997-08-03T00:00:00</publicationDate>
    <publisher>Arch Phys Med Rehabil</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,ASSESSING RISK,SURVEILLANCE,SCREENING AND SURVEILLANCE,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;Until recently, studies of balance abilities were conducted on nursing home residents or volunteers in a clinical laboratory setting. Little is known about balance abilities of older adults living independently in large urban cities or who represent different ethnic backgrounds. The purpose of this study was to describe balance abilities in these individuals. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;The results of this study can serve as norms for balance testing in urban-dwelling older adult populations from diverse backgrounds and may be useful for clinicians who are developing health promotion and fall prevention programs. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394413</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/simple-early-alzheimers-test.aspx]]&gt;</url>
    <title>Behind the Headlines -</title>
    <publicationDate>2010-11-12T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Scientists are developing a “30-second Alzheimer’s screening test” reported The Daily Telegraph. It said that such a test “could be available in as little as two years”.&lt;/P&gt;
&lt;P&gt;This news was based on research that gave MRI scans to 428 healthy people in their forties to look for changes in the intensity of white matter lesions (the nerve fibres) in specific areas of the brain. The study found that these brain changes were each present in 0.4-20% of participants and that their presence in specific areas was linked to poorer performance in some cognitive tests. There were also differences in the way men and women were affected.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>396994</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/ageing-process-reversed-in-mice.aspx]]&gt;</url>
    <title>Behind the Headlines - Aging process reversed in mice</title>
    <publicationDate>2010-11-29T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Scientists have managed to reverse the ageing process in a ‘landmark’ study,” reported the Daily Express. The newspaper said that research has shown that targeting the telomerase enzyme proved it is possible to protect body tissue from degenerating.]]&gt;</body>
  </document>
  <document>
    <id>386768</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/08August/Pages/arthritis-protein-blocks-alzheimers-disease.aspx]]&gt;</url>
    <title>Behind the Headlines - Arthritis may block Alzheimer's</title>
    <publicationDate>2010-08-23T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A protein produced in arthritis may “protect against the development of Alzheimer's disease,” reported BBC News. US research on mice has discovered that a protein called GM-CSF, produced in rheumatoid arthritis, may trigger the immune system to destroy the protein plaques found in Alzheimer’s disease.]]&gt;</body>
  </document>
  <document>
    <id>333934</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/12December/Pages/ARMD-sight-loss-asprin-treatment-no-benefit.aspx]]&gt;</url>
    <title>Behind the Headlines - Aspirin no help for sight loss in the elderly</title>
    <publicationDate>2010-12-02T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Aspirin “could stop you going blind”, according to the &lt;EM&gt;Daily Express,&lt;/EM&gt; which reports that taking aspirin daily&amp;nbsp;can cut the risk of developing age-related macular degeneration by almost a fifth. &lt;/P&gt;
&lt;P&gt;Age-related macular degeneration is a common cause of visual loss in the elderly. It occurs when the cells in the centre of the retina become progressively damaged. This damage eventually causes the loss of central vision, making reading and writing impossible for some people. &lt;/P&gt;
&lt;P&gt;The research behind this study was robust and well-conducted, but the results have been incorrectly reported in the &lt;EM&gt;Daily Express.&lt;/EM&gt; The large study, which lasted several years, found that aspirin had no significant effect on the risk of developing age-related macular generation, a point the researchers clearly highlight in their written results.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394420</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/benefits-of-statins-explored.aspx]]&gt;</url>
    <title>Behind the Headlines - Benefits of statins explored</title>
    <publicationDate>2010-11-09T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Thousands of deaths could be prevented a year if people at risk of heart attack or stroke are prescribed more powerful statins,” the Daily Mail reported. The newspaper said that intensive use of statins lowers cholesterol levels even further than standard therapy, cutting the risk of heart attack and stroke by a further 15%.&lt;/P&gt;
&lt;P&gt;The news report is based on a large meta-analysis of recent studies looking at the effectiveness of statins. A major strength is its size, involving data from 170,000 patients in 26 randomised trials, and this indicates that the results are probably reliable. It is important to point out that this research applies only to people at high risk of heart disease and stroke.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>332167</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/11November/Pages/Body-shape-and-dementia.aspx]]&gt;</url>
    <title>Behind the Headlines - Body shape and dementia</title>
    <publicationDate>2009-11-26T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Apple-shaped women face a doubled risk of dementia, according to the Daily Mail.

This news is based on Swedish research that measured the physical dimensions of 1,500 women and followed them for an average of 32 years. Those women with an “apple shape” (broader in the middle than the hips) faced an increased risk of dementia if they lived beyond 70 years. 
</description>
    <body>&lt;![CDATA[ &lt;P&gt;Apple-shaped women face a doubled risk of dementia, according to the &lt;EM&gt;Daily Mail.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This news is based on Swedish research that measured the physical dimensions of 1,500 women and followed them for an average of 32 years. Those women with an “apple shape” (broader in the middle than the hips) faced an increased risk of dementia if they lived beyond 70 years. &lt;/P&gt;
&lt;P&gt;This study was well designed and collected data over several years. However, the researchers were surprised to find no link between body mass index (BMI) and stroke risk, an association found in other studies. Other results also suggest the findings may have occurred by chance. Overall, this large study has not convincingly shown the link between apple-shaped women and dementia, and raises more questions than it answers. Further research into this area is needed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394414</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/simple-early-alzheimers-test.aspx]]&gt;</url>
    <title>Behind the Headlines - Brain scan is not an Alzheimer's test</title>
    <publicationDate>2010-11-12T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Scientists are developing a “30-second Alzheimer’s screening test” reported The Daily Telegraph. It said that such a test “could be available in as little as two years”.&lt;/P&gt;
&lt;P&gt;This news was based on research that gave MRI scans to 428 healthy people in their forties to look for changes in the intensity of white matter lesions (the nerve fibres) in specific areas of the brain. The study found that these brain changes were each present in 0.4-20% of participants and that their presence in specific areas was linked to poorer performance in some cognitive tests. There were also differences in the way men and women were affected.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>389180</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/09September/Pages/famine-nutrition-affects-brain-old-age.aspx]]&gt;</url>
    <title>Behind the Headlines - Brain toll of rationing studied</title>
    <publicationDate>2010-09-14T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Extreme World War II food shortages may have affected the brains of babies in the womb, BBC News reported. The website said that a study of Dutch adults found that performance in mental tests was weaker in people whose mothers were pregnant with them during times of severe rationing.]]&gt;</body>
  </document>
  <document>
    <id>383153</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/Depression-and-dementia-risk.aspx]]&gt;</url>
    <title>Behind the Headlines - Depression linked to dementia</title>
    <publicationDate>2010-07-07T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Having depression may nearly double the risk of developing dementia later in life,” reported BBC News. It said that a 17-year study of nearly 1,000 elderly people, found that 22% of those who were depressed at the start went on to develop dementia, compared with 17% of those who were not depressed.&lt;/P&gt;
&lt;P&gt;This is a well-designed study and was accurately reported by the BBC. It has several strengths and adds to the evidence of a link between the two conditions.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>395038</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/diabetes-drug-tested-in-dementia-study.aspx]]&gt;</url>
    <title>Behind the Headlines - Diabetes drug for Alzheimer’s explored</title>
    <publicationDate>2010-11-23T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “A common diabetes drug could be redeveloped as a new treatment for Alzheimer's,” reported the BBC. It said that metformin may help prevent the formation of “tau tangles”, a key brain abnormality linked to the disease.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>394425</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/beetroot-and-dementia.aspx]]&gt;</url>
    <title>Behind the Headlines - Does beetroot juice combat dementia?</title>
    <publicationDate>2010-11-04T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“A daily glass of beetroot juice could combat the onset of dementia among older adults,” reported the Daily Express.&lt;/P&gt;
&lt;P&gt;This news story is a based on a small study in 16 elderly people. The participants were given either a diet that was low or high in nitrates over a four-day period. Nitrates are present at high levels in beetroot and other vegetables, and converted into nitrites in the body, a chemical that is thought to increase blood flow. The participants’ blood flow to different regions of the brain was measured on a scan.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394424</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/new-drugs-stroke-recovery.aspx]]&gt;</url>
    <title>Behind the Headlines - Early work on stroke repair drugs</title>
    <publicationDate>2010-11-04T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,SECONDARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Stroke recovery might be improved by blocking a molecule that “stops brain cells working after a stroke,” BBC News has reported.&lt;/P&gt;
&lt;P&gt;The news comes from US research in mice that tested whether stroke recovery could be improved by blocking the action of a neurotransmitter chemical that normally inhibits the brain’s ability to repair itself. Scientists found that giving the mice a blocking drug a few days after a stroke helped the mice to recover movement better, but giving it too soon actually increased the damage caused by the stroke.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>383346</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/education-delays-dementia-and-alzheimers.aspx]]&gt;</url>
    <title>Behind the Headlines - Education 'blocks dementia'</title>
    <publicationDate>2010-07-26T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Education ‘helps brain compensate for dementia changes,’” BBC News reported today, saying that people who stay in education longer appear to be less affected by the brain changes that occur during dementia. According to the newstory, European researchers have found that those with more education were as likely to show biological dementia signs in their brains at death but less likely to have displayed symptoms of the disease while alive.]]&gt;</body>
  </document>
  <document>
    <id>386769</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/08August/Pages/fear-of-falling-makes-it-more-likely-to-happen.aspx]]&gt;</url>
    <title>Behind the Headlines - Fear of falling 'raises fall risk'</title>
    <publicationDate>2010-08-20T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Elderly people who worry about falling may double the chances that they will take a tumble,” reported &lt;EM&gt;The Daily Telegraph.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This study followed a group of elderly people between the ages of 70 and 90 for a year and looked at their risk of falling according to physiological measures such as their balance, strength and stability, and how this was affected by their fear of falling. It found that both physiological and psychological factors affected risk. People whose physiological profile suggested that they were at risk of a fall, but who did not perceive themselves to be, were less likely to fall than people who had a more realistic&amp;nbsp; awareness of their likelihood of falling.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394408</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/first-stem-cell-trial-in-stroke-patient.aspx]]&gt;</url>
    <title>Behind the Headlines - First stem cell trial in stroke patient</title>
    <publicationDate>2010-11-17T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,ACUTE MANAGEMENT,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ In a world first, a British man has had stem cells injected into his brain to repair the damage caused by stroke. Many newspapers reported this clinical trial, which is designed to test the safety of a new therapy for stroke damage&lt;BR&gt;The main purpose of this early experimental trial is to test the safety of a new stem cell therapy for the treatment of ischaemic stroke.]]&gt;</body>
  </document>
  <document>
    <id>386772</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/08August/Pages/Immune-system-genes-and-parkinsons-disease.aspx]]&gt;</url>
    <title>Behind the Headlines - Genetics of Parkinson's explored</title>
    <publicationDate>2010-08-16T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;"The immune system may have a key role in the development of Parkinson's disease," reported BBC News. It said that a study has found an association between genes controlling immunity and the condition Parkinson’s disease.&lt;/P&gt;
&lt;P&gt;The news reports appear to be accurate. This well-conducted, genome-wide association study found that particular genetic variants involved in the immune system are associated with Parkinson’s disease. While on its own, this region is only associated with a modest effect on Parkinson’s disease risk, the cumulative effect of this new association and others already identified is thought to be quite substantial.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>389179</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/09September/Pages/handshake-grip-mobility-test-early-death.aspx]]&gt;</url>
    <title>Behind the Headlines - Grip test predicts early death</title>
    <publicationDate>2010-09-10T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “A strong handshake will help you hold on to life,” the Daily Mail&amp;nbsp; reported today. The newspaper also said that good balance, a brisk walking pace and the ability to get up from a chair easily are all potential signs of a longer life.]]&gt;</body>
  </document>
  <document>
    <id>332168</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/11November/Pages/Immune-systems-and-aging.aspx]]&gt;</url>
    <title>Behind the Headlines - Immune systems and ageing</title>
    <publicationDate>2009-11-19T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Elderly people succumb to viruses 'because their immune systems work too hard',” &lt;EM&gt;The Daily Telegraph &lt;/EM&gt;has reported. The newspaper says that new research into the immune system could also affect the way flu vaccination is planned.&lt;/P&gt;
&lt;P&gt;This animal study tested immune responses and liver damage caused by a common virus, the herpes virus, in mice of different ages. When the researchers blocked part of the action of the immune system in older mice, they found that the mice survived with the virus for longer. This&amp;nbsp;suggests that their immune systems where previously causing liver damage. However, whether the results of this animal study can be applied to humans is debateable and will need further careful research.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>383818</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/head-size-and-Alzheimers-disease.aspx]]&gt;</url>
    <title>Behind the Headlines - Large heads give 'dementia benefit'</title>
    <publicationDate>2010-07-13T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Having a big head may protect against dementia,” reported the BBC. The news report said that research in 270 patients with Alzheimer’s disease found that a larger head size (as a marker of brain size) was linked to better performance in cognitive tests, even when patients had the same amount of brain loss assessed by MRI scan.&lt;/P&gt;
&lt;P&gt;This was a preliminary study that requires further research in a larger group of people. It is important to highlight that brain size is largely determined by genes and it is not clear whether it is possible to influence brain size during childhood sufficiently to promote greater brain function resilience following brain loss in later life.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>390677</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/10October/Pages/memory-drug-studied-in-mice.aspx]]&gt;</url>
    <title>Behind the Headlines - Memory drug studied in mice</title>
    <publicationDate>2010-10-13T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Daily Express reports today of a “drug to stop memory loss”. It said that a British team of researchers have made an amazing breakthrough and are a step closer to an “anti-ageing drug for the brain”.]]&gt;</body>
  </document>
  <document>
    <id>390679</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/10October/Pages/alzheimers-disease-drugs.aspx]]&gt;</url>
    <title>Behind the Headlines - NICE updates Alzheimer's drugs guidance</title>
    <publicationDate>2010-10-07T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Hundreds of thousands more patients in the early stages of Alzheimer's disease could get drug treatments following a U-turn by the health watchdog,” BBC News reported.&lt;/P&gt;
&lt;P&gt;Widespread news coverage has been given to new draft guidance from NICE for the treatment of Alzheimer’s disease. If the draft decision is upheld, the guidance would update previous recommendations for the NHS provision of the drugs donepezil, galantamine and rivastigmine for people in the early stages of the disease. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>397030</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/12December/Pages/dementia-pesticide-use.aspx]]&gt;</url>
    <title>Behind the Headlines - Pesticides and dementia</title>
    <publicationDate>2010-12-02T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Long-term exposure to pesticides leads to a greater risk of dementia, The Independent has reported.&lt;/P&gt;
&lt;P&gt;The news comes from a study of almost 1,000 French vineyard workers. It found that those directly exposed to pesticides over a long period performed less well in tests of mental (cognitive) ability than those who were not exposed at all. When the volunteers were tested again around five years later, the cognitive performance of workers directly exposed to pesticides had declined more in certain tests than that of workers who were not exposed.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>396996</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/ephb2-protein-alzheimers-disease-reversal.aspx]]&gt;</url>
    <title>Behind the Headlines - Protein provides Alzheimer's clue</title>
    <publicationDate>2010-11-29T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A gene therapy technique designed to ease the memory problems of Alzheimer's disease has been tested in rats, BBC News has reported. The website says that scientists took rats bred to have an Alzheimer’s-like condition and improved their memory problems by increasing levels of a chemical that helps brain cells signal to each other.]]&gt;</body>
  </document>
  <document>
    <id>389417</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/10October/Pages/bodybuilding-mice-and-long-life.aspx]]&gt;</url>
    <title>Behind the Headlines - Protien grants long life (to mice)</title>
    <publicationDate>2010-10-06T00:00:00</publicationDate>
    <publisher>Behind the Headlines -</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A protein powder used by bodybuilders “could increase life expectancy by 10 years”, according to the Daily Mail. The newspaper reports that consuming the powder can build muscle, boost fitness, improve balance and “increase life expectancy by 12 per cent”.]]&gt;</body>
  </document>
  <document>
    <id>389175</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/09September/Pages/brain-training-speed-dementia-alzheimers.aspx]]&gt;</url>
    <title>Behind the Headlines - Puzzling claims over brain games</title>
    <publicationDate>2010-09-02T00:00:00</publicationDate>
    <publisher>Behind the Headlines -</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "People who do puzzles and crosswords may stave off dementia longer,” according to BBC News. The website said that mentally stimulating activities may protect the brain from memory loss but also speed up mental decline once dementia takes hold.]]&gt;</body>
  </document>
  <document>
    <id>332169</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/11November/Pages/Quality-of-dementia-care-in-hospitals.aspx]]&gt;</url>
    <title>Behind the Headlines - Quality of dementia care in hospitals</title>
    <publicationDate>2009-11-17T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The quality of dementia care in hospitals has featured&amp;nbsp;in many newspapers. &lt;EM&gt;The Times&lt;/EM&gt; reported that campaigners have said, “Patients with dementia are staying too long in hospital and receiving ‘disgraceful’ care that worsens their condition.” &lt;EM&gt;The Daily Telegraph&lt;/EM&gt; said that “one in three never go back to their own homes and are discharged to a nursing home instead.”&lt;/P&gt;
&lt;P&gt;The news stories&amp;nbsp;are based on a report from the Alzheimer’s Society, which surveyed a large number of carers, nursing staff and nurse/ward managers on the quality of care given to people with dementia. Although the report gives the current opinion of a broad cross section of these groups of people, it cannot be considered a consensus. The figures that have been quoted by the newspapers should also be considered as the collective opinion of those surveyed.&lt;/P&gt;
&lt;P&gt;However, the people who were surveyed are among the most experienced in the care of people with Alzheimer’s, and their overwhelming opinion is that hospital care needs to be improved. The society has made several objectives to achieve this aim.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>395035</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/retirement-and-mental-health.aspx]]&gt;</url>
    <title>Behind the Headlines - Retirement and mental health</title>
    <publicationDate>2010-11-25T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Taking early retirement is beneficial, at least for your mental health,” BBC News has reported. The website said that a study of French national grid workers has shown that early retirement has positive benefits for mental health but makes no difference to physical illness.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>383155</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/restless-sleep-kicking-parkinsons-disease.aspx]]&gt;</url>
    <title>Behind the Headlines - Sleep disorder linked to Parkinson's</title>
    <publicationDate>2010-07-29T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Kicking and lashing out while asleep could mean you’re more likely to develop dementia or Parkinson’s disease,” reported the &lt;EM&gt;Daily Mail&lt;/EM&gt;. It said a study has found a link between a sleep disorder and a higher risk of certain types of dementia up to 50 years later.&lt;/P&gt;
&lt;P&gt;The study looked at people diagnosed with one of several related neurological conditions and analysed their history of a severe form of REM sleep behaviour disorder (RBD), a condition in which people can act out recurrent dreams and move excessively while asleep.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394418</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/stem-cells-muscle-decline.aspx]]&gt;</url>
    <title>Behind the Headlines - Stem cells tested on muscle ageing</title>
    <publicationDate>2010-11-11T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Scientists have created a ‘Mighty Mouse’ with muscles that stay powerful as it grows old,” the Daily Mail has reported. The newspaper said the ‘breakthrough’ paves the way for a “pill to give pensioners the strength of their youth, cutting the risks of falls and fractures in old age”.&lt;/P&gt;
&lt;P&gt;The story comes from research on mice that found that transplanting donor muscle stem cells into injured leg muscles led to a 50% increase in muscle mass and a 170% increase in muscle size. The improvements were maintained though the lifetime of the mouse. The findings could have implications for treating the loss of muscle mass and strength that occurs in human ageing, say the researchers. It may also have implications for the treatment of muscle wasting diseases such as muscular dystrophy.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>383816</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/08August/Pages/dementia-prevention-strategies.aspx]]&gt;</url>
    <title>Behind the Headlines - Study looks at reducing dementia</title>
    <publicationDate>2010-08-06T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Keeping one's brain active, trying not to become depressed and eating a diet rich in fruit and vegetables are the best ways to ward off developing dementia,”&amp;nbsp;according to a report in&amp;nbsp;&lt;EM&gt;The Daily Telegraph.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This study was set up to estimate how eliminating specific risk factors for dementia could reduce the number of people developing the condition. The researchers followed 1,433 elderly adults over seven years, during which they regularly assessed cognitive performance and several known and suspected risk factors for dementia.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>383820</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/vitamin-d-Parkinsons-disease.aspx]]&gt;</url>
    <title>Behind the Headlines - Vitamin D and Parkinson's</title>
    <publicationDate>2010-07-13T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Low vitamin D levels may increase a person's risk of developing Parkinson's disease,” BBC News has reported. Its website said that people with the lowest levels of vitamin D had a three-fold higher risk of developing Parkinson’s disease.&lt;/P&gt;
&lt;P&gt;The news is based on research that followed over 3,000 Finnish people aged 50 to 79 years over a period of 29 years. Scientists took a measurement of the participants’ blood vitamin D levels and looked at how the subsequent risk of developing Parkinson’s disease over the period related to their blood vitamin D levels.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394423</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/11November/Pages/vitamin-E-and-stroke-risk.aspx]]&gt;</url>
    <title>Behind the Headlines - Vitamin E 'affects stroke risk'</title>
    <publicationDate>2010-11-05T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Taking vitamin E could slightly increase the risk of a particular type of stroke,” reported BBC News. It said that a study has found that for every 1,250 people taking vitamin E, there is the chance of one extra haemorrhagic stroke - bleeding in the brain.&lt;/P&gt;
&lt;P&gt;This large and well-conducted systematic review found that taking vitamin E increased the risk of haemorrhagic stroke (the less common type of stroke) by 22%. The vitamin also slightly reduced the risk of ischaemic stroke (due to a clot in the brain). This equates to one extra haemorrhagic stroke for every 1,250 people taking vitamin E, and one ischaemic stroke prevented for every 476 people.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94184</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11999259&amp;query_hl=200]]&gt;</url>
    <title>Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review</title>
    <publicationDate>2002-07-07T00:00:00</publicationDate>
    <publisher>Med J Aust</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,CANCER,BREAST,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To assess the (i) benefits, (ii) harms and (iii) costs of continuing mammographic screening for women 70 years and over.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Women 70 years and over, in consultation with their healthcare providers, may want to decide for themselves whether to continue mammographic screening. Decision-support materials are needed for women in this age group. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95052</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4092957&amp;chk=5qTJwU]]&gt;</url>
    <title>Better health in old age: report from Professor Ian Philp</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NSF FOR OLDER PEOPLE,LATER LIFE,ADULTS,OLDER PEOPLE,NATIONAL SERVICE FRAMEWORKS,PREVENTION,GENERAL / OVERVIEWS,DISEASE MANAGEMENT,ISCHAEMIC STROKE,HAEMORRHAGIC STROKE,SMOKING CESSATION,PREVENTION,PRIMARY PREVENTION,PREVENTION,DISEASE MANAGEMENT,GENERAL / OVERVIEWS,PUBLIC HEALTH,STROKE,MANAGEMENT &amp; INTERVENTIONS,HEALTHCARE &amp; HEALTH SERVICES,MANAGEMENT &amp; POLICY,FRAMEWORKS,METHODS,IMPACT ASSESSMENT,2008-SEPTEMBER,MONTHLY ADDITIONS,GROUPS,POPULATIONS,ANALYSIS &amp; RESEARCH,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report highlights progress since 2001 under the National Service Framework for Older People and sets out a vision for the future.]]&gt;</body>
  </document>
  <document>
    <id>346410</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/02February/Pages/BMI-and-survival-in-older-people.aspx]]&gt;</url>
    <title>BMI and survival in older people</title>
    <publicationDate>2010-02-15T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “Being fat can help you live longer in old age,” the &lt;EM&gt;Daily Express&lt;/EM&gt; reported. It said the death rate for people aged 70 to 75 years is lowest for those classed as overweight, while those who are obese have the same risk as people of ‘normal’ weight. According to the paper, being underweight is linked with the highest risk of death.]]&gt;</body>
  </document>
  <document>
    <id>377439</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/05May/Pages/beer-belly-alzheimers-fat-risk.aspx]]&gt;</url>
    <title>Body fat 'linked to Alzheimer's'</title>
    <publicationDate>2010-05-24T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Having a “pot belly” in middle age raises the risk of Alzheimer’s disease and dementia later in life, according to the Daily Mail.&lt;/P&gt;
&lt;P&gt;The news is based on research into whether total brain volume was associated with measurements such as body mass index (BMI), waist size, fat under the skin and fat around the organs. As part of the study, several hundred middle-aged participants had their body fat and brains scanned. The results suggested that a larger waist and more fat surrounding the organs were both associated with decreased brain volume. However, this early research did not examine whether any participants went on to develop Alzheimer’s or dementia. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101926</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12849582&amp;query_hl=21]]&gt;</url>
    <title>Breast and cervical cancer screening among Korean American elderly women</title>
    <publicationDate>2002-08-04T00:00:00</publicationDate>
    <publisher>Eur J Oncol Nurs</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,BREAST,OVARY,CANCER,SCREENING,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The purpose of this study was to estimate the prevalence and correlates of breast and cervical cancer screening tests among Korean American elderly women. This study examined the effects of individual socio-demographic background, acculturation level (e.g., proportion of life spent in the US, spoken English proficiency), health status and access to health care on uptake of mammography and Pap smear tests in the past 2 years. Subjects were 130 Korean American women aged 60 and older living in the Greater Metropolitan Baltimore Area. A cross-sectional face-to-face interview was conducted. The 2-year prevalence was only 35% for mammography and 29% for Pap smear tests. In multiple logistic regression analysis, educational attainment, government support, multiple chronic conditions, and routine checkups were associated with having mammography. Age, acculturation and insurance were associated with having a Pap test. Taking advantage of the positive influence of identified covariates may increase the effectiveness of cancer control interventions among Korean American elderly women. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101929</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14583166&amp;query_hl=23]]&gt;</url>
    <title>Breast and cervical cancer screening for women between 50 and 69 years of age: what prompts women to screen?</title>
    <publicationDate>2003-08-03T00:00:00</publicationDate>
    <publisher>Womens Health Issues</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CANCER,BREAST,CERVIX]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The objective of this study was to examine mammography and cervical cancer screening rates among women aged 50 to 69 and to understand which prompts are effective for improving screening compliance. A self-administered survey was sent to 800 randomly selected participants in a health region in a relatively poor, rural province in Eastern Canada with a universal health care system. Since 1995, New Brunswick has instituted a biannual self-referral mammography screening program for women between 50 and 69 years of age. The response rate to the survey was 66%. Mammography screening compliance was 73% and was most significantly associated with annual clinical breast examinations, compliance with cervical cancer screening, and physician suggestion (p &amp;lt;.001). Cervical cancer screening compliance was 91% and was significantly associated with annual clinical breast examinations, compliance with mammography screening, and physician suggestion (p&amp;lt;.001). Contact with a physician is most effective for promoting screening compliance. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>276159</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.bgs.org.uk/Publications/Compendium/compend_index.htm]]&gt;</url>
    <title>British Geriatrics Society Compendium</title>
    <publicationDate>2007-12-12T00:00:00</publicationDate>
    <publisher>British Geriatrics Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,FALLS,DEMENTIA,STROKE,SCREENING AND SURVEILLANCE,NSF FOR OLDER PEOPLE,PARKINSON'S DISEASE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Links to further resources on: specialty of geriatric medicine; ethics and legal issues; acute hospital based issues in health care of older people; community interface issues in health care of older people; training section; and individual service specifications.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Links to further resources on: specialty of geriatric medicine; ethics and legal issues; acute hospital based issues in health care of older people; community interface issues in health care of older people; training section; and individual service specifications.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;See also &lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm" target="_blank"&gt;British Geriatrics Society: Reference Material Index&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Index&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#new" target="_blank"&gt;What's new?&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#bone" target="_blank"&gt;Bone health&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#governance" target="_blank"&gt;Governance (Government and Service Delivery)&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#history" target="_blank"&gt;History of Geriatric Medicine&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#incontinence" target="_blank"&gt;Incontinence, Bladder and Bowel Health&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#mental" target="_blank"&gt;Mental Health&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#multi" target="_blank"&gt;Multi-specialties (GPswSI, Nurses, Therapists and multi-disciplinary issues)&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#palliative" target="_blank"&gt;Palliative and end of life care&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#training" target="_blank"&gt;Training, Academic Medicine, CPD and Revalidation&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.bgs.org.uk/Publications/Reference%20Material/reference_material_index.htm#other" target="_blank"&gt;Other useful references&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95372</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/634.asp]]&gt;</url>
    <title>Calculating the costs of efficient care homes</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This study updates work from 2002 looking at what constitutes reasonable fees for care homes for older people in England.]]&gt;</body>
  </document>
  <document>
    <id>101930</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14639612&amp;query_hl=25]]&gt;</url>
    <title>Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women</title>
    <publicationDate>2004-08-01T00:00:00</publicationDate>
    <publisher>Int J Cancer</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CERVIX,CANCER,SCREENING,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Although the relation between cervical cancer and the human papillomavirus (HPV) has been established beyond doubt, the introduction of HPV detection in cervical cancer screening is halted, primarily by the high rate of false positivity in relation to morbidity, since the majority of women infected with HPV will not develop lesions. To counteract overconsumption of cervical cancer screening in elderly women, we wanted to test the hypothesis that women of 50 years or older who are HPV-negative and have a cytologically normal smear might be encouraged to refrain from further screening. As a first step, the prevalence of high-risk HPV in a population of 1,936 women of 50 years and older was investigated. After an initial decline, a slightly higher prevalence can be seen with increasing age. There is a decrease in the prevalence of multiple infections with age, paralleled by an increase in single infections, especially of HPV type 16 in the eldest-age group. However, neither the decrease in multiple infections nor the increase in single infections is statistically significant. The data obtained in this study show that, even in the presence of a slight increase in the HPV prevalence in elderly women, approximately 94% of the elderly women can be withdrawn from the cervical cancer screening. However, a follow-up study will be necessary to determine the frequency of (re)infection as well as the course of an HPV infection in elderly women. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>380401</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/06June/Pages/alzheimers-disease-magnet-therapy.aspx]]&gt;</url>
    <title>Can magnets ease Alzheimer's?</title>
    <publicationDate>2010-06-24T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Applying magnets to the brains of Alzheimer's disease sufferers helps them understand what is said to them”, The Independent has claimed.&lt;/P&gt;
&lt;P&gt;The news is based on a small trial of an experimental magnetic therapy called rTMS, which some believe can reorganise brain cells and improve neurological functions.&lt;/P&gt;
&lt;P&gt;Over four weeks, five patients were given rTMS and five were given two weeks of sham treatment followed by two weeks of real rTMS. The rTMS was applied to the area of the brain known to be involved in speech and communication, which are often impaired during Alzheimer’s disease. After two weeks, those treated solely with rTMS showed improvements in sentence comprehension. Those receiving the sham treatment did not improve. The sham group then improved a similar amount after two weeks of real rTMS.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101955</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9767334&amp;query_hl=43]]&gt;</url>
    <title>Cancer screening of older women : a primary care issue</title>
    <publicationDate>1998-08-02T00:00:00</publicationDate>
    <publisher>Cancer Pract</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING,CANCER,OVARY,CERVIX,BREAST,COLORECTAL,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;The purpose of this retrospective chart review was to examine whether family practice physicians and residents were screening older women for breast, gynecologic, and colorectal cancers as recommended by the American Cancer Society, the Guide to Clinical Preventive Services, and Healthy People 2000. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Barriers for appropriate cancer screening for older women exist for both the provider and the patient; however, many of these obstacles can be overcome. Improving the resident's exposure to the current recommendations, increasing geriatric content in the training program, and initiating a reminder system may reduce some of the provider barriers. The use of midlevel providers may increase the preventive services offered to older women as well as educate and empower these women to become responsible for their own healthcare. Together, physicians and midlevel providers can become patient advocates through political activism, encouraging legislation that guarantees payment for cancer screening tests. Finally, primary care providers can become actively engaged in research that explores the healthcare concerns of older women. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374896</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/04April/Pages/prostate-cancer-screening-test-anxiety.aspx]]&gt;</url>
    <title>Cancer tests 'can lead to anxiety'</title>
    <publicationDate>2010-04-09T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Men could potentially be distressed by prostate cancer screening, according to BBC News. The website said that even if a tissue sample shows no signs of cancer, men can experience increased levels of distress and doctors should warn men about how testing may affect their mood.&lt;/P&gt;
&lt;P&gt;The research behind this news tracked men’s mood and anxiety from an initial blood test until three months after a tissue sample confirmed that they did not have cancer. The results showed that a small proportion of men had clinically significant levels of distress throughout testing and even after a clear result.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313365</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nmc-uk.org/General-public/Older-people-and-their-carers/Care-and-respect-every-time-new-guidance-for-the-care-of-older-people/]]&gt;</url>
    <title>Care and Guidance for older people</title>
    <publicationDate>2009-03-31T00:00:00</publicationDate>
    <publisher>Nursing and Midwifery Council</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN id=lblMainArticle&gt;The guidance is aimed at working nurses, but also has implications for pre- and post- registration education and training, and can be used by employers&amp;nbsp;as a benchmark for delivery. Carers and other healthcare professionals will also find this guidance useful and relevant to their work.&lt;/SPAN&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313513</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pifonline.org.uk/?o=1097&amp;newsitem=4387]]&gt;</url>
    <title>Care Quality Commission Launches</title>
    <publicationDate>2009-04-03T00:00:00</publicationDate>
    <publisher>Patient Information Forum</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Care Quality Commission (CQC) launched on April 1st bringing together the independent regulation of health and adult social care in England. The Commission will regulate health and adult social care services, whether provided by the NHS, local authorities, private companies or voluntary organisations. The Commission will also protect the rights of people detained under the Mental Health Act.]]&gt;</body>
  </document>
  <document>
    <id>383137</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.policyexchange.org.uk/images/publications/pdfs/Careless_-_Jul__10.pdf]]&gt;</url>
    <title>Careless: Funding long-term care for the elderly</title>
    <publicationDate>2010-07-27T00:00:00</publicationDate>
    <publisher>Policy Exchange</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A fundamental demographic shift is taking place. The number of older people is growing rapidly while the number of young people and those of working age are shrinking. As people age, the likelihood of them requiring some form of care and support increases.&lt;/P&gt;
&lt;P&gt;Includes sections on:&lt;/P&gt;
&lt;P&gt;What is long-term care?&lt;/P&gt;
&lt;P&gt;No political appetite for reform&lt;/P&gt;
&lt;P&gt;No-one knows about long-term care&lt;/P&gt;
&lt;P&gt;The costs of long-term care&lt;/P&gt;
&lt;P&gt;Is there an urgent need for reform?&lt;/P&gt;
&lt;P&gt;How do we pay for reform?&lt;/P&gt;
&lt;P&gt;Priorities for the coalition&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>269580</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.healthcarecommission.org.uk/_db/_documents/Caring_for_dignity.pdf]]&gt;</url>
    <title>Caring for Dignity: A national report on dignity in care for older people while in hospital</title>
    <publicationDate>2007-09-27T00:00:00</publicationDate>
    <publisher>Healthcare Commission</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,SCREENING AND SURVEILLANCE,PRIMARY CARE,SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The Healthcare Commission's 2006 publication ‘Living well in later life’ highlighted the lack of dignity and respect for older people in acute hospitals as a major area of concern. As a result of this, they decided to focus on dignity as a key theme in the annual health check for 2006/2007 and to undertake a targeted inspection programme to assess the extent to which NHS trusts are meeting the Government’s core standards relating to dignity in care for hospital inpatients.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Review of dignity in care&lt;/H2&gt;
&lt;P&gt;The number of older people in the population is increasing rapidly. Although many are living a healthy and active life, a substantial proportion of older people often need care in hospital. This need increases with age and their stay in hospital may become more frequent or longer. Maintaining patients’ dignity and treating them with respect while in hospital is of paramount importance to older people, but anecdotal evidence indicates that this does not always happen.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Our 2006 publication ‘Living well in later life’ highlighted the lack of dignity and respect for older people in acute hospitals as a major area of concern. As a result of this, we decided to focus on dignity as a key theme in the annual health check for 2006/2007 and to undertake a targeted inspection programme to assess the extent to which NHS trusts are meeting the Government’s core standards relating to dignity in care for hospital inpatients.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Our assessments highlighted a number of trusts that were at risk of non-compliance with the core standards relevant to providing dignity and respect for patients in their declarations for the 2006/2007 annual health check.&amp;nbsp; We found 35 trusts to be at highest risk and, of these, 12 were already being pursued on dignity as part of other routine follow-up activity. As a result, 23 trusts were identified as requiring more detailed scrutiny, which involved interviews with staff at various levels and observation of one ward for the elderly and one with a mixture of elderly and non-elderly people in each site visited. At least one ward was visited during mealtimes.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The key aspects we observed during our inspection visits were:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;the ward environment, including privacy issues 
&lt;LI&gt;mealtime activity 
&lt;LI&gt;the behaviour of staff&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Following the visits, we assessed the trusts on a five-point scale and we issued notification letters to those trusts that were found to be at risk of non-compliance with one or more standards. These trusts were expected to reflect this in their declarations for the 2006/2007 annual health check.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Based on the scrutiny against standards and the issues identified by other evidence, a number of key themes emerged as the essential elements for ensuring that older people were being provided care in a way that was dignified and that matched their personal needs while in hospital. The themes identified were:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;involving older people in their care 
&lt;LI&gt;delivering personal care in a way that ensures dignity for the patient 
&lt;LI&gt;having a workforce that is equipped to deliver good quality care 
&lt;LI&gt;strong leadership at all levels 
&lt;LI&gt;supportive ward environment&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Overall, we were encouraged by evidence&amp;nbsp;that acute trusts are making efforts to respond to concerns about delivering care that respects dignity.&amp;nbsp; However, there is no room for complacency and NHS acute trusts must embed an approach to care that ensures dignity for patients. Although we found no major breaches of national standards, there is still a considerable need for improvement in many areas and we have made the necessary recommendations in our report ‘Caring for dignity’.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93902</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/mgmt/careold.html]]&gt;</url>
    <title>Caring for older people after acute illness</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,FALLS,SERVICE ORGANISATION,REHABILITATION,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This Bandolier article reviews the following studies:&lt;/P&gt;
&lt;P&gt;1. Parker G and colleagues. Best place of care for older people after acute and during subacute illness: a systematic review. J Health Serv Res Policy Vol 5, No 3: July 2000 &lt;/P&gt;
&lt;P&gt;2. Allen KR, Counsell SR. Josephson RA et al. Improving clinical and functional outcomes of hospitalised older patients with cardiovascular illness, Cardiovascular Reviews and reports 1996; 17:43-57 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93872</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15194251&amp;query_hl=28]]&gt;</url>
    <title>Change in stroke incidence, case fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study)</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Lancet</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,BACKGROUND]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band126/b126-2.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"This detailed study took an in-depth look at stroke incidence in Oxfordshire. Because of an ageing population, more strokes would have been expected. Fewer occurred. Both treatment of pre-morbid conditions, and improved risk factors contributed, but how much by each is not clear. Oxfordshire probably does as well as most places in implementation of preventative medicine, and many people have taken on board healthy living advice. Together these have resulted in reducing the number of strokes in the population of 2004 by about 55 per 100,000 people over what would have been expected without them. This is beginning to look like good value".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101958</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11584035&amp;query_hl=48]]&gt;</url>
    <title>Choice stepping reaction time: a composite measure of falls risk in older people</title>
    <publicationDate>2001-08-05T00:00:00</publicationDate>
    <publisher>J Gerontol A Biol Sci Med Sci</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,ASSESSING RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;This study investigated the neuropsychological, sensorimotor, speed, and balance contributions to a new test of choice stepping reaction time (CSRT) and determined whether this new test is an important predictor of falls in older people. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;This study identifies a new test that provides a composite measure of falls risk in older people and elucidates the relative importance of specific physiological and neuropsychological systems in the initiation of fast and appropriate step responses. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>33799</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csp.org.uk/uploads/documents/evidencebrief_stroke_EB02.pdf]]&gt;</url>
    <title>Clinical cost effectiveness of physiotherapy in the management of older people following a stroke</title>
    <publicationDate>2002-03-01T00:00:00</publicationDate>
    <publisher>Chartered Society of Physiotherapy</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The National Service Framework is a landmark policy initiative for stroke. It represents a genuine opportunity for physiotherapists to improve the care of patients following a stroke.</description>
    <body>&lt;![CDATA[ This report is one of four commissioned to support physiotherapists implementing the Older People's NSF. They are: 
&lt;P&gt;1. Effectiveness of falls prevention and rehabilitation strategies in older people: implications for physiotherapy.&lt;/P&gt;
&lt;P&gt;2. The effectiveness of physiotherapy in the palliative care of older people.&lt;/P&gt;
&lt;P&gt;3. The clinical and cost effectiveness of physiotherapy in the management of common rheumatological conditions of old age.&lt;/P&gt;
&lt;P&gt;4. The clinical and cost effectiveness of physiotherapy in the management of older people following a stroke.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374906</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/04April/Pages/Clot-risk-in-prostate-cancer.aspx]]&gt;</url>
    <title>Clot risk in prostate cancer</title>
    <publicationDate>2010-04-15T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Prostate cancer patients have double the risk of suffering blood clots which can lead to DVT,” the Daily Mail reported. It said that the risk of DTV (deep vein thrombosis) is greatest for men undergoing hormone therapy for prostate cancer and in younger men with advanced-stage cancer.&lt;/P&gt;
&lt;P&gt;This large study in 76,000 Swedish men looked at the rates of thromboembolic diseases, which include DVT and pulmonary embolism (PE), and found that they occurred more often in men with prostate cancer than in the general population. The risk of these diseases varied according to which cancer treatment was used, with the highest risk in men who were primarily treated with hormone therapy. These men had about 2.5 times the rate of DVT and twice the rate of PE compared to the general male population.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101962</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11925605&amp;query_hl=54]]&gt;</url>
    <title>Colonoscopic screening and follow-up for colorectal cancer in the elderly</title>
    <publicationDate>2002-08-04T00:00:00</publicationDate>
    <publisher>World Journal of Gastroenterology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CANCER,COLORECTAL,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To improve the prevention and treatment of senile patients with colorectal cancer by evaluating the importance of colonoscopy in clinical screening and follow-up. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Colonoscopic screening and follow-up of the elderly for colorectal cancer and pre-cancerous lesion (adenomatoid polyp) can increase the detectable rate of early colorectal cancer and improve its prevention and treatment. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101964</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12907348&amp;query_hl=56]]&gt;</url>
    <title>Colonoscopy screening in the elderly: when to stop</title>
    <publicationDate>2003-08-03T00:00:00</publicationDate>
    <publisher>American Journal of Gastroenterology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CANCER,COLORECTAL,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;The age to begin colorectal cancer (CRC) screening is based on the risk of neoplasia and is published in screening guidelines. The age to stop screening is unknown but should be based, in part, on the same principle. The purpose of this study was to establish whether the prevalence of neoplasia detected by colonoscopy diminished with advancing age, to warrant ceasing colonoscopic screening.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;The prevalence of advanced neoplasia continues to increase with age. Subjects undergoing colonoscopy for screening had a greater risk for neoplasia than did subjects with symptoms. There is no decline in yield of advanced neoplasia to justify stopping screening colonoscopy in the elderly. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>303859</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2008/12December/Pages/Prostatecancertreatment.aspx]]&gt;</url>
    <title>Combined prostate treatment</title>
    <publicationDate></publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CANCER,PROSTATE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the Headlines - your guide to the science that makes the news. Created by NHS Choices</description>
    <body>&lt;![CDATA[ Prostate cancer patients should be treated with "radiotherapy as well as hormones" according to The Daily Telegraph. It reports that scientists recommend that using both treatments should be the standard for tackling the cancer, instead of the current practice prescribing long-term hormone treatment only.]]&gt;</body>
  </document>
  <document>
    <id>235475</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csci.org.uk/pdf/paf_consultation_010806.pdf]]&gt;</url>
    <title>Commission for Social Care Inspection: A New Framework for Performance Assessment of Adult Social Care 2006-7</title>
    <publicationDate></publicationDate>
    <publisher>Social Care Institute for Excellence</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This report, funded by the Social Care Institute for Excellence, summarises the outcomes valued by older people and lessons learned from authorities developing services for older people in England and Wales.</description>
    <body>&lt;![CDATA[ This report, funded by the Social Care Institute for Excellence,&amp;nbsp;summarises the outcomes valued by older people and lessons learned from authorities developing services for older people in England and Wales.]]&gt;</body>
  </document>
  <document>
    <id>235483</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csci.org.uk/PDF/making_choices_taking_risks.pdf]]&gt;</url>
    <title>Commission for Social Care Inspection: Making Choices Taking Risks</title>
    <publicationDate></publicationDate>
    <publisher>Commission for Social Care Inspection</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This paper highlights some of the risk-related factors that may prevent older people from living life the way they choose, proposes some ways that social care can support people’s aspirations and choices and identi&amp;#64257; es some challenges.</description>
    <body>&lt;![CDATA[ This paper highlights some of the risk-related factors that may prevent older people from living life the way they choose, proposes some ways that social care can support people’s aspirations and choices and identi? es some challenges.]]&gt;</body>
  </document>
  <document>
    <id>319595</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.endoflifecareforadults.nhs.uk/assets/downloads/pubs_Core_competences_guide.pdf]]&gt;</url>
    <title>Common core competences and principles for health and social care workers working with adults at the end of life PDF</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>NHS End of Life Care Programme</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=4 face=Frutiger-Light&gt;&lt;FONT size=4 face=Frutiger-Light&gt;
&lt;P align=left&gt;It recognised that the delivery of quality end of life care services to individuals, their families and carers will require nothing less than a cultural shift in attitude and behaviour within the health and social care workforce.&lt;/P&gt;
&lt;P align=left&gt;The Department of Health, working with the NHS End of Life Care Programme, has commissioned three foundation projects based on the core common requirements for workforce outlined in the strategy to start taking this work forward.&lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT size=4 face=Frutiger-Light&gt;&lt;FONT size=4 face=Frutiger-Light&gt;&lt;/P&gt;&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>319637</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ic.nhs.uk/webfiles/publications/Social%20Care/RAP%20Full%20Report/2007-08/RAP%20Report.pdf]]&gt;</url>
    <title>Community Care Statistics 2007-2008: Referrals, assessments and packages of care for adults, england. PDF</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>The Health and Social Care Information Centre.</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=Arial size=3&gt;&lt;FONT face=Arial size=3&gt;
&lt;P align=left&gt;The Referrals, Assessments and Packages of Care Project (RAP) was developed to provide a coherent set of National Statistics on adult community care. Community care is the process by which requests for social care help made to Councils with Adult Social Services Responsibilities (CASSRs) are translated, via assessment and care planning into appropriate services. Most of the information presented has been collected since 2000-01. Some of the waiting times data was collected for the first time in 2004-05, information around carers in 2005-06 and the age split of clients receiving services by ethnicity in 2006-07.&lt;/P&gt;&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>374928</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/4/408?rss=1]]&gt;</url>
    <title>Comparative Effectiveness of 10 Antiepileptic Drugs in Older Adults With Epilepsy</title>
    <publicationDate>2010-04-12T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objective&amp;nbsp; To compare the effectiveness of antiepileptic drugs (AEDs) for use in older adults with epilepsy.]]&gt;</body>
  </document>
  <document>
    <id>271114</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/housing/2158.asp]]&gt;</url>
    <title>Comparing models of housing with care for later life</title>
    <publicationDate>2007-10-23T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SECONDARY CARE,SURVEILLANCE,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Interest is growing in the role of housing schemes for older people that combine independent living with relatively high levels of care. This comparative study of seven schemes in England examines different models of housing with care for older people.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Key points&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;There appeared to be no single dominant model of housing with care that was most effective. The combination of independence and security offered by all schemes appeared to be highly attractive to older people from a range of backgrounds. 
&lt;LI&gt;Schemes developed in partnership between housing associations and local statutory sector services were more likely to be responding to local needs and shortfall in existing services. Independent providers were able to exercise more autonomy. 
&lt;LI&gt;The profile of residents was different in each scheme, reflecting entry criteria operated by the managing organisations. This allowed communities of people with similar life experiences and backgrounds to develop. 
&lt;LI&gt;The size of schemes did not appear to influence the levels of care that could be offered, but did affect the variety and range of facilities and amenities available to residents. Larger schemes appeared to offer some social advantages. 
&lt;LI&gt;Location and design features were important influences on how schemes operated and on residents' daily lives, particularly the size of each dwelling. Accommodation that was very small impacted on residents' lifestyle, and had implications for care delivery. Greater emphasis is needed on 'space for living'. 
&lt;LI&gt;The housing needs of older people entering such schemes should not be underestimated. For residents, the 'housing' element of housing with care schemes was not a secondary consideration. 
&lt;LI&gt;Informal support from family or volunteers was often integral to the functioning of schemes and the well-being of individual residents. 
&lt;LI&gt;Not all care and support needs could be met within the schemes, especially if people had dementia-type illnesses or challenging behaviours.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>328781</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/9/1114]]&gt;</url>
    <title>Comparison of Risk Factor Profiles in Incidental Lewy Body Disease and Parkinson Disease</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>Archives of Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To explore whether associations of potential risk factors for incidental Lewy body disease (iLBD) are similar to those for Parkinson disease (PD).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Brain autopsy study (1988-2004) of subjects without evidence of neurodegenerative disease or tremor who were evaluated by at least 1 physician within 1 year of death. Researchers analyzed incidental Lewy pathology blinded to clinical abstraction.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;Olmsted County, Minnesota.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Subjects:&lt;/STRONG&gt;&lt;BR&gt;Residents of Olmsted County and the immediate vicinity aged older than 60 years.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;BR&gt;&lt;/STRONG&gt;Whether risk factors previously associated with PD in Olmsted County are also associated with iLBD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Of 235 subjects, 34 had iLBD (14.5%). The overall risk factor profiles for iLBD and PD were fairly similar between the 2 sets of odds ratio (OR) estimates, with 11 of 16 ORs in the same direction. Prior Olmsted County studies documented 7 risk factors with statistically significant associations with PD; for physician occupation and caffeine intake, the ORs for iLBD were in the same direction and statistically significant, whereas for education, head injury, and number of children, they were in the same direction but not significant; they were in the opposite direction but not statistically significant for depression and anxiety. Incidental Lewy body disease was not associated with various end-of-life conditions or causes of death, though these patients were slightly older and more likely cachectic.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;Based on this exploratory study, iLBD and PD appear to have similar risk factor profiles. Thus, at least some cases of iLBD could represent preclinical PD, arrested PD, or a partial syndrome due to a lesser burden of causative factors. Incidental Lewy body disease is not explained by nonspecific end-of-life brain insults.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93846</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://bmj.bmjjournals.com/cgi/content/full/311/7020/1602]]&gt;</url>
    <title>Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease.</title>
    <publicationDate>1995-07-02T00:00:00</publicationDate>
    <publisher>British Medical Journal</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NEUROLOGICAL CONDITIONS,PARKINSON'S DISEASE,MOVEMENT DISORDERS,PARKINSON'S DISEASE,PARKINSON'S DISEASE &amp; AKINETIC RIGID SYNDROMES,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This RCT has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band23/b23-4.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;Time and patience are needed in assessing treatments for chronic diseases. Parkinson's disease is just one example, but here we are fortunate that randomised controlled studies begun over 10 years ago are now providing answers about what, and what not, to use".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317429</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70094-8/fulltext#article_upsell]]&gt;</url>
    <title>Confronting the crisi in dementia care</title>
    <publicationDate>2009-05-30T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ On March 24, 2009, against a backdrop of global financial turmoil, the Alzheimer's Association released its &lt;I&gt;Alzheimer's Disease &lt;/I&gt;&lt;A class=ja50-ce-inter-ref href="http://www.alz.org/national/documents/report_alzfactsfigures2009.pdf" target="_blank"&gt;&lt;I&gt;Facts and Figures &lt;/I&gt;&lt;/A&gt;report. Among the alarming statistics is an estimate that care for people with dementia costs more than US$148 billion per year in the USA alone. As governments around the globe reassess their finances in an effort to avert or at least limit the effects of financial meltdown, spending on care for people with dementia must not be neglected.]]&gt;</body>
  </document>
  <document>
    <id>313509</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/content/short/301/16/1671]]&gt;</url>
    <title>Continuity of Outpatient and Inpatient Care by Primary Care Physicians for Hospitalized Older Adults</title>
    <publicationDate>2009-04-22T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=Verdana size=2&gt;Little is known about the extent of continuity&lt;SUP&gt; &lt;/SUP&gt;of care across the transition from outpatient care to hospitalization.&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>374933</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/2/217?rss=1]]&gt;</url>
    <title>Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults</title>
    <publicationDate>2010-02-08T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Abnormal cerebrospinal fluid (CSF) biomarker levels predict development of Alzheimer disease with good accuracy and are thought to precede cognitive deterioration.]]&gt;</body>
  </document>
  <document>
    <id>291068</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.leeds.ac.uk/lihs/auhe/papers/cea_ageism.pdf]]&gt;</url>
    <title>Cost-effectiveness analysis and ageism: a review of the theoretical literature</title>
    <publicationDate>2008-06-25T00:00:00</publicationDate>
    <publisher>Leeds University</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,THE WHY,HOW DOES AGEISM OCCUR?,WHAT IS AGEISM?]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Report prepared for the Department of Health, June 2008.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Cost-effectiveness analysis and ageism: a review of the theoretical literature (University of Leeds, Leeds Institute of Health Services)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Cost-effectiveness analysis (CEA) is a form of economic evaluation in which outcomes are normally measured using the quality-adjusted life-year (QALY). QALYs are constructed by combining information on the length and health-related quality of life. In the QALY, periods in a health state are valued by multiplying health-related quality of life by the duration one remains in that state. Results from a cost-effectiveness analysis are&lt;BR&gt;presented in terms of the investment required in order to provide a one QALY improvement – the cost-per-QALY ratio. The use of cost-effectiveness analysis has been argued to be a form of indirect discrimination in the theoretical literature and hence this legislation is of potential concern to the NHS as a major user of CEA. This review summarises the theoretical literature in order to address four main questions.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;AIM 1: What are the specific age-based criticisms and defences of CEA (and the QALY) within the literature?&lt;/LI&gt;
&lt;LI&gt;AIM 2: To what degree could alternative methods (including CEA variations) address the different equity concerns raised by parties within the general debate?&lt;/LI&gt;
&lt;LI&gt;AIM 3: Are alternatives presented to standard CEA within the theoretical literature incorporating equity arguments? (Including variations of the basic CEA method.)&lt;/LI&gt;
&lt;LI&gt;AIM 4: To what degree could alternative methods (including CEA variations) address the specific proposals of the Green Paper?&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>330000</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/sites/files/jrf/information-systems-for-older-people-summary.pdf]]&gt;</url>
    <title>Creating a stronger information, advice and advocacy system for older people</title>
    <publicationDate>2009-10-19T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The adult social care system needs to ensure older people get the information, advice and advocacy services they need to remain independent.&lt;/P&gt;
&lt;P&gt;This Solutions paper highlights recent work in Newcastle by the Quality of Life Partnership that's developed ways of working with existing systems to make them more 'older person friendly', efficient, and effective for all concerned. Lessons learnt include:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Invest in processes so that older people have a variety of ways of sharing their views and experiences.&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Persuade local partners that information and advice is not an add-on to the day job. It is the day job.&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Understand that partnership working is much more difficult, complex and time-consuming than working in isolation.&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Realise that some issues may need to be addressed across all age groups.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>321717</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/reprint/302/4/385]]&gt;</url>
    <title>CSF Biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment</title>
    <publicationDate>2009-07-22T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Context:&lt;/STRONG&gt;&lt;BR&gt;Small single-center studies have shown that cerebrospinal fluid (CSF) biomarkers may be useful to identify incipient Alzheimer disease (AD) in patients with mild cognitive impairment (MCI), but large-scale multicenter studies have not been conducted.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To determine the diagnostic accuracy of CSF ß-amyloid1-42 (Aß42), total tau protein (T-tau), and tau phosphorylated at position threonine 181 (P-tau) for predicting incipient AD in patients with MCI.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design, Setting, and Participants:&lt;/STRONG&gt;&lt;BR&gt;The study had 2 parts: a cross-sectional study involving patients with AD and controls to identify cut points, followed by a prospective cohort study involving patients with MCI, conducted 1990-2007. A total of 750 individuals with MCI, 529 with AD, and 304 controls were recruited by 12 centers in Europe and the United States. Individuals with MCI were followed up for at least 2 years or until symptoms had progressed to clinical dementia.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;/STRONG&gt;&lt;BR&gt;Sensitivity, specificity, positive and negative likelihood ratios (LRs) of CSF Aß42, T-tau, and P-tau for identifying incipient AD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;During follow-up, 271 participants with MCI were diagnosed with AD and 59 with other dementias. The Aß42 assay in particular had considerable intersite variability. Patients who developed AD had lower median Aß42 (356; range, 96-1075 ng/L) and higher P-tau (81; range, 15-183 ng/L) and T-tau (582; range, 83-2174 ng/L) levels than MCI patients who did not develop AD during follow-up (579; range, 121-1420 ng/L for Aß42; 53; range, 15-163 ng/L for P-tau; and 294; range, 31-2483 ng/L for T-tau, P &amp;lt; .001). The area under the receiver operating characteristic curve was 0.78 (95% confidence interval [CI], 0.75-0.82) for Aß42, 0.76 (95% CI, 0.72-0.80) for P-tau, and 0.79 (95% CI, 0.76-0.83) for T-tau. Cut-offs with sensitivity set to 85% were defined in the AD and control groups and tested in the MCI group, where the combination of Aß42/P-tau ratio and T-tau identified incipient AD with a sensitivity of 83% (95% CI, 78%-88%), specificity 72% (95% CI, 68%-76%), positive LR, 3.0 (95% CI, 2.5-3.4), and negative LR, 0.24 (95% CI, 0.21-0.28). The positive predictive value was 62% and the negative predictive value was 88%.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;This multicenter study found that CSF Aß42, T-tau, and P-tau identify incipient AD with good accuracy, but less accurately than reported from single-center studies. Intersite assay variability highlights a need for standardization of analytical techniques and clinical procedures.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392660</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.endoflifecare-intelligence.org.uk/view.aspx?rid=82]]&gt;</url>
    <title>Deaths in older adults in England</title>
    <publicationDate>2010-10-04T00:00:00</publicationDate>
    <publisher>National End of Life Care Intelligence Network</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING,PUBLIC HEALTH,OUTCOMES,POPULATIONS,GROUPS,ORGANISATIONS,AGE GROUPS,ADULTS,ALL CAUSES OF MORBIDITY &amp; MORTALITY,PUBLIC HEALTH ORGANISATIONS,OLDER PEOPLE,MONTHLY ADDITIONS,NOVEMBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This report, the fourth published by the National End of Life Care Intelligence Network, highlights the importance of understanding the differing needs of older adults at the end of life.&lt;/P&gt;
&lt;P&gt;Death occurs most frequently in old age. Currently, two thirds of people die aged 75 or over, with almost three quarters of women (74.4%) dying in this age group compared with 58.4% of men. Also, the age at which people die is increasing as people live longer. Already one in six people die aged 90 or over.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93901</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/AF/flow.html]]&gt;</url>
    <title>Decision analysis and guidelines for anticoagulation therapy to prevent stroke in patients with atrial fibrillation</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>Lancet</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CAUSES AND PRIMARY PREVENTION,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by Bandolier:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"The use of decision analysis methods, based on a systematic review of the literature and incorporating patient values, guidelines can be drawn up that are useful for clinical practice".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319606</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/assets/docs/200906300900332009_-_June_-_Joint_Statement.pdf]]&gt;</url>
    <title>Defeating dementia through research PDF</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES,CAUSES AND PREVENTION,PATHOLOGY,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=FSAlbert&gt;
&lt;P align=left&gt;700,000 people in the UK have dementia and one million people will develop the condition in the next 10 years.&lt;/FONT&gt;&lt;FONT face=FSAlbert size=1&gt;&lt;FONT face=FSAlbert size=1&gt;1 &lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT face=FSAlbert&gt;Dementia is caused by diseases of the brain that gradually rob people of their lives. There are no treatments to slow its progression, there is no cure and quality of dementia care in Britain remains in the bottom third of Europe.&lt;/P&gt;
&lt;P align=left&gt;By 2018 dementia will cost the UK £27bn a year.&lt;/FONT&gt;&lt;FONT face=FSAlbert size=1&gt;&lt;FONT face=FSAlbert size=1&gt;2 &lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT face=FSAlbert&gt;Without research to provide better prevention, diagnosis and treatment, the emotional and financial burden of dementia will be unaffordable, even within the next decade.&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>262578</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=262578]]&gt;</url>
    <title>Dementia Knowledge Week 2007: Pharmacological treatments - Cholinesterase inhibitors</title>
    <publicationDate>2007-06-25T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia Knowledge Week 2007: Pharmacological treatments - Cholinesterase inhibitors&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Cholinesterase Inhibitors&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessment&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Loveman, E. et al. &lt;A href="http://www.hta.ac.uk/execsumm/summ1001.htm" target="_blank"&gt;The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease&lt;/A&gt;. HTA 2006; Vol 10: number 1.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews and meta analyses&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;1. &amp;nbsp;Beier, M T. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17316151&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Treatment strategies for the behavioral symptoms of alzheimer's disease: focus on early pharmacologic intervention&lt;/A&gt;. Pharmacotherapy 2007; 27 (3): 399-411.&lt;/P&gt;
&lt;P&gt;2. &amp;nbsp;Birks, J. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005593/frame.html" target="_blank"&gt;Cholinesterase inhibitors for alzheimer's disease&lt;/A&gt;. The Cochrane Library, 2006, No. 1, (Cd005593) Source Notes: Update Software, Online or Cd-Rom, Updated Quarterly, Issn: 1464-780x.&lt;BR&gt;&amp;nbsp;3. &amp;nbsp;Boustani, M; Peterson, B; Hanson, L; Harris, R, and Lohr, KN. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=12779304&amp;amp;ordinalpos=6&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force&lt;/A&gt;. Annals of Internal Medicine, 2003 Jun 3, Vol. 138, No. 11, P. 927-37, (119 Ref), Issn: 0003-4819.&lt;BR&gt;&amp;nbsp;4. &amp;nbsp;Clarfield, AM. Review: pharmacological and non-pharmacological interventions improve outcomes in patients with dementia and in their caregivers. Evidence-Based Mental Health, 2001 Nov, Vol. 4, No. 4, P. 109, (4 Ref) , Issn: 1362-0347.&lt;BR&gt;&amp;nbsp;5. &amp;nbsp;Coelho, F and Birks, J. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001499/frame.html" target="_blank"&gt;Physostigmine for alzheimer's disease. &lt;/A&gt;Cochrane Database of Systematic Reviews (Online), {Cochrane-Database- Syst-Rev}, 2001, No. 2, P. Cd001499, 56 Refs, Issn: 1469-493x.&lt;BR&gt;&amp;nbsp;6. &amp;nbsp;Craig, D and Birks, J. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004746/frame.html" target="_blank"&gt;Galantamine for vascular cognitive impairment&lt;/A&gt;. Cochrane Database of Systematic Reviews (Online), {Cochrane-Database- Syst-Rev}, 2006 (Epub), No. 1, P. Cd004746, 26 Refs, Issn: 1469-493x.&lt;BR&gt;&amp;nbsp;7. &amp;nbsp;Dos, Santos Neto Leopoldo Luiz; de, Vilhena Toledo Maria Alice; Medeiros, Souza Patrícia, and de, Souza Gustavo Almeida. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17173107&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;The use of herbal medicine in alzheimer's disease-a systematic review.&lt;/A&gt; Evidence-Based Complementary and Alternative Medicine : Ecam, {Evid- Based-Complement-Alternat-Med}, Dec 2006 (Epub: 23 Oct 2006), Vol. 3, No. 4, P. 441-5, Issn: 1741-427x.&lt;BR&gt;&amp;nbsp;8. &amp;nbsp;Fischer, C; Bozanovic, R; Atkins, J H, and Rourke, S B. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16902281&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Treatment of delusions in alzheimer's disease - response to pharmacotherapy.&lt;/A&gt; Dementia and Geriatric Cognitive Disorders 2006; 22 (3): 260-266.&lt;BR&gt;&amp;nbsp;9. &amp;nbsp;Franco, K N and Messinger, Rapport B. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16503315&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.&lt;/A&gt; Journal of the American Medical Directors Association {J-Am-Med-Dir- Assoc}, 2006, Vol/Iss/Pg. 7/3 (201-202), Eissn: 1538-9375, Issn: 1525-8610.&lt;BR&gt;&amp;nbsp;10. &amp;nbsp;Gabryelewicz, Tomasz; Barcikowska, Maria, and Jarczewska, Dorota L. (&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16529064&amp;amp;ordinalpos=5&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Alzheimer's disease therapy--theory and practice&lt;/A&gt;) [Terapia choroby alzheimera--teoria a praktyka]. Wiadomosci Lekarskie (Warsaw Poland : 1960), {Wiad-Lek}, 2005, Vol. 58, No. 9-10, P. 528-35, 46 Refs, Issn: 0043-5147.&lt;BR&gt;&amp;nbsp;11. &amp;nbsp;Geldmacher, D S. Treatment guidelines for alzheimer's disease: redefining perceptions in primary care. Primary Care Companion to the Journal of Clinical Psychiatry {Prim- Care-Companion-J-Clin-Psych}, 2007, Vol/Iss/Pg. 9/2 (113-121), Eissn: 1555-211x, Issn: 1523-5998.&lt;BR&gt;&amp;nbsp;12. &amp;nbsp;Gilley, DW. Review: cholinesterase inhibitors reduce burden and care time for informal carers of people with alzheimer's disease. Evidence-Based Mental Health, 2006 Feb, Vol. 9, No. 1, P. 19, (2 Ref), Issn: 1362-0347.&lt;BR&gt;&amp;nbsp;13. &amp;nbsp;Grimmer, T and Kurz, A. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17154660&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Effects of cholinesterase inhibitors on behavioural disturbances in alzheimer's disease: a systematic review&lt;/A&gt;. Drugs and Aging 2006; 23 (12): 957-967.&lt;BR&gt;&amp;nbsp;14. &amp;nbsp;Grossberg, G T. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16238903&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in alzheimer's disease&lt;/A&gt;. Current Medical Research and Opinion {Curr-Med-Res-Opin}, 2005, Vol /Iss/Pg. 21/10 (1631-1639), Issn: 0300-7995.&lt;BR&gt;&amp;nbsp;15. &amp;nbsp;Haywood, W M and Mukaetova, Ladinska E B. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17062329&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Sex influences on cholinesterase inhibitor treatment in elderly individuals with alzheimer's disease&lt;/A&gt;. American Journal Geriatric Pharmacotherapy 2006; 4 (3): 273-286.&lt;BR&gt;&amp;nbsp;16. &amp;nbsp;Henriksen, A L; St, Dennis C; Setter, S M, and Tran, J T. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16934009&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Dementia with lewy bodies: therapeutic opportunities and pitfalls. &lt;/A&gt;Consultant Pharmacist 2006; 21 (7): 563-575.&lt;BR&gt;&amp;nbsp;17. &amp;nbsp;Lahiri, DK and Farlow, MR. Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in alzheimer's disease. Evidence-Based Mental Health, 2003 Aug, Vol. 6, No. 3, P. 94, (3 Ref), Issn: 1362-0347.&lt;BR&gt;&amp;nbsp;18. &amp;nbsp;Lanctôt, K L; Herrmann, N; Yau, K K; Khan, L R; Liu, B A; LouLou, M M, and Einarson, T R.&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=12975222&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt; Efficacy and safety of cholinesterase inhibitors in alzheimer's disease: a meta-analysis&lt;/A&gt;. Canadian Medical Association Journal 2003; 169 (6): 557-564.&lt;BR&gt;&amp;nbsp;19. &amp;nbsp;Leroi, I; Collins, D, and Marsh, L. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16806271&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Non-dopaminergic treatment of cognitive impairment and dementia in parkinson's disease: a review&lt;/A&gt;. Journal of the Neurological Sciences {J-Neurol-Sci}, 25 Oct 2006, Vol /Iss/Pg. 248/1-2 (104-114), Issn: 0022-510x.&lt;BR&gt;&amp;nbsp;20. &amp;nbsp;Lingler, J H; Martire, L M, and Schulz, R. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15935021&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Caregiver-specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis&lt;/A&gt;. Journal of the American Geriatrics Society {J-Am-Geriatr-Soc}, 2005, Vol/Iss/Pg. 53/6 (983-990), Eissn: 1532-5415, Issn: 0002-8614.&lt;BR&gt;&amp;nbsp;21. &amp;nbsp;Livingston, G and Katona, C. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=10713577&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;How useful are cholinesterase inhibitors in the treatment of alzheimer's disease? A number needed to treat analysis&lt;/A&gt;. International Journal of Geriatric Psychiatry 2000; 15 (3): 203-207.&lt;BR&gt;&amp;nbsp;22. &amp;nbsp;Luijpen, M W; Scherder, E J A; Van, Someren E J W; Swaab, D F, and Sergeant, J A. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=14640320&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Non-pharmacological interventions in cognitively impaired and demented patients - a comparison with cholinesterase inhibitors&lt;/A&gt;. Reviews in the Neurosciences 2003; 14 (4): 343-368.&lt;BR&gt;&amp;nbsp;23. &amp;nbsp;Maidment, I.; Fox, C., and Boustani, M. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004747/frame.html" target="_blank"&gt;Cholinesterase inhibitors for Parkinson's disease dementia.&lt;/A&gt; Cochrane Database of Systematic Reviews: Reviews 2006 Issue 1 John Wiley &amp;amp; Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD004747.pub2&lt;BR&gt;&amp;nbsp;24. &amp;nbsp;Maidment, I D; Fox, C, and Boustani, M. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/cldare/articles/DARE-20050391/frame.html" target="_blank"&gt;A review of studies describing the use of acetyl cholinesterase inhibitors in parkinson's disease dementia.&lt;/A&gt; Acta Psychiatrica Scandinavica {Acta-Psychiatr-Scand}, 2005, Vol/Iss /Pg. 111/6 (403-409), Issn: 0001-690x.&lt;BR&gt;&amp;nbsp;25. &amp;nbsp;Modrego, P J. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17168714&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;The effect of drugs for alzheimer disease assessed by means of neuroradiological techniques&lt;/A&gt;. Current Medicinal Chemistry 2006; 13 (28): 3417-3424.&lt;BR&gt;&amp;nbsp;26. &amp;nbsp;Morgan, D. Review: pharmacological and non-pharmacological interventions improve outcomes in patients with dementia and their caregivers. Evidence-Based Nursing, 2002 Jan, Vol. 5, No. 1, P. 20, (2 Ref), Issn: 1367-6539.&lt;BR&gt;&amp;nbsp;27. &amp;nbsp;Ouyang, L S and Yu, B C. Study of evidence based medicine in drug treatment for mild and moderate dementia. Chinese Journal of Clinical Rehabilitation 2005; 9 (9): 146-147.&lt;BR&gt;&amp;nbsp;28. &amp;nbsp;Qizilbash, N; Whitehead, A; Higgins, J; Wilcock, G; Schneider, L, and Farlow, M. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=9842955&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Cholinesterase inhibition for alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration&lt;/A&gt;. Jama : the Journal of the American Medical Association, {Jama}, 25 Nov 1998, Vol. 280, No. 20, P. 1777-82, Issn: 0098-7484.&lt;BR&gt;&amp;nbsp;29. &amp;nbsp;Rossom, R; Adityanjee, A, and Dysken, M. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15903287&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Efficacy and tolerability of memantine in the treatment of dementia&lt;/A&gt;. American Journal Geriatric Pharmacotherapy 2004; 2 (4): 303-312.&lt;BR&gt;&amp;nbsp;30. &amp;nbsp;Santos, Neto L L D; De, Vilhena Toledo M A; Medeiros, Souza P, and De, Souza G A. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17173107&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;The use of herbal medicine in alzheimer's disease - a systematic review&lt;/A&gt;. Evidence-Based Complementary and Alternative Medicine {Evid-Based- Complement-Altern-Med}, 2006, Vol/Iss/Pg. 3/4 (441-445), Eissn: 1741-4288, Issn: 1741-427x.&lt;BR&gt;&amp;nbsp;31. &amp;nbsp;Sink, K M Holden K F Yaffe K. Drugs minimally effective for neuropsychiatric symptoms of dementia.&lt;BR&gt;&amp;nbsp;32. &amp;nbsp;Takeda, A; Loveman, E; Clegg, A; Kirby, J; Picot, J; Payne, E, and Green, C. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16323253&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in alzheimer's disease&lt;/A&gt;. International Journal of Geriatric Psychiatry, {Int-J-Geriatr- Psychiatry}, Jan 2006, Vol. 21, No. 1, P. 17-28, 38 Refs, Issn: 0885-6230.&lt;BR&gt;&amp;nbsp;33. &amp;nbsp;Trinh, N H; Hoblyn, J; Mohanty, S, and Yaffe, K. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=12517232&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in alzheimer disease: a meta-analysis&lt;/A&gt;. Journal of the American Medical Association 2003; 289 (2): 210-216.&lt;BR&gt;&amp;nbsp;34. &amp;nbsp;Wild, R.; Pettit, T., and Burns, A. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003672/frame.html" target="_blank"&gt;Cholinesterase inhibitors for dementia with Lewy bodies&lt;/A&gt;. Cochrane Database of Systematic Reviews: Reviews 2003 Issue 3 John Wiley &amp;amp; Sons, Ltd Chichester, UK DOI: 10.1002/14651858.CD003672&lt;BR&gt;&amp;nbsp;35. &amp;nbsp;Zöller, B; Hock, C, and Kull, H U. (&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11407240&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Rational therapy of alzheimer dementia based on current clinical studies&lt;/A&gt;) [Rationale therapie der alzheimer-demenz auf der grundlage aktueller klinischer studien]. Schweizerische Rundschau FüR Medizin Praxis = Revue Suisse De MéDecine Praxis, {Schweiz-Rundsch-Med-Prax}, 10 May 2001, Vol. 90, No. 19, P. 827-34, Issn: 1013-2058.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;1. &amp;nbsp;Anticholinesterases in alzheimer's disease. A modest effect on moderately severe disease. Prescrire International 2003; 12 (68): 230-231.&lt;BR&gt;&amp;nbsp;2. &amp;nbsp;Brodaty, H; Ames, D; Boundy, K L; Hecker, J; Snowdon, J; Storey, E, and Yates, M W. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11665948&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Pharmacological treatment of cognitive deficits in alzheimer's disease.&lt;/A&gt; Medical Journal of Australia 2001; 175 (6): 324-329.&lt;BR&gt;&amp;nbsp;3. &amp;nbsp;Carnero, Pardo C. (&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11299483&amp;amp;ordinalpos=12&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Are the new drugs for treatment of alzheimer's disease useful?&lt;/A&gt;) [Son útiles los nuevos fármacos contra la enfermedad de alzheimer?]. Revista De Neurologia, {Rev-Neurol}, Jan 16-31 2001, Vol. 32, No. 2, P. 176-9, 39 Refs, Issn: 0210-0010.&lt;BR&gt;&amp;nbsp;4. &amp;nbsp;Caro, JJ and Getsios, D. Long-term effects of second-generation cholinesterase inhibitors on clinical outcomes and costs of alzheimer's disease. Disease Management Health Outcomes, 2003, Vol. 11, No. 10, P. 617-31, (68 Ref), Issn: 1173-8790.&lt;BR&gt;&amp;nbsp;5. &amp;nbsp;Cummings, J L. Cholinesterase inhibitors: a new class of psychotropic compounds. American Journal of Psychiatry 2000; 157 (1): 4-15.&lt;BR&gt;&amp;nbsp;6. &amp;nbsp;Darvesh, S; Martin, E; Walsh, R, and Rockwood, K. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=14675561&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Differential effects of lipid-lowering agents on human cholinesterases.&lt;/A&gt; Clinical Biochemistry 2004; 37 (1): 42-49.&lt;BR&gt;&amp;nbsp;7. &amp;nbsp;Evans, J G; Wilcock, G, and Birks, J. Evidence-based pharmacotherapy of alzheimer's disease. International Journal of Neuropsychopharmacology 2004; 7 (3): 351-369.&lt;BR&gt;&amp;nbsp;8. &amp;nbsp;Farlow, M R. The search for disease modification in moderate to severe alzheimer disease: a critical review of current evidence. Neurology 2005; 65: 6 Suppl. 3.&lt;BR&gt;&amp;nbsp;9. &amp;nbsp;Frisoni, G B. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11517995&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Treatment of alzheimer's disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice&lt;/A&gt;. Journal of Neurology 2001; 248 (7): 551-557.&lt;BR&gt;&amp;nbsp;10. &amp;nbsp;Gauthier, S. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11772125&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Cholinergic adverse effects of cholinesterase inhibitors in alzheimer's disease: epidemiology and management&lt;/A&gt;. Drugs and Aging 2001; 18 (11): 853-862.&lt;BR&gt;&amp;nbsp;11. &amp;nbsp;Gauthier, S. Impact of new therapies on the management of alzheimer's disease. International Medical Journal 2000; 7: 1 (3-6).&lt;BR&gt;&amp;nbsp;12. &amp;nbsp;Giacobini, E. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=10850724&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Cholinesterase inhibitor therapy stabilizes symptoms of alzheimer disease&lt;/A&gt;. Alzheimer Disease and Associated Disorders 2000; 14: Suppl. 1.&lt;BR&gt;&amp;nbsp;13. &amp;nbsp;Hogan, David B; Goldlist, Barry; Naglie, Gary, and Patterson, Christopher. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15380159&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Comparison studies of cholinesterase inhibitors for alzheimer's disease&lt;/A&gt;. Lancet Neurology, {Lancet-Neurol}, Oct 2004, Vol. 3, No. 10, P. 622-6, Issn: 1474-4422.&lt;BR&gt;&amp;nbsp;14. &amp;nbsp;Ihl, R. (&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=12070846&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Dementing disorders. What benefits do the new anti-dementia drugs have?&lt;/A&gt;) [Demenzerkrankungen. Was bringen die neuen antidementiva?]. Mmw Fortschritte Der Medizin, {Mmw-Fortschr-Med}, 6 May 2002, Vol. Suppl 2, P. 24-6, 28-9, Issn: 1438-3276.&lt;BR&gt;&amp;nbsp;15. &amp;nbsp;Imbimbo, B P. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11475943&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for alzheimer's disease&lt;/A&gt;. Cns Drugs&amp;nbsp; 2001; 15 (5): 375-390.&lt;BR&gt;16. &amp;nbsp;Johannsen, P. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15377166&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Long-term cholinesterase inhibitor treatment of alzheimer's disease&lt;/A&gt;. Cns Drugs 2004; 18 (12): 757-768.&lt;BR&gt;&amp;nbsp;17. &amp;nbsp;Lingler, J H; Schulz, R. Editor s Vellas B, and Giacobini, E. Do the benefits of anti-dementia drugs extend to caregivers? Research and Practice in Alzheimer's Disease 2006; 11; 322-327.&lt;BR&gt;&amp;nbsp;18. &amp;nbsp;Luchsinger, J A; Mayeux, R. Editor s Vellas B, and Giacobini, E. Summary of review: dietary factors and alzheimer's disease. Research and Practice in Alzheimer's Disease 2006; 11; 131-137.&lt;BR&gt;&amp;nbsp;19. &amp;nbsp;Machado, João Carlos and Caramelli, Paulo. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17012934&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Treatment of dementia: anything new?&lt;/A&gt; Current Opinion in Psychiatry, {Curr-Opin-Psychiatry}, Nov 2006, Vol. 19, No. 6, P. 575-80, 67 Refs, Issn: 0951-7367.&lt;BR&gt;&amp;nbsp;20. &amp;nbsp;Maelicke, A. Critical assessment and results: long-term treatment of dementia of the alzheimer type (ad 2000 study) [KRITISCHE BEWERTUNG DER ERGEBNISSE: LANGZEITBEHANDLUNG BEI DEMENZ VOM ALZHEIMER-TYP (AD2000-STUDIE).] Psychoneuro 2004; 30 (9): 514-516.&lt;BR&gt;&amp;nbsp;21. &amp;nbsp;McShane, R. Drug treatments for behavioural and psychological symptoms of dementia. A review. Cpd Bulletin Old Age Psychiatry 2000; 2 (2): 47-50.&lt;BR&gt;&amp;nbsp;22. &amp;nbsp;Nobili, F; Koulibaly, M; Vitali, P; Migneco, O; Mariani, G; Ebmeier, K; Pupi, A; Robert, P H; Rodriguez, G, and Darcourt, J. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=12163621&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Brain perfusion follow-up in alzheimer's patients during treatment with acetylcholinesterase inhibitors&lt;/A&gt;. Journal of Nuclear Medicine 2002; 43 (8): 983-990.&lt;BR&gt;&amp;nbsp;23. &amp;nbsp;Salmon, N. Cognitive stimulation therapy versus acetyl cholinesterase inhibitors for mild to moderate dementia: a latter-day david and goliath? British Journal of Occupational Therapy {Br-J-Occup-Ther}, 2006, Vol /Iss/Pg. 69/11 (528-530), Issn: 0308-0226.&lt;BR&gt;&amp;nbsp;24. &amp;nbsp;Schreiter, Gasser U and Gasser, T. (&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11789125&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;A comparison of cholinesterase inhibitors and ginkgo extract in treatment of alzheimer dementia&lt;/A&gt;) [Ein vergleich von cholinesterasehemmern und ginkgo-extrakt in der behandlung der alzheimer-demenz]. Fortschritte Der Medizin. Originalien, {Fortschr-Med-Orig}, 29 Nov 2001, Vol. 119, No. 3-4, P. 135-8.&lt;BR&gt;&amp;nbsp;25. &amp;nbsp;Schulz, V. Risks and costs of therapy with antidementia drugs: ginkgo biloba extract in comparison with acetylcholinesterase inhibitors [RISIKEN UND KOSTEN BEI DER THERAPIE MIT ANTIDEMENTIVA: GINKGO-BILOBA- EXTRAKT IM VERGLEICH MIT ACETYLCHOLINESTERASEHEMMERN.] Tagliche Praxis 2006; 47 (4): 869-874.&lt;BR&gt;&amp;nbsp;26. &amp;nbsp;Shanks, Michael F Venneri Annalena. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15703328&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Conventional&amp;nbsp; Trial&amp;nbsp; Designs&amp;nbsp; Offer&amp;nbsp; Limited Clinical Understanding of Cholinesterase-Inhibitor Treatment Effects in Alzheimer Disease&lt;/A&gt;. Am J Geriatr Psychiatry. 2005 Fe; 13(2): 170.&lt;BR&gt;&amp;nbsp;27. &amp;nbsp;Sobów, Tomasz and Kleczewska, Iwona. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17330176&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Cholinesterase inhibitors in mild cognitive impairment: a meta- analysis of randomized controlled trials&lt;/A&gt; [Inhibitory cholinesterazy w lagodnych zaburzeniach poznawczych: metaanaliza badan z randomizacj i z grup kontroln otrzymujc placebo]. Neurologia I Neurochirurgia Polska, {Neurol-Neurochir-Pol}, 2007 January-February, Vol. 41, No. 1, P. 13-21, Issn: 0028-3843.&lt;BR&gt;&amp;nbsp;28. &amp;nbsp;Sramek, J J and Cutler, N R. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=11186600&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Rbc cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in alzheimer disease therapy?&lt;/A&gt; Alzheimer Disease and Associated Disorders 2000; 14 (4): 216-227.&lt;BR&gt;&amp;nbsp;29. &amp;nbsp;Thompson, S; Lanctôt, K L, and Hermann, N. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15335298&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;The benefits and risks associated with cholinesterase inhibitor therapy in alzheimer's disease.&lt;/A&gt; Expert Opinion on Drug Safety {Expert-Opin-Drug-Saf}, 2004, Vol/Iss /Pg. 3/5 (425-440), Issn: 1474-0338.&lt;BR&gt;&amp;nbsp;30. &amp;nbsp;Wilkinson, D G; Francis, P T; Schwam, E, and Payne, Parrish J. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=15132713&amp;amp;ordinalpos=8&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Cholinesterase inhibitors used in the treatment of alzheimer's disease: the relationship between pharmacological effects and clinical efficacy&lt;/A&gt;. Drugs and Aging 2004; 21 (7): 453-478.&lt;BR&gt;&amp;nbsp;31. &amp;nbsp;Windisch, M. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=10961442&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Approach towards an integrative drug treatment of alzheimer's disease.&lt;/A&gt; Journal of Neural Transmission, Supplement 2000; 59.&lt;BR&gt;&amp;nbsp;32. &amp;nbsp;Zanetti, O; Calabria, M, and Cotelli, M. Effectiveness of the association of donepezil and reality orientation therapy [L'EFFICACIA DELL'ASSOCIAZIONE TRA FARMACI E REALITY ORIENTATION THERAPY.] Giornale Di Gerontologia 2004; 52 (5): 408-411.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;A href="nelh:262532:0" name=internalLink&gt;
&lt;P&gt;Dementia Knowledge Week Contents Page&lt;/P&gt;
&lt;P&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>303844</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/01January/Pages/Dementiadrugdanger.aspx]]&gt;</url>
    <title>Dementia medication danger</title>
    <publicationDate>2009-01-09T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,TREATMENT AND CARE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the Headlines - your guide to the science that makes the news. Created by NHS Choices.</description>
    <body>&lt;![CDATA[ Liquid cosh treatment kills dementia patients reports the independant. the paper is referring to antipsychotic drugs to control aggresive or violent behaviour among people with dementia.]]&gt;</body>
  </document>
  <document>
    <id>317416</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dementia.stir.ac.uk/pdffolder/DementiaNow-Vol6-Part5-May09-InfectionControl.pdf]]&gt;</url>
    <title>Dementia Now June 2009 edition [PDF]</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>Dementia Services Development Centre</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES,CAUSES AND PREVENTION,PATHOLOGY,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The June edition of Dementia Now magazine, published by the Dementia Services Development Centre.]]&gt;</body>
  </document>
  <document>
    <id>273750</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://dementia.stir.ac.uk/pdffolder/DementiaNow-Vol4-Part7-Sep07-Hydration.pdf]]&gt;</url>
    <title>Dementia Now September 2007: Hydration</title>
    <publicationDate>2007-09-03T00:00:00</publicationDate>
    <publisher>Dementia Services Development Centre</publisher>
    <publicationType>BRIEFING</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Dementia Now is the monthly research magazine from the Dementia Services Development Centres.</description>
    <body>&lt;![CDATA[ 1&lt;/FIRSTPAGE&gt;&lt;FIRSTPAGEID&gt;1&lt;/FIRSTPAGEID&gt;&lt;PAGE&gt;&lt;PAGEID&gt;1&lt;/PAGEID&gt;&lt;PAGESEQUENCE&gt;-1&lt;/PAGESEQUENCE&gt;&lt;PAGETITLE&gt;&lt;/PAGETITLE&gt;&lt;PAGEBODY&gt;&lt;P&gt;Each month the Dementia Services Development Centre's monthly research magazine tackles a different theme. This month looks at &lt;STRONG&gt;hydration&lt;/STRONG&gt;. 
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;On the featured topic, you will get:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;An introduction to the topic 
&lt;LI&gt;Links to web resources 
&lt;LI&gt;A list of library resources from our specialist dementia library 
&lt;LI&gt;An archive of featured themes, building from the re-launch&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;For current awareness, you will get&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;A digest of news stories from web-based newspapers 
&lt;LI&gt;A list of new additions to the dementia library&lt;/LI&gt;&lt;/UL&gt;]]&amp;gt;&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;]]&gt;</body>
  </document>
  <document>
    <id>319624</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://dementia.stir.ac.uk/pdffolder/DementiaPerspective-Spring2009.pdf]]&gt;</url>
    <title>Dementia Perspective spring edition PDF</title>
    <publicationDate>2009-04-01T00:00:00</publicationDate>
    <publisher>Dementia Services Development Centre</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ dementia now spring edition.]]&gt;</body>
  </document>
  <document>
    <id>250871</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/News_and_Campaigns/Campaigning/PDF/Dementia_UK_Full_Report.pdf]]&gt;</url>
    <title>Dementia UK: A Report into the prevalence and cost of dementia (Full Report)</title>
    <publicationDate>2007-02-27T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,TREATMENT AND CARE,DEFINITION AND TYPES,DEMENTIA,LATER LIFE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report from the Alzheimer's Society, published in February 2007,&amp;nbsp;provides the most detailed and robust picture to date of prevalence and economic impact of dementia in the UK.]]&gt;</body>
  </document>
  <document>
    <id>250772</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/News_and_Campaigns/Campaigning/PDF/Dementia_UK_Summary.pdf]]&gt;</url>
    <title>Dementia UK: A Report into the prevalence and cost of dementia (Summary Report)</title>
    <publicationDate>2007-02-27T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ DEMENTIA,NEUROLOGICAL CONDITIONS,LATER LIFE,DEMENTIA,TREATMENT AND CARE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report from the Alzheimer's Society, published on the 27th February 2007,&amp;nbsp;provides the most detailed and robust picture to date of prevalence and economic impact of dementia in the UK. The report shows that as the UK’s population ages the number of people with dementia will grow substantially. It also shows that dementia costs the UK £17 billion a year.]]&gt;</body>
  </document>
  <document>
    <id>313538</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/guidance/index.jsp?action=download&amp;o=43727]]&gt;</url>
    <title>Dementia: audit support</title>
    <publicationDate>2009-04-03T00:00:00</publicationDate>
    <publisher>National Institute for Clinical Excellence (NICE)</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Audit support is developed to support the implementation of NICE guidance. The aim is to help NHS organisations with a baseline assessment and to assist with the audit process, thereby helping to ensure that practice is in line with the NICE recommendations. This audit support has been produced in response to the report by the All-Party Parliamentary Group on Dementia entitled ‘Always a last resort’. The report found that over-prescribing of antipsychotics in care homes is a problem, and recommended local and national audit of the use of antipsychotics for people with dementia in care homes.]]&gt;</body>
  </document>
  <document>
    <id>268817</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ageuk.org.uk/get-involved/campaign/depression-in-later-life-down-but-not-out/?paging=false]]&gt;</url>
    <title>Depression in later life: Down but not out</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,MENTAL HEALTH,DEPRESSION,PUBLIC HEALTH,OUTCOMES,POPULATIONS,GROUPS,AGE GROUPS,ADULTS,MENTAL &amp; BEHAVIOURAL DISORDERS,DEPRESSION,OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Depression is the commonest mental health problem among older people, affecting about one in eight who live at home and 40 per cent of those living in care homes. Ill health, disability, bereavement and ‘daily hassles’ are all contributory factors. But depression is not an inevitable part of growing old. Promoting a concept of ‘successful ageing’ developed at the Nuffield Institute for Health, the report calls for improved health and care services to improve older people’s quality of life through meaningful activities, socialising and help in adjusting to loss.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>328777</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/9/1099]]&gt;</url>
    <title>Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>Archives of Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To assess the predictive value of baseline measures of impairment, disability, and quality of life for the timing of initiation of symptomatic treatment in early Parkinson disease (PD).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Inception cohort analysis.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;Ambulatory population from multiple sites in the United States and Canada.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;Four hundred thirteen patients with early, untreated PD who participated in 2 double-blind trials that assessed the potential of experimental drugs to serve as disease-modifying agents in PD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Intervention:&lt;/STRONG&gt;&lt;BR&gt;Participants were randomized into treatment groups: creatine (n = 67), minocycline (n = 66), coenzyme Q10 (n = 71), GPI-1485 (n = 71), and placebo (n = 138).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measure:&lt;/STRONG&gt;&lt;BR&gt;Time between baseline assessment and need for the initiation of symptomatic treatment for PD. The following baseline variables were assessed for their relation to the main outcome measure, while adjusting for possible treatment effect: sex; age; level of education; race/ethnicity; disease duration; occupational status; and Unified Parkinson Disease Rating Scale (UPDRS), Medical Outcomes Study Short Form Survey, Modified Rankin Scale, Schwab and England Activities of Daily Living Scale, Total Functional Capacity Scale, 39-item Parkinson Disease Questionnaire, and Geriatric Depression Scale scores. Variables reaching statistical threshold in univariate analyses ({alpha} = .15) were entered into a multivariable Cox proportional hazards regression model using time to symptomatic treatment as the dependent variable.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Approximately half (48.5%) of the participants reached end point within 12 months. Higher baseline impairment and disability, as determined by UPDRS III (motor section), UPDRS II (activities of daily living section, participant rating), and Modified Rankin Scale scores and level of education were independently associated with an earlier need for symptomatic treatment.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;In early PD, greater impairment and disability and higher level of education are independently associated with an earlier need for symptomatic treatment.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>33849</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nao.org.uk/publications/0203/services_for_older_people.aspx]]&gt;</url>
    <title>Developing effective services for older people</title>
    <publicationDate>2003-03-31T00:00:00</publicationDate>
    <publisher>National Audit Office</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ REHABILITATION,NSF FOR OLDER PEOPLE,TREATMENT AND CARE,SCREENING,SURVEILLANCE,AGEISM,DEMENTIA,FALLS,SCREENING AND SURVEILLANCE,STROKE,LATER LIFE,ADULTS,POPULATION BASED &amp; PREVENTATIVE SERVICES,SERVICE PROVISION,OLDER PEOPLE,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,MANAGEMENT &amp; POLICY,DECISION MAKING,SERVICES,MONTHLY ADDITIONS,2008-SEPTEMBER,POPULATIONS,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN class=nsflinkdesc&gt;Report by NAO April 2003 on progress so far.&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>94121</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://stroke.ahajournals.org/cgi/content/full/31/12/3067]]&gt;</url>
    <title>Diagnostic testing for coagulopathies in patients with ischemic stroke</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>Stroke</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,ISCHAEMIC STROKE,STROKE,ACUTE MANAGEMENT,REHABILITATION,STROKE,LATER LIFE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;systematic review&amp;nbsp;has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000287832" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;The authors concluded 'coagulation tests are often of little value in the evaluation of general patients with ischaemic stroke'.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Despite the limitations outlined, the authors' conclusions appear to follow from the data presented".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374897</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/04April/Pages/Alzheimers-risk-and-diet.aspx]]&gt;</url>
    <title>Diet 'affects' Alzheimer's risk</title>
    <publicationDate>2010-04-13T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Eating lots of nuts, fish and poultry while cutting down on red meat and butter could reduce the risk of Alzheimer’s disease,” reported The Times. These findings come from a study of over 2,000 elderly people in New York.&lt;/P&gt;
&lt;P&gt;The study looked at the dietary patterns of people aged 65 and over and followed them for an average of four years. It found a lower risk of developing Alzheimer’s in people with a diet that included more salad dressing, nuts, fish, tomatoes, poultry, cruciferous vegetables, fruits and dark and green leafy vegetables, and lower intakes of high-fat dairy products, red meat, offal and butter.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374912</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474442210700028/abstract?rss=yes]]&gt;</url>
    <title>Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis</title>
    <publicationDate>2010-01-18T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Idiopathic Parkinson's disease can present with symptoms similar to those of multiple system atrophy or progressive supranuclear palsy. We aimed to assess whether metabolic brain imaging combined with spatial covariance analysis could accurately discriminate patients with parkinsonism who had different underlying disorders.]]&gt;</body>
  </document>
  <document>
    <id>332528</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_108136.pdf]]&gt;</url>
    <title>Dignity in care: input assessment - DH interventions</title>
    <publicationDate>2009-11-10T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;In May 2009, Opinion Leader were commissioned to undertake an independent review of the Dignity in Care Campaign.&lt;/P&gt;
&lt;P&gt;The review aims to answer whether or not the campaign is making a difference to the way services are being provided and commissioned across health, social care, local authorities and the independent sector and the way people experience care.&lt;/P&gt;
&lt;P&gt;One of the key objectives set out in the tender specification for the review, was to understand and describe from the viewpoints of a range of stakeholders, which specific interventions or activities at national or local level have worked or not worked well in the campaign and why.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This report sets out the range of interventions employed by DH in taking forward the Dignity in Care Campaign to support Opinion Leader’s analysis of interventions at a national level.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321724</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/reprint/361/3/245.pdf]]&gt;</url>
    <title>Disclosure of APOE genotype for risk of Alzheimer's disease</title>
    <publicationDate>2009-07-16T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;The apolipoprotein E (APOE) genotype provides information on the risk of Alzheimer's disease, but the genotyping of patients and their family members has been discouraged. We examined the effect of genotype disclosure in a prospective, randomized, controlled trial.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Methods:&lt;/STRONG&gt;&lt;BR&gt;We randomly assigned 162 asymptomatic adults who had a parent with Alzheimer's disease to receive the results of their own APOE genotyping (disclosure group) or not to receive such results (nondisclosure group). We measured symptoms of anxiety, depression, and test-related distress 6 weeks, 6 months, and 1 year after disclosure or nondisclosure.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;There were no significant differences between the two groups in changes in time-averaged measures of anxiety (4.5 in the disclosure group and 4.4 in the nondisclosure group, P=0.84), depression (8.8 and 8.7, respectively; P=0.98), or test-related distress (6.9 and 7.5, respectively; P=0.61). Secondary comparisons between the nondisclosure group and a disclosure subgroup of subjects carrying the APOE {varepsilon}4 allele (which is associated with increased risk) also revealed no significant differences. However, the {varepsilon}4-negative subgroup had a significantly lower level of test-related distress than did the {varepsilon}4-positive subgroup (P=0.01). Subjects with clinically meaningful changes in psychological outcomes were distributed evenly among the nondisclosure group and the {varepsilon}4-positive and {varepsilon}4-negative subgroups. Baseline scores for anxiety and depression were strongly associated with post-disclosure scores of these measures (P&amp;lt;0.001 for both comparisons).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;The disclosure of APOE genotyping results to adult children of patients with Alzheimer's disease did not result in significant short-term psychological risks. Test-related distress was reduced among those who learned that they were APOE {varepsilon}4–negative. Persons with high levels of emotional distress before undergoing genetic testing were more likely to have emotional difficulties after disclosure.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95407</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/SCR678.asp]]&gt;</url>
    <title>Disparities between market rates and state funding of residential care</title>
    <publicationDate>1998-07-05T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This research shows that there are frequent disparities between the fees that state agencies are willing to pay and the full, reasonable cost of long-term care. The researchers conclude that lack of returns are discouraging private sector care home operators from investing in good quality stock for clients dependent entirely on state funding.]]&gt;</body>
  </document>
  <document>
    <id>313515</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=456]]&gt;</url>
    <title>Do NSAIDs delay onset of dementia?</title>
    <publicationDate>2009-04-23T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ New research shows that people over 65 who are heavy users of nonsteroidal anti-inflammatory drugs (NSAIDs), such as Ibuprofen and Naproxen, show a high incidence of dementia.]]&gt;</body>
  </document>
  <document>
    <id>292675</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.prisonreformtrust.org.uk/temp/DoingspTime.pdf]]&gt;</url>
    <title>Doing time: the experiences and needs of older people in prison</title>
    <publicationDate>2008-08-22T00:00:00</publicationDate>
    <publisher>Prison Reform Trust</publisher>
    <publicationType>BRIEFING</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING,SCREENING AND SURVEILLANCE,SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This briefing aims to give older people in prison a voice. The Prison Reform Trust believe that to develop more effective ways of working with older prisoners, an important first step is to hear directly from them. Although noting a general improvement in prison healthcare, the report finds older prisoners can face difficulties continuing their medication when imprisoned and routinely fail to receive preventative and screening services.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This briefing aims to give older people in prison a voice. The Prison Reform Trust believe that to develop more effective ways of working with older prisoners, an important first step is to hear directly from them. Although noting a general improvement in prison healthcare, the report finds older prisoners can face difficulties continuing their medication when imprisoned and routinely fail to receive preventative and screening services.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374941</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/99?rss=1]]&gt;</url>
    <title>Donepezil Treatment and Changes in Hippocampal Structure in Very Mild Alzheimer Disease</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,PATHOLOGY,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objective&amp;nbsp; To compare longitudinal changes in the hippocampal structure in subjects with very mild dementia of the Alzheimer type (DAT) treated with donepezil hydrochloride, untreated subjects with very mild DAT, and controls without dementia.]]&gt;</body>
  </document>
  <document>
    <id>374952</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/58?rss=1]]&gt;</url>
    <title>Dopamine Agonist Withdrawal Syndrome in Parkinson Disease</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objectives&amp;nbsp; To report and characterize a dopamine agonist (DA) withdrawal syndrome (DAWS) in Parkinson disease.]]&gt;</body>
  </document>
  <document>
    <id>321710</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/7/877]]&gt;</url>
    <title>Dysfunction of the default mode network in Parkinson disease</title>
    <publicationDate>2009-07-07T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To examine the integrity of the default mode network in patients with Parkinson disease (PD). Previous functional neuroimaging experiments have studied executive deficits in patients with PD with regard to task-related brain activation. However, recent studies suggest that executive performance also relies on the integrity of the default mode network (ie, medial prefrontal cortex, posterior cingulate cortex, precuneus, and lateral parietal and medial temporal cortices), characterized by a deactivation of these cortical areas during the performance of executive tasks.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;We used functional magnetic resonance imaging to investigate cortical deactivations during a card-sorting task (retrieval and manipulation of short-term memory contents) compared with a simple sensory-motor matching task. In addition, a functional connectivity analysis was performed.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;Tertiary outpatient clinic.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;Seven patients with mild to moderate PD (not taking medication) and 7 healthy controls.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measure:&lt;/STRONG&gt;&lt;BR&gt;Cortical deactivations.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Both groups showed comparable deactivation of the medial prefrontal cortex but different deactivation in the posterior cingulate cortex and the precuneus. Compared with controls, patients with PD not only showed less deactivation of the posterior cingulate cortex and the precuneus, they even demonstrated a reversed pattern of activation and deactivation. Connectivity analysis yielded that in contrast to healthy individuals, medial prefrontal cortex and the rostral ventromedial caudate nucleus were functionally disconnected in PD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;We describe specific malfunctioning of the default mode network during an executive task in PD. This finding is plausibly linked to dopamine depletion and may critically contribute to the understanding of executive deficits in PD.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>380341</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/alzheimers-experimental-blood-test.aspx]]&gt;</url>
    <title>Early days for Alzheimer's test</title>
    <publicationDate>2010-07-06T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A simple blood test may soon be able to “predict Alzheimer's disease up to 10 years before symptoms appear”, says &lt;EM&gt;The Daily Telegraph&lt;/EM&gt;. The newspaper says researchers have discovered that a rise in levels of a protein called clusterin may be an early sign of the disease.&lt;/P&gt;
&lt;P&gt;The observational and laboratory studies that lie behind this report have been well conducted and reported, and its authors have found clusterin levels are linked to cognitive decline, the severity of disease in people with Alzheimer’s and the rate of clinical progression of Alzheimer’s disease. However, the researchers do not suggest that this may be used to diagnose disease, at least not yet. In fact they say that their study does not support the clinical use of clusterin levels as a standalone biomarker for Alzheimer’s disease. These are interesting findings, but early ones that will lead to more research about protein markers of this disease rather than directly to a clinical test.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94185</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12792376&amp;query_hl=202]]&gt;</url>
    <title>Early nutritional screening of older adults: review of nutritional support</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>J Infus Nurs</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,OLD AGE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Protein-energy malnutrition and its consequences can have considerable impact on the quality of life of the elderly. Healthcare providers working with older adults are challenged to recognize individuals at risk for undernutrition and to initiate early nutritional assessment and intervention strategies to prevent malnutrition. In so doing, they can assist in improving the quality of life for the older adult and decrease healthcare costs associated with serious outcomes of malnutrition. Current knowledge about the nutritional needs of the elderly, definition of malnutrition, age-related risk factors, and causes of malnutrition in the elderly are presented in this article. A practical approach to preventing the occurrence of malnutrition is suggested through the use of a quick and easy nutritional screening assessment tool, the Mini Nutritional Assessment (MNA). Recommendations for specialized nutritional support, as well as its role in wound healing and immune enhancement, are discussed. Where available, scientific data supporting its use are included. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319618</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/content/full/360/26/2696?query=TOC]]&gt;</url>
    <title>Easing the shortage in adult primary care - is it all about money?</title>
    <publicationDate>2009-06-25T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ As Americans debate health care reform, it is easy to forget&lt;SUP&gt; &lt;/SUP&gt;that success may depend as much on the availability of primary&lt;SUP&gt; &lt;/SUP&gt;care physicians for adults as on the specifics of the reforms&lt;SUP&gt; &lt;/SUP&gt;themselves. Access to health insurance does not ensure access&lt;SUP&gt; &lt;/SUP&gt;to timely medical care, particularly in places where doctors&lt;SUP&gt; &lt;/SUP&gt;are in short supply, are not accepting new patients, or are&lt;SUP&gt; &lt;/SUP&gt;not accepting patients with some types of insurance. Effective&lt;SUP&gt; &lt;/SUP&gt;primary care can improve the quality of care and health outcomes&lt;SUP&gt; &lt;/SUP&gt;and save money. But to the extent that easing the shortage of&lt;SUP&gt; &lt;/SUP&gt;primary care physicians will require additional funds, the initial&lt;SUP&gt; &lt;/SUP&gt;costs of reform will increase.]]&gt;</body>
  </document>
  <document>
    <id>33805</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csp.org.uk/director/libraryandpublications/publications.cfm?item_id=74C87568D0F2F9B5D0146DE7164F4137]]&gt;</url>
    <title>Effectiveness of falls prevention and rehabilitation strategies in older people</title>
    <publicationDate>2001-02-16T00:00:00</publicationDate>
    <publisher>Chartered Society of Physiotherapy</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report is one of four commissioned to support physiotherapists implementing the Older People's NSF. They are: 
&lt;UL&gt;
&lt;LI&gt;Effectiveness of falls prevention and rehabilitation strategies in older people: implications for physiotherapy. 
&lt;LI&gt;The clinical effectiveness of physiotherapy in the palliative care of older people. 
&lt;LI&gt;The clinical and cost effectiveness of physiotherapy in the management of common rheumatological conditions of old age. 
&lt;LI&gt;The clinical and cost effectiveness of physiotherapy in the management of older people following a stroke.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>94187</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14533563&amp;query_hl=204]]&gt;</url>
    <title>Effectiveness of screening for osteoporosis by bone density measurement for the prevention of fractures: a review of the evidence</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Nippon Eiseigaku Zasshi</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,OSTEOPOROSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &amp;nbsp;To review evidence on the benefits of screening women and men for osteoporosis, a Pub Med search was performed in English papers published between 1990 and 2002. We used data from a cohort study to estimate risk of fracture from bone mineral density. Bone mineral density measured by dual X-ray absorptiometry (DXA) can predict bone fracture among elderly women, peri- and early post-menopausal women, and elderly men. It is recommended that all white women older than 65 years be screened routinely for osteoporosis. We suggest that Japanese elderly women should receive BMD measurements as a screening, but we have still issues to be solved including age from when the screening should be started, methods, and how to treat the women found to have osteoporosis at the screening. For peri- and postmenopausal women and elderly men, it might be beneficial to measure BMD as a screening and start treatment for those patients found to have osteoporosis. However, incidence of fractures for these people is lower than that for elderly women. One bone mass measurement can predict bone fracture risk for as long as over 10 years or more, but predictive ability of BMD decreases with time. Therefore, cost effectiveness needs to be reviewed to determine the benefits of screening among peri-menopausal women and men. Although bone assessment by quantitative ultra sound (QUS) method by ultrasound can also predict future fractures, only a relatively small number of longitudinal studies have been conducted in the Western countries, and there is no established evidence by means of longitudinal studies among Japanese. It is necessary in Japan to seek such evidence, however, since this method is widely used for an osteoporosis examinations.]]&gt;</body>
  </document>
  <document>
    <id>94189</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=9522788]]&gt;</url>
    <title>Effectiveness of screening older people for impaired vision in community setting</title>
    <publicationDate>1998-07-05T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,EYESIGHT,SCREENING,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To assess whether population screening for impaired vision among older people in the community leads to improvements in vision. DESIGN: Systematic review of randomised controlled trials of population screening in the community that included any assessment of vision or visual function with at least 6 months' follow up.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Screening of asymptomatic older people in the community is not justified on present evidence. Visual impairment in this age group can usually be reduced with treatment. It is unclear why no benefit was seen. Further work is needed to clarify what interventions are appropriate for older people with unreported impairment of vision.&amp;nbsp;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374953</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/27?rss=1]]&gt;</url>
    <title>Effects of a Dopamine Agonist on the Pharmacodynamics of Levodopa in Parkinson Disease</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Background&amp;nbsp; Treatment of Parkinson disease commonly includes levodopa and dopamine agonists; however, the interaction of these 2 drugs is poorly understood.&lt;/P&gt;
&lt;P&gt;Objective&amp;nbsp; To examine the effects of a dopamine agonist on the motor response to levodopa.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374945</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/71?rss=1]]&gt;</url>
    <title>Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objectives&amp;nbsp; To examine the effects of aerobic exercise on cognition and other biomarkers associated with Alzheimer disease pathology for older adults with mild cognitive impairment, and assess the role of sex as a predictor of response.]]&gt;</body>
  </document>
  <document>
    <id>328751</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/reprint/302/5/517]]&gt;</url>
    <title>Elder Self-neglect and Abuse and Mortality Risk in a Community-Dwelling Population</title>
    <publicationDate>2009-08-05T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Context:&lt;BR&gt;&lt;/B&gt;Both elder self-neglect and abuse have become&lt;SUP&gt; &lt;/SUP&gt;increasingly prominent public health issues. The association&lt;SUP&gt; &lt;/SUP&gt;of either elder self-neglect or abuse with mortality remains&lt;SUP&gt; &lt;/SUP&gt;unclear.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Objective:&lt;BR&gt;&lt;/B&gt;To examine the relationship of elder self-neglect&lt;SUP&gt; &lt;/SUP&gt;or abuse reported to social services agencies with all-cause&lt;SUP&gt; &lt;/SUP&gt;mortality among a community-dwelling elderly population.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Design, Setting, and Participants:&lt;BR&gt;&lt;/B&gt;Prospective, population-based&lt;SUP&gt; &lt;/SUP&gt;cohort study (conducted from 1993 to 2005) of residents living&lt;SUP&gt; &lt;/SUP&gt;in a geographically defined community of 3 adjacent neighborhoods&lt;SUP&gt; &lt;/SUP&gt;in Chicago, Illinois, who were participating in the Chicago&lt;SUP&gt; &lt;/SUP&gt;Health and Aging Project (CHAP; a longitudinal, population-based,&lt;SUP&gt; &lt;/SUP&gt;epidemiological study of residents aged &lt;IMG border=0 alt== src="/libraryImages/Later%20Life/contentID328751/nelhImp_0000_ge.gif"&gt;65 years). A subset&lt;SUP&gt; &lt;/SUP&gt;of these participants had suspected elder self-neglect or abuse&lt;SUP&gt; &lt;/SUP&gt;reported to social services agencies.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Main Outcome Measures:&lt;BR&gt;&lt;/B&gt;Mortality ascertained during follow-up&lt;SUP&gt; &lt;/SUP&gt;and by use of the National Death Index. Cox proportional hazard&lt;SUP&gt; &lt;/SUP&gt;models were used to assess independent associations of self-neglect&lt;SUP&gt; &lt;/SUP&gt;or elder abuse reporting with the risk of all-cause mortality&lt;SUP&gt; &lt;/SUP&gt;using time-varying covariate analyses.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Results:&lt;BR&gt;&lt;/B&gt;Of 9318 CHAP participants, 1544 participants were&lt;SUP&gt; &lt;/SUP&gt;reported for elder self-neglect and 113 participants were reported&lt;SUP&gt; &lt;/SUP&gt;for elder abuse from 1993 to 2005. All CHAP participants were&lt;SUP&gt; &lt;/SUP&gt;followed up for a median of 6.9 years (interquartile range,&lt;SUP&gt; &lt;/SUP&gt;7.4 years), during which 4306 deaths occurred. In multivariable&lt;SUP&gt; &lt;/SUP&gt;analyses, reported elder self-neglect was associated with a&lt;SUP&gt; &lt;/SUP&gt;significantly increased risk of 1-year mortality (hazard ratio&lt;SUP&gt; &lt;/SUP&gt;[HR], 5.82; 95% confidence interval [CI], 5.20-6.51). Mortality&lt;SUP&gt; &lt;/SUP&gt;risk was lower but still elevated after 1 year (HR, 1.88; 95%&lt;SUP&gt; &lt;/SUP&gt;CI, 1.67-2.14). Reported elder abuse also was associated with&lt;SUP&gt; &lt;/SUP&gt;significantly increased risk of overall mortality (HR, 1.39;&lt;SUP&gt; &lt;/SUP&gt;95% CI, 1.07-1.84). Confirmed elder self-neglect or abuse also&lt;SUP&gt; &lt;/SUP&gt;was associated with mortality. Increased mortality risks associated&lt;SUP&gt; &lt;/SUP&gt;with either elder self-neglect or abuse were not restricted&lt;SUP&gt; &lt;/SUP&gt;to those with the lowest levels of cognitive or physical function.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Conclusion:&lt;BR&gt;&lt;/B&gt;Both elder self-neglect and abuse reported&lt;SUP&gt; &lt;/SUP&gt;to social services agencies were associated with increased risk&lt;SUP&gt; &lt;/SUP&gt;of mortality.&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321707</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/7/870]]&gt;</url>
    <title>Elevated serum pesticide levels and risk of Parkinson disease</title>
    <publicationDate>2009-07-07T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;Exposure to pesticides has been reported to increase the risk of Parkinson disease (PD), but identification of the specific pesticides is lacking. Three studies have found elevated levels of organochlorine pesticides in postmortem PD brains.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To determine whether elevated levels of organochlorine pesticides are present in the serum of patients with PD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Case-control study.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;BR&gt;&lt;/STRONG&gt;An academic medical center.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;Fifty patients with PD, 43 controls, and 20 patients with Alzheimer disease.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;BR&gt;&lt;/STRONG&gt;Levels of 16 organochlorine pesticides in serum samples.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;ß-Hexachlorocyclohexane (ß-HCH) was more often detectable in patients with PD (76%) compared with controls (40%) and patients with Alzheimer disease (30%). The median level of ß-HCH was higher in patients with PD compared with controls and patients with Alzheimer disease. There were no marked differences in detection between controls and patients with PD concerning any of the other 15 organochlorine pesticides. Finally, we observed a significant odds ratio for the presence of ß-HCH in serum to predict a diagnosis of PD vs control (odds ratio, 4.39; 95% confidence interval, 1.67-11.6) and PD vs Alzheimer disease (odds ratio, 5.20), which provides further evidence for the apparent association between serum ß-HCH and PD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;These data suggest that ß-HCH is associated with a diagnosis of PD. Further research is warranted regarding the potential role of ß-HCH as a etiologic agent for some cases of PD.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319632</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_101681?IdcService=GET_FILE&amp;dID=199192&amp;Rendition=Web]]&gt;</url>
    <title>End of life care strategy: quality markers and measures for end of life care PDF</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P class=introText&gt;The end of life care strategy published in July 2008 included a commitment to publish quality markers for end of life care.&lt;/P&gt;
&lt;P&gt;This was a response to the SHA Pathway Chairs for the NHS Next Stage Review, who identified the need for a national approach in order to raise the quality of care for people at the end of life. The SHA Pathway Chairs helped produce the consultation draft which was published in November 2008. This publication reflects the comments we received through the consultation.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321703</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673609613453.pdf]]&gt;</url>
    <title>England's big care debate</title>
    <publicationDate>2009-07-25T00:00:00</publicationDate>
    <publisher>The Lancet</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The UK's National Health Service (NHS), which is funded by taxation and social insurance, is a flagship service that is admired around the world. But many elderly people face a void if they are too frail to live on their own, or if any family is unable or unwilling to look after them, they face staying in a nursing home that could be run by a local authority or privately. Such nursing homes can be costly: a patient with Alzheimer's disease might need to pay £200&amp;nbsp;000 in total.]]&gt;</body>
  </document>
  <document>
    <id>321718</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/reprint/361/1/22.pdf]]&gt;</url>
    <title>Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly</title>
    <publicationDate>2009-07-02T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;It is unknown whether the rate of survival after in-hospital cardiopulmonary resuscitation (CPR) is improving and which characteristics of patients and hospitals predict survival.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Methods:&lt;/STRONG&gt;&lt;BR&gt;We examined fee-for-service Medicare data from 1992 through 2005 to identify beneficiaries 65 years of age or older who underwent CPR in U.S. hospitals. We examined temporal trends in the incidence of CPR and the rate of survival after CPR, as well as patient- and hospital-level predictors of survival to discharge.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;We identified 433,985 patients who underwent in-hospital CPR; 18.3% of these patients (95% confidence interval [CI], 18.2 to 18.5) survived to discharge. The rate of survival did not change substantially during the period from 1992 through 2005. The overall incidence of CPR was 2.73 events per 1000 admissions; the incidence was higher among black and other nonwhite patients. The proportion of patients undergoing in-hospital CPR before death increased over time and was higher for nonwhite patients. The survival rate was lower among patients who were men, were older, had more coexisting illnesses, or were admitted from a skilled-nursing facility. The adjusted odds of survival for black patients were 23.6% lower than those for similar white patients (95% CI, 21.2 to 25.9). The association between race and survival was partially explained by hospital effects: black patients were more likely to undergo CPR in hospitals that have lower rates of post-CPR survival. Among patients surviving in-hospital CPR, the proportion of patients discharged home rather than to a health care facility decreased over time.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;Survival after in-hospital CPR did not improve from 1992 through 2005. The proportion of in-hospital deaths preceded by CPR increased, whereas the proportion of survivors discharged home after undergoing CPR decreased. Black race was associated with higher rates of CPR but lower rates of survival after CPR.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>389167</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_119969]]&gt;</url>
    <title>Essence of Care 2010</title>
    <publicationDate>2010-10-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,SERVICE SECTORS,QUALITY AND MONITORING,ACUTE SERVICES,LATER LIFE,HEALTH &amp; WELLBEING,COMMISSIONING,QUALITY IMPROVEMENT,COMMISSIONING COMPETENCIES,CONTINUOUS IMPROVEMENT,INNOVATION AND IMPROVEMENT,EVALUATION,OUTCOMES,PERFORMANCE INDICATORS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Essence of Care has been refreshed and now contains 12 benchmarks, following a consultation exercise late in 2009. It aims to support localised quality improvement, by providing a set of established and refreshed benchmarks supporting front line care across care settings at a local level. &lt;/P&gt;
&lt;P&gt;The benchmarking process outlined in Essence of Care 2010 helps practitioners to take a structured approach to sharing and comparing practice, enabling them to identify the best and to develop action plans to remedy poor practice. &lt;/P&gt;
&lt;P&gt;This edition supersedes the previous versions originating since 2001.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>36233</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=36233]]&gt;</url>
    <title>Evaluation of pilot projects of breast cancer screening of women aged 65-69 years</title>
    <publicationDate></publicationDate>
    <publisher>National Research Register</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,CANCER,FOR REVIEW]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of pilot projects of breast cancer screening of women aged 65-69 years&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;FONT color=#000000&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;Garvican L. EVALUATION OF PILOT PROJECTS OF BREAST CANCER SCREENING OF WOMEN AGED 65-69 YEARS. &lt;I&gt;National Research Register&lt;/I&gt; 2003.&lt;BR&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P&gt;&lt;FONT color=#000000&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;AIM: To evaluate the &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;East Sussex&lt;/SPAN&gt;&lt;/FONT&gt;&lt;FONT color=#000000&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt; and Leeds/Wakefield pilot projects inviting women aged 65-69 for breast screening, in conjunction with the Cancer Screening Evaluation Unit, and to determine the implications for national implementation.&lt;BR&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P&gt;&lt;FONT color=#000000&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;RESEARCH SUBJECT GROUP&lt;BR&gt;The 20,300 women aged 65-69 and registered with general practitioners in East Sussex, Brighton and Hove are being systematically invited for screening at the two mobile screening units along with women aged 50-64. The pilot period is May 1996 until July 1999. Similarly the 24,500 women from &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;Leeds&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt; and &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;Wakefield&lt;/SPAN&gt;&lt;/FONT&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;&lt;FONT color=#000000&gt; will be invited from Spring 1997 - Spring 2000.&lt;BR&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: "&gt;&lt;FONT color=#000000&gt;SAMPLE SIZE, TYPE AND LOCATION, AND METHODS OF WORKING&lt;BR&gt;Statistics on uptake, recall biopsy and cancer detection rates, for the whole poplation of 65-69 year-olds will be collected. Data on the size and grade of all cancers detected, and associated lymph node status, will be linked with the&amp;lt;BR&amp;gt;women's screening history. Practical aspects such as satisfaction surveys, and reasons for any changes to normal procedures will be assessed from samples attending over defined time periods. This will involve a pragmatic approach to anticipate and evaluate potential problems which could arise on nation-wide implementation. Epidemiological and economic results will be analysed by the Cancer Evaluation Unit&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>94162</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12390062&amp;query_hl=182]]&gt;</url>
    <title>Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events</title>
    <publicationDate>2002-07-07T00:00:00</publicationDate>
    <publisher>Archives of Internal Medicine</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,SECONDARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;systematic review&amp;nbsp;has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000278400" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Aspirin use for the secondary prevention of thromboembolic events has a favourable benefit-to-risk profile and should be encouraged in those at high risk.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;There was adequate presentation and discussion of the study findings. The conclusions seem appropriate given the data presented".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94069</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://bjsm.bmjjournals.com/cgi/content/full/34/1/7]]&gt;</url>
    <title>Exercise in preventing falls and fall related injuries in older people: a review of randomised controlled trials</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>British Journal of Sports Medicine</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PREVENTION,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;systematic review&amp;nbsp;has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000268379" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Exercise is effective in lowering the risk of falls in selected groups and should form part of fall prevention programmes. Lowering fall-related injuries will reduce health care costs, but there is little information available on the costs associated with programme replication or the cost-effectiveness of exercise programmes aimed at preventing falls in older people.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;The level of the evidence on which the authors' conclusions were based would have been strengthened by including a discussion of results with respect to a formal validity assessment".&lt;BR&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>328782</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/9/1120]]&gt;</url>
    <title>Extrapyramidal Signs Before and After Diagnosis of Incident Alzheimer Disease in a Prospective Population Study</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>Archives of Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,PATHOLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;Extrapyramidal signs (EPSs) are commonly accepted as a feature of Alzheimer disease (AD) and may influence both the profile of impairment and prognosis.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To examine rates of occurrence and risk factors for all types of EPSs and to describe the impact of EPSs over time on the clinical course of AD.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Longitudinal study.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;The Washington Heights Hamilton Heights Inwood Columbia Aging Project.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Patients:&lt;/STRONG&gt;&lt;BR&gt;A total of 388 patients with incident AD (mean age, 79 years; 71.4% female).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;/STRONG&gt;&lt;BR&gt;Extrapyramidal signs rated by means of a standardized portion of the Unified Parkinson's Disease Rating Scale; prevalence and incidence rates and cumulative risk for non–drug-induced EPSs; and rates of change in EPSs over time, taking into account potential covariates.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Extrapyramidal signs were detected in 12.3% of patients at first evaluation and 22.6% at last evaluation. In a multivariate-adjusted generalized estimating equation model of change, total EPS score increased at an annual rate of 1.3%. Women (relative risk [RR], 1.57; P = .03), older patients (RR, 1.03; P = .02), and those with EPSs at baseline (RR, 2.07; P = .001) had greater rates of cognitive decline.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;Extrapyramidal signs occur frequently and progress significantly in AD. Patients with incident AD and concomitant EPSs have a greater rate of cognitive decline than do patients with incident AD but without EPSs. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>339064</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/01January/Pages/eye-test-for-diagnosing-Alzheimers-disease.aspx]]&gt;</url>
    <title>Eye scan could detect Alzheimer's</title>
    <publicationDate>2010-01-15T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,DEMENTIA,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The &lt;EM&gt;Daily Mirror&lt;/EM&gt; says there could be a “high street eye test for Alzheimer's” within five years. The newspaper says that new research in mice has shown that placing a harmless fluorescent dye into the retina of the eye could identify dying nerve cells, which are an early sign of Alzheimer's.]]&gt;</body>
  </document>
  <document>
    <id>95159</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009653]]&gt;</url>
    <title>Fair access to care services - guidance on eligibility criteria for adult social care</title>
    <publicationDate>2002-07-07T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This guidance provides councils with a framework for setting their eligibility criteria for adult social care, and should be implemented by April 2003. Implementation will lead to fairer and more consistent eligibility decisions across the country.]]&gt;</body>
  </document>
  <document>
    <id>93868</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/band91/b91-8.html]]&gt;</url>
    <title>Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elders</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>J Clinical Epidemiology</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ FALLS,ASSESSING RISK,LATER LIFE,PUBLIC HEALTH,DETERMINANTS,OUTCOMES,CAUSES OF HARM,ENVIRONMENTAL,SAFETY,POPULATIONS,SETTINGS,PLACES,AREAS,NEIGHBOURHOODS,MUSCULOSKELETAL DISORDERS,FRACTURES,GROUPS,AGE GROUPS,ADULTS,2008-OCTOBER,MONTHLY ADDITIONS,OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by Bandolier:&lt;/P&gt;
&lt;P&gt;"There's good methodology here. In Mr Punch's words, "that's the way to do it". There is a table of sensitivities and specificities so that the impact of various risk scores can be examined, either in terms of likelihood ratios or absolute risk. &lt;BR&gt;&lt;BR&gt;How useful is it? Firstly it is simple, with four easily-remembered keys to risk of recurrent falls. If an older person has some or all of these, then it may be worth a hard look at things that might help. For instance, an older person with previous falls, visual impairment and on benzodiazepines has a score of 12 and a one-year risk of recurrent falls of 1 in 3. That's 1 in 1 over three years. So thinking about alternatives to, or no benzodiazepines, or suggesting changes in the home or institutional environment, or alert systems in case of a fall might all make sense. &lt;BR&gt;&lt;BR&gt;Assessing older people in the community for their risk of falling could be a useful feature of clinical governance or quality improvement. It is a big problem".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>346414</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/reprint/303/3/288]]&gt;</url>
    <title>Falls and older adults</title>
    <publicationDate>2010-01-20T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=2 face=Verdana&gt;Falls are the leading cause of deaths related to injury among&lt;SUP&gt; &lt;/SUP&gt;people 65 years and older. More than one-third will fall each&lt;SUP&gt; &lt;/SUP&gt;year; two-thirds of those who fall will fall again within 6&lt;SUP&gt; &lt;/SUP&gt;months. Although falling is not normal, older people are more&lt;SUP&gt; &lt;/SUP&gt;likely to fall because of sensory changes, bones that are less&lt;SUP&gt; &lt;/SUP&gt;dense, slower reflexes, and reduced strength. These changes&lt;SUP&gt; &lt;/SUP&gt;affect walking and balance. &lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>250987</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csp.org.uk/uploads/documents/csp_falls_audit2.pdf]]&gt;</url>
    <title>Falls Audit Pack - guideline for the collaborative, rehabilitative management of elderly people who have fallen</title>
    <publicationDate></publicationDate>
    <publisher>Chartered Society of Physiotherapy</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION,ASSESSING RISK,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Falls Audit Pack - guideline for the collaborative, rehabilitative management of elderly people who have fallen&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;FONT face=Frutiger-Roman size=1&gt;
&lt;P align=left&gt;This falls audit pack will form an important resource for trusts, with which to evaluate their conformance with the National Service Framework. It should be used by therapists and others working with older people to assure the quality and effectiveness of their services and contribute to the reduction of falls and subsequent disability among older people.&lt;BR&gt;&lt;/P&gt;&lt;/FONT&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>321698</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csp.org.uk/uploads/documents/csp_FP_factsheet_2008.pdf]]&gt;</url>
    <title>Falls prevention 2008</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>Chartered Society of Physiotherapy</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Many falls are preventable. Yet falls represent over half of hospital admissions for accidental injury amongst older people. Are you at risk?]]&gt;</body>
  </document>
  <document>
    <id>374908</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/04April/Pages/Fish-oil-and-brain-function-in-older-people.aspx]]&gt;</url>
    <title>Fish oil 'no benefit' to elderly</title>
    <publicationDate>2010-04-29T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Fish oil supplements 'don't help the elderly',” the Daily Mail reported. It said a study has found that people aged 70 to 80 who took fish oil supplements for two years did not perform any better in memory and concentration tests than those who took a placebo.&lt;/P&gt;
&lt;P&gt;This study followed 867 older adults who were cognitively healthy at the start of the study. Over two years, the cognitive performance of a group of people given fish oil was no different to that of a group given a placebo, and neither group showed significant decline in cognitive function. The participants already seemed to have reasonable intake of fish oils and were in good cognitive health, which could have limited the ability of the fish oil supplements to have an impact on cognitive performance.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374929</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/2010.84v1?rss=1]]&gt;</url>
    <title>Food Combination and Alzheimer Disease Risk: A Protective Diet</title>
    <publicationDate>2010-04-12T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objective&amp;nbsp; To assess the association between food combination and Alzheimer disease (AD) risk. Because foods are not consumed in isolation, dietary pattern (DP) analysis of food combination, taking into account the interactions among food components, may offer methodological advantages.]]&gt;</body>
  </document>
  <document>
    <id>281656</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.shef.ac.uk/FRAX/]]&gt;</url>
    <title>FRAX: WHO Fracture Risk Assessment Tool</title>
    <publicationDate>2008-03-07T00:00:00</publicationDate>
    <publisher>University of Sheffield</publisher>
    <publicationType>CARE PATHWAY</publicationType>
    <topics>&lt;![CDATA[ MUSCULOSKELETAL,OSTEOPOROSIS,BONE DISORDERS,CONDITIONS,EMERGENCY CARE,TRAUMA AND ORTHOPAEDICS,CLINICAL LIBRARY,TRAUMA,FRACTURE,TRAUMA (NATURE OF INJURY),LOWER LIMB,TRAUMA (BODY LOCATION),ASSESSING RISK,PREVENTION,FALLS,LATER LIFE,FRACTURE,METABOLIC BONE DISEASE,FRAGILITY FRACTURES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This online tool has been developed to predict the 10 year risk of osteoporosis fractures for use in primary care.  The tool, although available through the University of Sheffield website, has been developed by the World Health Organisation together with a technical report entitled Assessment of Osteoporosis at the Primary Health Care Level.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This online tool has been developed to predict the 10 year risk of osteoporosis fractures for use in primary care.&amp;nbsp; The tool, although available through the University of Sheffield website, has been developed by the World Health Organisation together with a technical report entitled Assessment of Osteoporosis at the Primary Health Care Level. &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.who.int/entity/chp/topics/Osteoporosis.pdf" target="_blank"&gt;www.who.int/entity/chp/topics/Osteoporosis.pdf&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93891</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10517425&amp;query_hl=47]]&gt;</url>
    <title>Fruit and vegetable intake in relation to risk of ischemic stroke</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CAUSES AND PRIMARY PREVENTION,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This cohort study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/FVstroke.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"This large study provides another valuable reason to eat fruit and vegetables and supports the current recommendation to eat at least five to six servings of fruit and vegetables a day".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95370</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/944.asp]]&gt;</url>
    <title>Future costs of long-term care for older people</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This study updates projections on future demand and spending on long-term care for older people, looking forward to 2051.]]&gt;</body>
  </document>
  <document>
    <id>380399</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/old-age-genes-identified.aspx]]&gt;</url>
    <title>Genes behind long life found</title>
    <publicationDate>2010-07-02T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;“Genes that mean you will live to 100” have been discovered by scientists, said The Daily Telegraph.&lt;/P&gt;
&lt;P&gt;The news is based on a study by US scientists who have built a genetic model that can predict exceptional longevity, defined as survival well beyond the average human lifespan, with 77% accuracy. &lt;/P&gt;
&lt;P&gt;This is an interesting study that built and tested a genetic model for exceptional longevity in over 1,000 centenarians and 1,200 control subjects. It indicates that genetic factors play a critical and complex role in living an exceptionally long time. However, as the scientists note, their model is not perfect and further research on the variations of the human genome are needed to improve on this.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>346409</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/02February/Pages/telomere-aging-genetics-discovered.aspx]]&gt;</url>
    <title>Genetics behind ageing probed</title>
    <publicationDate>2010-02-08T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Genetic tests to determine how quickly a person will age may soon be available, according to several newspapers. The news is based on the recent discovery of a genetic variation that apparently predisposes some people to faster ageing.]]&gt;</body>
  </document>
  <document>
    <id>93878</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/band3/b3-2.html]]&gt;</url>
    <title>Getting Research into Practice (GRiP) Stroke Rehabilitation</title>
    <publicationDate>1994-07-03T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Stroke represents a condition which is responsible for the consumption of a large proportion of the NHS budget; about 4% is spent each year on cerebrovascular disease, and the biggest part of that is on the aftermath of stroke.]]&gt;</body>
  </document>
  <document>
    <id>95085</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/OlderpeoplesNSFstandards/DH_4002294]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: falls</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION,ASSESSING RISK,REHABILITATION,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The aim of this standard is to reduce the number of falls which result in serious injury and ensure effective treatment and rehabilitation for those who have fallen.</description>
    <body>&lt;![CDATA[ Practice examples aimed at reducing the number of falls which result in serious injury and ensuring effective treatment and rehabilitation for those who have fallen.]]&gt;</body>
  </document>
  <document>
    <id>95081</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeoplePromotionProject/OlderPeoplePromotionProjectArticle/fs/en?CONTENT_ID=4002289&amp;chk=KVVxk4]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: general hospital care</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Practice examples aimed at ensuring older people receive the specialist help they need in hospital and that they receive the maximum benefit from having been in hospital.]]&gt;</body>
  </document>
  <document>
    <id>95080</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeoplePromotionProject/OlderPeoplePromotionProjectArticle/fs/en?CONTENT_ID=4002287&amp;chk=4xCeO8]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: intermediate care</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Practice examples aimed at providing integrated services to promote faster recovery from illness, prevent unnecessary acute hospital admissions, support timely discharge and maximise independent living.]]&gt;</body>
  </document>
  <document>
    <id>95090</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeoplePromotionProject/OlderPeoplePromotionProjectArticle/fs/en?CONTENT_ID=4002283&amp;chk=58KaWR]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: mental health in older people</title>
    <publicationDate>2007-02-08T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ TREATMENT AND CARE,DEMENTIA,LATER LIFE,NSF FOR OLDER PEOPLE,ADULTS,NATIONAL SERVICE FRAMEWORKS,GOOD PRACTICE,OLDER PEOPLE,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,FRAMEWORKS,FRAMES OF REFERENCE,MANAGEMENT &amp; POLICY,AGE GROUPS,POPULATIONS,GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Practice examples aimed at promoting good mental health in older people and to treat and support those older people with dementia and depression.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Practice examples aimed at promoting good mental health in older people and to treat and support those older people with dementia and depression:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Bradford Health Action Zone&lt;/LI&gt;
&lt;LI&gt;Salford Mental Health Services and Salford &amp;amp; Trafford Health Authority&lt;/LI&gt;
&lt;LI&gt;Age Concern Oxfordshire Flexible Carers Service&lt;/LI&gt;
&lt;LI&gt;South Manchester Memory Clinic&lt;/LI&gt;
&lt;LI&gt;Cambridge&lt;/LI&gt;
&lt;LI&gt;Teeside Young Onset Dementia Team&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95076</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeoplePromotionProject/OlderPeoplePromotionProjectArticle/fs/en?CONTENT_ID=4002285&amp;chk=f8JgQm]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: person centred care</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Practice examples aimed at ensuring that older people are treated as individuals and they receive appropriate and timely packages of care which meet their needs as individuals, regardless of health and social services boundaries.]]&gt;</body>
  </document>
  <document>
    <id>95093</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeoplePromotionProject/OlderPeoplePromotionProjectArticle/fs/en?CONTENT_ID=4002295&amp;chk=3zlAJj]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: promotion of health and active life in older age</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CAUSES AND PRIMARY PREVENTION,FALLS,STROKE,PREVENTION,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Practice examples aimed at extending the healthy life expectancy of older people.]]&gt;</body>
  </document>
  <document>
    <id>95083</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeoplePromotionProject/OlderPeoplePromotionProjectArticle/fs/en?CONTENT_ID=4002291&amp;chk=zrxP%2BG]]&gt;</url>
    <title>Good practice examples in the older people's NSF standards: strokes</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ STROKE,NEUROLOGICAL CONDITIONS,NSF FOR OLDER PEOPLE,LATER LIFE,CAUSES AND PRIMARY PREVENTION,SERVICE ORGANISATION,STROKE,REHABILITATION,ACUTE MANAGEMENT,SECONDARY PREVENTION,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Practice examples aimed at reducing the incidence of strokes in the population and making sure that those who have had a stroke have prompt access to integrated stroke care services.]]&gt;</body>
  </document>
  <document>
    <id>95909</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4005851&amp;chk=ozVeMn]]&gt;</url>
    <title>Good practice in continence services</title>
    <publicationDate>2000-08-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Prompt, high quality, comprehensive continence services are an essential part of the NHS. Incontinence is a treatable condition. But in 1999 the Audit Commission reported that "In practice district nurses implement a conservative care plan focused on managing the problem rather than treating the underlying cause". Children, young mothers, people with learning or physical disabilities and older people all experience problems with bladder and bowel management, and sometimes, both. In some situations as many as 1 in 7 women aged 45 - 64 living at home may have problems with incontinence.]]&gt;</body>
  </document>
  <document>
    <id>260377</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://whqlibdoc.who.int/hq/1998/WHO_HPR_AHE_98.1.pdf]]&gt;</url>
    <title>Growing Older - Staying Well</title>
    <publicationDate>1998-01-01T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Ageing and physical activity in everyday life.</description>
    <body>&lt;![CDATA[ A 22-page report on the role of physical activity in healthy ageing.]]&gt;</body>
  </document>
  <document>
    <id>278794</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.food.gov.uk/news/newsarchive/2007/oct/publicinstguide]]&gt;</url>
    <title>Guidance for Caterers</title>
    <publicationDate>2008-02-05T00:00:00</publicationDate>
    <publisher>The Food Standards Agency</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This page features practical guidance including weekly example menus to help caterers working across the UK provide food that meets the nutritional needs of adults. It is intended for use in, for example, workplace canteens, hospitals, prisons, local and central Government and older people’s residential care homes.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;The guidance&lt;/H2&gt;
&lt;P&gt;There are two pieces of guidance available. One for those working with people aged over 75 years in residential care. This updates guidance produced in 2006 and provides a second example menu. It is designed to help caterers reduce saturated fat, salt and sugar intakes, and improve consumption of some vitamin and minerals.&lt;/P&gt;
&lt;P&gt;The second is for those who provide food to adults (aged 19 to 74) and includes three example menus.&lt;/P&gt;
&lt;P&gt;Neither of the guidance documents includes advice for people with specific medical dietary needs.&lt;/P&gt;
&lt;P&gt;The Agency is developing example menus for prisons. These will be available here at a later date.&lt;/P&gt;
&lt;P&gt;The FSA nutrient and food based guidelines for UK institutions sets out the principals behind this advice. These are based on Government recommendations. The Caroline Walker Trust report, which can be found below, also informed the development of the guidance.&lt;/P&gt;
&lt;P&gt;Both guidance documents are accompanied by example menus and a menu analysis prepared by an independent dietitian, which shows how the menus meet the nutrient guidance. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.food.gov.uk/multimedia/pdfs/menusmen.pdf" target="_blank"&gt;Example menus for adult men 19-74 years&lt;/A&gt;&amp;nbsp;(PDF, 39 pages)&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.food.gov.uk/multimedia/pdfs/womenmenus.pdf" target="_blank"&gt;Example menus for adult women 19-74 years&lt;/A&gt;&amp;nbsp;(PDF, 38 pages)&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.food.gov.uk/multimedia/pdfs/womenmenus.pdf" target="_blank"&gt;Example menus for adults 19-74 years&lt;/A&gt;&amp;nbsp;(PDF, 41 pages)&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.food.gov.uk/multimedia/pdfs/carehomemenus.pdf" target="_blank"&gt;Example menus for care homes&lt;/A&gt;&amp;nbsp;(PDF, 63 pages)&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>313364</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nmc-uk.org/aArticle.aspx?ArticleID=3607]]&gt;</url>
    <title>Guidance for the care of older people</title>
    <publicationDate>2009-03-31T00:00:00</publicationDate>
    <publisher>Nursing and Midwifery Council</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN id=lblMainArticle&gt;The guidance is aimed at working nurses, but also has implications for pre- and post- registration education and training, and can be used by employers&amp;nbsp;as a benchmark for delivery. Carers and other healthcare professionals will also find this guidance useful and relevant to their work.&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>313362</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nmc-uk.org/aDisplayDocument.aspx?DocumentID=5593]]&gt;</url>
    <title>Guidance for the care of older people [PDF]</title>
    <publicationDate>2009-03-31T00:00:00</publicationDate>
    <publisher>Nursing and Midwifery Council</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN id=lblMainArticle&gt;The guidance is aimed at working nurses, but also has implications for pre- and post- registration education and training, and can be used by employers&amp;nbsp;as a benchmark for delivery. Carers and other healthcare professionals will also find this guidance useful and relevant to their work.&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>95918</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.audit-commission.gov.uk/olderpeople/olderpeopleguidance.asp]]&gt;</url>
    <title>Guidance on the commissioning of assistive technology services</title>
    <publicationDate></publicationDate>
    <publisher>Audit Commission</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ DISEASE MANAGEMENT,HEALTH MANAGEMENT,TRAUMA AND ORTHOPAEDICS,LATER LIFE,PODIATRY,STICKS AND WALKING DEVICES,WHEELCHAIRS,PROSTHETICS,APPLIANCES AND AIDS,ORTHOTICS,OCCUPATIONAL THERAPY,NHS ACTIVITIES,COMMISSIONING,SURGERY,NURSING,PHYSIOTHERAPY,NSF FOR OLDER PEOPLE,COMMISSIONING PROCESS,SPECIALIST COMMISSIONING,PROCUREMENT SKILLS,COMMISSIONING COMPETENCIES,SOCIAL CARE NEEDS,PEOPLE WITH DISABILITIES,DISEASE/CONDITION GROUPS,POPULATIONS SERVED,ASSESSMENT AND PLANNING,COMMISSIONING,SERVICE SECTORS,SOCIAL CARE,TYPES OF COMMISSIONING,KNOWLEDGE AND SKILLS,DECISION MAKING,DISABILITY MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=content&gt;This guidance describes how health and social care agencies should commission community equipment services as part of wider strategies to support independence. They should be used in the absence of locally agreed standards. The guidance covers:&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;SPAN class=content&gt;commissioning wheelchair services&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;SPAN class=content&gt;&lt;SPAN class=content&gt;commissioning&lt;/SPAN&gt; orthotic services&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;SPAN class=content&gt;&lt;SPAN class=content&gt;commissioning&lt;/SPAN&gt; prosthetics services&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>95176</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/assetRoot/04/08/71/55/04087155.pdf]]&gt;</url>
    <title>Guidance on the minimum contents for protocols for the care and management of older people with mental health problems</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This note sets out brief guidance on what protocols for the care and management of older people with mental health problems, which are required in the Prioirities and Planning Framework for 2003/06, might include.]]&gt;</body>
  </document>
  <document>
    <id>94025</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://bmj.bmjjournals.com/cgi/content/full/321/7267/1007]]&gt;</url>
    <title>Guidelines for the prevention of falls in people over 65</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ FALLS,LATER LIFE,PREVENTION,OUTCOMES,CAUSES OF HARM,ENVIRONMENTAL,ADULTS,INJURIES,POPULATION BASED &amp; PREVENTATIVE SERVICES,OLDER PEOPLE,MONTHLY ADDITIONS,DETERMINANTS,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,ANALYSIS,METHODS,SERVICES,2008-SEPTEMBER,2008,GROUPS,ANALYSIS &amp; RESEARCH,POPULATIONS,AGE GROUPS,FALLS,ACCIDENTS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;systematic review&amp;nbsp;has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000278393" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Most exercise programmes without other interventions do not reduce the incidence of falls in unselected older people living in the community. Individually tailored exercise programmes, administered by a qualified professional to women aged over 80 living in the community, reduce the incidence of falls. Exercise programmes reduce the risk of falls in a selected group of older people with mild deficits in strength and balance, who are living in the community. T'ai chi classes with individual tuition can reduce the number of falls in older people. &lt;BR&gt;&lt;BR&gt;Programmes that combine interventions (most studies include some form of exercise) reduce falls. Attention to postural hypotension, number of drugs, balance, transfers and gait is particularly effective. &lt;BR&gt;&lt;BR&gt;Home assessment of disability, with education in the risk areas and referral to the patient's doctor, reduces falls. Home assessment of risk and education in these areas without further referral does not reduce falls. The identification of patients who attend accident and emergency departments after falls, with subsequent assessment of medical and occupational therapy and referral and follow-up, reduces falls. &lt;BR&gt;&lt;BR&gt;Non-selective exercise programmes for the residents of nursing homes do not reduce falls. The assessment of residents after falls, with the development of individual treatment plans and staff education, decreases falls. Neck of femur fractures are prevented if nursing home residents wear hip protectors.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;STRONG&gt;The authors' conclusions seem to follow from the results presented, but should be treated with caution since the strength and direction of the evidence cannot be verified from this report".&lt;/STRONG&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>35910</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=35910]]&gt;</url>
    <title>Guidelines for the prevention of falls in people over 65.</title>
    <publicationDate>2001-10-21T00:00:00</publicationDate>
    <publisher>British Medical Journal</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FOR REVIEW,PREVENTION,FALLS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Multifaceted interventions reduce falls in older people (those over 65); Home assessment of older people at risk of falls without referral or direct intervention is not recommended. Assessment of high risk residents in nursing homes with relevant referral is effective. Evidence from well designed single trials shows that assessment and modification of risk factors of older people who have presented to an accident and emergency department after a fall and the provision of hip protectors in residents of nursing homes are effective.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Guidelines for the prevention of falls in people over 65.&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 12pt 27pt; TEXT-INDENT: -27pt; tab-stops: right 18.0pt left 27.0pt; mso-layout-grid-align: none"&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-ansi-language: EN-US"&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;Feder G, Cryer C, Donovan S, Carter Y. Guidelines for the prevention of falls in people over 65. &lt;I&gt;BMJ&lt;/I&gt; 2000;&lt;B&gt;321&lt;/B&gt;:1007-11.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 12pt 27pt; TEXT-INDENT: -27pt; tab-stops: right 18.0pt left 27.0pt; mso-layout-grid-align: none"&gt;&lt;A href="http://bmj.bmjjournals.com/cgi/content/full/321/7267/1007?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=10&amp;amp;RESULTFORMAT=1&amp;amp;title=Guidelines+for+the+prevention+of+falls&amp;amp;andorexacttitle=and&amp;amp;andorexacttitleabs=and&amp;amp;andorexactfulltext=and&amp;amp;searchid=1082457286948_4395&amp;amp;stored_search=&amp;amp;FIRSTINDEX=0&amp;amp;sortspec=relevance&amp;amp;resourcetype=1,2,3,4" target="_blank"&gt;View the Guideline &lt;/A&gt;on the BMJ web site 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 12pt 27pt; TEXT-INDENT: -27pt; tab-stops: right 18.0pt left 27.0pt; mso-layout-grid-align: none"&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-ansi-language: EN-US"&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>33780</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/aboutnice/whoweare/aboutthehda/hdapublications/prevention_and_reduction_of_accidental_injury_in_children_and_older_people_evidence_briefing.jsp]]&gt;</url>
    <title>HDA prevention and reduction of accidental injury in children and older people</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>NICE</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ PREVENTION,FALLS,LATER LIFE,OUTCOMES,DETERMINANTS,CAUSES OF HARM,ENVIRONMENTAL,INJURIES,ADULTS,CHILDREN,OLDER PEOPLE,POPULATION BASED &amp; PREVENTATIVE SERVICES,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,SERVICES,2008-OCTOBER,MONTHLY ADDITIONS,POPULATIONS,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Accidental injury is a leading cause of death and disability - WHO suggests that by 2020 injury be the largest single reason for loss of healthy human life-years. The government has identified accidental injury as a priority for action and targets have been set to reduce rates of death and serious injury associated with accidental injury in England. &lt;/P&gt;
&lt;P&gt;This summary is an important first step in developing the evidence base for the prevention and reduction of accidental injury. It presents an overview of the findings and recommendations from a review of selected systematic and other reviews. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317325</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[https://nutrition.solidcasts.com/xml/download/1683/audio/4131/Health_Ageing_TF_-_John_Mathers_Presentation1.m4a]]&gt;</url>
    <title>Healthy aging: the role of nutrition and lifestyle Podcast 1</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>British Nutrition Foundation</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A&amp;nbsp;podcast discussing healthy ageing and the role nutrition and lifestyle play.]]&gt;</body>
  </document>
  <document>
    <id>317327</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[https://nutrition.solidcasts.com/xml/download/1683/audio/4215/Healthy_Ageing_Oral_Health_Presentation.m4a]]&gt;</url>
    <title>Healthy aging: the role of nutrition and lifestyle Podcast 2</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>British Nutrition Foundation</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A podcast detailing healthy ageing.]]&gt;</body>
  </document>
  <document>
    <id>272032</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=272032]]&gt;</url>
    <title>Heart Failure in Later Life</title>
    <publicationDate>2007-10-31T00:00:00</publicationDate>
    <publisher>Later Life Specialist Library</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ CARDIOVASCULAR DISEASES,CONDITIONS,HEART FAILURE,GENERAL  / OVERVIEWS,LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,HEART DISEASE,HEART FAILURE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>An editorial written by Dr Neil Gillespie to tie in with the Cardiovascular Specialist Library's Heart Failure Knowledge Week.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Heart Failure in Later Life&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Heart Failure is a disease of old age. Its prevalence and incidence increases with age.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Presentation may be variable and symptoms and signs may not be clear because of the presence of additional co-morbidity.&amp;nbsp; The disease may present with severe breathlessness and associated pulmonary oedema or it may present more insidiously with symptoms of fatigue and exertional dyspnoea.&amp;nbsp; Patients may require further investigations to confirm the diagnosis. These include electrocardiography, echocardiography and chest radiology. Most treatments have been evaluated for patients who have heart failure and abnormal systolic function. However, many older patients who have heart failure have preserved systolic function. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The main components of treatment are diuretics for symptoms and signs of fluid retention together with an Angiotensin Converting Enzyme inhibitor for those patients with left ventricular systolic dysfunction. B-blockade is also of proven benefit and patients with advanced disease may also benefit from treatment with spironolactone. Digoxin has been used for many years and may improve morbidity for heart failure patients. The benefit of newer treatments is less clear. However when care is co-ordinated in a multidisciplinary way, outcomes are better.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.dundee.ac.uk/ageinghealth/staff/profiles/neil_gillespie.htm" target="_blank"&gt;Dr Neil Gillespie&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/cardiovascular/Page.aspx?&amp;amp;pagename=HFNKWHOME" target="_blank"&gt;Link to the Cardiovascular Specialist Library's Heart Failure Knowledge Week&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93908</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/Arthritis/VDmusceld.html]]&gt;</url>
    <title>Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged 60 years or more</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Am J Clin Nutr</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by Bandolier:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"Bandolier has already reported on the effects of vitamin D supplements on fractures and falls. Reductions in fractures may be due in part to the known beneficial effect of vitamin D on calcium homeostasis, but also in part to a reduction in falls due to a beneficial effect on muscle strength. A new study lends further support for a direct effect of vitamin D on muscle".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>328767</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/reprint/14/5/151]]&gt;</url>
    <title>Higher red blood cell distribution width was associated with increased risk of mortality in adults</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;cohort study.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;USA.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;8175 participants &amp;gt;=45 years of age (mean age 62 y, 54% women) from the civilian non-institutionalised population. 3 participants were excluded because insufficient information was available to search the National Death Index.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Risk factors:&lt;/STRONG&gt;&lt;BR&gt;RDW values were divided by quintiles (12.6–12.95%, 13–13.4%, 13.45–14.05%, and &amp;gt;14.05%). Results were adjusted for age, sex, and ethnicity.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Outcomes:&lt;/STRONG&gt;&lt;BR&gt;all-cause mortality.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main results:&lt;/STRONG&gt;&lt;BR&gt;Overall, 2428 (30%) participants died during 12 years of follow-up. Increasing RDW values were associated with increasing risk of all-cause mortality (table). Every 1% increase in RDW was associated with 22% increased risk of mortality after adjusting for multiple risk factors.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion:&lt;/STRONG&gt;&lt;BR&gt;Higher red blood cell distribution width was associated with increased risk of mortality in adults &amp;gt;=45 years of age.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>275423</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/download_info.php?downloadID=70]]&gt;</url>
    <title>Home from Home: Quality of care for people with dementia living in care homes</title>
    <publicationDate>2007-11-28T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,SERVICE SECTORS,QUALITY AND MONITORING,MENTAL HEALTH SERVICES,LATER LIFE,DEMENTIA,TREATMENT AND CARE,NEUROLOGICAL CONDITIONS,RECENT ADDITIONS,ALZHEIMER'S DISEASE,DEMENTIA,CONDITIONS,RESIDENTIAL CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Alzheimer's Society's Home From Home report calls for care homes to begin operating as specialist dementia care providers. Research shows a typical person with dementia in a care home spends just two minutes in every six hours socially interacting with other people - most of these residents are in the advanced stages of dementia and rely on the support of trained staff.&lt;/P&gt;
&lt;P&gt;The Home From Home report features a survey of more than 3,500 people, including relatives of people with dementia, care home staff and managers. The survey shows;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;More than half of people with a relative in residential care say there is not enough for the person with dementia to do each day 
&lt;LI&gt;Over one in four family carers feel they do not receive enough information about the care and treatment of the person they care for 
&lt;LI&gt;Care home staff say providing care that improves the quality of life of residents with dementia is the top factor in job satisfaction&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Neil Hunt, chief executive of the Alzheimer's Society, says,&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; 'Hundreds of thousands of people with dementia are living in residential care and yet the majority of staff do not have adequate training. We hear the horror stories, but also the hope among people with dementia and their carers about the difference good dementia care can make.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; Care homes must operate as specialist care providers with dementia training a mandatory requirement for all staff. Dementia training ensures care staff understand the reality of the condition as well as the positive impact they can have on people living with a diagnosis and their carers.'&lt;/P&gt;
&lt;P&gt;Connie Harris, from Essex, cares for her partner Lionel. She says,&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; 'Lionel has lived in two different care homes since he was diagnosed with Alzheimer's disease. He left one after two weeks because staff failed to make the simplest checks on his personal care. Where he is now the staff see Lionel as a person and have the skills to support his medical needs. There is no comparison between them and the huge effect good dementia care has had on both on our lives.'&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>387444</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0012244;jsessionid=8533E130CBFA5AF255D9D284582F0B47.ambra02]]]&gt;</url>
    <title>Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial</title>
    <publicationDate>2010-09-09T00:00:00</publicationDate>
    <publisher>Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial</publisher>
    <publicationType>RANDOMISED CONTROLLED TRIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION,TREATMENT AND CARE,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;An increased rate of brain atrophy is often observed in older subjects, in particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain atrophy, cognitive impairment and dementia. Plasma concentrations of homocysteine can be lowered by dietary administration of B vitamins.&lt;/P&gt;
&lt;P&gt;The objective of this report was to determine whether supplementation with B vitamins that lower levels of plasma total homocysteine can slow the rate if brain atrophy in subjects with mild cognitive impairment in a randomised comtrolled trial.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>33769</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071478]]&gt;</url>
    <title>How can we help older people not fall again? implementing the older people's NSF falls standard</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NSF FOR OLDER PEOPLE,PREVENTION,LATER LIFE,FALLS,DETERMINANTS,CAUSES OF HARM,ENVIRONMENTAL,ADULTS,OLDER PEOPLE,NATIONAL SERVICE FRAMEWORKS,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,HEALTHCARE &amp; HEALTH SERVICES,MANAGEMENT &amp; POLICY,FRAMEWORKS,ALLIED HEALTH PROFESSIONALS,CARE,2008-OCTOBER,MONTHLY ADDITIONS,POPULATIONS,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;How can we help older people not fall again? implementing the older people's NSF falls standard&lt;/pageTitle&gt;&lt;pageBody&gt;This document provides guidance for commissioners to implement the National Service Framework for Older People Standard 6 falls prevention.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>95908</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/LettersAndCirculars/HealthServiceCirculars/HealthServiceCircularsArticle/fs/en?CONTENT_ID=4004092&amp;chk=H604sn]]&gt;</url>
    <title>HSC 2001/008: Community equipment services</title>
    <publicationDate>2001-08-05T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This guidance applies to community equipment services for all age groups including children. It sets out action that should be taken to improve provision by the development of integrated local authority and NHS equipment services, particularly in counjunction with the intermediate care initiative.]]&gt;</body>
  </document>
  <document>
    <id>328759</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/reprint/361/13/1235.pdf]]&gt;</url>
    <title>http://content.nejm.org/cgi/content/short/361/13/1235</title>
    <publicationDate>2009-09-24T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;A complete remission is essential for prolonging survival in patients with acute myeloid leukemia (AML). Daunorubicin is a cornerstone of the induction regimen, but the optimal dose is unknown. In older patients, it is usual to give daunorubicin at a dose of 45 to 50 mg per square meter of body-surface area.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Methods:&lt;/STRONG&gt;&lt;BR&gt;Patients in whom AML or high-risk refractory anemia had been newly diagnosed and who were 60 to 83 years of age (median, 67) were randomly assigned to receive cytarabine, at a dose of 200 mg per square meter by continuous infusion for 7 days, plus daunorubicin for 3 days, either at the conventional dose of 45 mg per square meter (411 patients) or at an escalated dose of 90 mg per square meter (402 patients); this treatment was followed by a second cycle of cytarabine at a dose of 1000 mg per square meter for 6 days. The primary end point was event-free survival.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;The complete remission rates were 64% in the group that received the escalated dose of daunorubicin and 54% in the group that received the conventional dose (P=0.002); the rates of remission after the first cycle of induction treatment were 52% and 35%, respectively (P&amp;lt;0.001). There was no significant difference between the two groups in the incidence of hematologic toxic effects, 30-day mortality (11% and 12% in the two groups, respectively), or the incidence of moderate, severe, or life-threatening adverse events (P=0.08). Survival end points in the two groups did not differ significantly overall, but patients in the escalated-treatment group who were 60 to 65 years of age, as compared with the patients in the same age group who received the conventional dose, had higher rates of complete remission (73% vs. 51%), event-free survival (29% vs. 14%), and overall survival (38% vs. 23%).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;In patients with AML who are older than 60 years of age, escalation of the dose of daunorubicin to twice the conventional dose, with the entire dose administered in the first induction cycle, effects a more rapid response and a higher response rate than does the conventional dose, without additional toxic effects. (Current Controlled Trials number, ISRCTN77039377 [controlled-trials.com] ; and Netherlands National Trial Register number, NTR212.)&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317426</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70094-8/fulltext]]&gt;</url>
    <title>http://www.library.nhs.uk/LATERLIFE/ViewResource.aspx?resID=317416&amp;tabID=289</title>
    <publicationDate>2009-05-30T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ On March 24, 2009, against a backdrop of global financial turmoil, the Alzheimer's Association released its &lt;I&gt;Alzheimer's Disease &lt;/I&gt;&lt;A class=ja50-ce-inter-ref href="http://www.alz.org/national/documents/report_alzfactsfigures2009.pdf" target="_blank"&gt;&lt;I&gt;Facts and Figures &lt;/I&gt;&lt;/A&gt;report. Among the alarming statistics is an estimate that care for people with dementia costs more than US$148 billion per year in the USA alone. As governments around the globe reassess their finances in an effort to avert or at least limit the effects of financial meltdown, spending on care for people with dementia must not be neglected.]]&gt;</body>
  </document>
  <document>
    <id>374936</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/2/187?rss=1]]&gt;</url>
    <title>Hypertension, Executive Dysfunction, and Progression to Dementia: The Canadian Study of Health and Aging</title>
    <publicationDate>2010-02-08T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Midlife hypertension has long been established as a risk factor for dementia, but the role of late-life hypertension remains unclear.]]&gt;</body>
  </document>
  <document>
    <id>374924</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/4/462?rss=1]]&gt;</url>
    <title>Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E {varepsilon}4 Allele</title>
    <publicationDate>2010-04-12T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ To investigate with fluorodeoxyglucose positron emission tomography whether regional reductions in the cerebral metabolic rate for glucose (CMRgl) previously found in cognitively healthy late-middle-aged apolipoprotein E (APOE) {varepsilon}4 carriers extend to members of the Latino Mexican American community.]]&gt;</body>
  </document>
  <document>
    <id>317308</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=396]]&gt;</url>
    <title>Ibuprofen appears not to prevent Alzheimer’s among very elderly</title>
    <publicationDate>2009-04-23T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;IMG class=alignright alt=Drugs src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID317308/nelhImp_0000_20090421152108pills.jpg%26amp%3Bmax_width%3D200%26amp%3Bmax_height%3D200"&gt; &lt;/P&gt;
&lt;P&gt;A study published in the journal Neurology has shown that nonsteroidal anti-inflammatory drugs (NSAIDs) do not prevent Alzheimer's disease or other forms of dementia.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374939</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/131?rss=1]]&gt;</url>
    <title>Ideal Management of Diabetes Mellitus and Dementia: Walking a Tightrope Between Hyperglycemia and Hypoglycemia</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Although acute hypoglycemia may be associated with cognitive impairment in children with type 1 diabetes, no studies to date have evaluated whether hypoglycemia is a risk factor for dementia in older patients with type 2 diabetes.]]&gt;</body>
  </document>
  <document>
    <id>393605</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.kingsfund.org.uk/publications/implementing_the_end.html]]&gt;</url>
    <title>Implementing the End of Life Care Strategy - Lessons from good practice</title>
    <publicationDate>2010-10-28T00:00:00</publicationDate>
    <publisher>The Kings Fund</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This new report has been published by The Kings Fund. It is aimed at those responsible for commissioning and organising end of life care services at a local level.&lt;/P&gt;
&lt;P&gt;The paper uses evidence from The King’s Fund’s evaluation of the Marie Curie Delivering Choice Programme to highlight examples of good practice and learning for the organisation and delivery of end-of-life care across England. It provides guidance on the delivery options and ongoing challenges in the organisation of end-of-life care that can be implemented or adapted to suit local contexts of care. Many of the lessons that are presented in this paper will also provide a valuable resource for those involved in the quality, innovation, productivity and prevention (QIPP) agenda.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94698</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.npc.co.uk/ebt/merec/cns/dementia/resources/merec_extra_no14.pdf]]&gt;</url>
    <title>Implications of AD2000 for the treatment of Alzheimer's disease</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>MeReC Extra</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,ALZHEIMER'S DISEASE,DEMENTIA,TREATMENT AND CARE,LATER LIFE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;EM&gt;MeReC Extra&lt;/EM&gt; is produced by the National Prescribing Centre and addresses current issues, questions and controversies by providing brief updates and overviews on recent key clinical papers and guidelines that could influence or change practice.]]&gt;</body>
  </document>
  <document>
    <id>95910</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ihi.org/IHI/Topics/Improvement/ImprovementMethods/ImprovementStories/SystemwideImprovementOfServicesForOlderPeople.htm]]&gt;</url>
    <title>Improvement Report: Systemwide improvement of services for older people</title>
    <publicationDate></publicationDate>
    <publisher>London Older People’s Service Development Programme</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Improvement report for the London Older Peoples’ Service Improvement Programme, aiming to promote independence in the community, through the delivery of person-centred and co-ordinated services.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>338938</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_111223]]&gt;</url>
    <title>Improving care and saving money: learning the lessons on prevention and early intervention for older people</title>
    <publicationDate>2010-01-18T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This document provides the key learning from the national Partnerships for Older People Projects (POPP) programme.]]&gt;</body>
  </document>
  <document>
    <id>296911</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/2326.asp]]&gt;</url>
    <title>Improving care in residential care homes: a literature review</title>
    <publicationDate>2008-10-29T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SURVEILLANCE,SECONDARY CARE,SCREENING AND SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This review examines the research evidence available to support improved care for older people in residential homes.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This review examines the research evidence available to support improved care for older people in residential homes.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The research&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;By a team from the University of Warwick and University of the West of England, with support from the University of York&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Key points:&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;In general, few studies report specifically on residential care. Most research has been conducted in nursing homes; several other studies make no distinction between nursing and residential homes, using the umbrella term ‘care homes’ to encompass both.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; * The literature on improved care focuses primarily on the quality of clinical care. There is a paucity of quality-of-life measures reflecting the resident’s voice. The voice of minority ethnic residents is almost entirely absent from the literature. 
&lt;LI&gt;There is evidence that medical cover for care home residents is sub-optimal. Care could be restructured to give greater scope for proactive and preventive interventions.&amp;nbsp; 
&lt;LI&gt;Partnership working between district nurses and care home staff appears largely to occur by default at present. There is opportunity for a more strategic approach to providing nursing support in residential homes.&amp;nbsp; 
&lt;LI&gt;There is considerable research on the relationship between nurse staffing and nursing care home quality in the US. Quality is measured through clinical-based outcomes for residents and organisational outcomes. Conclusions are difficult to draw, however, due to inconsistencies in the evidence base.&amp;nbsp; 
&lt;LI&gt;There is evidence that better management of medication is needed in nursing homes. Pharmacist reviews of medication can have a positive effect. Similar evidence is lacking for residential care homes.&amp;nbsp; 
&lt;LI&gt;Inter-institutional transfers and ensuring patient safety across settings is important. To date, research has mainly focused on the care home and hospital interface; transfers from residential to nursing homes represent a research gap.&amp;nbsp; 
&lt;LI&gt;Interesting research is reported from the US and other non-UK sources. Some findings will be generalisable to UK residential care; a systematic process is recommended to identify these. &lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>95202</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4010156&amp;chk=wy7cRo]]&gt;</url>
    <title>Improving older people's services - policy into practice: inspection of older people's services</title>
    <publicationDate>2002-07-07T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This document details findings from 23 inspections carried out on older people's services. The aim of these inspections was to see whether the new policies had become embedded in the operational practice of social services, and the impact that changes of policy and social services infrastructure had made to the way that operational staff delivered good outcomes for older people. The focus of this phase of inspections was to see how well councils had moved from policy to practice.]]&gt;</body>
  </document>
  <document>
    <id>267443</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.mhilli.org/documents/Inquiryfinalreport-EXECSUMMARY.pdf]]&gt;</url>
    <title>Improving Services and Support for Older People with Mental Health Problems: The final report from the UK inquiry</title>
    <publicationDate>2007-08-13T00:00:00</publicationDate>
    <publisher>UK Inquiry into Mental Health and Well-Being in Later Life</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,AGEISM,SCREENING AND SURVEILLANCE,DEMENTIA,MENTAL HEALTH,SCREENING,DELIRIUM,DEMENTIA,OUTCOMES,ADULTS,MENTAL &amp; BEHAVIOURAL DISORDERS,CARERS,QUALITY,GOOD PRACTICE,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,MANAGEMENT &amp; POLICY,HEALTHCARE &amp; HEALTH SERVICES,SERVICES,CARE,HEALTH SERVICES,FRAMES OF REFERENCE,GEOGRAPHY,NATIONAL,AGE GROUPS,POPULATIONS,GROUPS,SETTINGS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The UK Inquiry into Mental Health and Well-Being in Later Life has published its final report, Improving Services and Support for Older People with Mental Health Problems.  The report follows the Inquiry's first report, Promoting Mental Health and Well-Being in Later Life, which was published in June 2006.</description>
    <body>&lt;![CDATA[ &lt;P&gt;The UK Inquiry into Mental Health and Well-Being in Later Life has published its final report, Improving Services and Support for Older People with Mental Health Problems. &lt;/P&gt;
&lt;P&gt;The report follows the Inquiry's first report, Promoting Mental Health and Well-Being in Later Life, which was published in June 2006.&lt;/P&gt;
&lt;P&gt;Click here to download:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.mhilli.org/documents/Pressrelease-UKInquiryintoMentalHealthandWell-BeinginLaterLife-13August2007.pdf#pressrelease" target="_blank"&gt;Press release &lt;/A&gt;(Pdf, 67 KB, 2 pages) 
&lt;LI&gt;&lt;A href="http://www.mhilli.org/documents/Inquiryfinalreport-EXECSUMMARY.pdf" target="_blank"&gt;Executive summary&lt;/A&gt; (Pdf, 428 KB, 11 pages) 
&lt;LI&gt;&lt;A href="http://www.mhilli.org/documents/Inquiryfinalreport-FULLREPORT.pdf" target="_blank"&gt;Full report&lt;/A&gt; (Pdf, 1.4 MB, 124 pages) 
&lt;LI&gt;&lt;A href="http://www.mhilli.org/documents/Coverletter-InquiryfinalreportFINAL.pdf" target="_blank"&gt;Cover letter from Inquiry chairman&lt;/A&gt; (Pdf, 76 KB, 1 page)&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>236129</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=236129]]&gt;</url>
    <title>Improving the quality of life for older people</title>
    <publicationDate></publicationDate>
    <publisher>IMprovement and Development Agency</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Improving the quality of life for older people&lt;/pageTitle&gt;&lt;pageBody&gt;This&amp;nbsp;guidance identifies the lessons learned from 50 local government associations, and highlights how services might be improved for older people.&amp;nbsp; 'Improving the quality of life for older people'&amp;nbsp;highlights shared priorities agreed between central government and the Local Government Association (LGA).&amp;nbsp;&amp;nbsp; &lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>374919</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/5/589?rss=1]]&gt;</url>
    <title>Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients</title>
    <publicationDate>2010-05-10T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;
&lt;P&gt;Context&amp;nbsp; An association between dopamine-replacement therapies and impulse control disorders (ICDs) in Parkinson disease (PD) has been suggested in preliminary studies.&lt;/P&gt;
&lt;P&gt;Objectives&amp;nbsp; To ascertain point prevalence estimates of 4 ICDs in PD and examine their associations with dopamine-replacement therapies and other clinical characteristics.&lt;/P&gt;
&lt;P&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94190</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=10720355]]&gt;</url>
    <title>Incidence and types of preventable adverse events in elderly patients: population based review of medical records</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,FALLS,SURVEILLANCE,ASSESSING RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To determine the incidence and types of preventable adverse events in elderly patients. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Preventable adverse events were more common among elderly patients, probably because of the clinical complexity of their care rather than age based discrimination. Preventable adverse drug events, events related to medical procedures, and falls were especially common in elderly patients and should be targets for efforts to prevent errors. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374930</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/3/347?rss=1]]&gt;</url>
    <title>Increased Melanoma Risk in Parkinson Disease: A Prospective Clinicopathological Study</title>
    <publicationDate>2010-03-08T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objective&amp;nbsp; To evaluate the possible association of Parkinson disease (PD) and melanoma in North America.&lt;/P&gt;
&lt;P&gt;Design, Setting, and Patients&amp;nbsp; Thirty-one centers enrolled patients with idiopathic PD. At visit 1, a neurologist obtained a medical history. At visit 2, a dermatologist recorded melanoma risk factors, performed a whole-body examination, and performed a biopsy of lesions suggestive of melanoma for evaluation by a central dermatopathology laboratory. We compared overall prevalence of melanoma with prevalence calculated from the US Surveillance Epidemiology and End Results (SEER) cancer database and the American Academy of Dermatology skin cancer screening programs.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93900</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/aspirin/asstroch.html]]&gt;</url>
    <title>Indications for early aspirin use in acute ischaemic stroke. A combined analysis of 40,000 randomised patients from the Chinese acute stroke trial and the international stroke trial</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>Stroke</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ STROKE,ISCHAEMIC STROKE,NEUROLOGICAL CONDITIONS,LATER LIFE,STROKE,ACUTE MANAGEMENT,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This meta analysis has been reviewed by Bandolier:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"Early use of aspirin is of benefit in a wide range of patients after ischaemic stroke".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93859</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/band66/b66-3.html]]&gt;</url>
    <title>Injuries from falls are increasing in older adults</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This Bandolier article reviews the following studies:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;P Kannus et al. Fall-induced injuries and deaths among older adults. JAMA 1999 281: 1895-99.&lt;/LI&gt;
&lt;LI&gt;P Kannus et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999 353: 802-5.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319635</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.relres.org/publicationspages/InspectionInAction.html]]&gt;</url>
    <title>Inspection in Action: Making inspection work</title>
    <publicationDate>2009-05-31T00:00:00</publicationDate>
    <publisher>R&amp;RA</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The (now defunct) care home regulator, the Commission for Social Care Inspection (CSCI), established a system of star ratings in 2007 by which it assessed and rated registered care homes across England. Scrutiny of a number of SCI reports raised R&amp;amp;RA concerns about the basis that had been adopted for awarding the stars. In particular, worries centred on CSCI’s definition of ‘adequate’ whereby a home is awarded 1 star. The R&amp;amp;RA subsequently undertook a survey of 100 randomly selected inspection reports of homes rated as ‘adequate’. This report presents the findings.]]&gt;</body>
  </document>
  <document>
    <id>268787</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ageuk.org.uk/money-matters/consumer-advice/insurance-advice/?paging=false]]&gt;</url>
    <title>Insurance and Age</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,WHAT IS AGEISM?,HOW DOES AGEISM OCCUR?,THE WHY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Older people often complain that the insurance industry discriminates against them: premiums rise, excesses increase and cover may not be available at all to people above a certain age limit. This summary explores the discrimination older people face in relation to motor insurance, travel insurance and car hire, and includes a series of recommendations for the insurance industry.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93890</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11176840&amp;query_hl=45]]&gt;</url>
    <title>Intake of fish and omega-3 fatty acids and risk of stroke in women</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This cohort study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/fishstro.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"The few associations that were found in this study were based on a small number of stroke cases and there was no consistency among the associations observed. For example, an association was found between the highest intake of omega-3 fatty acids and risk of total stroke, but only one association was found among the seven subtypes of stroke.&lt;/P&gt;
&lt;P&gt;Based on these results the association between fish and omega-3 polyunsaturated fatty acid intake and stroke risk is still open to question. The effect looks small, but a larger number of stroke cases are needed to provide a more definitive answer".&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95912</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.audit-commission.gov.uk/reports/AC-REPORT.asp?CatID=ENGLISH%5EHEALTH%5ESUBJECT%5EH-AUDIT&amp;ProdID=0CDFF060-E76E-11d6-B1E3-0060085F8572]]&gt;</url>
    <title>Integrated services for older people: building a whole system approach in England</title>
    <publicationDate></publicationDate>
    <publisher>Audit Commission</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;SPAN class=content&gt;This study looks at the way in which authorities, trusts and other organisations are working together, alongside older people, to promote integrated services in England.&lt;/SPAN&gt; &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313503</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD007146/frame.html]]&gt;</url>
    <title>Interventions for preventing falls in older people living in the community</title>
    <publicationDate>2009-04-15T00:00:00</publicationDate>
    <publisher>Cochrane Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Approximately 30% of people over 65 years of age living in the community fall each year.]]&gt;</body>
  </document>
  <document>
    <id>321658</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.uroweb.org/fileadmin/user_upload/Guidelines/14%20Hypogonadism.pdf]]&gt;</url>
    <title>Investigation, treatment and monitoring of late-onset hypogonadism in males</title>
    <publicationDate>2005-06-01T00:00:00</publicationDate>
    <publisher>European Association of Urology</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Androgen deficiency in the ageing male has become a topic of increasing interest and debate throughout the world. Demographic data demonstrates the increasing percentage of the population that is found in the older age groups. The data also support the concept that testosterone falls progressively with age and that a significant percentage of men over the age of 60 years have serum testosterone levels that are below the lower limits of young adult men (age 20-30 years). The principal questions raised by these observations are whether older hypogonadal men will benefit from testosterone treatment and what will be the risks associated with such intervention. The past decade has brought evidence of benefit of androgen treatment of hypogonadal men on multiple target organs and recent studies show short-term beneficial effects of testosterone in older men that are similar to those in younger men.]]&gt;</body>
  </document>
  <document>
    <id>235481</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialpolicy/1974.asp]]&gt;</url>
    <title>Involving Chinese older people in policy and practice</title>
    <publicationDate>2007-01-31T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This study from the University of Sheffield, was aimed to enable Chinese older people to influence policy and practice. It also allowed them to reflect on their experiences of involvement.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Involving Chinese older people in policy and practice&lt;/pageTitle&gt;&lt;pageBody&gt;This study from the University of Sheffield, was aimed to enable Chinese older people to influence policy and practice. It also allowed them to reflect on their experiences of involvement.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93887</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/hliving/StroOCP.html]]&gt;</url>
    <title>Ischaemic stroke risk with oral contraceptives</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ WOMEN'S HEALTH,FERTILITY CONTROL,CONTRACEPTION,LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION,COMBINED HORMONAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Ischaemic stroke risk with oral contraceptives&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This meta analysis has been reviewed by Bandolier:&lt;/P&gt;
&lt;P&gt;"This paper provides a lovely example of how results can be misleading. Firstly, the differences in study design (e.g. many early studies did not adjust for smoking or hypertension) made the estimated risk of stroke much higher than it really is. Secondly, the estimated relative risk of stroke is double (based on a handful of studies with few case numbers, 'estimated' is the key word here), but the absolute risk is one additional ischaemic stroke per year per 24,000 non-smoking, normotensive women using low-oestrogen oral contraceptives. In other words, the risk is very small and similar to risks we usually accept as part of living. The information makes it possible for women and their partners to decide if the risk is acceptable to them".&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>308474</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/03March/Pages/Keepactiveforlongerlife.aspx]]&gt;</url>
    <title>Keep active 'for longer life'</title>
    <publicationDate>2009-03-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Behind the headlines - your guide to the science that makes the news. Created by NHSChoices</description>
    <body>&lt;![CDATA[ "Men in their 50's who increase their exercise regime live more than two years longer than couch potatoes of the same age." The Guardian reported. It said that men who do just three hours of sport or heavy gardening a week live 2.3 years longer than sedentary men, and a year longer than those who do moderate exercise.]]&gt;</body>
  </document>
  <document>
    <id>260378</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://whqlibdoc.who.int/publications/9241562102.pdf]]&gt;</url>
    <title>Keep fit for life: Meeting the nutritional needs of older persons</title>
    <publicationDate>2002-05-01T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ An 83-page report on recommendations for healthy ageing, the epidemiological and social aspects of ageing, the impact of physical activity, and the nutritional guidelines for healthy ageing, with references provided.]]&gt;</body>
  </document>
  <document>
    <id>319633</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ageuk.org.uk/health-wellbeing/keeping-your-body-healthy/keeping-cool-in-a-heatwave-/?paging=false]]&gt;</url>
    <title>Keeping cool in a heatwave PDF</title>
    <publicationDate>2009-06-24T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The four national Age Concerns in the UK have joined together with Help the Aged to form new national charities dedicated to improving the lives of older people.&lt;/P&gt;
&lt;P&gt;Summer is usually enjoyable but very high temperatures and humidity can present a risk to health‚ and older people are particularly susceptible to heat-related illness.&lt;BR&gt;&lt;BR&gt;This guide explains:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;how to protect yourself from the heat 
&lt;LI&gt;how to recognise heat-related illness‚ and what to do when someone shows signs of it.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>317305</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=407]]&gt;</url>
    <title>Later retirements ‘delays Alzheimer’s onset’</title>
    <publicationDate>2009-05-18T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ British scientists have found that keeping the brain active by working later in life reduces the risk of developing Alzheimer’s disease at a younger age&lt;A href="http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;amp;archive=0&amp;amp;id=407" target="_blank"&gt;&lt;/A&gt;]]&gt;</body>
  </document>
  <document>
    <id>93886</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/content/abstract/341/21/1557]]&gt;</url>
    <title>Light to moderate alcohol consumption and the risk of stroke among U.S. male physicians</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CAUSES AND PRIMARY PREVENTION,STROKE,OUTCOMES,MEN,OCCUPATIONAL GROUPS,MALE,STROKE &amp; TIA,CIRCULATORY DISEASES,PUBLIC HEALTH,DETERMINANTS,LIFESTYLE,SOCIAL DETERMINANTS,ALCOHOL CONSUMPTION,INDIVIDUAL BEHAVIOUR,POPULATIONS,GROUPS,GENDER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This cohort study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/alcishast.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"This cohort study found that light to moderate drinking, between one and seven drinks a week, reduced the risk of ischaemic stroke by 23% in men. It did not examine the effects of consuming two or more drinks a day. There was no association between alcohol consumption and hemorrhagic stroke".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321715</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/reprint/302/4/412]]&gt;</url>
    <title>Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality</title>
    <publicationDate>2009-07-22T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Context:&lt;/STRONG&gt;&lt;BR&gt;Circulating concentration of lipoprotein(a) (Lp[a]), a large glycoprotein attached to a low-density lipoprotein–like particle, may be associated with risk of coronary heart disease (CHD) and stroke.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To assess the relationship of Lp(a) concentration with risk of major vascular and nonvascular outcomes.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Study Selection:&lt;/STRONG&gt;&lt;BR&gt;Long-term prospective studies that recorded Lp(a) concentration and subsequent major vascular morbidity and/or cause-specific mortality published between January 1970 and March 2009 were identified through electronic searches of MEDLINE and other databases, manual searches of reference lists, and discussion with collaborators.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Data Extraction:&lt;/STRONG&gt;&lt;BR&gt;Individual records were provided for each of 126 634 participants in 36 prospective studies. During 1.3 million person-years of follow-up, 22 076 first-ever fatal or nonfatal vascular disease outcomes or nonvascular deaths were recorded, including 9336 CHD outcomes, 1903 ischemic strokes, 338 hemorrhagic strokes, 751 unclassified strokes, 1091 other vascular deaths, 8114 nonvascular deaths, and 242 deaths of unknown cause. Within-study regression analyses were adjusted for within-person variation and combined using meta-analysis. Analyses excluded participants with known preexisting CHD or stroke at baseline.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Data Synthesis:&lt;/STRONG&gt;&lt;BR&gt;Lipoprotein(a) concentration was weakly correlated with several conventional vascular risk factors and it was highly consistent within individuals over several years. Associations of Lp(a) with CHD risk were broadly continuous in shape. In the 24 cohort studies, the rates of CHD in the top and bottom thirds of baseline Lp(a) distributions, respectively, were 5.6 (95% confidence interval [CI], 5.4-5.9) per 1000 person-years and 4.4 (95% CI, 4.2-4.6) per 1000 person-years. The risk ratio for CHD, adjusted for age and sex only, was 1.16 (95% CI, 1.11-1.22) per 3.5-fold higher usual Lp(a) concentration (ie, per 1 SD), and it was 1.13 (95% CI, 1.09-1.18) following further adjustment for lipids and other conventional risk factors. The corresponding adjusted risk ratios were 1.10 (95% CI, 1.02-1.18) for ischemic stroke, 1.01 (95% CI, 0.98-1.05) for the aggregate of nonvascular mortality, 1.00 (95% CI, 0.97-1.04) for cancer deaths, and 1.00 (95% CI, 0.95-1.06) for nonvascular deaths other than cancer.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion:&lt;/STRONG&gt;&lt;BR&gt;Under a wide range of circumstances, there are continuous, independent, and modest associations of Lp(a) concentration with risk of CHD and stroke that appear exclusive to vascular outcomes.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>123866</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.audit-commission.gov.uk/Products/NATIONAL-REPORT/4C4C40BE-6383-40E0-8B26-48D7FAF39A56/HCC_older%20PeopleREP.pdf]]&gt;</url>
    <title>Living well in later life.</title>
    <publicationDate></publicationDate>
    <publisher>Commission for Healthcare Audit and Inspection</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN class=content&gt;The Audit Commission, the &lt;A href="http://www.healthcarecommission.org.uk/Homepage/fs/en" target="_blank"&gt;Healthcare Commission&lt;/A&gt;, and the &lt;A href="http://www.csci.org.uk/" target="_blank"&gt;Commission for Social Care Inspection&lt;/A&gt;&amp;nbsp; have jointly undertaken a review to create a national snapshot of the state of services for older people. The review looked at a range of services including care services and services that contribute towards the wellbeing and quality of life of older people. It also looked at progress against the government's National Service Framework for Older People. &lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>321654</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_103137?IdcService=GET_FILE&amp;dID=201554&amp;Rendition=Web]]&gt;</url>
    <title>Living well with dementia: a National Dementia Strategy implementation plan</title>
    <publicationDate>2009-07-22T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,TREATMENT AND CARE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The National Dementia Strategy Implementation Plan describes the implementation task, arrangements for national and regional support, and the programmes that have been put in place to support delivery of Living well with dementia: a National Dementia Strategy.&amp;nbsp;&amp;nbsp;This refreshed plan replaces the one that was issued alongside the Strategy on 3 February 2009.]]&gt;</body>
  </document>
  <document>
    <id>87844</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2118403&amp;query_hl=1]]&gt;</url>
    <title>Locomotor disability in very elderly people: value of a programme for screening and provision of aids for daily living.</title>
    <publicationDate>1990-05-17T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,FALLS,SURVEILLANCE,PRIMARY CARE,FOR REVIEW,ASSESSING RISK,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To assess the prevalence of potentially reversible locomotor disabilities in elderly subjects and the cost effectiveness of providing aids for daily living.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Appreciable degrees of unrecognised locomotor disability are detected on screening of very elderly people living independently. Providing aids offers a feasible and cost effective means of improving function in such people.&amp;nbsp;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>324665</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rcplondon.ac.uk/pubs/contents/55a60dba-3ba6-429c-8d2d-b1f178513b2b.pdf]]&gt;</url>
    <title>Long term neurological conditions: management at the interface between neurology, rehabilitation and palliative care</title>
    <publicationDate>2008-03-01T00:00:00</publicationDate>
    <publisher>Royal College of Physicians</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Aims&lt;/STRONG&gt;: Long-term neurological conditions (LTNCs) comprise a diverse set of conditions resulting from injury or disease of the nervous system that will affect an individual for life. Some 10 million people in the UK are living with a neurological condition which has a significant impact on their lives, and they make up 19% of hospital admissions. These guidelines recommend a collaborative model for interaction between the different specialties involved in the care of people with LTNCs.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Intended audience&lt;/STRONG&gt;: Doctors and healthcare professionals involved in the long-term support, rehabilitation and palliative care of people in the later stages of long-term neurological conditions.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Publication history information&lt;/STRONG&gt;: Published March 2008.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Available to the general public.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321723</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://content.nejm.org/cgi/reprint/361/3/255.pdf]]&gt;</url>
    <title>Longitudinal modeling of age-related memory decline and the APOE &amp;#949;4 effect</title>
    <publicationDate>2009-07-16T00:00:00</publicationDate>
    <publisher>New England Journal of Medicine</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;The APOE {varepsilon}4 allele is associated with the risk of late-onset Alzheimer's disease. The age at which memory decline diverges among persons who are homozygous for the APOE {varepsilon}4 allele, those who are heterozygous for the allele, and noncarriers is unknown.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Methods:&lt;/STRONG&gt;&lt;BR&gt;Using local advertisements, we recruited cognitively normal subjects between the ages of 21 and 97 years, who were grouped according to their APOE {varepsilon}4 status. We then followed the subjects with longitudinal neuropsychological testing. Anyone in whom mild cognitive impairment or dementia developed during follow-up was excluded. We compared the rates of decline in predetermined cognitive measures between carriers and noncarriers of the APOE {varepsilon}4 allele, using a mixed model for longitudinal change with age.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;We analyzed 815 subjects: 317 APOE {varepsilon}4 carriers (79 who were homozygous for the APOE {varepsilon}4 allele and 238 who were heterozygous) and 498 noncarriers. Carriers, as compared with noncarriers, were generally younger (mean age, 58.0 vs. 61.4 years; P&amp;lt;0.001) and were followed for a longer period (5.3 vs. 4.7 years, P=0.01), with an equivalent duration of formal education (15.4 years) and proportion of women (69%). Longitudinal decline in memory in carriers began before the age of 60 years and showed greater acceleration than in noncarriers (P=0.03), with a possible allele–dose effect (P=0.008). We observed similar although weaker effects on measures of visuospatial awareness and general mental status.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;Age-related memory decline in APOE {varepsilon}4 carriers diverges from that of noncarriers before the age of 60 years, despite ongoing normal clinical status.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374920</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/5/564?rss=1]]&gt;</url>
    <title>Long-term Blood Pressure Fluctuation and Cerebrovascular Disease in an Elderly Cohort</title>
    <publicationDate>2010-05-10T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Background&amp;nbsp; The importance of subclinical cerebrovascular disease in the elderly is increasingly recognized, but its determinants have not been fully explicated. Elevated blood pressure (BP) and fluctuation in BP may lead to cerebrovascular disease through ischemic changes and compromised cerebral autoregulation.&lt;/P&gt;
&lt;P&gt;Objective&amp;nbsp; To determine the association of BP and long-term fluctuation in BP with cerebrovascular disease.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317435</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/full/66/5/563]]&gt;</url>
    <title>Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease</title>
    <publicationDate>2009-05-31T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=2&gt;&lt;FONT face=Verdana&gt;The objective of this study was to compare the long-term outcomes of subjects&lt;SUP&gt; &lt;/SUP&gt;initially treated with pramipexole dihydrochloride with those&lt;SUP&gt; &lt;/SUP&gt;of subjects initially treated with levodopa in the Comparison&lt;SUP&gt; &lt;/SUP&gt;of the Agonist Pramipexole With Levodopa on Motor Complications&lt;SUP&gt; &lt;/SUP&gt;of Parkinson's Disease (CALM-PD) trial.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>374940</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/107?rss=1]]&gt;</url>
    <title>Lost in Translation: Epidemiology, Risk, and Alzheimer Disease</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ There is increasing emphasis on interdisciplinary translation in biomedical research.1 A major push toward prevention of Alzheimer disease (AD) is spawning translational research2 that should span basic, clinical, and population investigations. Epidemiological studies, which address our understanding of risk and protective factors for disease at the population level, are contributing less than they could to translational research. In part, this is because the key concept of risk is being "lost in translation," muddling interpretations and leading to interdisciplinary frustrations. As epidemiologists, we offer a framework for resolving some of the confusion.]]&gt;</body>
  </document>
  <document>
    <id>374921</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/5/542?rss=1]]&gt;</url>
    <title>LRRK2 and Parkinson Disease</title>
    <publicationDate>2010-05-10T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objectives&amp;nbsp; To review the molecular genetics and functional biology of leucine-rich repeat kinase 2 (LRRK2) in parkinsonism and to summarize the opportunities and challenges to develop interventions for Parkinson disease (PD) based on this genetic insight.]]&gt;</body>
  </document>
  <document>
    <id>223646</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csci.org.uk/PDF/making_choices_taking_risks.pdf]]&gt;</url>
    <title>Making Choices: taking risks, A discussion paper.</title>
    <publicationDate></publicationDate>
    <publisher>Commission for Social Care Inspection (CSCI)</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This paper highlights some of the risk-related factors that may prevent older people from living life the way they choose, proposes some ways that social care can support people’s aspirations and choices and identi&amp;#64257;es some challenges.</description>
    <body>&lt;![CDATA[ &lt;FONT face=ConduitITC-Light size=4&gt;
&lt;P align=left&gt;This paper highlights some of the risk-related factors that may prevent older people from living life the way they choose, proposes some ways that social care can support people’s aspirations and choices and identi. es some challenges.&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>95392</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/234.asp]]&gt;</url>
    <title>Making direct payments work for older people</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,LATER LIFE,AGEISM,HOW DOES AGEISM OCCUR?,THE WHY,PPI IN PRACTICE,INDIVIDUAL INVOLVEMENT,PATIENT CHOICE,DIRECT PAYMENTS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This study examined how older people use direct payments and how services can support them in doing so.]]&gt;</body>
  </document>
  <document>
    <id>87849</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8956803&amp;query_hl=10]]&gt;</url>
    <title>Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.</title>
    <publicationDate>1996-05-24T00:00:00</publicationDate>
    <publisher>Br Cancer</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FOR REVIEW,SCREENING AND SURVEILLANCE,SCREENING,BREAST,CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ We studied outcomes of mammographic screening in women older than 65 years. In 1975, breast cancer screening was started in Nijmegen, The Netherlands, for women aged 35-65 years. Since 1977, approximately 7700 older women have also been invited for biennial one-view mammography. This report is based on ten screening rounds from 1975 to 1994. The results of the subsequent screening rounds in the age groups 65-69 years, 70-74 years and 75 years and older were: participation rates 55%, 39% and 15%; screen-detected cancer rates 5.6%, 6.9% and 7.8%; interval cancer rates 2.0%, 1.8%, and 3.5%; and predictive values of referral 62%, 64% and 62% respectively. In all age groups, screen-detected patients had smaller tumours and a lower prevalence of axillary lymph node involvement than unscreened patients. Our conclusion is that, in women aged 65 years, and older, breast cancer can be detected at an earlier stage by mammographic screening.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>87851</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9061265&amp;query_hl=12]]&gt;</url>
    <title>Mammographic screening in older women. Is it worthwhile?</title>
    <publicationDate>1997-05-15T00:00:00</publicationDate>
    <publisher>Drugs.Aging</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,BREAST,CANCER,SCREENING,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The optimal upper age limit in mammographic screening for breast cancer is still a matter for debate. The incidence of breast cancer rises gradually with increasing age and, without screening, breast cancer in elderly women is diagnosed at a more advanced stage than in younger women. After menopause, much of the glandular tissue of the breast is replaced by fat, which facilitates the mammographic detection of breast cancer in older women. Furthermore, the tumour growth rate decreases with increasing age. Recently, a reduction in breast cancer mortality due to mammographic screening has been shown for women aged up to 75 years. There is a lack of data for women over the age of 75 years, however, because the number of women screened in the only study that included this age category is too small to give reliable results. We conclude that mammographic screening is beneficial at least up to the age of 75 years, and may also be beneficial up to age 85 years in healthy women with a good life expectancy.]]&gt;</body>
  </document>
  <document>
    <id>87856</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12791422&amp;query_hl=14]]&gt;</url>
    <title>Mammography screening in elderly women: efficacy and cost-effectiveness.</title>
    <publicationDate>2003-06-11T00:00:00</publicationDate>
    <publisher>Crit Rev Oncol Hematol</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,BREAST,CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The definition of an upper age limit for breast cancer screening is a rather complex issue, influenced by several conditions. Randomised trials specifically designed to investigate this aspect are not available, but all process indicators (positive predictive value, length of sojourn time, sensitivity of the test) indicate that screening efficacy does not change with increasing age. On the other hand, competing causes of death could decrease screening efficacy beyond age 74. Screening benefits depend on life expectancy and people with &amp;lt;5-10 years life expectancy are unlikely to benefit from screening, so it is still worthwhile considering the variability of life expectancy at different ages. Furthermore, economical implications are evident. Public health recommendations need to weigh the benefit of screening elderly women against costs, negative side effects and potential harm due to overdiagnosis and overtreatment of screen-detected lesions expected to have no effect on mortality. In this scenario, the medical system has an ethical obligation to properly inform the population invited to screening. Over the age of 74 years, encouraging individualized decisions may be more appropriate and may indicate further screening for those subjects for whom the potential benefit outweighs the potential negative effects.]]&gt;</body>
  </document>
  <document>
    <id>319622</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sign.ac.uk/pdf/sign111.pdf]]&gt;</url>
    <title>Management of Hip Fracture in Older People PDF</title>
    <publicationDate></publicationDate>
    <publisher>SIGN</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ SIGN Guidance on hip fracture.]]&gt;</body>
  </document>
  <document>
    <id>395026</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=395026]]&gt;</url>
    <title>Managing incontinence</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Managing incontinence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Incontinence – that is loss of bladder or bowel control – can affect men and women but bladder problems tend to be more common in women. Not only can it cause skin irritation and hygiene problems, it can significantly affect your day-to-day life and confidence when away from home. &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ageuk.org.uk/Documents/EN-GB/Information-guides/AgeUKIG15-Age-UK-Incontinence-Guide_inf.pdf" target="_blank"&gt;Managing incontinence (PDF)&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>395040</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_122007]]&gt;</url>
    <title>Managing winter</title>
    <publicationDate>2010-11-23T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Letter underlining the importance of ensuring the NHS is well prepared for winter.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94292</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncchta.org/projectdata/1_project_record_published.asp?PjtId=1121&amp;SearchText=You+Selected++AND++AND+]]&gt;</url>
    <title>Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology</title>
    <publicationDate>2005-07-03T00:00:00</publicationDate>
    <publisher>Health Technology Assessment</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,DEMENTIA,TREATMENT AND CARE,LATER LIFE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;The purpose of this study was to develop and validate a psychometrically rigorous measure of HRQoL for people with dementia. The measure was intended to be: (1) suitable for use in the UK; (2) available in self- and proxy-report versions for people with dementia and their carers, respectively; and (3) appropriate for use in mild/moderate and severe dementia. The aim was to keep the perspective of the person with dementia central in all stages of questionnaire development and evaluation. &lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;The 28-item DEMQOL and 31-item DEMQOL-Proxy provide a method for evaluating HRQoL in dementia. The new measures show comparable psychometric properties to the best available dementia-specific measures, provide both self- and proxy-report versions for people with dementia and their carers, are appropriate for use in mild to moderate dementia (MMSE =10) and are suitable for use in the UK. DEMQOL-Proxy also shows promise in severe dementia. As DEMQOL and DEMQOL-Proxy give different but complementary perspectives on quality of life in dementia, it is recommended that both measures are used together. In severe dementia, only DEMQOL-Proxy should be used.&lt;/P&gt;
&lt;P&gt;Further research with DEMQOL is needed to: (1)&amp;nbsp;confirm these findings in an independent sample; (2)&amp;nbsp;evaluate responsiveness; (3)&amp;nbsp;investigate the feasibility of use in specific subgroups and in economic evaluation; and (4)&amp;nbsp;develop population norms. Additional research is needed to address the psychometric challenges of self-report in dementia and validating new dementia-specific HRQoL measures.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>260067</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=260067]]&gt;</url>
    <title>Measuring resources in later life: A review of the data</title>
    <publicationDate>2007-03-01T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SECONDARY CARE,SURVEILLANCE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Measuring resources in later life: A review of the data&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;A 40-page research report by Sue Middleton, Ruth Hancock, Karen Kellard, Jacqueline Beckhelling, Viet-Hai Phung and Kim Perren. &lt;/P&gt;
&lt;P&gt;This report explores the needs of people in later life, including expenditure, health, social networks, services, housing and neighbourhood, as well as income. &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>87866</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8642154&amp;query_hl=20]]&gt;</url>
    <title>Medical screening of older drivers as a traffic safety measure-a comparative Finnish-Swedish evaluation study</title>
    <publicationDate>1997-05-15T00:00:00</publicationDate>
    <publisher>Journal of the American Geriatrics Society</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,FOR REVIEW,PRIMARY CARE,SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;To evaluate the safety effect of age-related medical screening of older drivers by comparing the licensing laws and accident rates for older road users in Finland and Sweden.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;We found no safety-related reasons to implement age-related medical screening of older drivers of the kind practiced in Finland. On the contrary, by producing a modal shift toward a more risky mode of travelling, this screening may indirectly lead to higher fatality rates among older road users. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>33828</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4008020&amp;chk=cC38JM]]&gt;</url>
    <title>Medicines and older people implementing medicines-related aspects of the NSF for older people</title>
    <publicationDate>2001-03-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,TREATMENT AND CARE,ACUTE MANAGEMENT,REHABILITATION,SCREENING AND SURVEILLANCE,STROKE,DEMENTIA,FALLS,PARKINSON'S DISEASE,NSF FOR OLDER PEOPLE,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The National Service Framework (NFS) for older people defines standards for health and social services to ensure high quality care. This document describes how the use of medicines for and by older people can be improved. It was produced for this particular NSF because the majority of older people are taking prescribed medicines, in conjunction with other remedies they buy themselves. However, its principles are relevant and transferable to other patients with chronic conditions covered by other NSFs.]]&gt;</body>
  </document>
  <document>
    <id>319628</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70146-2/fulltext]]&gt;</url>
    <title>Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Background&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are common forms of dementia that substantially affect quality of life. Currently, the only treatment licensed for PDD is rivastigmine, and there are no licensed treatments for DLB. We aimed to test the safety and efficacy of the N-methyl D-aspartate (NMDA) receptor antagonist memantine in patients with PDD or DLB.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Methods&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;We did a parallel-group, 24-week, randomised controlled study of memantine (20 mg per day) versus placebo at four psychiatric and neurological outpatient clinics in Norway, Sweden, and the UK during 2005—08. Patients were included if they fulfilled the UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria for Parkinson's disease (PD) and developed dementia according to the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM IV) criteria at least 1 year after the onset of motor symptoms (PDD) or met the revised consensus operationalised criteria for DLB. Patients were assigned to a computer-generated randomisation list. All physicians who had contact with patients were masked to treatment allocation. The primary outcome measure was clinical global impression of change (CGIC), which ranged from 1 to 7 points, and a low score means a better outcome. Analysis was by intention to treat based on the last observation carried forward. This trial is registered, number ISRCTN89624516.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Findings&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;72 patients with PDD or DLB were randomly assigned and started treatment: 34 with memantine and 38 with placebo. 56 (78%) completed the study. All withdrawals were owing to adverse events, but the proportion of withdrawals was similar in both groups. At week 24 the patients in the memantine group had better CGIC scores than those taking placebo (mean difference 0·7, 95% CI 0·04—1·39; p=0·03). With the exception of improved speed on attentional tasks in the memantine group (a quick test of cognition [AQT] form: difference 12·4, 95% CI 6·0—30·9; p=0·004), there were no significant differences between the groups in secondary outcome measures.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Interpretation&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;Patients with DLB or PDD might benefit from treatment with memantine, which was well tolerated. Large-scale studies are now required to confirm our preliminary findings.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Funding&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;The Western Norway Regional Health Authority; H Lundbeck A/S.&lt;/DIV&gt;&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>319631</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70144-9/fulltext]]&gt;</url>
    <title>Memantine: a new hope for treatment of Lewy body-related dementias?</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Lewy body-related dementias—Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB)—constitute the second most frequent cause of primary degenerative dementias. Although there are some subtle differences, these disorders have major overlaps in their clinical presentation and pathology, and are likely to represent two entities on the same disease range.]]&gt;</body>
  </document>
  <document>
    <id>282748</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sparc.ac.uk/media/downloads/executivesummaries/exec_summary_hollands.pdf]]&gt;</url>
    <title>Mind Where You Walk! Older people's vision and stepping</title>
    <publicationDate>2008-04-07T00:00:00</publicationDate>
    <publisher>SPARC</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,ASSESSING RISK,PREVENTION,FALLS,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>An executive summary of a SPARC project by Mark Hollands and Graham Chapman.</description>
    <body>&lt;![CDATA[ &lt;P&gt;In the United Kingdom, around 30% of adults over the age of 65 living in the community fall each year. Falls are a major cause of disability and the leading cause of mortality due to injury among older people aged over 75. Those older people who survive a fall often suffer ongoing problems such as injury and infection, loss of confidence, loss of mobility leading to social isolation and depression, increased dependency and permanent disability. Most falls in all age groups occur during walking on a level surface and therefore there is a clear need to understand the mechanisms underlying age-related changes in walking performance before this major health issue can be fully addressed. &lt;/P&gt;
&lt;P&gt;Previous research suggests that one contributing factor to age-related falls during walking is likely to be decline in the ability of older adults' brains to process visual information describing environmental features (e.g. obstacles and safe places to step) and use this information to generate appropriate stepping movements. &lt;/P&gt;
&lt;P&gt;The study will be the first to examine how the brain's ability to use vision in this way is affected by ageing and factors associated with falls risk. This information will be invaluable in contributing to our understanding of why people are more prone to falling with increasing age and help in the development of both diagnostic techniques to identify older adults at risk of falling and treatment and intervention programmes that promote safe walking.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87899</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10360098&amp;query_hl=37]]&gt;</url>
    <title>Mobility screening in the elderly and resulting referral</title>
    <publicationDate>1999-05-11T00:00:00</publicationDate>
    <publisher>Irish Medical Journal</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PRIMARY CARE,SURVEILLANCE,SCREENING: FOR REVIEW,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aims of this study were to test the usefulness of the Royal College of General Practitioners' (RCGP) mobility screening questionnaire in Irish general practice and to use it to assess the level of mobility problems in the over-75 year old population. Questionnaire screening survey in six faculty areas of the Irish College of General Practitioners(ICGP) well-spread geographically to be representative of the Irish population. Participants were a random sample of 627 people aged 75 years or over, from the General Medical Services list of 92 volunteer general practitioners. The Royal College of General Practitioners' screening questionnaire for mobility was administered by each person's doctor. Suggested interventions were also noted. 92% felt able to get around the house independently, with 78% able to manage stairs independently. The commonest aid to mobility was a stick, used by 27%. Mental impairment was closely associated with inability to get around the house (86% of those not independent around the house scored less than 8 on the Abbreviated Mental Test Score). Analysis of referral patterns indicated possible deficiencies in the availability of physiotherapy in certain areas. The RCGP mobility screening questionnaire was easy to use, and helpful in detecting problems which might require attention.]]&gt;</body>
  </document>
  <document>
    <id>282745</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sparc.ac.uk/media/downloads/executivesummaries/exec_summary_vasilakis.pdf]]&gt;</url>
    <title>Modelling Health Systems: Delivering care to older patients with hip fracture</title>
    <publicationDate>2008-04-07T00:00:00</publicationDate>
    <publisher>SPARC</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,ASSESSING RISK,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>SPARC executive summary by Christos Vasilakis, Dorota Lecznarowicz and Chooi Lee.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Fractured neck of femur, or hip fracture, is associated with osteoporosis and thus the incident rate is significantly higher in older people. In the UK, the care for older patients with hip fracture has been identified as an area with the highest potential for improving the quality and value of clinical care through changes in the organisation of care delivery. One of the challenges is the ability to identify the organisational changes that will lead to the desired improvements. &lt;/P&gt;
&lt;P&gt;Computer simulation is a common scientific approach to evaluating the likely response of a health system to a range of suggested changes. Under this approach, the progress of patients through the care delivery processes is imitated by a computer model. Thus, the description of the relevant care delivery processes needs to be available before the computer model can be developed. &lt;/P&gt;
&lt;P&gt;This study utilises recent developments in information technology to describe the diagnostic, treatment and administrative processes involved in the care for older patients presenting with symptoms of hip fracture to an NHS Acute Hospital. &lt;/P&gt;
&lt;P&gt;The knowledge gained from this study, in addition to informing future simulation studies, will help guide best practice in preparing an effective integrated care pathway and potentially lead to improvements in patient outcomes and satisfaction, such as the potential for survival, recovery, and independence after the fracture.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319610</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/publications/monitoring-poverty-wales-2009]]&gt;</url>
    <title>Monitoring poverty and social exclusion in Wales 2009</title>
    <publicationDate>2009-06-03T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;This study reviews ten-year trends in Welsh low-income statistics.&lt;/STRONG&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;The New Policy Institute has produced its 2009 edition of indicators of poverty and social exclusion in Wales, providing a comprehensive analysis of trends. &lt;/P&gt;
&lt;P&gt;This is the second update of Monitoring poverty and social exclusion in Wales, following the original report in 2005, but is the first to be published in a recession. After reviewing ten-year trends in low income statistics, its focus shifts to unemployment and problem debt. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>281326</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://icn.csip.org.uk/_library/Resources/Housing/Support_materials/Reports/MCGVdocument.pdf]]&gt;</url>
    <title>More Choice, Greater Voice: a toolkit for producing a strategy for accommodation with care for older people</title>
    <publicationDate>2008-02-29T00:00:00</publicationDate>
    <publisher>Care Services Improvement Partnership</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,SECONDARY CARE,HEALTH &amp; WELLBEING,INNOVATION AND IMPROVEMENT,SYSTEMS THINKING,ORGANISATIONS,WHOLE SYSTEMS THINKING,SERVICE REDESIGN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document provides a toolkit for undertaking
work that will support a whole system approach
to planning and developing accommodation and
care. It is published by the Housing Learning
and Improvement Network at the Care Services
Improvement Partnership at the Department of
Health and the Department of Communities and
Local Government</description>
    <body>&lt;![CDATA[ &lt;P&gt;This document provides a toolkit for undertaking work that will support a whole system approach to planning and developing accommodation and&lt;BR&gt;care. It is published by the Housing Learning and Improvement Network at the Care Services Improvement Partnership at the Department of Health and the Department of Communities and Local Government.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;It is good practice rather than mandatory and has been prepared specifically to accompany the government’s new National Housing Strategy&lt;BR&gt;for an Ageing Society, to offer guidance for commissioners and providers to enable them to produce accommodation and care strategies for older people.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;It will be helpful to a range of people working at local and regional level. Those working to develop strategies that co-ordinate the planning of health, housing and social care bodies will find assistance here in developing an approach and structuring material. Those within local authority housing or adult social care departments whose requirements may be more focused on particular services will find materials here that will help them set those specific concerns into a wider context. Development staff within provider organisations, such as Registered Social Landlords and those in the private sector, will find here materials that they&lt;BR&gt;can use to understand and respond to the concerns of their statutory partners. It will inform a range of local documents such as the local development framework and joint strategic needs assessments.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Contents&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;Executive summary 2 
&lt;LI&gt;The structure of the study 4 
&lt;LI&gt;Commissioning the study 5 
&lt;LI&gt;Structures for support &amp;amp; liaison 6 
&lt;LI&gt;Consultation &amp;amp; Participation 8 
&lt;LI&gt;A vision to inform a strategic direction 12 
&lt;LI&gt;Recognising key influencing factors 13 
&lt;LI&gt;Determining an approach 15 
&lt;LI&gt;Establishing population size &amp;amp; trends 16 
&lt;LI&gt;Data reflecting housing circumstances 23 
&lt;LI&gt;Indicators of potential need 25 
&lt;LI&gt;Mapping local provision 32 
&lt;LI&gt;The context in National Policy 38 
&lt;LI&gt;Understanding the local policy context 40 
&lt;LI&gt;Outlining a new pattern of provision 43 
&lt;LI&gt;Possible drafting recommendations &amp;amp; an action plan 46 
&lt;LI&gt;Other useful information 50&lt;/LI&gt;&lt;/OL&gt;]]&gt;</body>
  </document>
  <document>
    <id>267501</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk/musculoskeletal/Page.aspx?prv=y&amp;pagename=RA]]&gt;</url>
    <title>Musculoskeletal Specialist Library: National Knowledge Week - Rheumatoid Arthritis</title>
    <publicationDate>2007-08-14T00:00:00</publicationDate>
    <publisher>Musculoskeletal Specialist Library</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Our approach to RA has changed in recent years and with more therapeutic options and intensive treatment long-term remission is becoming a realistic aim in many people with the disease. Scientific advances promise an exciting future. The Rheumatoid Arthritis (RA) National Knowledge Week provides an opportunity to present up-to-date information that has been subject to rigorous selection criteria. Coverage has been developed on the basis of topics suggested by a panel of experts in the field. Information is organised by topic areas and links are provided within each section to relevant NICE guidance, systematic reviews, clinical trials and patient information.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Our approach to RA has changed in recent years and with more therapeutic options and intensive treatment long-term remission is becoming a realistic aim in many people with the disease. Scientific advances promise an exciting future. The Rheumatoid Arthritis (RA) National Knowledge Week provides an opportunity to present up-to-date information that has been subject to rigorous selection criteria. Coverage has been developed on the basis of topics suggested by a panel of experts in the field. Information is organised by topic areas and links are provided within each section to relevant NICE guidance, systematic reviews, clinical trials and patient information.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Contents&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Basic science&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Which are the best prognostic factors in early rheumatoid arthritis?&lt;/LI&gt;
&lt;LI&gt;What we have learnt from molecular biology about rheumatoid arthritis?&lt;/LI&gt;
&lt;LI&gt;What do we know about genetics and rheumatoid arthritis in terms of susceptibility to and severity of disease and response to treatment?&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;Clinical aspects&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Why is cardiovascular disease so common in RA and what can we do about it?&lt;/LI&gt;
&lt;LI&gt;What is the relationship between malignancy and rheumatoid arthritis?&lt;/LI&gt;
&lt;LI&gt;What is the relationship between infection and rheumatoid arthritis (RA)?&lt;/LI&gt;
&lt;LI&gt;How big a problem is osteoporosis in rheumatoid arthritis and what can we do about it?&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Drug treatment&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;How early should treatment be started in RA?&lt;/LI&gt;
&lt;LI&gt;Is glucocorticoid therapy still relevant in rheumatoid arthritis?&lt;/LI&gt;
&lt;LI&gt;Is there still more to learn about using methotrexate and other DMARDs?&lt;/LI&gt;
&lt;LI&gt;What lies beyond anti-TNF alpha treatment?&lt;/LI&gt;
&lt;LI&gt;How should we be using TNF alpha inhibitors in 2007?&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Other treatment modalities&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Is the rheumatoid foot still a Cinderella topic?&lt;/LI&gt;
&lt;LI&gt;Does physiotherapy still have a role in RA?&lt;/LI&gt;
&lt;LI&gt;Is advice on joint protection and education worthwhile?&lt;/LI&gt;
&lt;LI&gt;Are complementary and alternative treatments useful in RA?&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Has surgery for RA moved on?&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Has hip surgery for rheumatoid arthritis moved on?&lt;/LI&gt;
&lt;LI&gt;Has surgery for the rheumatoid knee moved on?&lt;/LI&gt;
&lt;LI&gt;Has surgery for RA of the ankle and foot moved on?&lt;/LI&gt;
&lt;LI&gt;The role of surgery in rheumatoid disease of the shoulder&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Annual Evidence Update&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Rheumatoid Arthritis - Annual Evidence Update for year ending 31 March 2007&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>381378</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://alzheimers.org.uk/site/scripts/documents_info.php?categoryID=200149&amp;documentID=1339&amp;pageNumber=1]]&gt;</url>
    <title>My name is not dementia</title>
    <publicationDate>2010-07-01T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,TREATMENT AND CARE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Following on from the Dementia - out of the shadows&amp;nbsp; report, in which people with dementia spoke out about stigma and the impact that the diagnosis had on their lives, the Alzheimer's Society has undertaken a new project focusing on quality of life in dementia. The new report My name is not dementia presents the findings of the first stage of this project.&amp;nbsp;]]&gt;</body>
  </document>
  <document>
    <id>273409</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/Falls/Pages/Audit.aspx]]&gt;</url>
    <title>National Clinical Audit of Falls and Bone Health in Older People</title>
    <publicationDate>2007-11-08T00:00:00</publicationDate>
    <publisher>Royal College of Physicians</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ORGANISATIONAL AND OTHER ISSUES,CLINICAL LIBRARY,EMERGENCY CARE,PREVENTION,ASSESSING RISK,FALLS,LATER LIFE,ACCIDENT PREVENTION,ACCIDENT PREVENTION,TRAUMA (NATURE OF INJURY),FRACTURE,TRAUMA (BODY LOCATION),ETHICS AND STANDARDS,REHABILITATION,AUDIT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The Clinical Effectiveness and Evaluation unit (CEEu) of the Royal College of Physicians was commissioned by the Healthcare Commission to perform a National Falls and Bone Health in Older People three year programme of work.</description>
    <body>&lt;![CDATA[ &lt;P&gt;The national importance of Falls and Bone Health is reflected in the National Service Framework (NSF) for Older People and the recent NICE Guidelines on Falls and on Osteoporosis. The NSF details a model service and requires all local health and social services systems to have integrated falls services by April 2005.&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;National Clinical Audit of Falls and Bone Health in Older People Report&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The National Clinical Audit of Falls and Bone Health in Older People Report is now available. This is the first national audit that examines the clinical services provided to older people who have fallen and sustained a fragility fracture.&lt;/P&gt;
&lt;P&gt;The report provides a comprehensive picture of services across England, Northern Ireland and Wales.&amp;nbsp; Results show deficiencies are widespread and more needs to be done and can be done to prevent unnecessary injury and disability.&lt;/P&gt;&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;]]&gt;</body>
  </document>
  <document>
    <id>281705</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=281705]]&gt;</url>
    <title>National Dementia Strategy website</title>
    <publicationDate>2008-03-10T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ STROKE,MENTAL HEALTH,ADULT CONDITIONS,DEMENTIA,LATER LIFE,DEFINITION AND TYPES,CAUSES AND PREVENTION,PATHOLOGY,TREATMENT AND CARE,DIAGNOSIS,DEMENTIA,REHABILITATION,MANAGEMENT ISSUES,GENERAL/OTHER,OCT-DEC 08,NATIONAL STROKE STRATEGY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>New Department of Health National Dementia Strategy website.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Dementia Strategy website&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;National Dementia Strategy&lt;/H2&gt;
&lt;P&gt;The objectives of the project are to develop a national dementia strategy and implementation plan for publication in October 2008. The strategy will address three key themes – raising awareness, early diagnosis and intervention and improving the quality of care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Improving services and support for people with dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Recent reports have emphasised the need to enhance joint health and social care mental health teams in the community so people with dementia and their families and carers get the help and support they need.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/NationalDementiaStrategy/DH_083349" target="_blank"&gt;Link to Improving services and support for people with dementia document &lt;/A&gt;(Full-text PDF)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Dementia Strategy work programme and planned events&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Development of the National Dementia Strategy is expected to take twelve months. It will be fully supported in its work by the Care Services Improvement Partnership (CSIP), and the detailed work programme will be determined by an external stakeholder group.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/NationalDementiaStrategy/DH_083352" target="_blank"&gt;Dementia strategy work programme and planned events&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Resources /tools&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A number of products are planned to underpin the wider National Dementia Strategy work programme:&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Strengthening the involvement of people with dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This CSIP toolkit provides good practice guidance for practitioners and commissioners on how to engage and communicate with people who have dementia.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/everybodys-business/download-documents.html" target="_blank"&gt;Download from the CSIP website&lt;/A&gt; (opens new window)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;CSIP short breaks fact sheet&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This fact sheet provides commissioners, providers and planners with information on a variety of models of short breaks including principles that will enable the outcomes specified by service users and their carers to be met and alternatives to the traditional approach to providing short breaks in a care home.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/silo/files/short-breaks-pdf.pdf" target="_blank"&gt;Download from the CSIP website&lt;/A&gt; (opens new window)&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>282975</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://cymru.gov.uk/topics/health/research/research/gain/socialdeterminants/older-people/;jsessionid=3tpHLRndPwk2T7YzzpvWw1Lm4Lfv09fXTDsG0ptHzDx2FTwjxGRB!2138048893?lang=en&amp;ts=3]]&gt;</url>
    <title>National Health Targets for Older People</title>
    <publicationDate>2008-04-11T00:00:00</publicationDate>
    <publisher>Welsh Assembly Government</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A systematic review published by the Welsh Assembly Government.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Social Determinants for Older People's Health&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Welsh Assembly Government has identified Health Gain Targets in five priority areas. These are: coronary heart disease; cancer; mental health; the health of older people; and the health of children (Welsh Assembly Government, 2006a). In order to identify indicators associated with the five areas, a series of reviews were commissioned. The aim of this project was to carry out a systematic review of the social determinants of older people’s health and to develop social indicators from these determinants that could be monitored in the Welsh population. A secondary aim was to carry out a systematic review of the effectiveness of interventions designed to tackle these determinants.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>268970</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/National%20Heart%20Failure%20Audit%20April%202007.pdf]]&gt;</url>
    <title>National Heart Failure Audit: Initial report for the audit period ending April 2007</title>
    <publicationDate>2007-04-02T00:00:00</publicationDate>
    <publisher>NHS The Information Centre</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,HEART DISEASE,HEART FAILURE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Aimed at healthcare professionals, managers and clinical governance leads, the report describes how the audit has been modified to support a national roll-out. The report also describes how participation will help providers and NHS commissioners measure standards of care against evidence-based best practice and national standards, identify gaps in care and improve services.</description>
    <body>&lt;![CDATA[ &lt;P&gt;The first report for the National Heart Failure Audit presents key findings and recommendations from a pilot phase undertaken between October 2006 and March 2007.&lt;/P&gt;
&lt;P&gt;Aimed at healthcare professionals, managers and clinical governance leads, the report describes how the audit has been modified to support a national roll-out. The report also describes how participation will help providers and NHS commissioners measure standards of care against evidence-based best practice and national standards, identify gaps in care and improve services.&lt;/P&gt;
&lt;P&gt;The national heart failure audit rolled out nationally at the end of July 2007. Information about the audit was sent to named cardiology leads in all hospitals in England and Wales, chief executives, members of the British Society for Heart Failure and to cardiac networks in England and Wales.&lt;/P&gt;
&lt;P&gt;The National Heart Failure Audit is run jointly by The Information Centre and the British Society for Heart Failure, and funded by the Healthcare Commission.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>260751</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.scie-socialcareonline.org.uk/profile.asp?guid=74ee88ce-b757-47a1-b6cf-2f1060e51e0b]]&gt;</url>
    <title>National Older People's Mental Health Programme - Age Equality: What does it mean for older people's mental health services?</title>
    <publicationDate></publicationDate>
    <publisher>Care Services Improvement Partnership</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,MENTAL HEALTH,HOW DO I INVOLVE...?,OLDER PEOPLE,PEOPLE WITH MENTAL HEALTH ISSUES,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Guidance Note - Everybody's Business. Integrated mental health services for older adults: a service development guide.</description>
    <body>&lt;![CDATA[ &lt;P&gt;A 4-page report on older people's mental health services:&lt;/P&gt;
&lt;P&gt;Providing age inclusive services is an issue currently hotly debated across the country. In some cases it is even slowing progress in the implementation of &lt;EM&gt;Everybody's Business&lt;/EM&gt;. This short paper attempts to clarify what is meant by service provision based on need not age. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>36411</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nsc.nhs.uk/]]&gt;</url>
    <title>National screening committee (NSC)</title>
    <publicationDate></publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>260770</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rcplondon.ac.uk/pubs/books/strokeaudit/strokeaudit2006.pdf]]&gt;</url>
    <title>National Sentinel Stroke Audit Phase I (organisational audit) 2006/ Phase II (clinical audit) 2006</title>
    <publicationDate>2007-04-02T00:00:00</publicationDate>
    <publisher>Royal College of Physicians</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SERVICE ORGANISATION,STROKE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The results of this stroke audit show that inpatient specialist care has made significant progress, with both an increase in the proportion of hospitals with a stroke unit (79% in 2004 to 91% in 2006) and an increase in the size of the units in England. However, there are still unacceptable waits for brain scans and starting treatment, and problems remain with stroke patients getting timely access to therapists and social workers.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>33826</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4003066&amp;chk=wg3bg0]]&gt;</url>
    <title>National service framework for older people</title>
    <publicationDate>2001-05-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,DEMENTIA,FALLS,SCREENING AND SURVEILLANCE,STROKE,SERVICE ORGANISATION,ACUTE MANAGEMENT,REHABILITATION,TREATMENT AND CARE,SCREENING,SURVEILLANCE,PREVENTION,PARKINSON'S DISEASE,REHABILITATION,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &amp;nbsp;A National Service Framework for Older People has been established to look at the problems older people face in receiving care in order to deliver higher quality services. The key standards that underpin the Framework are outlined. These include plans to eradicate age discrimination and to support person-centred care with newly integrated services. A new layer of intermediate care is being developed at home or in care settings, while general hospital care should be delivered by the appropriate hospital staff. The NHS is also to take action on stroke prevention, in the promotion of health and active life and a reduction in the number of falls for older people. Integrated mental health services are to be provided for older people. The process of translating these nationally supported standards into local delivery is outlined.]]&gt;</body>
  </document>
  <document>
    <id>33757</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4002965]]&gt;</url>
    <title>National service framework for older people meeting the milestones (supporting documentation for NSF champions)</title>
    <publicationDate>2002-10-09T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,PREVENTION,SURVEILLANCE,FALLS,DEMENTIA,STROKE,SCREENING AND SURVEILLANCE,TREATMENT AND CARE,ACUTE MANAGEMENT,SERVICE ORGANISATION,REHABILITATION,SCREENING,PARKINSON'S DISEASE,REHABILITATION,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National service framework for older people meeting the milestones (supporting documentation for NSF champions)&lt;/pageTitle&gt;&lt;pageBody&gt;This document can be used by NSF Champions either as a stand-alone resource to help them translate the main issues of their work into action, and/or as a reference work that provides national background facts and figures.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>95071</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4008132&amp;chk=Q2YCDF]]&gt;</url>
    <title>National service framework for older people report of progress and future challenges</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE,STROKE,ISCHAEMIC STROKE,GENERAL / OVERVIEWS,DISEASE MANAGEMENT,PREVENTION,HAEMORRHAGIC STROKE,GENERAL / OVERVIEWS,DISEASE MANAGEMENT,PREVENTION,DISEASE MANAGEMENT,SECONDARY PREVENTION,PREVENTION,PRIMARY PREVENTION,GENERAL / OTHER,MANAGEMENT ISSUES,SERVICE MODELS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report highlights the progress made by the NHS and social care under the National Service Framework for older people since 2001. It also signals the challenges and activities for the years ahead.]]&gt;</body>
  </document>
  <document>
    <id>94694</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.healthcarecommission.org.uk/assetRoot/04/01/85/03/04018503.pdf]]&gt;</url>
    <title>National survey of stroke patients 2005</title>
    <publicationDate>2005-07-03T00:00:00</publicationDate>
    <publisher>Healthcare Commission</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,STROKE,LATER LIFE,STROKE,SERVICE ORGANISATION,REHABILITATION,ACUTE MANAGEMENT,NSF FOR OLDER PEOPLE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Summary&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The national survey of stroke patients provides an assessment of the experiences of people who have received care and treatment for stroke in England. The survey covers many aspects of the experiences of patients, from diagnosis to long term rehabilitation, with particular reference to the aims set out in standard five of the National Service Framework for Older People.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319592</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csp.org.uk/director/press/pressreleases.cfm?item_id=0CC7E620B64353B8D336CD21F30F191E]]&gt;</url>
    <title>Nearly two thirds of UK adults risk their health through insufficient exercise</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>Chartered Society of Physiotherapy</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P class=textSummary&gt;The CSP launches its Move for Health campaign with new figures suggesting the poor state of the UK's health and fitness&lt;/P&gt;&lt;!-- Amended by Rob on 05 10 05 --&gt;
&lt;P class=textSummary&gt;Almost two thirds of UK adults could be threatening their future health because of a lack of exercise, according to a &lt;A href="http://www.csp.org.uk/director/press/pressreleases.cfm?item_id=0CC7E620B64353B8D336CD21F30F191E#notes" target="_blank"&gt;new survey&lt;/A&gt;[1] by the Chartered Society of Physiotherapy (CSP). 63 per cent of those questioned said they were not getting enough exercise, and could therefore be putting themselves at greater risk of life threatening illnesses like cancer, heart disease and stroke.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321704</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/7/829]]&gt;</url>
    <title>Neurobiological changes in the hippocampus during normative aging</title>
    <publicationDate>2009-07-07T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=Verdana size=2&gt;The number of individuals older than 65 years is projected to&lt;SUP&gt; &lt;/SUP&gt;exceed 71.5 million in the year 2030, which is twice the number&lt;SUP&gt; &lt;/SUP&gt;alive during the year 2000. While this dramatic increase in&lt;SUP&gt; &lt;/SUP&gt;the number of individuals at risk for Alzheimer and vascular&lt;SUP&gt; &lt;/SUP&gt;disease will pose a significant challenge to the health care&lt;SUP&gt; &lt;/SUP&gt;industry, many older individuals will not actually die of these&lt;SUP&gt; &lt;/SUP&gt;age-related dementias. Instead, a significant proportion of&lt;SUP&gt; &lt;/SUP&gt;those older than 65 years will have to cope with alterations&lt;SUP&gt; &lt;/SUP&gt;in memory function that are associated with normative aging.&lt;SUP&gt; &lt;/SUP&gt;A clear understanding of the neurobiological mechanisms underlying&lt;SUP&gt; &lt;/SUP&gt;normal age-related changes will be essential in helping elderly&lt;SUP&gt; &lt;/SUP&gt;populations maintain cognitive performance with increasing age.&lt;SUP&gt; &lt;/SUP&gt;This review covers the major age-related alterations in the&lt;SUP&gt; &lt;/SUP&gt;hippocampus, a critical structure for learning and memory.&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>313335</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=313335]]&gt;</url>
    <title>New Alzheimer's drug tested</title>
    <publicationDate>2009-04-14T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Behind the Headlines - your guide to the science that makes the news.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;New Alzheimer's drug tested&lt;/pageTitle&gt;&lt;pageBody&gt;A recent drug study “offers hope for Alzheimer’s treatment” according to The Times. The newspaper reports that after three months’ treatment with a new drug called CPHPC, all of the SAP protein linked to Alzheimer’s had been cleared from the brains of patients with milder forms of the disease.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>279411</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://newdynamics.group.shef.ac.uk/]]&gt;</url>
    <title>New Dynamics of Ageing: a Cross-Council Research Programme</title>
    <publicationDate>2008-02-11T00:00:00</publicationDate>
    <publisher>NDA Programme</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The New Dynamics of Ageing programme is a five year multidisciplinary research initiative with the ultimate aim of improving quality of life of older people. The programme is a unique collaboration between five UK Research Councils - ESRC, EPSRC, BBSRC, MRC and AHRC - and is the largest and most ambitious research programme on ageing ever mounted in the UK...</description>
    <body>&lt;![CDATA[ &lt;H2&gt;About the Programme&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The New Dynamics of Ageing Programme is a seven year multidisciplinary research initiative with the ultimate aim of improving quality of life of older people. The programme is a unique collaboration between five UK Research Councils - ESRC, EPSRC, BBSRC, MRC and AHRC - and is the largest and most ambitious research programme on ageing ever mounted in the UK.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The programme aims to develop practical policy and implementation guidance and novel scientific, technological and design responses to help older people enjoy better quality lives as they age. This requires integrating understandings of the changing meanings, representations and experiences of ageing and the key factors shaping them (including behavioural, biological, clinical, cultural, historical, social, economic and technological), through direct engagement with older people and user organisations. The programme will harness inputs from a wide range of disciplines to reveal the dynamic interplay between ageing individuals and their changing technological, cultural, social and physical environments - local, national and global - and to develop methods and means for overcoming the consequent constraints on the quality of life of older people.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317311</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/new_funding_for_ucl.aspx]]&gt;</url>
    <title>New funding for research into genetic causes of Parkinson’s</title>
    <publicationDate>2009-05-11T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Parkinson's Disease Society (PDS) has announced funding of nearly £270,000 to Dr Gyorgy Szabadkai at University College London (UCL) for research into gene DJ-1, which is linked to Parkinson's disease.]]&gt;</body>
  </document>
  <document>
    <id>269958</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.who.int/mediacentre/news/releases/2007/pr53/en/index.html]]&gt;</url>
    <title>New guide on building age-friendly cities</title>
    <publicationDate>2007-10-01T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>WHO has released the first guide on age-friendly cities. The guide, which is based on consultations with older people in 33 cities in 22 countries, has identified the key physical, social and services attributes of age-friendly urban settings. Istanbul, London, Melbourne, Mexico City, Moscow, Nairobi, New Delhi, New York, Rio de Janeiro, Shanghai, and Tokyo were part of the consultation along with many other regional centres and towns.</description>
    <body>&lt;![CDATA[ &lt;P&gt;&amp;nbsp;The guide is aimed primarily at urban planners, but older citizens can use it to monitor progress towards more age-friendly cities. At its heart is a checklist of age-friendly features. For example, an age-friendly city has sufficient public benches that are well-situated, well-maintained and safe, as well as sufficient public toilets that are clean, secure, accessible by people with disabilities and well-indicated. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Other key features of an age-friendly city include:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;well-maintained and well-lit sidewalks; 
&lt;LI&gt;public buildings that are fully accessible to people with disabilities; 
&lt;LI&gt;city bus drivers who wait until older people are seated before starting off and priority seating on buses; 
&lt;LI&gt;enough reserved parking spots for people with disabilities; 
&lt;LI&gt;housing integrated in the community that accommodates changing needs and abilities as people grow older; 
&lt;LI&gt;friendly, personalized service and information instead of automated answering services; 
&lt;LI&gt;easy-to-read written information in plain language; 
&lt;LI&gt;public and commercial services and stores in neighbourhoods close to where people live, rather than concentrated outside the city; and 
&lt;LI&gt;a civic culture that respects and includes older persons.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The growing proportion of older people in our population is an established trend. Their share in the global population is predicted to double from 11% in 2006 to 22% in 2050. At the same time, our world is growing increasingly urban: as of 2007, more than half of the global population are urban dwellers and by 2030 about three out of every five people in the world are expected to live in cities.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313541</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/media/C39/99/200928Glaucoma.pdf]]&gt;</url>
    <title>New NICE guidelines to help save the sight of thousands of people with or at risk of glaucoma</title>
    <publicationDate>2009-04-21T00:00:00</publicationDate>
    <publisher>National Institute for Clinical Excellence (NICE)</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,EYESIGHT,GLAUCOMA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Thousands of people with or at risk of developing a potentially blinding form of glaucoma will benefit from a new guideline to be published this week. The National Institute for Health and Clinical Excellence (NICE) and the National Clinical Guideline Centre will issue a guideline to improve the diagnosis and management of chronic open angle glaucoma (COAG) and ocular hypertension (OHT). Available from 22 April, it will set out how best to diagnose COAG, how people with COAG, OHT or at risk of COAG should be monitored, and which treatments should be considered.]]&gt;</body>
  </document>
  <document>
    <id>313367</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/new_research_pink1_gene.aspx]]&gt;</url>
    <title>New PDS-funded research on role of PINK1 gene</title>
    <publicationDate>2009-03-18T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The PINK1 gene, one of five associated with inherited Parkinson's, was discovered by PDS-funded scientists in 2004. The new study, carried out at the Institute of Neurology, looked at mutations in the gene, how these mutations affect cells, and why dopamine-producing nerve cells may become vulnerable and more likely to die.]]&gt;</body>
  </document>
  <document>
    <id>317317</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/news_article.php?newsID=463]]&gt;</url>
    <title>New tool could help predict dementia in older people</title>
    <publicationDate>2009-05-14T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Scientists have developed a new ‘risk index’ that helps predict which individuals over the age of 65 may go on to develop dementia.]]&gt;</body>
  </document>
  <document>
    <id>95162</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/assetRoot/04/06/17/29/04061729.pdf]]&gt;</url>
    <title>New ways of working in stroke care</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ STROKE,DELIVERY OF CARE,NEUROLOGICAL CONDITIONS,LATER LIFE,ACUTE MANAGEMENT,SERVICE ORGANISATION,STROKE,REHABILITATION,SECONDARY PREVENTION,NSF FOR OLDER PEOPLE,STROKE,DISEASE MANAGEMENT,ISCHAEMIC STROKE,HAEMORRHAGIC STROKE,DISEASE MANAGEMENT,MANAGEMENT ISSUES,SERVICE MODELS,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Examples of new or extended roles for those involved with the care of stroke victims and their carers.]]&gt;</body>
  </document>
  <document>
    <id>333075</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=333075]]&gt;</url>
    <title>NHS Evidence - later life newsletter archive</title>
    <publicationDate>2009-12-15T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,DEMENTIA,FALLS,SCREENING AND SURVEILLANCE,STROKE,PARKINSON'S DISEASE,HEALTH &amp; WELLBEING,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;NHS Evidence - later life newsletter archive&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Below you will find previous issues of the monthly newsletter: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.createsend2.com/T/ViewEmail/y/2D939F8ABC387A95/1F709E10419B19E3C9C291422E3DE149" target="_blank"&gt;December 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail3.com/T/ViewEmail/y/8C7CA4883BC2C145/1F709E10419B19E3C9C291422E3DE149" target="_blank"&gt;November 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail1.com/T/ViewEmail/y/2A55FC3EE73221B4/1F709E10419B19E3C9C291422E3DE149" target="_blank"&gt;October 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-mentalhealth.cmail3.com/T/ViewEmail/y/A41D1756CA9F63AA/6211EDF9F1969DCA9A8E73400EDACAB4" target="_blank"&gt;Special Issue: Alzheimer's Disease &amp;amp; Dementia AEU 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail3.com/T/ViewEmail/y/226AA695EAEFB819/1F709E10419B19E3C9C291422E3DE149" target="_blank"&gt;September 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail3.com/T/ViewEmail/y/78EF3C410B4C27B1/26155299578FE0FEF039C523302FD418" target="_blank"&gt;August 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail3.com/T/ViewEmail/y/189E574C19489B7D/26155299578FE0FEF039C523302FD418" target="_blank"&gt;July 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail2.com/T/ViewEmail/y/F84579E43D2EC184/26155299578FE0FEF039C523302FD418" target="_blank"&gt;Special Issue: Calling all dementia specialists&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail4.com/T/ViewEmail/y/90B8623693F87F6F/26155299578FE0FEF039C523302FD418" target="_blank"&gt;May &amp;amp; June 2010&lt;/A&gt;&lt;A href="http://nhsevidence-laterlife.cmail4.com/T/ViewEmail/y/90B8623693F87F6F/26155299578FE0FEF039C523302FD418" target="_blank"&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://minervation.createsend.com/reports/viewCampaign.aspx?ID=6B0B29A84E5668A5" target="_blank"&gt;March 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://nhsevidence-laterlife.cmail1.com/T/ViewEmail/y/FE4A42BD4DE0C891" target="_blank"&gt;November 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>289687</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=289687]]&gt;</url>
    <title>NHS Evidence Later Life Specialist Collection: Content Development Strategy 2010</title>
    <publicationDate>2010-10-07T00:00:00</publicationDate>
    <publisher>NHS Evidence Later Life Specialist Collection</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;NHS Evidence Later Life Specialist Collection: Content Development Strategy 2010&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The&amp;nbsp;Later Life&amp;nbsp;Specialist&amp;nbsp;collection content development strategy contains the following information:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Scope of this strategy&lt;/LI&gt;
&lt;LI&gt;Purpose/ aims of the later life specialist collection&lt;/LI&gt;
&lt;LI&gt;Target audience&lt;/LI&gt;
&lt;LI&gt;Key stakeholders&lt;/LI&gt;
&lt;LI&gt;Taxonomy&lt;/LI&gt;
&lt;LI&gt;Types of information included in the collection&lt;/LI&gt;
&lt;LI&gt;Selection criteria and quality control&lt;/LI&gt;
&lt;LI&gt;Annual Evidence Updates&lt;/LI&gt;
&lt;LI&gt;Appendix 1: Sources of evidence&lt;/LI&gt;
&lt;LI&gt;Appendix 2: Annual Evidence Update Search Strategies&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93877</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/band38/b38-2.html]]&gt;</url>
    <title>NNTs for stroke prevention</title>
    <publicationDate>1997-07-06T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Bandolier has gathered together some information on NNTs for stroke prevention calculated from randomised trials of primary and secondary prevention.]]&gt;</body>
  </document>
  <document>
    <id>280046</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4008486]]&gt;</url>
    <title>No secrets: guidance on developing and implementing multi-agency policies and procedures to protect vulnerable adults from abuse</title>
    <publicationDate>2000-03-20T00:00:00</publicationDate>
    <publisher>Department of Health and Home Office</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document gives guidance to local agencies who have a responsibility to investigate and take action when a vulnerable adult is believed to be suffering abuse. It offers a structure and content for the development of local inter-agency policies, procedures and joint protocols which will draw on good practice nationally and locally.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This document gives guidance to local agencies who have a responsibility to investigate and take action when a vulnerable adult is believed to be suffering abuse. It offers a structure and content for the development of local inter-agency policies, procedures and joint protocols which will draw on good practice nationally and locally.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4008486?IdcService=GET_FILE&amp;amp;dID=28362&amp;amp;Rendition=Web" target="_blank"&gt;Download full document &lt;/A&gt;(NB LARGE FILE) (PDF, 1216K) 
&lt;LI&gt;&lt;A href="http://http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4008486?IdcService=GET_FILE&amp;amp;dID=1575&amp;amp;Rendition=Web" target="_blank"&gt;Download text-only version of guidance&lt;/A&gt; (PDF, 158K) 
&lt;LI&gt;&lt;A href="http://http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4005604" target="_blank"&gt;No secrets: the protection of vulnerable adults - Findings from an analysis of local codes of practice&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93888</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/cgi/reprint/131/5/352.pdf]]&gt;</url>
    <title>Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>Annals of Internal Medicine</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CAUSES AND PRIMARY PREVENTION,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This meta analysis has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/homstroke.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"Non-fasting total homocysteine is an independent risk factor for stroke in men and women aged 60 years or older. Levels above 14 µmol/L are associated with an 80% increased risk of total stroke".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317430</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70068-7/fulltext]]&gt;</url>
    <title>Non-motor symptoms of Parkinson’s disease:dopaminergic pathophysiology and treatment</title>
    <publicationDate>2009-05-31T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Several studies, including work from the Parkinson's disease (PD) non-motor group and others, have established that the non-motor symptoms of PD are common, occur across all stages of PD, are under-reported, and are a key determinant of quality of life. Research suggests that the non-motor symptoms of the disease are frequently unrecognised by clinicians and remain untreated. Even when identified, there is a common perception that many of these symptoms are untreatable. The role of dopaminergic drugs in treating the various non-motor problems of PD, although clinically recognised, has received little attention. In this Review, we investigate the dopaminergic basis of the range of non-motor symptoms that occur in PD such as depression, apathy, sleep disorders (including rapid-eye movement sleep behaviour disorder), and erectile dysfunction. We discuss the evidence that these symptoms are treatable, at least in part, with various dopaminergic strategies and, where relevant, we also refer to the use of deep-brain stimulation of appropriate targets in the brain. This Review provides a comprehensive overview of the management of this challenging aspect of PD.]]&gt;</body>
  </document>
  <document>
    <id>95057</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/OlderpeoplesNSFstandards/DH_4071271]]&gt;</url>
    <title>NSF for older people standard 1: rooting out age discrimination</title>
    <publicationDate>2008-02-15T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,WHAT IS AGEISM?,HOW DOES AGEISM OCCUR?,THE WHY,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aim of this standard is to ensure that older people are never unfairly discriminated against in accessing NHS or social care services as a result of their age.]]&gt;</body>
  </document>
  <document>
    <id>95060</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/OlderpeoplesNSFstandards/DH_4002286]]&gt;</url>
    <title>NSF for older people standard 2: person-centred care</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aim of this standard is to ensure that older people are treated as individuals and that they receive appropriate and timely packages of care which meet their needs as individuals, regardless of health and social services boundaries.]]&gt;</body>
  </document>
  <document>
    <id>95061</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeopleArticle/fs/en?CONTENT_ID=4002288&amp;chk=KTYh5B]]&gt;</url>
    <title>NSF for older people standard 3: intermediate care</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aim of this standard is to provide integrated services to promote faster recovery from illness, prevent unnecessary acute hospital admissions, support timely discharge and maximise independent living.]]&gt;</body>
  </document>
  <document>
    <id>95063</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeopleArticle/fs/en?CONTENT_ID=4002290&amp;chk=IWiGWo]]&gt;</url>
    <title>NSF for older people standard 4: general hospital care</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aim of this standard is to ensure that older people receive the specialist help they need in hospital and that they receive the maximum benefit from having been in hospital.]]&gt;</body>
  </document>
  <document>
    <id>95065</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeopleArticle/fs/en?CONTENT_ID=4002292&amp;chk=Z9zK4j]]&gt;</url>
    <title>NSF for older people standard 5: stroke</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,STROKE,SECONDARY PREVENTION,ACUTE MANAGEMENT,REHABILITATION,SERVICE ORGANISATION,CAUSES AND PRIMARY PREVENTION,STROKE,LATER LIFE,NSF FOR OLDER PEOPLE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aim of this standard is to reduce the incidence of stoke in the population and ensure that those who have had a stroke have prompt access to integrated stroke care services.]]&gt;</body>
  </document>
  <document>
    <id>95067</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/OlderPeoplesServices/OlderPeopleArticle/fs/en?CONTENT_ID=4002284&amp;chk=q4tpUL]]&gt;</url>
    <title>NSF for older people standard 7: mental health in older people</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NSF FOR OLDER PEOPLE,LATER LIFE,DEMENTIA,TREATMENT AND CARE,ADULTS,OLDER PEOPLE,NATIONAL SERVICE FRAMEWORKS,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,MANAGEMENT &amp; POLICY,FRAMEWORKS,GROUPS,POPULATIONS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The aim of this standard is to promote good mental health in older people and to treat and support those older people with dementia and depression.]]&gt;</body>
  </document>
  <document>
    <id>328779</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/9/1106]]&gt;</url>
    <title>Occupation and Risk of Parkinsonism</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>Archives of Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;We examined risk of parkinsonism in occupations (agriculture, education, health care, welding, and mining) and toxicant exposures (solvents and pesticides) putatively associated with parkinsonism.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&lt;BR&gt;To investigate occupations, specific job tasks, or exposures and risk of parkinsonism and clinical subtypes.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Case-control.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;Eight movement disorders centers in North America.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;Inclusion criteria were parkinsonism (=2 cardinal signs), diagnosis within 8 years of recruitment (to minimize survival bias), and ability to participate in detailed telephone interviews. Control subjects were primarily nonblood relatives or acquaintances of patients.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;/STRONG&gt;&lt;BR&gt;This multicenter case-control study compared lifelong occupational and job task histories to determine associations with parkinsonism and certain clinical subtypes (postural instability and gait difficulty and age at diagnosis =50 years).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;Findings in 519 cases and 511 controls were analyzed. Work in agriculture, education, health care, or welding was not associated with increased risk of parkinsonism. Unexpected increased risks associated with legal, construction and extraction, or religious occupations were not maintained after adjustment for duration. Risk of parkinsonism increased with pesticide use (odds ratio, 1.90; 95% confidence interval, 1.12-3.21), use of any of 8 pesticides mechanistically associated with experimental parkinsonism (2.20; 1.02-4.75), and use of 2,4-dichlorophenoxyacetic acid (2.59; 1.03-6.48). None of the specific occupations, job tasks, or task-related exposures were associated with younger age at diagnosis (=50 years). Ever working in business and finance, legal occupations, construction and extraction, or transportation and material moving was associated with postural instability and gait difficulty subtype of parkinsonism. Tobacco use was inversely associated with parkinsonism risk.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion:&lt;/STRONG&gt;&lt;BR&gt;The association of disease risk with pesticides support a toxicant-induced cause of parkinsonism.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317307</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=408]]&gt;</url>
    <title>Old age weight loss ‘signals dementia’</title>
    <publicationDate>2009-05-19T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ US scientists have shown that older people who are thinner or lose weight quickly are at a higher risk of developing dementia, especially if they started out overweight or obese.]]&gt;</body>
  </document>
  <document>
    <id>87924</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6567113&amp;query_hl=75]]&gt;</url>
    <title>Old people in the community. Three. Screening for health.</title>
    <publicationDate>1984-07-08T00:00:00</publicationDate>
    <publisher>Nurs Times</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,FOR REVIEW,SURVEILLANCE,PRIMARY CARE,ADULTS,OLDER PEOPLE,SCREENING,POPULATION BASED &amp; PREVENTATIVE SERVICES,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,SERVICES,MONTHLY ADDITIONS,2008-OCTOBER,AGE GROUPS,POPULATIONS,COMMUNITIES,GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87933</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9629824&amp;query_hl=90]]&gt;</url>
    <title>Older men's concerns about their urological health: a qualitative study</title>
    <publicationDate>1998-05-21T00:00:00</publicationDate>
    <publisher>Aust N Z J Public Health</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,FOR REVIEW]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ While there has been widespread recent interest in men's health issues, and prostate cancer in particular, there have been few studies to determine which issues are important from the viewpoint of men themselves. This study was undertaken to identify genitourinary issues of concern to older men. A series of 19 focus groups involved 137 men and 14 women from a broad demographic background. Men expressed consistent concern about urinary symptoms, prostate cancer and sexual function. They revealed misunderstanding and a desire for more information about all issues. Urinary symptoms had a high impact on quality of life that could be made worse by environmental constraints such as working conditions and availability of toilets. Prostate cancer was a concern in all groups, even those at low risk, and men believed that screening for prostate cancer should be offered. Men believed sexuality was not recognised as an issue of concern to older people. Potential barriers to health action included stoicism, not talking about health issues and poor relationships with doctors. The study suggests a substantial need for community and professional education and for health promotion focused on preventable morbidity.]]&gt;</body>
  </document>
  <document>
    <id>291239</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ippr.org.uk/members/download.asp?f=/ecomm/files/older_people_and_wellbeing.pdf&amp;a=skip]]&gt;</url>
    <title>Older People and Wellbeing</title>
    <publicationDate>2008-07-29T00:00:00</publicationDate>
    <publisher>Institute for Public Policy Research</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>ippr's report highlights that older people's mental health and wellbeing has been severely neglected while young people's health and wellbeing have been the focus of many new policies and debate.  2.4 million older people are estimated to have depression which impairs their quality of life.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Urgent action needs to be take action to curb a decline in mental health and wellbeing amongst the over 65s, according to a&amp;nbsp; report&amp;nbsp; from the institute for public policy report (ippr).&lt;/P&gt;
&lt;P&gt;ippr highlights that older people's mental health and wellbeing has been severely neglected while young people's health and wellbeing have been the focus of many new policies and debate.&amp;nbsp; 2.4 million older people are estimated to have depression which impairs their quality of life.&lt;/P&gt;
&lt;P&gt;ippr’s report found a strong association between levels of deprivation amongst older people and poor emotional wellbeing. Although pensioner poverty has reduced overall since 1997, in 2006 /7 (the latest figures) 2.5 million people over 65 were living in poverty, up 300,000 on the previous year.&lt;/P&gt;
&lt;P&gt;ippr's report Older People and Wellbeing&amp;nbsp; shows that another significant contributing factor to low well being in older people is the number of older people living alone. This has resulted from increases in divorce and separation, and the ageing of the population, with many women outliving their husbands. Of those living alone, 17 per cent rated themselves as ‘often/always lonely’ compared with two per cent living with others, and 80 per cent of the ‘often lonely’ lived alone. ippr argues that more needs to be done to ensure that those most at risk of depression are made the focus of community initiatives and policy priorities.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95102</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Olderpeoplesservices/index.htm]]&gt;</url>
    <title>Older people's services useful links</title>
    <publicationDate></publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A list of resources and external websites.]]&gt;</body>
  </document>
  <document>
    <id>260069</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=260069]]&gt;</url>
    <title>Older people's views and experiences of resources in later life</title>
    <publicationDate>2007-04-02T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,SECONDARY CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Older people's views and experiences of resources in later life&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;An edition of Findings: Informing Change (April 2007) from the Joseph Rowntree Foundation.&lt;/P&gt;
&lt;P&gt;Older people's views and experiences of resources in later life:&lt;/P&gt;
&lt;P&gt;With increasing numbers of older people living longer, the future of their financial and service provision is a key policy concern, while poverty among the present generation of older people remains an important issue. This qualitative study, by the Centre for Research in Social Policy at Loughborough University, explores how older people use and value available resources, and how they had planned for retirement and are planning for future older life.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>332518</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/sites/files/jrf/older-people-vision-for-care-full.pdf]]&gt;</url>
    <title>Older people's vision for long term care</title>
    <publicationDate>2009-11-18T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,NHS ACTIVITIES,SERVICE SECTORS,PATIENT AND PUBLIC INVOLVEMENT,LATER LIFE,HEALTH &amp; WELLBEING,COMMUNITY AND DOMICILIARY SERVICES,RESIDENTIAL CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Highlighting what older people in care homes want and need.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;How can we ensure a 'better life' for older people in residential and nursing care homes when their voices are rarely heard? &lt;/P&gt;
&lt;P&gt;This study examined the experiences and aspirations of these older people and highlights their ambition to increasingly influence decisions about care, support and wider issues such as: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Whether or not to move to a care home&lt;/LI&gt;
&lt;LI&gt;What helps to enhance their quality of life&lt;/LI&gt;
&lt;LI&gt;What is needed to promote their inclusion in care home, family and wider community life.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>87944</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14572434&amp;query_hl=100]]&gt;</url>
    <title>Opportunities for oral cancer screening among older African-American women</title>
    <publicationDate>2003-11-20T00:00:00</publicationDate>
    <publisher>Prev Med.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ CLIENT GROUPS,WOMEN,OLDER PEOPLE,SERVICE DELIVERY,ETHNICITY AND HEALTH,FOR REVIEW,SCREENING,CANCER,MOUTH,SCREENING AND SURVEILLANCE,LATER LIFE,CANCER,DISEASES AND CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ BACKGROUND: Older persons with smoking histories are important targets for oral cancer screening. Although older persons in low-income communities often lack regular dental care, little is known about the characteristics of groups at greatest risk for poor screening. METHODS: Survey data from 576 African-American women aged 45-93 were used to identify predictors of smoking and recency and type of dental care. RESULTS: Fifty-nine percent of respondents were current or former smokers, and 62% reported dental care within the past 3 years. Among smokers, no recent dental care was associated with older age, worse health, not working, no regular medical provider, and no recent mammography. CONCLUSIONS: These results suggest that episodic visits to non dentist providers offer opportunities for oral screening in high-risk populations.]]&gt;</body>
  </document>
  <document>
    <id>287549</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sparc.ac.uk/media/downloads/executivesummaries/exec_summary_pearson.pdf]]&gt;</url>
    <title>Optimisation of skeletal muscle responses and quality of life to exercise in people over 60 years old: healthy diet vs dietary supplementation</title>
    <publicationDate>2008-05-30T00:00:00</publicationDate>
    <publisher>SPARC</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>An executive summary of a SPARC project by Dr Gladys Pearson, Professor Claire Stewart &amp; Leigh Breen, Manchester Metropolitan University.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Older people have the greatest barriers (mostly in terms of ability/opportunity) to participating in exercise, and thus have the highest incidence of decreased ease in carrying out tasks of daily living. In an ageing society, the negative effects of age on skeletal muscle performance would be reduced if compliance to exercise regimens could be encouraged through simple advice on timing, duration, frequency, intensity, as well as appropriate nutritional interventions. Research into the impact of optimal nutrition/diet supplementation in young and/or athletic populations is extensive. Such data are scarce when considering healthy, older populations. We therefore propose to investigate the impact of healthy eating habits with or without supplementation, on exercise responsiveness. This protocol seeks to maximise training benefits on the neural muscular and tendinous complexes.&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Key findings&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Older people living in the community are able and willing to maintain an exercise and nutrition routine geared towards maintaining and improving physical health. 
&lt;LI&gt;Exercise and nutritional programmes have measurable impacts on the physical health of older people. 
&lt;LI&gt;Nutritional supplements are necessary for helping to reduce the extent of ageing related muscle wasting. 
&lt;LI&gt;Protein and carbohydrate supplements, taken in conjunction with low-intensity supervised exercise, significantly increase knee extension strength and size. 
&lt;LI&gt;This research suggests that exercise does not necessarily have to be very intensive to give significant benefits in individuals. Older people need to be careful when undertaking high-intensity (strenuous) exercise. 
&lt;LI&gt;The results suggest that low-intensity exercise combined with supplementation may be a sufficiently effective way of improving muscle performance, but further analysis and research is needed in this area.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>319612</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/publications/care-funding-options]]&gt;</url>
    <title>Options for care funding: what could be done now?</title>
    <publicationDate>2009-03-04T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Changes that can be made immediately to improve the UK's care funding system.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Many experts, the public and the Government agree that the UK needs a new care funding system: evidence shows that the present system is unfair, unclear and unsustainable. This summary updates a &lt;A href="http://www.jrf.org.uk/publications/how-can-funding-long-term-care-adapt-ageing-population" target="_blank"&gt;Solutions produced in 2007&lt;/A&gt;, and suggests four costed, fairer and more sustainable methods of funding including: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;equity release, allowing older homeowners to pay for home-based care by deferring the costs until their home is sold; 
&lt;LI&gt;higher capital limits for care home fees to help those with modest assets; 
&lt;LI&gt;doubling the personal expenses allowance for people living in care homes supported by local authorities; and 
&lt;LI&gt;restructuring help for people in nursing homes, breaking down the barrier between health and social care.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>328769</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/reprint/14/5/149]]&gt;</url>
    <title>Oral vitamin D prevents non-vertebral and hip fractures in a dose-dependent manner in patients &gt;=65 years of age</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Question:&lt;/STRONG&gt;&lt;BR&gt;In patients &amp;gt;=65 years of age, does oral vitamin D prevent non-vertebral and hip fractures?&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Review scope:&lt;/STRONG&gt;&lt;BR&gt;Included studies evaluated oral vitamin D supplementation and reported &amp;gt;=1 fracture in patients with mean age &amp;gt;=65 years; studies had to be double-blind and have &amp;gt;=1 year of follow-up. Exclusion criteria included uncontrolled, observational, or animal studies; and studies of patients with organ transplantation or stroke, and those taking steroids or treatment for Parkinson disease. Outcomes were first or repeated non-vertebral fracture or hip fracture.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Review methods:&lt;/STRONG&gt;&lt;BR&gt;Medline and Cochrane Controlled Trials Register (1960 to Aug 2008), EMBASE/Excerpta Medica (1991 to Aug 2008), reference lists, and abstracts from the American Society of Bone and Mineral Research (1995–2007) were searched, and experts were contacted for randomised controlled trials (RCTs). 12 high-quality RCTs (n = 42 279, mean age 78 y, 89% women) met the selection criteria.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319593</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk/musculoskeletal/viewResource.aspx?resid=316060&amp;code=eda768c13c5db6ab747fa1eafdbfe1c6]]&gt;</url>
    <title>Osteoporosis Annual Evidence Update 2009</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>Muscloskeletal Specialist Collection</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Osteoporosis annual evidence update 2009 is now live.]]&gt;</body>
  </document>
  <document>
    <id>239297</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.scie.org.uk/publications/knowledgereviews/kr13.pdf]]&gt;</url>
    <title>Outcomes-focused services for older people</title>
    <publicationDate></publicationDate>
    <publisher>Social Care Institute for Excellence</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This knowledge review includes a review of research evidence on the outcomes valued by older people and the factors that facilitate and inhibit achieving these outcomes. It also contains a postal survey of localities and social services managers in England and Wales known to be interested in developing outcomes-focused approaches to older people’s services; and in-depth studies in six localities.</description>
    <body>&lt;![CDATA[ This knowledge review includes a review of research evidence on the outcomes valued by older people and the factors that facilitate and inhibit achieving these outcomes. It also contains a postal survey of localities and social services managers in England and Wales known to be interested in developing outcomes-focused approaches to older people’s services; and in-depth studies in six localities. &lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>250985</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pickereurope.org/Filestore/Publications/paincarehomes_final.pdf]]&gt;</url>
    <title>Pain in Older People - The Carer's Perspective</title>
    <publicationDate>2007-03-01T00:00:00</publicationDate>
    <publisher>Patients Association</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The aim of the research was to improve our understanding of how chronic pain is perceived and responded to in care homes in England by exploring the views and experiences of residents from nursing homes in different parts of the country.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Chronic pain is one of the most common reasons people seek medical help and depending on the severity of their pain is thought to use health services up to five times more often than the rest of the population.&amp;nbsp; Many carers are looking after people with chronic pain and therefore researching how pain impacts on their patients' quality of life and how their patients' pain is managed provides an interesting perspective for those interested in improving the standards of care for older people in pain.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Study aims and methods&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;The aim of the research was to improve our understanding of how chronic pain is perceived and responded to in care homes in England by exploring the views and experiences of residents from nursing homes in different parts of the country. Research questions focused on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;residents’ assessment of their own pain 
&lt;LI&gt;how residents’ pain is usually managed or treated 
&lt;LI&gt;their own role in its management 
&lt;LI&gt;and whether they think anything can be done to improve its management.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Conclusions&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Chronic pain is widespread amongst the residents of care homes. This leads both staff and residents to accept pain as an inevitable consequence of growing old. 
&lt;LI&gt;The effects of chronic pain significantly reduce residents’ quality of life, limiting their mobility, restricting their social life, causing depression, irritability and tiredness. 
&lt;LI&gt;The management of pain in care homes is heavily dependent upon basic pain relief medication, dispensed on a routine rather than an individualised basis. 
&lt;LI&gt;Although seen as the most effective form of pain relief by many residents, medication is often viewed with suspicion and taken reluctantly. 
&lt;LI&gt;Residents rarely see their GPs and appear to take little part in any reviews of their medication. 
&lt;LI&gt;The high level of stoicism amongst residents means that they often suffer in silence, yet care home staff are failing to ask residents about their pain. 
&lt;LI&gt;There is a general failure to explore or offer alternative pain relief solutions and more could be done to support residents’ own efforts to relieve pain. 
&lt;LI&gt;Whilst specialist appliances and facilities can help to alleviate pain, the use of some equipment, particularly hoists, can exacerbate discomfort. 
&lt;LI&gt;Activities which can alleviate pain or offer comfort are often dependent on staff time.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>380395</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_117104]]&gt;</url>
    <title>Pandemic Influenza Preparedness Programme Team, social care flu resilience social care self-assessment tool</title>
    <publicationDate>2010-06-30T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;SPAN style="WIDOWS: 2; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: separate; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; ORPHANS: 2; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px" class=Apple-style-span&gt;&lt;SPAN style="FONT-FAMILY: Arial, Helvetica, sans-serif; COLOR: rgb(51,51,51); FONT-SIZE: 12px" class=Apple-style-span&gt;
&lt;P style="PADDING-BOTTOM: 0px; LINE-HEIGHT: 1.25em; MARGIN: 0px 0px 1em; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px" class=introText&gt;This report contains the results of the social care self assessment tool issued to local authorities (LAs) with social services responsibilities in England in October 2009. The results will help LAs in reviewing and improving their pandemic preparedness plans.&lt;/P&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>374909</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/04April/Pages/parkinsons-brain-probe-trialled.aspx]]&gt;</url>
    <title>Parkinson's eased by brain probe</title>
    <publicationDate>2010-04-29T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A brain “pacemaker” can fight Parkinson's disease, according to The Independent. The newspaper said that combining deep brain stimulation (DBS) implant surgery with standard drug treatment has been found to give greater improvement in motor function and to reduce symptoms more than drug treatment alone.&lt;/P&gt;
&lt;P&gt;The research behind this news was a trial involving 366 people with advanced Parkinson’s disease that was not being adequately controlled with medication. It found that after a year, those who had a DBS implant had greater improvements in quality of life than those receiving medical treatment alone. This was particularly due to improvements in mobility, bodily discomfort and the ability to carry out the activities of daily living. However, DBS surgery was not without risks, and about 19% of patients had serious adverse effects, mainly infections.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>380342</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/July07/Pages/parkinsons-transplanted-cell-failure.aspx]]&gt;</url>
    <title>Parkinson's transplant clues</title>
    <publicationDate>2010-07-01T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Foetal transplants for Parkinson's disease&amp;nbsp;patients have been “brought closer to reality” by new research, said &lt;EM&gt;The Independent&lt;/EM&gt; today.&lt;/P&gt;
&lt;P&gt;Trials of the experimental technique, which implants tissue from foetuses into the brain, had been stopped in the 1990’s after many patients experienced uncontrollable jerky movements known as dyskinesias. This new research was a follow-up study of two patients who had experienced the side effect after being treated with neural transplants some 15 years ago. Its findings suggest that dyskinesias may be due to imbalances in neurotransmitters following the transplants, and that these may be treatable with drugs.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>281353</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.prap.group.shef.ac.uk/PRAP_report_final_Dec07.pdf]]&gt;</url>
    <title>Partnerships and Regulation in Adult Protection</title>
    <publicationDate>2007-12-21T00:00:00</publicationDate>
    <publisher>University of Sheffield</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,WHAT IS AGEISM?,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This three year study is part of the Department of Health's funded research programme on the Modernisation of Adult Social Care. It is one of a series of projects.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;&lt;A href="http://www.prap.group.shef.ac.uk/index.htm" target="_blank"&gt;Link to Partnerships and Regulation in Adult Protection website&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Background&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;This study examined issues relating to partnership working arrangements in adult protection across England and Wales and explored perceptions of the impact of regulation (and regulatory practices) on adult protection. An important issue in adult protection is the way in which different regulatory authorities, professionals and providers of care and support engage with each other to ensure the protection of vulnerable adults. The study examined the extent and nature of inter-agency work in this field and explored perceptions of regulation and legislation pertinent to the area.&lt;BR&gt;This research provides a firm evidence base from which to develop policy and practice in adult protection.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Contents&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Acknowledgements Page 4 
&lt;LI&gt;Executive Summary Page 5 
&lt;LI&gt;Introduction Page 11 
&lt;LI&gt;Background to the Study Page 13 
&lt;LI&gt;Policy relevance Page 16 
&lt;LI&gt;Purpose of the Study Page 20 
&lt;LI&gt;Research Questions Page 23 
&lt;LI&gt;Methodology Page 24 
&lt;LI&gt;Chapter One: Partnership Working arrangements Page 33 
&lt;LI&gt;Chapter Two: Partnership Working – strengths, barriers and disadvantages Page 36 
&lt;LI&gt;Chapter Three: Regulation and Legislation in Adult Protection Page 50 
&lt;LI&gt;Chapter Four: The views of Adult Protection Committees Page 53 
&lt;LI&gt;Chapter Five: Adult Protection Co-ordinators: characteristics and perspectives Page 72 
&lt;LI&gt;Chapter Six: The views of Senior Managers Page 84 
&lt;LI&gt;Chapter Seven: Perspectives of Operational Staff Page 99 
&lt;LI&gt;Chapter Eight: Use of the Partnership Assessment Tool Page 127 
&lt;LI&gt;Chapter Nine: Research Conclusions from Phase Two Page 137 
&lt;LI&gt;Chapter Ten: Phase Three: Service users, family and employees of supportive organisations Page 140 
&lt;LI&gt;Chapter Eleven: Conclusions and Recommendations Page 157 
&lt;LI&gt;Chapter Twelve: Messages for Adult Protection Page 169 
&lt;LI&gt;Bibliography Page 174 
&lt;LI&gt;Appendix A: Case Study Sites Page 178 
&lt;LI&gt;Appendix B: Research Governance Approval List Page 179 
&lt;LI&gt;Appendix C: Sample details of Phase 3 Page 185 
&lt;LI&gt;Appendix D: Dissemination Activity and Outputs Page 186&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>296741</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/PartnershipsforOlderPeopleProjects/index.htm]]&gt;</url>
    <title>Partnerships for Older People Projects (POPPs)</title>
    <publicationDate>2008-10-28T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,DEMENTIA,FALLS,SCREENING AND SURVEILLANCE,STROKE,NSF FOR OLDER PEOPLE,HEALTH &amp; WELLBEING,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The Department of Health's Social Care, Local Government and Care Partnerships Directorate is leading the 'Partnerships for Older People Projects' (POPP) programme. The aim of this programme is to deliver and evaluate (through 29 Local Authority led pilots, locally innovative approaches, aimed at creating a sustainable shift in resources and culture away from institutional and hospital-based crisis care for older people towards earlier, targeted interventions within their own homes and communities.</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Partnerships for Older People Projects (POPPs)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Department of Health's Social Care, Local Government and Care Partnerships Directorate is leading the 'Partnerships for Older People Projects' (POPP) programme. The aim of this programme is to deliver and evaluate (through 29 Local Authority led pilots, locally innovative approaches, aimed at creating a sustainable shift in resources and culture away from institutional and hospital-based crisis care for older people towards earlier, targeted interventions within their own homes and communities.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Evaluation of the POPP programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;October 2008&lt;/P&gt;
&lt;P&gt;The Department of Health has funded a national evaluation of the POPP programme. The evaluation produced an interim report of progress providing early findings and key lessons learnt in October 2007. A further interim report of progress covering the period up to March 2008 is now available. The evaluation is ongoing and further final findings will be reported in Autumn 2009.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.dh.gov.uk/en/SocialCare/Deliveringadultsocialcare/Olderpeople/PartnershipsforOlderPeopleProjects/index.htm?IdcService=GET_FILE&amp;amp;dID=175348&amp;amp;Rendition=Web" target="_blank"&gt;Download National Evaluation of Partnerships for Older People Projects:Interim report of progress: October 2008 (PDF, 457K)&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>296034</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/Documents/Falls-PPI-report-Final-Version-08-09-01.pdf]]&gt;</url>
    <title>Patient and Public Involvement: Older People's Experiences of Falls and Bone Health Services (England)</title>
    <publicationDate>2008-10-01T00:00:00</publicationDate>
    <publisher>Royal College of Physicians</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,LATER LIFE,FALLS,HOW DO I INVOLVE...?,OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This report presents the findings of a study to investigate the experiences and thoughts of patients who have used falls services in NHS trusts around England. It is a joint patient involvement project with the Royal College of Physicians (RCP) and Help the Aged. It has been funded by the Healthcare Commission and Help the Aged as a patient and public involvement project. There is also an executive summary.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This report presents the findings of a study to investigate the experiences and thoughts of patients’ who have used falls services in NHS trusts around England. The participants were patients who were currently or had recently been attending a falls service. Most such patients have had a recent fall: others had been referred because they were considered to be at particular risk of falling. This study complements the findings from the recent set of national audits investigating the organisation of falls services (2005/6) and the clinical care received by a sample of patients who had fallen and sustained fractures (2006/7).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313499</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/discovery_award.aspx]]&gt;</url>
    <title>PDS announces £10 million funding for new discovery award</title>
    <publicationDate>2009-04-14T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Parkinson's Disease Society (PDS) has launched a major new breakthrough-orientated research initiative today. The Discovery Award is aimed at accelerating progress in finding a cure for Parkinson's.]]&gt;</body>
  </document>
  <document>
    <id>313497</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/40_years_research_achievements.aspx]]&gt;</url>
    <title>PDS celebrates 40 years of research achievements</title>
    <publicationDate>2009-04-20T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ As part of celebrations for &lt;A href="http://www.parkinsons.org.uk/support_us/parkinsons_awareness_week.aspx" target="_blank"&gt;Parkinson's Awareness Week 2009&lt;/A&gt; (20-26 April), the Parkinson's Disease Society has today&amp;nbsp;published a new brochure 'Four decades of discovery', which highlights major achievements in Parkinson's research over the last 40 years.]]&gt;</body>
  </document>
  <document>
    <id>374944</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/80?rss=1]]&gt;</url>
    <title>Physical Exercise, Aging, and Mild Cognitive Impairment: A Population-Based Study</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Physical exercise is associated with decreased risk of dementia and Alzheimer disease.]]&gt;</body>
  </document>
  <document>
    <id>277776</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.cpa.org.uk/cpa/policies_on_ageing.html]]&gt;</url>
    <title>Policies on Ageing</title>
    <publicationDate>2008-01-24T00:00:00</publicationDate>
    <publisher>Centre for Policy on Ageing</publisher>
    <publicationType>POLICY</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,DEMENTIA,FALLS,STROKE,SCREENING AND SURVEILLANCE,HEALTH &amp; WELLBEING,PARKINSON'S DISEASE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This Centre for Policy on Ageing (CPA) resource provides easy access to the policy documents, reports and briefings that are raising the profile of issues around the care of older people and the implications of an ageing population.</description>
    <body>&lt;![CDATA[ &lt;P&gt;The government has produced important policy initiatives on the future of health and social care and a strategy for ageing. This resource provides easy access to the policy documents, reports and briefings that are raising the profile of issues around the care of older people and the implications of an ageing population.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Transforming Social Care 
&lt;LI&gt;Care Calculator 
&lt;LI&gt;Putting people first: A shared vision and commitment to the transformation of adult social care 
&lt;LI&gt;Meeting the aspirations of the British people 
&lt;LI&gt;2007 Pre-Budget report and comprehensive spending review, October 2007 
&lt;LI&gt;Tackle poverty and promote greater independence and well-being in later life 
&lt;LI&gt;etc.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>332519</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/download_info.php?downloadID=356]]&gt;</url>
    <title>Poor dementia care in hospitals is costing lives and hundreds of millions</title>
    <publicationDate>2009-11-17T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;People with dementia - who occupy a quarter of all hospital beds - are staying far longer in hospital than people without the condition who go in for the same treatment.&lt;/P&gt;
&lt;P&gt;Poor hospital care also had a negative impact on the people's dementia and physical health. The majority of people with dementia leave hospital worse than when they arrive and a third enter a care home, unable to return home.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374895</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/content/short/303/19/1908?rss=1]]&gt;</url>
    <title>Predicting Dementia</title>
    <publicationDate>2010-05-19T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The study involved 2415 adults aged 75 years or older with no cognitive impairment at baseline who were asked if their memory was becoming worse and if this worried them (a possible indicator of severity). Participants were assessed 11/2 and 3 years later for mild cognitive impairment and dementia.]]&gt;</body>
  </document>
  <document>
    <id>374895</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/content/short/303/19/1908?rss=1]]&gt;</url>
    <title>Predicting Dementia</title>
    <publicationDate>2010-05-19T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The study involved 2415 adults aged 75 years or older with no cognitive impairment at baseline who were asked if their memory was becoming worse and if this worried them (a possible indicator of severity). Participants were assessed 11/2 and 3 years later for mild cognitive impairment and dementia.]]&gt;</body>
  </document>
  <document>
    <id>374916</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/content/short/303/19/1908?rss=1]]&gt;</url>
    <title>Predicting Dementia</title>
    <publicationDate>2010-05-18T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;An elderly person's subjective sense that his or her memory is worsening appears to predict progression to dementia, especially if this impairment is a source of worry, report German researchers (Jessen F et al. Arch Gen Psychiatry. 2010;67[4]:414-422).&lt;/P&gt;
&lt;P&gt;The study involved 2415 adults aged 75 years or older with no cognitive impairment at baseline who were asked if their memory was becoming worse and if this worried them (a possible indicator of severity). Participants were assessed 11/2 and 3 years later for mild cognitive impairment and dementia.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374916</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/content/short/303/19/1908?rss=1]]&gt;</url>
    <title>Predicting Dementia</title>
    <publicationDate>2010-05-18T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DIAGNOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;An elderly person's subjective sense that his or her memory is worsening appears to predict progression to dementia, especially if this impairment is a source of worry, report German researchers (Jessen F et al. Arch Gen Psychiatry. 2010;67[4]:414-422).&lt;/P&gt;
&lt;P&gt;The study involved 2415 adults aged 75 years or older with no cognitive impairment at baseline who were asked if their memory was becoming worse and if this worried them (a possible indicator of severity). Participants were assessed 11/2 and 3 years later for mild cognitive impairment and dementia.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93866</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/band91/b91-7.html]]&gt;</url>
    <title>Predicting early stroke survival</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,ACUTE MANAGEMENT,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This Bandolier article reviews the following studies:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;EA Baird et al. A three-item scale for the early prediction of stroke recovery. Lancet 2001 357: 2095-2099.&lt;/LI&gt;
&lt;LI&gt;Y Wang et al. A prognostic index for 30-day mortality after stroke. Journal of Clinical Epidemiology 2001 54: 766-773.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95189</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/assetRoot/04/06/62/64/04066264.pdf]]&gt;</url>
    <title>Preparing older people's strategies: linking housing to health, social care and other local strategies</title>
    <publicationDate>2002-07-07T00:00:00</publicationDate>
    <publisher>Social Services Inspectorate</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This document is designed to complement the 2002/03 guidance on producing effective housing strategies and plans produced by the Chartered Institute of Housing.]]&gt;</body>
  </document>
  <document>
    <id>319630</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(09)70139-5/fulltext]]&gt;</url>
    <title>Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Background&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;Alzheimer's disease (AD) pathology is common in patients with amnestic mild cognitive impairment (aMCI) without dementia, but the prevalence of AD pathology in patients with subjective cognitive impairment (SCI) and non-amnestic mild cognitive impairment (naMCI) is unknown. AD is characterised by decreased CSF concentrations of Aß&lt;SPAN class=ja50-ce-inf&gt;42&lt;/SPAN&gt; and increased concentrations of tau. We investigated the prevalence of a CSF AD profile in patients with SCI, naMCI, or aMCI and the association of this profile with cognitive outcome in each group.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Methods&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;Patients with SCI, naMCI, aMCI, and neurologically healthy controls were recruited from 20 memory clinics across Europe, between January, 2003, and June, 2005, into this prospective cohort study. A CSF AD profile was defined as an abnormal ratio of Aß&lt;SPAN class=ja50-ce-inf&gt;42&lt;/SPAN&gt;:tau. Patients were assessed annually up to 3 years. Outcome measures were changes in memory, overall cognition, mini-mental state examination (MMSE) score, daily function, and progression to AD-type dementia.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Findings&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;The CSF AD profile was more common in patients with SCI (31 of 60 [52%]), naMCI (25 of 37 [68%]), and aMCI (56 of 71 [79%]) than in healthy controls (28 of 89 [31%]). The profile was associated with cognitive decline in patients with naMCI (memory, MMSE, and daily function) and in patients with aMCI (MMSE and daily function). In patients with aMCI, a CSF AD profile was predictive of AD-type dementia (OR 26·8, 95% CI 1·6—456·4).&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Interpretation&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;AD is a common cause of SCI, naMCI, and aMCI and is associated with cognitive decline in patients with naMCI or aMCI. Patients with SCI might be in the early stages of AD, and cognitive decline might become apparent only after longer follow-up.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Funding&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;European Commission; Ana Aslan International Foundation.&lt;/DIV&gt;&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>330007</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474442209702364/abstract?rss=yes]]&gt;</url>
    <title>Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis</title>
    <publicationDate>2009-11-01T00:00:00</publicationDate>
    <publisher>The Lancet</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Background&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;Reliable data on the prevalence and predictors of post-stroke dementia are needed to inform patients and carers, plan services and clinical trials, ascertain the overall burden of stroke, and understand its causes. However, published data on the prevalence and risk factors for pre-stroke and post-stroke dementia are conflicting. We undertook this systematic review to assess the heterogeneity in the reported rates and to identify risk factors for pre-stroke and post-stroke dementia.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Methods&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;Studies published between 1950 and May 1, 2009, were identified from bibliographic databases, reference lists, and journal contents pages. Studies were included if they were on patients with symptomatic stroke, were published in English, reported on a series of consecutive eligible patients or volunteers in prospective cohort studies, included all stroke or all ischaemic stroke, measured dementia by standard criteria, and followed up patients for at least 3 months after stroke. Pooled rates of dementia were stratified by study setting, inclusion or exclusion of pre-stroke dementia, and by first, any, or recurrent stroke. Pooled odds ratios were calculated for factors associated with pre-stroke and post-stroke dementia.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Findings&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;We identified 22 hospital-based and eight population-based eligible cohorts (7511 patients) described in 73 papers. The pooled prevalence of pre-stroke dementia was higher (14·4%, 95% CI 12·0—16·8) in hospital-based studies than in population-based studies (9·1%, 6·9—11·3). Although post-stroke (=1 year) dementia rates were heterogeneous overall, 93% of the variance was explained by study methods and case mix; the rates ranged from 7·4% (4·8—10·0) in population-based studies of first-ever stroke in which pre-stroke dementia was excluded to 41·3% (29·6—53·1) in hospital-based studies of recurrent stroke in which pre-stroke dementia was included. The cumulative incidence of dementia after the first year was little greater (3·0%, 1·3—4·7) per year in hospital-based studies than expected on the basis of recurrent stroke alone. Medial temporal lobe atrophy, female sex, and a family history of dementia were strongly associated with pre-stroke dementia, whereas the characteristics and complications of the stroke and the presence of multiple lesions in time and place were more strongly associated with post-stroke dementia.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Interpretation&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;After study methods and case mix are taken into account, reported estimates of the prevalence of dementia are consistent: 10% of patients had dementia before first stroke, 10% developed new dementia soon after first stroke, and more than a third had dementia after recurrent stroke. The strong association of post-stroke dementia with multiple strokes and the prognostic value of other stroke characteristics highlight the central causal role of stroke itself as opposed to the underlying vascular risk factors and, thus, the likely effect of optimum acute stroke care and secondary prevention in reducing the burden of dementia.&lt;/DIV&gt;&lt;/DIV&gt;
&lt;DIV class=ja50-ce-abstract-section&gt;
&lt;H3 class=ja50-ce-section-title&gt;Funding&lt;/H3&gt;
&lt;DIV class=ja50-ce-simple-para&gt;None.&lt;/DIV&gt;&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>269070</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.who.int/cardiovascular_diseases/guidelines/PocketGL.ENGLISH.AFR-D-E.rev1.pdf]]&gt;</url>
    <title>Prevention of cardiovascular disease: Pocket guidelines for assessment and management of cardiovascular risk</title>
    <publicationDate>2007-01-01T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CARDIOVASCULAR RISK,HEART DISEASE,CORONARY HEART DISEASE,SCREENING,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people. They include; 1. People with risk factors who have not yet developed clinically manifest cardiovascular disease (primary prevention). 2. People with established CHD, CeVD or peripheral vascular disease (secondary prevention).</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Prevention of cardiovascular disease: Pocket guidelines for assessment and management of cardiovascular risk&lt;/H2&gt;
&lt;H2&gt;Overview&lt;/H2&gt;
&lt;P&gt;These pocket guidelines provide evidence-based guidance on how to reduce the incidence of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular disease (CeVD) and peripheral vascular disease in two categories of people. They include; 1. People with risk factors who have not yet developed clinically manifest cardiovascular disease (primary prevention). 2. People with established CHD, CeVD or peripheral vascular disease (secondary prevention).&lt;/P&gt;
&lt;P&gt;The accompanying World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts enable the estimation of total cardiovascular risk of people in the first category. The evidence-based recommendations given in Part 1 of these guidelines, provide guidance on which specific preventive actions to initiate, and with what degree of intensity. People in the second category have high cardiovascular risk and need intensive lifestyle interventions and appropriate drug therapy as elaborated in Part II of these guidelines. Risk stratification using risk charts is not required for making treatment decisions in them. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.who.int/cardiovascular_diseases/guidelines/Pocket_GL_information/en/index.html" target="_blank"&gt;Link to webpage&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.who.int/mediacentre/news/releases/2007/pr47/en/index.html" target="_blank"&gt;Link to news story&lt;/A&gt;&amp;nbsp;- 12 September 2007&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321284</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_103146]]&gt;</url>
    <title>Prevention package for older people</title>
    <publicationDate>2009-07-22T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING,COMMISSIONING,SERVICE SECTORS,ASSESSMENT AND PLANNING,DEMAND MANAGEMENT,POPULATIONS SERVED,OLDER PEOPLE,COMMISSIONING PROCESS,HEALTH PROMOTION AND DISEASE PREVENTION SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The prevention package raises the focus on prevention as a means of ensuring good health, well-being and independence in later life, by promoting and encouraging uptake of comprehensive health and social care services for older people. Announced in 2008, the health prevention package was launched on 22 July 2009.&lt;/P&gt;
&lt;P&gt;As health and well-being are major concerns for people in later years the health prevention package forms the Department of Health’s main contribution to the government’s ageing strategy Building a Society for All Ages which was launched on 13 July 2009 by Phil Hope, Minister of State for Care Services and Angela Eagle, Minister of State for Pensions and an Ageing Society.&lt;/P&gt;
&lt;P&gt;The prevention package:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;brings together information on existing health ‘entitlements’ including sight tests, flu vaccination and cancer screening; 
&lt;LI&gt;promotes best practice around falls prevention and effective fracture management; 
&lt;LI&gt;introduces measures to improve access to affordable footcare services; 
&lt;LI&gt;updates national intermediate care guidance; 
&lt;LI&gt;summarises existing progress on audiology and telecare.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>319627</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/content/extract/14/3/90]]&gt;</url>
    <title>Prognosis - review - long term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairement</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;H2&gt;QUESTION &lt;/H2&gt;
&lt;P&gt;In elderly people with mild cognitive impairment (MCI), what&lt;SUP&gt; &lt;/SUP&gt;is the long-term rate of conversion to dementia?&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;REVIEW SCOPE &lt;/H2&gt;
&lt;P&gt;Included studies examined the progression of MCI, defined according&lt;SUP&gt; &lt;/SUP&gt;to accepted criteria. &lt;I&gt;Outcomes&lt;/I&gt; were dementia or probable Alzheimer&lt;SUP&gt; &lt;/SUP&gt;disease.&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;REVIEW METHODS &lt;/H2&gt;
&lt;P&gt;Medline, EMBASE/Excerpta Medica, and PsycINFO (to Mar 2008)&lt;SUP&gt; &lt;/SUP&gt;were searched for cohort studies with 5 years of follow-up.&lt;SUP&gt; &lt;/SUP&gt;15 studies (n = 2404, mean age 62–82 y) met the selection&lt;SUP&gt; &lt;/SUP&gt;criteria. Mean follow-up was 6 years (range 5–10 y).&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;MAIN RESULTS &lt;/H2&gt;
&lt;P&gt;The cumulative conversion rate to dementia was 31% (15 studies)&lt;SUP&gt; &lt;/SUP&gt;and to Alzheimer disease was 33% (11 studies). The table shows&lt;SUP&gt; &lt;/SUP&gt;annual conversion rates. Annual conversion rates were lower&lt;SUP&gt; &lt;/SUP&gt;in studies with longer duration of follow-up.&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;CONCLUSION &lt;/H2&gt;
&lt;P&gt;In elderly people with mild cognitive impairment who were followed&lt;SUP&gt; &lt;/SUP&gt;for 10 years, the annual conversion rate to dementia was 3.3%.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>328785</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/reprint/66/9/1151]]&gt;</url>
    <title>Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>Archives of Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Background:&lt;/STRONG&gt;&lt;BR&gt;Mild cognitive impairment is increasingly recognized as an important public health problem associated with increased risk of developing dementia. Annual conversion rates, however, vary across different studies with clinic samples showing higher rates of conversion than community-based samples.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objectives:&lt;/STRONG&gt;&lt;BR&gt;To establish whether the rates of conversion from mild cognitive impairment to dementia differed according to recruitment source and, if so, to investigate factors that might explain this discrepancy.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Design:&lt;/STRONG&gt;&lt;BR&gt;Rates and predictors of conversion were examined in a prospective longitudinal study at a single center.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Setting:&lt;/STRONG&gt;&lt;BR&gt;Among the participants, 46% were recruited from a clinical setting and 54% were recruited directly through community outreach.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participants:&lt;/STRONG&gt;&lt;BR&gt;One hundred eleven individuals with mild cognitive impairment were followed up longitudinally for an average of 2.4 years (range, 0.5-4.0 years).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Main Outcome Measures:&lt;/STRONG&gt;&lt;BR&gt;Conversion from mild cognitive impairment to dementia.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results:&lt;/STRONG&gt;&lt;BR&gt;During the follow-up period, 28 individuals progressed to dementia with a mean (SD) time to conversion of 2.19 (0.72) years. The clinic sample had an annual conversion rate of 13%, whereas the community sample had an annual conversion rate of 3%. In a Cox proportional hazards model, clinic recruitment source alone was associated with an increased hazard of incident dementia (hazard ratio = 3.50; 95% confidence interval, 1.31-9.18; P = .01). When other variables were added to the model, only baseline functional impairment as measured by the Clinical Dementia Rating Scale (and no demographic, cognitive, or neuroimaging variables or mild cognitive impairment subtype) accounted for the differences in conversion rates across the 2 cohorts.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt;&lt;BR&gt;These findings add to the growing literature to suggest that the degree of functional impairment at baseline is an important predictor of conversion to dementia and may help explain differences in findings between epidemiological and clinic-based studies.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93885</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=10797031]]&gt;</url>
    <title>Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This cohort study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/AF/clineff.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"Stroke and haemorrage rates in patients on warfarin for primary prevention of stroke were similar in a clinical population to those found in randomised trials".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374934</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/2/195?rss=1]]&gt;</url>
    <title>Prospective Study of Endogenous Circulating Estradiol and Risk of Stroke in Older Women</title>
    <publicationDate>2010-02-08T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ To test the hypothesis that circulating endogenous estradiol is associated with stroke risk in older postmenopausal women. Stroke incidence increases after menopause, when endogenous estrogen levels fall, yet exogenous estrogen increases strokes in older postmenopausal women. The relation between endogenous estrogen and stroke is unclear.]]&gt;</body>
  </document>
  <document>
    <id>282688</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/2202.asp]]&gt;</url>
    <title>Providing nursing support within residential care homes</title>
    <publicationDate>2008-04-04T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This study examines a joint NHS-Local Authority initiative providing a dedicated nursing and physiotherapy team to three residential care homes in Bath and North East Somerset. The initiative aims to meet the nursing needs of residents where they live and to train care home staff in basic nursing.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This study examines a joint NHS-Local Authority initiative providing a dedicated nursing and physiotherapy team to three residential care homes in Bath and North East Somerset. The initiative aims to meet the nursing needs of residents where they live and to train care home staff in basic nursing.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Hospital admissions and nursing home transfers were prevented. Care home staff and managers preferred residents to be able to stay in their home when they were ill, as did residents themselves.&amp;nbsp; 
&lt;LI&gt;Enhancing health-orientated education and training of care home staff was challenging at first but relationships improved, and the confidence and professionalism of care staff grew. 
&lt;LI&gt;Residents’ nursing needs cannot simply be equated with their level of dependency. For example, a resident with dementia can be functionally independent yet have major, often un-communicated health needs. 
&lt;LI&gt;The early detection of illness and resulting opportunity for early intervention was a major part of the team’s work. Residents were likely to benefit from improved quality of life. 
&lt;LI&gt;Overall, estimates of costs and savings ranged from a 'worst case' scenario of £2.70 extra to a more likely scenario of £36.90 saved per resident per week. Savings were mainly in reduced use of NHS services, while the Primary Care Trust and Adult Social Services both funded the intervention, highlighting the need for partnership working to sustain funding. 
&lt;LI&gt;The researchers conclude that any increase in cost should be measured against the benefits of promoting long-term quality of life, quality of care and providing a firm foundation for future workforce development. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313496</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/response_to_brain_donor_appeal.aspx]]&gt;</url>
    <title>Public respond in their thousands to Parkinson's Brain Donor Appeal</title>
    <publicationDate>2009-04-27T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The launch of the &lt;A href="http://www.parkinsons.org.uk/about_us/news/news_items/general_news/parkinsons_brain_donor_appeal.aspx" target="_blank"&gt;Parkinson's Brain Donor Appeal&lt;/A&gt; during &lt;A href="http://www.parkinsons.org.uk/support_us/parkinsons_awareness_week.aspx" target="_blank"&gt;Parkinson's Awareness Week&lt;/A&gt; has resulted in a huge surge of interest from people wanting to leave their brains to Parkinson's research.&lt;BR&gt;The appeal gained extensive national, regional and international press coverage.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>278981</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers.org.uk/site/scripts/document_pdf.php?documentID=150]]&gt;</url>
    <title>Putting Care Right: Your guide to choosing a care home</title>
    <publicationDate>2008-02-06T00:00:00</publicationDate>
    <publisher>Alzheimer's Society</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ DEMENTIA,NEUROLOGICAL CONDITIONS,LATER LIFE,TREATMENT AND CARE,DEMENTIA,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Alzheimer's Society's Putting Care Right - your guide to choosing a care home features the essential issues to consider when deciding on a care home for a person with dementia. It lists questions families can put to care home staff and includes blank pages for notes on the places they visit.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Alzheimer's Society's Putting Care Right - your guide to choosing a care home&amp;nbsp; features the essential issues to consider when deciding on a care home for a person with dementia. It lists questions families can put to care home staff and includes blank pages for notes on the places they visit.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Actor Tony Robinson, an Alzheimer's Society ambassador says,&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; I had no idea how to begin my search for a care home after my mum developed Alzheimer's disease. Taking the decision to move into residential care will never be an easy one, but being armed with the right information can really help.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This guide raises the crucial questions everyone should ask about care homes. It will also help people to understand how to recognise quality care and help them to start demanding the high standards of care that people with dementia deserve.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The charity's survey found a third of people over 55 have experience of looking for care homes, but nationwide more than more than four out of ten people admit they would not know what to look for in a good care home. Skilled staff appear to be more important than a nicely decorated room when it comes to deciding on the quality of residential care. A choice of activities and access to outside space was also rated as important by more than 94 per cent of people.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Neil Hunt, chief executive of Alzheimer's Society says,&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; One in three people over 65 will end their life with a form of dementia and many will spend their final years in a care home. Our Putting Care Right campaign is about ensuring people with dementia get access to quality care. This means compulsory dementia training for all staff and tougher inspection and regulation systems. It also means challenging our views and raising expectations of care for people with dementia in care homes.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>276068</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081118]]&gt;</url>
    <title>Putting people first: a shared vision and commitment to the transformation of adult social care</title>
    <publicationDate>2007-12-10T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>POLICY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,SECONDARY CARE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document outlines the collaboration between central and local government, setting out the shared aims and values which will guide the transformation of adult social care.  The shared ambition is to put people first through a radical reform of public services, enabling people to live their own lives as they wish, confident that services are of high quality, are safe and promote their own individual needs for independence, well-being and dignity.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Across Government, the shared ambition is to put people first through a radical reform of public services, enabling people to live their own lives as they wish, confident that services are of high quality, are safe and promote their own individual needs for independence, well-being and dignity.&lt;/P&gt;
&lt;P&gt;This ministerial concordat establishes the collaboration between central and local government, the sector's professional leadership, providers and the regulator.&amp;nbsp; It sets out the shared aims and values which will guide the transformation of adult social care, and recognises that the sector will work across shared agendas with users and carers to transform people’s experience of local support and services.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93895</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=12829554]]&gt;</url>
    <title>Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ STROKE,NEUROLOGICAL CONDITIONS,LATER LIFE,CAUSES AND PRIMARY PREVENTION,STROKE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This meta analysis has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/cardiac/cholstroke.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"In randomised trials, cholesterol reduction reduces the risk of stroke". &lt;/P&gt;
&lt;P&gt;This study has also been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000290750" target="_blank"&gt;Centre for reviews and Dissemination (CRD&lt;/A&gt;):&lt;/P&gt;
&lt;P&gt;"&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;The authors have a stated conflict of interest in that they have filed a patent application on the formula of a combined pill to simultaneously reduce four cardiovascular risk factors".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>395034</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/SocialCare/Carers/index.htm]]&gt;</url>
    <title>Recognised, valued and supported: next steps for the Carers Strategy</title>
    <publicationDate>2010-11-25T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,SERVICE SECTORS,QUALITY AND MONITORING,LATER LIFE,HEALTH &amp; WELLBEING,QUALITY IMPROVEMENT,SOCIAL CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This sets out the Government's priorities for carers, identifies the actions that the Government will take over the next four years to ensure the best possible outcomes for carers and those they support, including:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Supporting those with caring responsibilities to identify themselves as carers at an early stage, recognising the value of their contribution and involving them from the outset both in designing local care provision and in planning individual care packages 
&lt;LI&gt;Enabling those with caring responsibilities to fulfil their educational and employment potential 
&lt;LI&gt;Personalised support both for carers and those they support, enabling them to have a family and community life 
&lt;LI&gt;Supporting carers to remain mentally and physically well.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>374925</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/4/428?rss=1]]&gt;</url>
    <title>Reduced Lean Mass in Early Alzheimer Disease and Its Association With Brain Atrophy</title>
    <publicationDate>2010-04-12T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objective&amp;nbsp; To examine body composition in individuals with early AD and without dementia and its relation to cognition and brain volume.]]&gt;</body>
  </document>
  <document>
    <id>95416</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/SC78.asp]]&gt;</url>
    <title>Regulating residential care for elderly people</title>
    <publicationDate>1996-07-07T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Over 300,000 people in England now live in the 12,000 residential care homes for elderly people registered and inspected by local authorities. How effective is this machinery for maintaining standards? What are the options for change? This study, by Patricia Day, Rudolf Klein and Sharon Redmayne of the Centre for the Analysis of Social Policy at the University of Bath, addresses these issues as a contribution to the debate prompted by the Department of Health's decision to review the whole system of regulation.]]&gt;</body>
  </document>
  <document>
    <id>94126</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://nzhta.chmeds.ac.nz/publications/stroke.pdf]]&gt;</url>
    <title>Rehabilitation of cerebrovascular disorder (stroke): early discharge and support. A critical appraisal of the literature</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>New Zealand Health Technology Assessment</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;systematic review&amp;nbsp;has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000136728" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Studies identified for critical appraisal had limitations that should be considered when interpreting the following conclusions: &lt;BR&gt;&lt;BR&gt;1. There is currently insufficient evidence to suggests that early discharge from hospital after a stroke confers any advantage in terms of effectiveness or cost effectiveness compared with conventional care. A well designed study based in New Zealand setting using appropriate methodology is required in order to provide further evidence for change in current management of stroke patients in New Zealand. &lt;BR&gt;&lt;BR&gt;2. A range of services should be maintained for the management of patients following a stroke. Home-based services do have a role to play in the rehabilitation of stroke patients. &lt;BR&gt;&lt;BR&gt;3. Current evidence supported the use of domiciliary occupational therapy in patients following a stroke. However, further research assessing domiciliary occupational therapy in a RCT with observer blinded to the patient's group would provide more robust data. &lt;BR&gt;&lt;BR&gt;4. There was some evidence suggesting community support programmes reduced caregiver anxiety but further research is required to examine this issue in depth".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319639</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.mwcscot.org.uk/web/FILES/Publications/CC__MWC_joint_report.pdf]]&gt;</url>
    <title>Remember - i'm still me - care commission and mental welfare commission joint report on the quality of care for people with dementia living in care homes in Scotland PDF</title>
    <publicationDate>2009-06-30T00:00:00</publicationDate>
    <publisher>Mental Welfare commission for scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=UniversLT-Light color=#58585a&gt;&lt;FONT face=UniversLT-Light color=#58585a&gt;
&lt;P align=left&gt;Older people living in care homes are some of the most vulnerable people in society. They depend on the staff that look after them to ensure that they receive the best possible care to meet their needs.&lt;/P&gt;
&lt;P align=left&gt;What is it like to have dementia and be living in a care home? Do people get the care and respect they need and deserve? Do care home staff know enough about the people in their care? We called this report “Remember, I’m Still Me” because we found that staff delivering care can sometimes “forget” the person inside the dementia. Staff need to know as much as possible about the lives, personalities, likes and dislikes of the people they care for in order to give them the best possible care, treatment and quality of life.&lt;/P&gt;&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>331072</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/@sta/@perf/documents/digitalasset/dh_108581.pdf]]&gt;</url>
    <title>Report from the Ministerial Summit on Dementia Research</title>
    <publicationDate>2009-11-05T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ One of the commitments made in the National Dementia Strategy was to hold a Ministerial Summit on Dementia Research. This took place on 21 July 2009. The independent report of the event is now available.]]&gt;</body>
  </document>
  <document>
    <id>329921</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_108302.pdf]]&gt;</url>
    <title>Report on the prescribing of anti-psychotic drugs to people with dementia</title>
    <publicationDate>2009-11-12T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,EMERGENCY CARE,CLINICAL LIBRARY,PRESCRIBING,PSYCHIATRY,VIOLENT PATIENTS,PANIC STRICKEN PATIENTS,NHS ACTIVITIES,PHARMACY,MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,TREATMENT AND CARE,DEMENTIA,PSYCHOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ In recognition of widespread concern about the over-prescription of anti-psychotic drugs, and as part of the priority being given to improving care for people with dementia, Professor Sube Banerjee was asked to undertake an independent clinical review of the use of anti-psychotic drugs.&amp;nbsp;&amp;nbsp;Professor Banerjee has completed his review and the Government has issued its response to his findings.]]&gt;</body>
  </document>
  <document>
    <id>95053</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4092840&amp;chk=EI/d1f]]&gt;</url>
    <title>Resource document from Professor Ian Philip, National Director for older people's health to secretary of state for health</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This document aims to provide a resource for NHS and Social Care staff involved in the implementation of the NSF. It should be read in conjunction with ‘&lt;A href="http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4092957&amp;amp;chk=5qTJwU" target="_blank"&gt;Better Health in Old Age – A progress Report’&lt;/A&gt;.]]&gt;</body>
  </document>
  <document>
    <id>319625</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/content/extract/14/3/80]]&gt;</url>
    <title>Review - enhanced oral hygiene prevents respiratory infection in elderly peoples in hopsitals and nursing homes</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;H2&gt;QUESTION &lt;/H2&gt;
&lt;P&gt;In elderly people in hospitals and nursing homes, does enhanced&lt;SUP&gt; &lt;/SUP&gt;oral hygiene prevent respiratory infection?&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;REVIEW SCOPE &lt;/H2&gt;
&lt;P&gt;Included studies evaluated the effect of enhanced oral hygiene&lt;SUP&gt; &lt;/SUP&gt;care or frequent professional oral care on respiratory infection&lt;SUP&gt; &lt;/SUP&gt;in elderly people in hospitals or nursing homes. &lt;I&gt;Outcomes&lt;/I&gt; were&lt;SUP&gt; &lt;/SUP&gt;respiratory infection, pneumonia, and death from pneumonia.&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;REVIEW METHODS &lt;/H2&gt;
&lt;P&gt;Medline, Cochrane Central Register of Controlled Trials, and&lt;SUP&gt; &lt;/SUP&gt;National Health Service Economic Evaluation Database (1996 to&lt;SUP&gt; &lt;/SUP&gt;Nov 2007); and reference lists were searched for randomised&lt;SUP&gt; &lt;/SUP&gt;controlled trials (RCTs) published in English, German, Dutch,&lt;SUP&gt; &lt;/SUP&gt;or a Nordic language between 1996 and 2007. Studies involving&lt;SUP&gt; &lt;/SUP&gt;patients with mechanical ventilation or tube-feeding were excluded.&lt;SUP&gt; &lt;/SUP&gt;3 RCTs (n = 807) met the selection criteria. 1 placebo-controlled&lt;SUP&gt; &lt;/SUP&gt;trial was double-blinded. An additional crossover trial (n =&lt;SUP&gt; &lt;/SUP&gt;46) of uncertain randomisation status did not provide useful&lt;SUP&gt; &lt;/SUP&gt;data.&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;!-- null --&gt;&lt;!-- null --&gt;&lt;BR clear=right&gt;&lt;/P&gt;
&lt;H2&gt;MAIN RESULTS &lt;/H2&gt;
&lt;P&gt;Meta-analysis was not done because of differences in interventions&lt;SUP&gt; &lt;/SUP&gt;and outcomes. The table shows the results of individual trials.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>332529</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/content/14/6/176.full.pdf]]&gt;</url>
    <title>Review: exercise interventions reduce falls in elderly people living in the community</title>
    <publicationDate>2009-11-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION,OUTCOMES,INDIVIDUAL BEHAVIOUR,ENVIRONMENTAL,CAUSES OF HARM,INJURIES,ADULTS,MONTHLY ADDITIONS,OLDER PEOPLE,POPULATION BASED &amp; PREVENTATIVE SERVICES,COMMUNITY DEVELOPMENT,HEALTH PROTECTION,DETERMINANTS,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,PHYSICAL ACTIVITY,SERVICES,GROUPS,AGE GROUPS,POPULATIONS,2009 DECEMBER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;DIV id=sec-1 class=section&gt;
&lt;H2&gt;Question&lt;/H2&gt;
&lt;P id=p-1&gt;What is the effectiveness of interventions for reducing falls in community-dwelling elderly people?&lt;/P&gt;&lt;/DIV&gt;
&lt;DIV id=sec-2 class=section&gt;
&lt;H2&gt;Review scope&lt;/H2&gt;
&lt;P id=p-2&gt;Included studies compared fall-prevention interventions with usual care, control interventions, or other fall-prevention interventions in elderly people; included mainly people who lived in the community; and reported rate of falls or number of people who fell. &lt;/P&gt;&lt;/DIV&gt;
&lt;DIV id=sec-3 class=section&gt;
&lt;H2&gt;Review methods&lt;/H2&gt;
&lt;P id=p-3&gt;CENTRAL (&lt;EM&gt;Cochrane Library&lt;/EM&gt;, Issue 2, 2008); Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, Medline, CINAHL, and EMBASE/Excerpta Medica (May 2008); PsycINFO and AMED (Sep 2007); trial registries; and reference lists were searched for randomised controlled trials (RCTs) and quasi-RCTs. &lt;/P&gt;&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>280044</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.bgs.org.uk/Publications/Compendium/compend_4-2.htm]]&gt;</url>
    <title>Revisions of the British Geriatrics Society compendium documents on intermediate care and patient letters</title>
    <publicationDate>2008-02-20T00:00:00</publicationDate>
    <publisher>British Geriatrics Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Intermediate care - guidance for commissioners and providers of health and social care and guidelines for geriatricians on copying letters to patients.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Intermediate care - &lt;A href="http://www.bgs.org.uk/Publications/Compendium/compend_4-2.htm" target="_blank"&gt;guidance&lt;/A&gt; for commissioners and providers of health and social care:&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The concept of intermediate care (I.C.) was first signalled in the National Beds Enquiry (1), became policy in the NHS Plan (2) and was implemented in England through the National Service Framework (NSF) for Older People (3). I.C. is conceived as a range of service models aimed at “care closer to home” and has involved the expansion and development of community health and social services. Some confusion has arisen because of varying definitions and terminology in respect of I.C. - both at local level and between UK counties. However, the two underpinning aims are, firstly, to provide a genuine alternative to hospital admission for some carefully selected patients and, secondly, to provide early supported discharges for others. Both aims require the provision of opportunities for further assessment and rehabilitation of older people. It is also expected that the increased availability of I.C. will prevent frail older people transferring to long-term care directly from an acute service.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.bgs.org.uk/Publications/Compendium/compend_2-6.htm" target="_blank"&gt;Guidelines&lt;/A&gt; for geriatricians on copying letters to patients:&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Under the NHS Plan, it was proposed that all clinicians, in Primary and Secondary Care, send copies of their clinical letters to the patients. This was subsequently downgraded to good practice advice, mainly because of the appreciation of the administrative cost of such a policy and competing priorities. Implementation of the practice has been very patchy. This article reviews the evidence around the risks and benefits of copying letters to patients, particularly with the older client group in mind, and presents the view of the British Geriatrics Society.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>277841</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rightcare.org.uk/]]&gt;</url>
    <title>Right care, Right deal</title>
    <publicationDate>2008-01-25T00:00:00</publicationDate>
    <publisher>Help The Aged, Counsel and Care, Carers UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,PRIMARY CARE,SECONDARY CARE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A national campaign to build public awareness and support for the need for brave and innovative solutions for the social care system for older and disabled people, their families and carers.</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;A national campaign to build public awareness and support for the need for brave and innovative solutions for the social care system for older and disabled people, their families and carers.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;The Government has indicated that social care is an urgent political priority. In advance of an expected green paper in 2008, this campaign combines three of the UK’s largest charities working with older people, their families and carers to urge the Government to renew its vision for the future of social care in England.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;What we want&lt;/H2&gt;
&lt;P&gt;Right care Right deal is a new coalition campaign to achieve the right solution for social care in England.&lt;/P&gt;
&lt;P&gt;We want a future where people can live their lives, their way; supported by a care system which is funded through a clear, simple and sustainable deal, entered into by the state, community, family and individuals.&lt;/P&gt;
&lt;P&gt;In short, we want a social care system that:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Enables people to assess their own needs and to choose the right support. 
&lt;LI&gt;Is better funded, sustainable and more efficient. 
&lt;LI&gt;Supports families and carers as an integral part of the system. 
&lt;LI&gt;Reaches more people, earlier. 
&lt;LI&gt;Offers individuals a fair, simple and consistent deal. 
&lt;LI&gt;Is easy to understand, access and use.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Publications and downloads&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.helptheaged.org.uk/NR/rdonlyres/D06BDB1F-1EF4-4DEB-AB26-BF579BEC7D4B/0/CarersUK_executive_summary.pdf" target="_blank"&gt;Carers UK: Time for a new social contract?&lt;/A&gt;&lt;BR&gt;(PDF, 324k) 
&lt;LI&gt;&lt;A href="http://www.helptheaged.org.uk/NR/rdonlyres/C015ED99-2E85-4613-96DC-7FBB59378E96/0/CC_executive_summary.pdf" target="_blank"&gt;Counsel and Care: A charter for change&lt;/A&gt;&lt;BR&gt;(PDF, 125k) 
&lt;LI&gt;&lt;A href="http://www.helptheaged.org.uk/NR/rdonlyres/AEAFF67D-6B5A-4D03-8667-53D6D2FBCD8C/0/HtA_executive_summary.pdf" target="_blank"&gt;Help the Aged: Vision for social care&lt;/A&gt;&lt;BR&gt;(PDF, 334k) 
&lt;LI&gt;&lt;A href="http://www.helptheaged.org.uk/NR/rdonlyres/A92932CF-10B8-49F3-8014-A79018F8E3E7/0/rcrd_release_250108.pdf" target="_blank"&gt;Campaign press release&lt;/A&gt;&lt;BR&gt;(PDF,59k)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93881</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15035663]]&gt;</url>
    <title>Rising statin use and effect on ischemic stroke outcome</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>BMC Medicine</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CAUSES AND PRIMARY PREVENTION,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This observational study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band124/b124-5.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"No observational study provides certainty for a cause-effect relationship, unless a very considerable body of evidence can be built up, and the effect is large. One problem is that confounding may be going on because of factors whose importance we do not appreciate. Here, at least, patients in generally worse health before the stroke, and with a similar spectrum of severity of stroke, had a better outcome if they were taking a statin before they had their stroke".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>395027</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ageuk.org.uk/health-wellbeing/relationships-and-family/protecting-yourself/?paging=false]]&gt;</url>
    <title>Safeguarding older people from abuse</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This factsheet is designed to help you if you know an older person who is being abused or who may be at risk of abuse. Whether you know the individual involved through your role as a professional, carer, relative or friend, we all have an important part to play in safeguarding them from abuse.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>294230</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.scie.org.uk/publications/briefings/briefing28/index.asp]]&gt;</url>
    <title>SCIE Research briefing 28: Assistive technology and older people</title>
    <publicationDate>2008-08-29T00:00:00</publicationDate>
    <publisher>Social Care Institute for Excellence</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Key messages&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The term ‘assistive technology’ incorporates a wide variety of devices.&lt;/LI&gt;
&lt;LI&gt;Assistive technology can be supportive, preventive or responsive.&lt;/LI&gt;
&lt;LI&gt;The increasing proportion of older people in the population makes the use of assistive technology an attractive option in social services.&lt;/LI&gt;
&lt;LI&gt;Perceptions vary as to whether or not assistive technology has sufficient benefits.&lt;/LI&gt;
&lt;LI&gt;Existing research supports the greater use of assistive technology but further evaluation and ‘local learning’ is needed.&lt;/LI&gt;
&lt;LI&gt;The views and needs of people using assistive technology need to be taken into account.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>313368</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/stem_cell_breakthrough.aspx]]&gt;</url>
    <title>Scientists develop embryo-free stem cell breakthrough</title>
    <publicationDate>2009-03-02T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ British and Canadian scientists have found a way to make an almost limitless supply of stem cells that could potentially be used safely in patients, while avoiding the ethical dilemma of destroying embryos.]]&gt;</body>
  </document>
  <document>
    <id>287558</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sdo.lshtm.ac.uk/files/adhoc/139-research-summary.pdf]]&gt;</url>
    <title>Scoping exercise on fallers' clinics</title>
    <publicationDate>2008-05-09T00:00:00</publicationDate>
    <publisher>National Institute for Health Research</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,ASSESSING RISK,PREVENTION,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Published by the National Institute for Health Research Service Delivery and Organisation Programme (SDO), this research summary describes how fallers’ clinics function, and explores ways in which their success can be measured so that a much-needed economic appraisal can be carried out.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Key findings&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Fallers’ clinics in the UK aim to reduce the health impact and costs associated with falls. Current services cost approximately £32.5 million per year. 
&lt;LI&gt;Clinics vary greatly in their organisation, the skills mix of their staff, the procedures used, and how they manage their clients. 
&lt;LI&gt;The evidence indicates clinics have negligible clinical effect, but the ability to assess this is constrained by the variability in their organisation and limited outcome data. 
&lt;LI&gt;A common service pathway can be identified, but the key parameters must be linked to reliable information on costs and clinical effectiveness in order to conduct economic modelling. 
&lt;LI&gt;Further research in several key areas would generate high-quality data to tie together currently disparate evidence.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>389512</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.scotland.gov.uk/Publications/2010/09/10151751/17]]&gt;</url>
    <title>Scotland's National Dementia Strategy</title>
    <publicationDate>2010-10-06T00:00:00</publicationDate>
    <publisher>The Scottish Government</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,LATER LIFE,ADULT CONDITIONS,DEMENTIA,DEMENTIA,NEUROLOGICAL CONDITIONS,RECENT ADDITIONS,DEMENTIA,CONDITIONS,OCTOBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Dementia is a national priority for this administration, and this strategy was devised last year to reflect the importance we all attach to this agenda – and also to build on the significant work which was already underway in Scotland in key areas such as early diagnosis, improving care pathways, and public awareness.&lt;/P&gt;
&lt;P&gt;This strategy will therefore transform dementia services by developing common standards of care for the first time; by producing a framework to&lt;BR&gt;ensure that all staff who provide care and support are skilled and knowledgeable about dementia; and by significantly improving care pathways, and strengthening the integration of health and social&lt;BR&gt;care services – &amp;nbsp;including in the area informationsharing.&lt;/P&gt;
&lt;P&gt;We will also continue to improve the level of diagnosis of dementia, and develop work to reduce the use of psychoactive drugs in managing&lt;BR&gt;the illness.&lt;/P&gt;
&lt;P&gt;Includes information on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Introduction&lt;/LI&gt;
&lt;LI&gt;The rights of people with dementia and their carers&lt;/LI&gt;
&lt;LI&gt;Preparation of this strategy&lt;/LI&gt;
&lt;LI&gt;The Challenge&lt;/LI&gt;
&lt;LI&gt;Five key challenges&lt;/LI&gt;
&lt;LI&gt;Transformational change to dleiver world class dementia care and treatment in Scotland&lt;/LI&gt;
&lt;LI&gt;Our moddel for change&lt;/LI&gt;
&lt;LI&gt;Actions to support the change programme&lt;/LI&gt;
&lt;LI&gt;Monitoring implementation&amp;nbsp; of the strategy&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>94191</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12948112&amp;query_hl=211]]&gt;</url>
    <title>Screening mammography in the elderly: a review of the issues</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>J Am Med Womens Assoc</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,BREAST,CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &amp;nbsp;Women age 70 and older have the highest incidence and mortality from breast cancer of any age group. Despite this increased burden of disease, studies show that older women are the least likely to be screened for breast cancer. Barriers to routine mammography in this population include transportation and logistical issues, psychosocial barriers, low literacy levels, and institutional barriers. A variety of interventions, such as community health educators and mobile mammography, have been effective at increasing screening mammography among older women. Although limited, studies have reported that screening mammography reduced breast cancer mortality among women age 65 and older. Research supports continued screening with mammography for elderly women as long as their health is not significantly compromised by comorbid illness, and most organizational guidelines support screening mammography in healthy elderly women. Ultimately, the decision to continue breast cancer screening should be made by the patient and her physician after carefully weighing the risks and benefits of the procedure, which generally become more favorable as women age.]]&gt;</body>
  </document>
  <document>
    <id>95047</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4114989]]&gt;</url>
    <title>Securing better mental health for older adults</title>
    <publicationDate>2005-07-03T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ DEMENTIA,LATER LIFE,TREATMENT AND CARE,NSF FOR OLDER PEOPLE,ADULTS,PROTOCOLS,OLDER PEOPLE,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,FRAMES OF REFERENCE,MANAGEMENT &amp; POLICY,AGE GROUPS,POPULATIONS,GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document marks the start of an initiative to combine forces across mental health and older people's services to ensure that older people with mental illness do not miss out on the improved services that younger adults or those without mental illness have seen.</description>
    <body>&lt;![CDATA[ This document marks the start of a new initiative to combine forces across mental health and older people’s services to ensure that older people with mental illness do not miss out on the improved services that younger adults or those without mental illness have seen. It provides a vision for how all mainstream health and social care services, with the support of specialist services, should work together to secure better mental health for older adults, and describes how the Department of Health is aiming to help deliver this.]]&gt;</body>
  </document>
  <document>
    <id>289447</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csci.org.uk/pdf/Dementia%20Report-web.pdf]]&gt;</url>
    <title>See me, not just the dementia: Understanding people's experiences of living in a care home</title>
    <publicationDate>2008-07-01T00:00:00</publicationDate>
    <publisher>Commission for Social Care Inspection (CSCI)</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ DEMENTIA,NEUROLOGICAL CONDITIONS,DELIVERY OF CARE,TREATMENT AND CARE,DEFINITION AND TYPES,DEMENTIA,LATER LIFE,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This report, See me, not just the dementia, looks at the experiences of people with dementia living in care homes in England, with a particular focus on whether their care offers dignity and respect. Most similar studies have relied on the views of carers, care staff and people in the early stages of dementia. This study examines directly the experiences of people including those with advanced dementia.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This report, See me, not just the dementia, looks at the experiences of people with dementia living in care homes in England, with a particular focus on whether their care offers dignity and respect.&lt;/P&gt;
&lt;P&gt;Most similar studies have relied on the views of carers, care staff and people in the early stages of dementia. This study examines directly the experiences of people ncluding those with advanced dementia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This special report includes filmed interviews. To give you a taster here are some extracts with video clips:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Dementia: &lt;A href="http://www.csci.org.uk/about_us/publications/dementia_report/dementia_knowing_the_person.aspx" target="_blank"&gt;Knowing the person&lt;/A&gt; 
&lt;LI&gt;Positive practice: &lt;A href="http://www.csci.org.uk/about_us/publications/dementia_report/positive_practice.aspx" target="_blank"&gt;How we inspect&lt;/A&gt; 
&lt;LI&gt;SOFI: &lt;A href="http://www.csci.org.uk/about_us/publications/dementia_report/sofi_its_value.aspx" target="_blank"&gt;Its value as an inspection tool&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95899</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4009325&amp;chk=/EuEFn]]&gt;</url>
    <title>Seeking consent: working with older people</title>
    <publicationDate>2001-08-05T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ WHAT IS AGEISM?,HOW DOES AGEISM OCCUR?,THE WHY,LATER LIFE,AGEISM,SURGERY,ETHICS AND PROFESSIONAL STANDARDS,INFORMED CONSENT,PREOPERATIVE PREPARATIONS,PERIOPERATIVE MANAGEMENT,NSF FOR OLDER PEOPLE,ELDERLY CARE,OPTIMISING PATIENT HEALTH,CONSENT AND ASSENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Aimed at those involved in the treatment or care of older people, this DH booklet provides legal and best practice guidance on seeking consent from those in their care. Part one focuses on the appropriate procedures for seeking consent from those who are able to give it. It examines the nature of consent and the concept of 'capacity'. It also details the type of information people are likely to require in order to make an informed consent decision. Part two considers what should be done when a person is incapable of giving or refusing consent. It explains the use of 'advance directives' and how a person's 'best interests' can be determined. As in the previous section, a brief practical example is used to illustrate a typical scenario. Section three covers consent to involvement in research. The final section deals with decisions concerning withdrawing or withholding life-prolonging treatment.]]&gt;</body>
  </document>
  <document>
    <id>328746</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/full/66/8/929]]&gt;</url>
    <title>Seizures in Alzheimer Disease</title>
    <publicationDate>2009-08-01T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Background:&lt;BR&gt;&lt;/B&gt;Transient symptoms in Alzheimer disease (AD)&lt;SUP&gt; &lt;/SUP&gt;are frequent and include seizures, syncope, and episodes of&lt;SUP&gt; &lt;/SUP&gt;inattention or confusion. The incidence of seizures in AD and&lt;SUP&gt; &lt;/SUP&gt;predictors of which patients with AD might be more predisposed&lt;SUP&gt; &lt;/SUP&gt;to them is based primarily on retrospective studies and is not&lt;SUP&gt; &lt;/SUP&gt;well established.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Objective:&lt;BR&gt;&lt;/B&gt;To determine the incidence and predictors of&lt;SUP&gt; &lt;/SUP&gt;new-onset unprovoked seizures.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Design:&lt;BR&gt;&lt;/B&gt;Prospective cohort study.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Setting:&lt;BR&gt;&lt;/B&gt;Three academic centers.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Patients:&lt;BR&gt;&lt;/B&gt;Four hundred fifty-three patients with probable&lt;SUP&gt; &lt;/SUP&gt;AD observed prospectively from mild disease stages since 1992.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Main Outcome Measure:&lt;BR&gt;&lt;/B&gt;Informant interviews every 6 months&lt;SUP&gt; &lt;/SUP&gt;included questions about whether the patient had a seizure (convulsion,&lt;SUP&gt; &lt;/SUP&gt;fainting, or "funny" spell) and whether diagnosis or treatment&lt;SUP&gt; &lt;/SUP&gt;for epilepsy or seizure was made. Two epileptologists independently&lt;SUP&gt; &lt;/SUP&gt;retrospectively reviewed all available medical records for 52&lt;SUP&gt; &lt;/SUP&gt;patients with positive responses to either of these questions,&lt;SUP&gt; &lt;/SUP&gt;and using a specific checklist form, events were diagnosed as&lt;SUP&gt; &lt;/SUP&gt;to whether they were unprovoked seizures (intrarater concordance,&lt;SUP&gt; &lt;/SUP&gt;&lt;IMG border=0 alt={kappa} src="/libraryImages/Later%20Life/contentID328746/nelhImp_0000_kappa.gif"&gt;&amp;nbsp;=&amp;nbsp;0.67). Diagnosis of unprovoked seizures constituted&lt;SUP&gt; &lt;/SUP&gt;the event in survival analyses. Potential predictors included&lt;SUP&gt; &lt;/SUP&gt;sex, age, race/ethnicity, educational achievement, duration&lt;SUP&gt; &lt;/SUP&gt;of illness, baseline cognition and function, depression, medical&lt;SUP&gt; &lt;/SUP&gt;comorbidities, and time-dependent use of cholinesterase inhibitors&lt;SUP&gt; &lt;/SUP&gt;and neuroleptic agents, apolipoprotein E genotype, and previous&lt;SUP&gt; &lt;/SUP&gt;electroencephalographic findings.&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Results:&lt;/B&gt; &lt;BR&gt;Over the course of 3518 visit-assessments (per&lt;SUP&gt; &lt;/SUP&gt;patient: mean, 7.8; maximum, 27), 7 patients (1.5%) developed&lt;SUP&gt; &lt;/SUP&gt;seizures. Younger age was associated with higher risk (hazard&lt;SUP&gt; &lt;/SUP&gt;ratio, 1.23; 95% confidence interval, 1.08-1.41; &lt;I&gt;P&lt;/I&gt;&amp;nbsp;=&amp;nbsp;.003&lt;SUP&gt; &lt;/SUP&gt;for each additional year of age) of seizure incidence. No other&lt;SUP&gt; &lt;/SUP&gt;predictor was significant. The overall incidence of seizures&lt;SUP&gt; &lt;/SUP&gt;was low (418 per 100&amp;nbsp;000 person-years of observation) although&lt;SUP&gt; &lt;/SUP&gt;significantly higher than expected for idiopathic unprovoked&lt;SUP&gt; &lt;/SUP&gt;seizures in similar age ranges of the general population (hazard&lt;SUP&gt; &lt;/SUP&gt;ratio, 8.06; 95% confidence interval, 3.23-16.61).&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;B&gt;Conclusions:&lt;BR&gt;&lt;/B&gt;&lt;/FONT&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;Unprovoked seizures are uncommon in AD, but&lt;SUP&gt; &lt;/SUP&gt;they do occur more frequently than in the general population.&lt;SUP&gt; &lt;/SUP&gt;Younger age is a risk factor for seizures in AD.&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>292678</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.bmj.com/cgi/reprint/337/aug13_2/a957.pdf]]&gt;</url>
    <title>Self reported receipt of care consistent with 32 quality indicators: national population survey of adults aged 50 or more in England</title>
    <publicationDate>2008-08-22T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SURVEILLANCE,SCREENING AND SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This report assesses the receipt of effective healthcare interventions in England by adults aged 50 or more with serious health conditions. It showed that there was a large gap between recommended care and care that is actually received.</description>
    <body>&lt;![CDATA[ This report assesses the receipt of effective healthcare interventions in England by adults aged 50 or more with serious health conditions. It showed that there was a large gap between recommended care and care that is actually received.]]&gt;</body>
  </document>
  <document>
    <id>250984</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sdo.lshtm.ac.uk/files/project/30-final-report.pdf]]&gt;</url>
    <title>Self-assessment of health and social care needs by older people (Final Report)</title>
    <publicationDate></publicationDate>
    <publisher>NHS Service and Delivery Organisation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SPECIAL CARE DENTISTRY,OLDER PEOPLE,NSF FOR OLDER PEOPLE,ORAL HEALTH,LATER LIFE,SPECIALIST DENTISTRY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This review considers the evidence base for ‘self-assessment’ by older people in managing and identifying health and social care needs.]]&gt;</body>
  </document>
  <document>
    <id>250982</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sdo.lshtm.ac.uk/files/adhoc/30-research-summary.pdf]]&gt;</url>
    <title>Self-assessment of health and social care needs by older people (Summary Report)</title>
    <publicationDate></publicationDate>
    <publisher>NHS Service and Delivery Organisation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=MyriadMM_215_600_ color=#231f20 size=2&gt;
&lt;P&gt;This research summary presents the main findings of a review of selfassessment in health and social care, commissioned by the NHS Service Delivery and Organisation Research and Development Programme (SDO).&lt;/P&gt;
&lt;P&gt;This research summary will be of interest to those in health and social care who are seeking to introduce or improve collaborative approaches to assessing potentially complex needs.&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>374927</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/4/416?rss=1]]&gt;</url>
    <title>Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease</title>
    <publicationDate>2010-04-12T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Complex visual hallucinations (VHs) occur in several pathologic conditions; however, the neural mechanisms underlying these symptoms remain unclear. Although dopamine may have a role, indirect evidence indicates that serotonin may also contribute to the pathogenesis of complex VHs, probably via involvement of the serotonin 2 receptor.]]&gt;</body>
  </document>
  <document>
    <id>346412</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/03March/Pages/sexual-health-general-health-elderly.aspx]]&gt;</url>
    <title>Sex life linked to elderly health</title>
    <publicationDate>2010-03-10T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ “If you want good sex, you better get down the gym and tuck into your fruit and veg,” says the &lt;EM&gt;Daily Mirror&lt;/EM&gt;. The newspaper reports that a “big-bang theory” has found a link between sexual activity and general health.]]&gt;</body>
  </document>
  <document>
    <id>320472</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_102338?IdcService=GET_FILE&amp;dID=200872&amp;Rendition=Web]]&gt;</url>
    <title>Shaping the future of care together</title>
    <publicationDate>2009-07-14T00:00:00</publicationDate>
    <publisher>HM Government</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,POLICY,SERVICE SECTORS,HEALTH AND SOCIAL CARE,LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Shaping the Future of Care Together sets out a vision for a new care and support system. The Green Paper highlights the challenges faced by the current system and the need for radical reform, to develop a National Care Service that is fair, simple and affordable for everyone.&lt;/P&gt;
&lt;P&gt;Within the Green Paper, it sets out a number of consultation questions and asks everyone to provide their views about how they think Government can make this vision a reality and develop a care and support system fit for the 21st century.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The consultation will run from 14 July 2009 to 13 November 2009.&lt;/STRONG&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317302</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncpc.org.uk/policy/workforce2008.html]]&gt;</url>
    <title>Specialist palliative care workforce survey results published</title>
    <publicationDate>2009-05-14T00:00:00</publicationDate>
    <publisher>NHS End of Life Care Programme</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The key national findings are presented here to give cancer network level information to networks and providers so they can draw comparisons between this and the national data.]]&gt;</body>
  </document>
  <document>
    <id>387846</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.rcslt.org/docs/free-pub/dementia_paper.pdf]]&gt;</url>
    <title>Speech and language therapy provision for people with dementia - Position Paper</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>Royal College of Speech &amp; Language Therapists</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This position paper highlights the speech and language therapy provision that should be available to ensure equity of access for people with dementia, and the key role that SLTs should have within dementia teams.&lt;/P&gt;
&lt;P&gt;These speech and language therapy services should be adequately planned and resourced, based on local demography and need.&lt;/P&gt;
&lt;P&gt;The paper is intended to advise and generate discussion between commissioners and service providers regarding providing speech and language therapy services that meet the needs of people with dementia, their families, carers and other professionals in line with current national&lt;BR&gt;policies.&lt;/P&gt;
&lt;P&gt;An expert panel of SLTs convened by the RCSLT has produced this document after extensive consultation.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374907</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2010/04April/Pages/voice-test-parkinsons-disease-diagnosis.aspx]]&gt;</url>
    <title>Speech scan for Parkinson's</title>
    <publicationDate>2010-04-16T00:00:00</publicationDate>
    <publisher>NHS Choices - Behind the Headlines</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Parkinson’s disease “could be diagnosed by voice changes”, according to The Daily Telegraph. The newspaper said that Parkinson’s disease could be diagnosed earlier by testing for subtle changes in speech that often accompany the condition.&lt;/P&gt;
&lt;P&gt;This news story was based on research that compared different ways of analysing the sound wave patterns generated when vowels are spoken. The researchers found that one method could detect changes in articulation that were present in people with Parkinson’s disease but not a comparison group of healthy individuals.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>313366</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.parkinsons.org.uk/research/research_news/spinal_cord_treatment.aspx]]&gt;</url>
    <title>Spinal cord treatment offers hope for Parkinson's</title>
    <publicationDate>2009-03-20T00:00:00</publicationDate>
    <publisher>Parkinson's Disease Society</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ An alternative treatment to Deep Brain Stimulation (DBS) could bring new hope to people living with Parkinson's disease.]]&gt;</body>
  </document>
  <document>
    <id>317310</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=404]]&gt;</url>
    <title>Spinal fluids help predict Alzheimer’s progression</title>
    <publicationDate>2009-05-12T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ US scientists have developed a technique to predict Alzheimer’s onset by measuring biomarker levels in cerebrospinal fluid.]]&gt;</body>
  </document>
  <document>
    <id>273748</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.bgs.org.uk/Publications/Compendium/compend_1-3.htm]]&gt;</url>
    <title>Standards of Medical Care for Older People - Expectations and Recommendations</title>
    <publicationDate>2007-11-16T00:00:00</publicationDate>
    <publisher>British Geriatrics Society</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,FALLS,SCREENING AND SURVEILLANCE,STROKE,NSF FOR OLDER PEOPLE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Compendium document 1.3 (1997, Revised 2003 and 2007).</description>
    <body>&lt;![CDATA[ &lt;P&gt;This document describes the British Geriatrics Society's recommendations for standards of care for specialist services for older people and those with whom they work. It is envisaged the document will be of value to health professionals, primary care groups, NHS managers, general practitioners and voluntary agencies, in addition to geriatricians, old age psychiatrists and specialist registrars.&lt;/P&gt;
&lt;H3&gt;&lt;BR&gt;&amp;nbsp;&lt;/H3&gt;
&lt;H3&gt;Review date October 2010.&lt;/H3&gt;
&lt;P&gt;Authors: Dr J Morris, London and Dr D Beaumont for BGS Policy Committee&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93843</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/cardiac/statcog.html]]&gt;</url>
    <title>Statins and cognitive function</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,LATER LIFE,CAUSES AND PREVENTION,DEMENTIA,CONDITIONS,MILD COGNITIVE IMPAIRMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This Bandolier article reviews the following studies:&lt;/P&gt;
&lt;P&gt;1. M Etminan et al. The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy 2003 23: 726-730 [www.medscape.com/viewarticle/456866]. &lt;/P&gt;
&lt;P&gt;2. T Erikinjuntti et al. The effect of different diagnostic criteria on the prevalence of dementia. New England Journal of Medicine 1997 337: 1667-74. &lt;/P&gt;
&lt;P&gt;3. J Shepherd et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002 360: 1623-1630. &lt;/P&gt;
&lt;P&gt;4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 360: 7-22.&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;If there is any protective effect of statins on cognitive impairment, it is based on weak observational evidence".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>276263</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dhcarenetworks.org.uk/_library/Resources/Prevention/CSIP_Product/Involvement-of-people-with-dementia.pdf]]&gt;</url>
    <title>Strengthening the Involvement of People with Dementia: A Resource for Implementation</title>
    <publicationDate>2007-11-30T00:00:00</publicationDate>
    <publisher>Care Services Improvement Partnership</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ DEMENTIA,NEUROLOGICAL CONDITIONS,OLDER PEOPLE,HOW DO I INVOLVE...?,PATIENT AND PUBLIC INVOLVEMENT,LATER LIFE,TREATMENT AND CARE,DEMENTIA,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A resource from CSIP's National Older People's Mental Health Programme.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Strengthening the Involvement of People with Dementia Toolkit&lt;/H2&gt;
&lt;P&gt;This toolkit augments the section ‘Involving service users and their carers' in ‘Everybody's Business - a service development guide' (DH 2005). &lt;/P&gt;
&lt;P&gt;You can download the &lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/silo/files/strengthening-the-involvement-of-people-with-dementia.pdf" target="_blank"&gt;Involvement Toolkit&lt;/A&gt; along with the &lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/silo/files/supplementary-resource-final.pdf" target="_blank"&gt;Supplementary Resource&lt;/A&gt; which highlights areas of good practice in involving people with dementia in service planning, delivery and evaluation. We aim to add further useful documents in the &lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/service-user-and-carer-engagement-tool/strengthening-involvement-resources.html" target="_blank"&gt;Strengthening Involvement Resources&lt;/A&gt; section and would like to hear from you in the &lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/service-user-and-carer-engagement-tool/feedback-and-positive-practice.html" target="_blank"&gt;feedback section with further examples of positive practice&lt;/A&gt;. You can also discuss involvement issues with the team on &lt;A href="http://www.olderpeoplesmentalhealth.csip.org.uk/forum.html" target="_blank"&gt;The Meeting Place&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;"The toolkit builds on and strengthens the section on Involving service users and their carers in &amp;nbsp;Everybody's Business. Most importantly, people with dementia and their carers have been involved in its development. Therefore, it provides a true reflection of the skills and techniques people with dementia believe are important for engagement and involvement. It also demonstrates the valuable contribution that people with dementia can make."&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Ivan Lewis MP&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Parliamentary Under Secretary for Care Services&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94117</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://stroke.ahajournals.org/cgi/content/full/31/7/1555]]&gt;</url>
    <title>Streptokinase in acute ischemic stroke: an individual patient data meta-analysis: the Thrombolysis in Acute Stroke Pooling Project</title>
    <publicationDate>2000-07-02T00:00:00</publicationDate>
    <publisher>Stroke</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,ACUTE MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This meta analysis has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000273277" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&amp;nbsp;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Few factors influenced the response to SK. However, earlier administration, lower doses of SK, and avoidance of concomitant aspirin should be considered if further SK trials in acute stroke are planned.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;The authors' conclusions appear to be consistent with the evidence presented".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>277217</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/guidance/index.jsp?action=folder&amp;o=38871]]&gt;</url>
    <title>Stroke - draft consultation</title>
    <publicationDate>2008-01-10T00:00:00</publicationDate>
    <publisher>NICE</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A clinical practice guideline on Stroke: The diagnosis and acute management of stroke and transient ischaemic attacks is being developed for use in the NHS in England and Wales. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via the NICE website.</description>
    <body>&lt;![CDATA[ &lt;P&gt;A clinical practice guideline on Stroke: The diagnosis and acute management of stroke and transient ischaemic attacks is being developed for use in the NHS in England and Wales. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via the&amp;nbsp;NICE&amp;nbsp;website.&lt;/P&gt;
&lt;P&gt;Although individuals and organisations not registered as stakeholders are able to comment,&amp;nbsp;NICE recommend that you contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.&amp;nbsp;NICE work closely with stakeholder organisations and take their views very seriously.&lt;/P&gt;
&lt;P&gt;Note that the provisional recommendations presented here do not constitute the Institute's formal guidance on this topic. The recommendations are provisional and may change after consultation.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Consultation dates:&amp;nbsp; 10 January - 6 March 2008&lt;/H2&gt;]]&gt;</body>
  </document>
  <document>
    <id>33803</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.improvement.nhs.uk/stroke/]]&gt;</url>
    <title>Stroke service improvements</title>
    <publicationDate>2008-07-23T00:00:00</publicationDate>
    <publisher>NHS Modernisation Agency</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,ACUTE MANAGEMENT,SERVICE ORGANISATION,REHABILITATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ ‘Eurekas’ and case studies illustrating service improvements made by participants in the Clinical Governance Support Team Stroke Services programme.]]&gt;</body>
  </document>
  <document>
    <id>319607</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=425]]&gt;</url>
    <title>Study investigates alternative to antipsychotics for Alzheimer's</title>
    <publicationDate>2009-06-18T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A new study from the Institute of Psychiatry, funded by the Alzheimer’s Research Trust, will investigate whether the use of memantine could be a safer replacement to commonly-prescribed antipsychotic drugs for relieving symptoms of agitation.]]&gt;</body>
  </document>
  <document>
    <id>95373</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/614.asp]]&gt;</url>
    <title>Support for people with learning difficulties in residential settings who develop dementia</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,TREATMENT AND CARE,DEMENTIA,LATER LIFE,HEALTH &amp; WELLBEING,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This study looks at how residential settings for people with learning difficulties are coping as more residents develop dementia.]]&gt;</body>
  </document>
  <document>
    <id>284306</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/2201.asp]]&gt;</url>
    <title>Supporting older people in care homes at night</title>
    <publicationDate>2008-05-01T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SURVEILLANCE,SECONDARY CARE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A research report from the Joseph Rowntree Foundation.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This study explores the night-time care experiences of residents, relatives and staff in three care homes in Scotland. It identifies good practice and suggests improvements through a series of interventions. These are used to make recommendations for care regulators, commissioners and providers, home managers and night-time care staff.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Care commissioners do not routinely inspect care homes at night. When they do, it is with less rigour than during the day, and is generally only in response to a complaint or specific cause for concern. 
&lt;LI&gt;Managers in the care homes studied were insufficiently involved in night-time supervision and practice. 
&lt;LI&gt;Night staff often felt undervalued and isolated from the running of care homes. 
&lt;LI&gt;Night staff received less training than day staff – and little or none on responding to people with dementia, supporting continence, recognising and managing pain, or supporting good hydration and nutrition during the night. 
&lt;LI&gt;Where training was available to night staff, it was not specifically focused on night-time issues. 
&lt;LI&gt;Dependence on unfamiliar agency and bank staff increased the workload of regular staff and jeopardised quality of care for residents. 
&lt;LI&gt;Staff carried out routine and indiscriminate 'checking' (for breathing, falls and incontinence) throughout the night, due to a general culture of anxiety. 
&lt;LI&gt;There were often unacceptable levels of noise and light during the night, which affected residents' sleep and caused agitation. 
&lt;LI&gt;The night-time physical environment was disabling rather than enabling, especially for people with dementia. 
&lt;LI&gt;However, the action research part of the study showed that even relatively minor changes in practice could result in considerable improvements to the night-time care experience.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>346693</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346693]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Acute Care</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Acute Care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:346692:1" name=internalLink&gt;Back to Supporting People in Later Life Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;&lt;BR&gt;&lt;BR&gt;
&lt;H2&gt;Introduction&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 hspace=20 vspace=40 src="/libraryImages/Later%20Life/contentID346693/nelhImp_0000_sized.gif"&gt;&lt;BR&gt;&lt;BR&gt;&lt;/H2&gt;
&lt;P&gt;This section of the AEU contains important new evidence about management in the acute setting of elderly patients experiencing difficulties with independent living.&lt;BR&gt;&lt;BR&gt;We note the lack of high quality systematic reviews and clinical trials in this area.&amp;nbsp; This is particularly a concern given the pressures on health services to reform delivery of acute care.&amp;nbsp; &lt;BR&gt;&lt;BR&gt;Sheppard et al found that “Despite increasing interest in the potential of early discharge hospital at home services as a cheaper alternative to in-patient care, this review provides insufficient objective evidence of economic benefit or improved health outcomes.”&amp;nbsp; This is in contrast to lesser quality reviews, which tended to be more favourable towards new models of care.&amp;nbsp; For example, Bauer at al found “there is a direct correlation between the quality of discharge planning and readmission to hospital.”&lt;BR&gt;&lt;BR&gt;There is some evidence that we can identify patients most at risk of functional decline when they are first admitted to hospital.&amp;nbsp; De Saint-Hubert et al report that “functional status before or at admission, cognitive performance and social characteristics” are the most important risk factors for subsequent decline.&lt;BR&gt;&lt;BR&gt;It is clear that we are dealing with complex interventions for patients with complex needs.&amp;nbsp; Clinicians need to consider the evidence carefully in their own context.&amp;nbsp; Because of this high degree of heterogeneity amongst the evidence found, the studies have been broken down into the following sub-topics:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Prognosis and assessment&lt;/LI&gt;
&lt;LI&gt;Specialist units&lt;/LI&gt;
&lt;LI&gt;Quality of care&lt;/LI&gt;
&lt;LI&gt;Discharge planning&lt;/LI&gt;
&lt;LI&gt;Rehabilitation&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;Prognosis and&amp;nbsp;assessment&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Non-systematic reviews&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;de Saint-Hubert M, Schoevaerdts D, Poulain G, Cornette P, Swine C. Risk factors predicting later functional decline in older hospitalized patients. [Review] [44 refs]. Acta Clin Belg 2009; 64(3):187-94.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19670557" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Cohort studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Boyd CM, Ricks M, Fried LP et al. Functional decline and recovery of activities of daily living in hospitalized, disabled older women: the Women's Health and Aging Study I. J Am Geriatr Soc 2009; 57(10):1757-66.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19694869" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Brown CJ, Redden DT, Flood KL, Allman RM. The underrecognized epidemic of low mobility during hospitalization of older adults. J Am Geriatr Soc 2009; 57(9):1660-5.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19682121" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Corsinovi L, Bo M, Ricauda Aimonino N et al. Predictors of falls and hospitalization outcomes in elderly patients admitted to an acute geriatric unit. Archives of Gerontology &amp;amp; Geriatrics 2009; 49(1):142-5.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18674824" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cumbler E, Lyle H, Guerrasio J, Youngwerth J, Wald H. Vulnerability assessment on hospital admission predicts need for placement upon discharge for elderly patients. J Am Geriatr Soc 2009; 57(5):944-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19470031" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Drame M,&amp;nbsp; DP, A et al. Factors predictive of long-term mortality in patients aged 75 years or older hospitalized from the emergency department: the SAFES cohort. Presse Medicale.&amp;nbsp; 38(7-8)(Pp 1068-1075), 2009. Date of Publication: July/August 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19376682" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Feldblum I, German L, Bilenko N et al. Nutritional risk and health care use before and after an acute hospitalization among the elderly. Nutrition 2009; 25(4):415-20.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19101116" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fisher SR. In hospital functional assessments in the elderly and their association to post discharge health outcomes. Dissertation Abstracts International: Section B: The Sciences and Engineering. Vol.70(4-B),2009, Pp. 2242.&lt;BR&gt;[&lt;A href="http://etd.utmb.edu/theses/available/etd-06302008-103633/" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Garrouste-Orgeas M, Boumendil A, Pateron D et al. Selection of intensive care unit admission criteria for patients aged 80 years and over and compliance of emergency and intensive care unit physicians with the selected criteria: An observational, multicenter, prospective study. Crit Care Med 2009; 37(11):2919-28.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19866508" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Leff B, Burton L, Mader SL et al. Comparison of functional outcomes associated with hospital at home care and traditional acute hospital care. J Am Geriatr Soc 2009; 57(2):273-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19170781" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Salvi F, Morichi V, Grilli A et al. Predictive validity of the Identification of Seniors At Risk (ISAR) screening tool in elderly patients presenting to two Italian Emergency Departments. Aging-Clinical &amp;amp; Experimental Research 2009; 21(1):69-75&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19225272" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sleiman I, Rozzini R, Barbisoni P et al. Functional trajectories during hospitalization: a prognostic sign for elderly patients. Journals of Gerontology Series A-Biological Sciences &amp;amp; Medical Sciences 2009; 64(6):659-63.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19270181" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Van Der Schaaf M,&amp;nbsp; BA,&amp;nbsp; DD et al. Poor functional recovery after a critical illness: A longitudinal study. Journal of Rehabilitation Medicine.&amp;nbsp; 41(13)(Pp 1041-1048), 2009. Date of Publication: November 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19893999" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zafrir B,&amp;nbsp; LA,&amp;nbsp; BH. Nonagenarians in internal medicine: Characteristics, outcomes and predictors for in-hospital and post-discharge mortality. Israel Medical Association Journal.&amp;nbsp; 12(1)(Pp 10-15), 2010. Date of Publication: January 2010.&lt;BR&gt;[&lt;A href="http://www.ima.org.il/imaj/dynamic/web/showArt.asp?id=3146&amp;amp;nMonth=1&amp;amp;nYear=2010&amp;amp;sCat=Original%20Articles&amp;amp;sJur=Volume%2012" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Specialist units&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Systematic reviews&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Baztan JJ, Suarez-Garcia FM, Lopez-Arrieta J, Rodriguez-Manas L, Rodriguez-Artalejo F. Effectiveness of acute geriatric units on functional decline, living at home, and case fatality among older patients admitted to hospital for acute medical disorders: meta-analysis. [Review] [30 refs]. BMJ.&amp;nbsp; 338:B50, 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19164393" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Van Craen K,&amp;nbsp; BT,&amp;nbsp; WN et al. The effectiveness of inpatient geriatric evaluation and management units: A systematic review and meta-analysis. Journal of the American Geriatrics Society.&amp;nbsp; 58(1)(Pp 83-92), 2010. Date of Publication: January 2010.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20002509" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Experimental studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Vidan MT, Sanchez E, Alonso M, Montero B, Ortiz J, Serra JA. An intervention integrated into daily clinical practice reduces the incidence of delirium during hospitalization in elderly patients. J Am Geriatr Soc 2009; 57(11):2029-36.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19754498" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zelada MA, Salinas R, Baztan JJ. Reduction of functional deterioration during hospitalization in an acute geriatric unit. Archives of Gerontology &amp;amp; Geriatrics 2009; 48(1):35-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18022709" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Oh KM, Warnes AM, Bath P. Effectiveness of a rapid response service for frail older people. Nursing Older People 2009; 21(5):25-33.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19534170" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Quality of care&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Cohort studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Arora VM, Plein C, Chen S, Siddique J, Sachs GA, Meltzer DO. Relationship between quality of care and functional decline in hospitalized vulnerable elders. Med Care 2009; 47(8):895-901.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19597372" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Discharge planning&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Systematic reviews&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Shepperd S, Doll H, Broad J et al. Early discharge hospital at home. [Review] [77 refs][Update of Cochrane Database Syst Rev. 2005;(3):CD000356; PMID: 16034853]. Cochrane Database of Systematic Reviews 2009; (1):CD000356.&lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab000356.html" target="_blank"&gt;Cochrane Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Other reviews&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Bauer M, Fitzgerald L, Haesler E, Manfrin M. Hospital discharge planning for frail older people and their family. Are we delivering best practice? A review of the evidence. [References]. Journal of Clinical Nursing. Vol.18(18), Sep 2009, Pp. 2539-2546.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19374695" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Experimental studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Dedhia P, Kravet S, Bulger J et al. A quality improvement intervention to facilitate the transition of older adults from three hospitals back to their homes. J Am Geriatr Soc 2009; 57(9):1540-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19694865" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jack BW, Chetty VK, Anthony D&amp;nbsp; et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med 2009; 150(3):178-87.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19189907" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Giles LC, Hawthorne G, Crotty M. Health-related Quality of Life among hospitalized older people awaiting residential aged care. Health &amp;amp; Quality of Life Outcomes.&amp;nbsp; 7:71, 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19630996" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Roy CL, Kachalia A, Woolf S, Burdick E, Karson A, Gandhi TK. Hospital readmissions: physician awareness and communication practices. J Gen Intern Med 2009; 24(3):374-80.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18982395" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Smith ER, Stevens AB. Predictors of discharges to a nursing home in a hospital-based cohort. Journal of the American Medical Directors Association 2009; 10(9):623-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19883884" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wright RM, Sloane R, Pieper CF et al. Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study. American Journal of Geriatric Pharmacotherapy 2009; 7(5):271-80.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19948303" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zhang M,&amp;nbsp; HC, D et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: Retrospective cohort study. BMJ.&amp;nbsp; 338(7687)(Pp 155-158), 2009. Date of Publication: 17 Jan 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19129307" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Qualitative studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Graham CL, Ivey SL, Neuhauser L. From hospital to home: assessing the transitional care needs of vulnerable seniors. Gerontologist 2009; 49(1):23-33.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19363001" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Rehabilitation &lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Cohort studies&lt;/U&gt; &lt;BR&gt;
&lt;OL&gt;
&lt;LI&gt;Al-Ani AN, Flodin L, Soderqvist A et al. Does rehabilitation matter in patients with femoral neck fracture and cognitive impairment? A prospective study of 246 patients. Archives of Physical Medicine &amp;amp; Rehabilitation 2010; 91(1):51-7.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20103396" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;van der Schaaf M, Beelen A, Dongelmans DA, Vroom MB, Nollet F. Functional status after intensive care: a challenge for rehabilitation professionals to improve outcome. Journal of Rehabilitation Medicine 2009; 41(5):360-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19363570" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346696</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346696]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Assessment</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Assessment&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:346692:1" name=internalLink&gt;Back to&amp;nbsp;Supporting People in Later Life&amp;nbsp;Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;&lt;BR&gt;&lt;BR&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 hspace=20 vspace=40 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID346696/nelhImp_0000_iStock_000002653379Small.gif"&gt; 
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P align=justify&gt;&lt;BR&gt;This section covers validation studies of assessment tools for identifying patients at risk of functional decline. Important factors reported here include cognitive impairment, depression, multiple conditions (co-morbidity) and sleep disturbances.&lt;BR&gt;&lt;BR&gt;By its very nature, this type of evidence is less likely to be found in experimental research.&amp;nbsp; For this reason we included observational studies.&amp;nbsp; &lt;BR&gt;&lt;BR&gt;We grouped the results into the following categories:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Assessment&lt;/LI&gt;
&lt;LI&gt;Validation of assessment tools&lt;/LI&gt;
&lt;LI&gt;Co-morbidity&lt;/LI&gt;
&lt;LI&gt;Quality of life&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;BR&gt;
&lt;H2&gt;Assessment&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;U&gt;Policy reports from charities&lt;/U&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Age Concern&lt;/STRONG&gt;. &lt;A href="http://www.ageconcern.org.uk/AgeConcern/Documents/118_0609_Social_Exclusion_report.pdf" target="_blank"&gt;Social exclusion in later life: an exploration of risk factors&lt;/A&gt;&amp;nbsp;(PDF). July 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Age Concern&lt;/STRONG&gt;. &lt;A href="http://www.ageconcern.org.uk/AgeConcern/Documents/Prevention_in_practice_-_service_models_methods__impact_April_2009.pdf" target="_blank"&gt;Prevention in practice, service models, methods and impact&lt;/A&gt;&amp;nbsp;(PDF). April 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Joseph Rowntree Foundation&lt;/STRONG&gt;. &lt;A href="http://www.jrf.org.uk/sites/files/jrf/housing-market-stability-summary.pdf" target="_blank"&gt;How can we make the housing market more stable for vulnerable households?&lt;/A&gt;&amp;nbsp;(PDF). March 2010 &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&lt;U&gt;Non-systematic review&lt;/U&gt; &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Kee YY, Rippingale C. The prevalence and characteristic of patients with 'acopia'. Age &amp;amp; Ageing 2009; 38(1):103-5.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19029105" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Avila-Funes JA, Amieva H, Barberger-Gateau P et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc 2009; 57(3):453-61.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19245415" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Blozik E, Wagner JT, Gillmann G et al. Social network assessment in community-dwelling older persons: results from a study of three European populations. Aging Clinical &amp;amp; Experimental Research 2009; 21(2):150-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19448387" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cesari M, Kritchevsky SB, Newman AB et al. Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2009; 57(2):251-60.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19207142" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ensrud KE, Blackwell TL, Redline S et al. Sleep disturbances and frailty status in older community-dwelling men. J Am Geriatr Soc 2009; 57(11):2085-93.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19793160" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hackstaff L. Factors associated with frailty in chronically ill older adults. Soc Work Health Care 2009; 48(8):798-812.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20182990" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Heppenstall CP, Hanger HC, Wilkinson TJ. Predictors of discharge stability in the first year following hospital admission for a frail elderly population. Internal Medicine Journal 2009; 39(3):170-3.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18771437" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Iwarsson S, Horstmann V, Oswald F, Wahl H. Impact of sociocultural care and service context on instrumental activities of daily living dependence among very old European women. Topics in Geriatric Rehabilitation 2009; 25(3):251-65.&lt;BR&gt;[&lt;A href="http://journals.lww.com/topicsingeriatricrehabilitation/Abstract/2009/07000/Impact_of_Sociocultural_Care_and_Service_Context.10.aspx" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Iwasa H, Yoshida Y, Kumagai S, Ihara K, Yoshida H, Suzuki T. Depression status as a reliable predictor of functional decline among Japanese community-dwelling older adults: a 12-year population-based prospective cohort study. Int J Geriatr Psychiatry 2009; 24(11):1192-201.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19280681" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Szanton SL, Allen JK, Seplaki CL, Bandeen-Roche K, Fried LP. Allostatic load and frailty in the women's health and aging studies. Biological Research for Nursing 2009; 10(3):248-57.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18829589" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Vaz Fragoso CA, Gahbauer EA, Van Ness PH, Gill TM. Sleep-wake disturbances and frailty in community-living older persons. J Am Geriatr Soc 2009; 57(11):2094-100.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19793356" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Woo J, Leung J, Wong S, Kwok T, Lee J, Lynn H. Development of a simple scoring tool in the primary care setting for prediction of recurrent falls in men and women aged 65 years and over living in the community. J Clin Nurs 2009; 18(7):1038-49.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19207793" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Yamada S, Liu M, Fujimoto M et al. Identification of quasi-in-need-of-care state (QUINOCS) among community dwelling elderly people using a seven-item subset of the Functional Independence Measure (FIM). Disability &amp;amp; Rehabilitation 2009; 31(5):381-7.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18608424" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Validation of assessment tools&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Observational studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Kiely DK, Cupples LA, Lipsitz LA. Validation and comparison of two frailty indexes: The MOBILIZE Boston Study. J Am Geriatr Soc 2009; 57(9):1532-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19682112" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lambert S, Cheung W-Y, Davies S, Gardner L, Thomas V. Comparison of two tools developed to assess the needs of older people with complex care needs. [References]. Journal of Research in Nursing. Vol.14(5), Sep 2009, Pp. 421-436.&lt;BR&gt;[&lt;A href="http://jrn.sagepub.com/cgi/content/abstract/14/5/421" target="_blank"&gt;Sage Journals Online Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Meyer J. Comment: Comparison of two tools developed to assess the needs of older people with complex care needs. [References]. Journal of Research in Nursing. Vol.14(5), Sep 2009, Pp. 437-438.&lt;BR&gt;[&lt;A href="http://jrn.sagepub.com/cgi/reprint/14/5/437" target="_blank"&gt;Sage Journals Online Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Tsai AC, Chang T, Chen JT, Yang T. Population-specific modifications of the short-form Mini Nutritional Assessment and Malnutrition Universal Screening Tool for elderly Taiwanese. Int J Nurs Stud 2009; 46(11):1431-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19523628" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Young Y, Fan M, Parrish JM, Frick KD. Validation of a novel successful aging construct. Journal of the American Medical Directors Association 2009; 10(5):314-23.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19497543" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Zisberg A, Young HM, Schepp K. Development and psychometric testing of the Scale of Older Adults' Routine. J Adv Nurs 2009; 65(3):672-84.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19222665" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Co-morbidity&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Observational studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Lee PG, Cigolle C, Blaum C. The co-occurrence of chronic diseases and geriatric syndromes: the Health and Retirement Study. J Am Geriatr Soc 2009; 57(3):511-7.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19187416" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;BR&gt;
&lt;H2&gt;Quality of life&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Qualitative studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Murphy K, Cooney A, Shea EO, Casey D. Determinants of quality of life for older people living with a disability in the community. J Adv Nurs 2009; 65(3):606-16.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19222658" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Nelms L, Johnson V, Teshuva K, Foreman P, Stanley J. Social and health factors affecting community service use by vulnerable older people. Australian Social Work 2009; 62(4):507-25.&lt;BR&gt;[&lt;A href="http://www.informaworld.com/smpp/content~content=a917547574~db=all~jumptype=rss" target="_blank"&gt;Informaworld Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Thein M, Ershler WB, Artz AS et al. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine (Baltimore) 2009; 88(2):107-14.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19282701" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346697</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346697]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Assistive Technologies and Telehealth</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Assistive Technologies and Telehealth&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:346692:1" name=internalLink&gt;Back to Supporting People in Later Life Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;&lt;BR&gt;&lt;BR&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 hspace=20 vspace=45 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID346697/nelhImp_0000_iStock_000009439906Small.gif"&gt; 
&lt;H2&gt;Introduction&lt;/H2&gt;&lt;BR&gt;
&lt;P align=justify&gt;The information and telecommunications revolution offers tremendous potential for improving the care of older people, promoting their independence and reducing health service costs. For this reason, we specifically looked for studies that evaluated telehealth interventions.&lt;BR&gt;&lt;BR&gt;Most of these studies focused on patients with specific conditions, rather than the general category of “older people experiencing difficulties with independent living.”&amp;nbsp; A lot of studies have been carried out in the area of heart failure, for example.&amp;nbsp; However, we did find one systematic review that looked at the broad category of telerehabilitation.&amp;nbsp; Kairy et al concluded “While evidence is mounting concerning the efficacy and effectiveness of telerehabilitation, high-quality evidence regarding impact on resource allocation and costs is still needed to support clinical and policy decision-making.” &lt;/P&gt;&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;
&lt;H2&gt;Assistive technologies and telehealth&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Systematic reviews&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Dang S, Dimmick S, Kelkar G. Evaluating the evidence base for the use of home telehealth remote monitoring in elderly with heart failure. [Review] [45 refs]. Telemedicine Journal &amp;amp; E-Health 2009; 15(8):783-96.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19831704" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kairy D, Lehoux P, Vincent C, Visintin M. A systematic review of clinical outcomes, clinical process, healthcare utilization and costs associated with telerehabilitation. Disabil Rehabil 2009; 31(6):427-47.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18720118" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Non-systematic reviews&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Chan M, Campo E, Esteve D, Fourniols JY. Smart homes - current features and future perspectives. [Review] [80 refs]. Maturitas 2009; 64(2):90-7.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19729255" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Naditz A. Still standing: Telemedicine devices and fall prevention. Telemedicine and E-Health. Vol.15(2), Mar 2009, Pp. 137-141.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19292621" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Pountney D. Telecare and telehealth: enabling independent living. Nursing &amp;amp; Residential Care 2009; 11(3):148-51.&lt;BR&gt;[&lt;A href="http://www.internurse.com/cgi-bin/go.pl/library/article.cgi?uid=39665;article=NRC_11_3_148_151" target="_blank"&gt;Internurse Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Experimental studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Courtney M, Edwards H, Chang A, Parker A, Finlayson K, Hamilton K. Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24-week exercise and telephone follow-up program. J Am Geriatr Soc 2009; 57(3):395-403.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19245413" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Dar O,&amp;nbsp; RJ,&amp;nbsp; CC et al. A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: Results of the Home-HF study. European Journal of Heart Failure.&amp;nbsp; 11(3)(Pp 319-325), 2009. Date of Publication: March 2009.&amp;nbsp;&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19174529" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Giordano A, Scalvini S, Zanelli E et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol 2009; 131(2):192-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18222552" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Kangas M, Vikman I, Wiklander J, Lindgren P, Nyberg L, Jamsa T. Sensitivity and specificity of fall detection in people aged 40 years and over. Gait &amp;amp; Posture 2009; 29(4):571-4.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19153043" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mortara A,&amp;nbsp; PG, D et al. Home telemonitoring in heart failure patients: The HHH study (Home or Hospital in Heart Failure). European Journal of Heart Failure.&amp;nbsp; 11(3)(Pp 312-318), 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19228800" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Scherr D, Kastner P, Kollmann A et al. Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial. Journal of Medical Internet Research 2009; 11(3):e34.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19687005" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Vitacca M, Bianchi L, Guerra A et al. Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J 2009; 33(2):411-8.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18799512" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Whitten P,&amp;nbsp; BA,&amp;nbsp; MM, A,&amp;nbsp; BK,&amp;nbsp; JK. St. Vincent's home telehealth for congestive heart failure patients. Telemedicine and E-Health.&amp;nbsp; 15(2)(Pp 148-153), 2009. Date of Publication: 01 Mar 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19292623" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies and pilot studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Cavanaugh JT, Kochi N, Stergiou N. Nonlinear analysis of ambulatory activity patterns in community-dwelling older adults. Journals of Gerontology Series A: Biological Sciences &amp;amp; Medical Sciences 2010; 65(2):197-204.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19822625" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hedrick SC, Guihan M, Chapko MK et al. Assisted living pilot program: health outcomes. Journal of Aging &amp;amp; Health 2009; 21(1):190-208.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19074647" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hicks L, L,&amp;nbsp; FD, A,&amp;nbsp; DA. The application of remote monitoring to improve health outcomes to a rural area. Telemedicine and E-Health.&amp;nbsp; 15(7)(Pp 664-671), 2009. Date of Publication: 01 Sep 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19694598" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jia H, Chuang H, Wu SS, Wang X, Chumbler NR. Long-term effect of home telehealth services on preventable hospitalization use. Journal of Rehabilitation Research &amp;amp; Development 2009; 46(5):557-67.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19882490" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Lakey SL, Gray SL, Borson S. Assessment of older adults' knowledge of and preferences for medication management tools and support systems. Ann Pharmacother 2009; 43(6):1011-9.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19470855" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Mahoney DF, Mahoney EL, Liss E. AT EASE: Automated Technology for Elder Assessment, Safety, and Environmental monitoring. [References]. Gerontechnology. Vol.8(1), Win 2009, Pp. 11-25.&lt;BR&gt;[&lt;A href="http://www.gerontechnology.info/Journal/main.php?p=12&amp;amp;art=1094" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346692</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346692]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Contents</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN style="WIDOWS: 2; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: separate; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; ORPHANS: 2; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px; -webkit-text-decorations-in-effect: none; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px" class=Apple-style-span&gt;&lt;SPAN style="FONT-FAMILY: arial, helvetica, sans-serif; FONT-SIZE: 12px" class=Apple-style-span&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 hspace=20 vspace=20 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID346692/nelhImp_0001_iStock_000001587118Small.gif"&gt;NHS Evidence - later life's Supporting People in Later Life Annual Evidence Update 2010 aims to provide healthcare professionals with a clear path to the most important recent evidence about caring for older people who are experiencing difficulties with independent living due to health problems.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;Older people may experience these difficulties for a number of reasons.&amp;nbsp; Some may lack social networks, others may be experiencing a general functional decline or increasing frailty.&amp;nbsp; Still others may have carers who are finding it increasingly difficult to cope.&amp;nbsp; &lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;It is in the interests of patients, carers and health professionals alike to be able to recognise, evaluate and, hopefully, prevent or delay the transition to hospital care in patients who are finding it hard to cope.&amp;nbsp; We hope that this AEU will help you to identify appropriate tools and interventions to fit your patients’ needs.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;The topic has been broken down into the following topics:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;A href="nelh:346693:1" name=internalLink&gt;Acute Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346694:1" name=internalLink&gt;Residential and Supported Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346695:1" name=internalLink&gt;Primary and Community Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346696:1" name=internalLink&gt;Assessment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346697:1" name=internalLink&gt;Assistive Technologies and Telehealth&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346698:1" name=internalLink&gt;Independent Living&lt;/A&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;The AEU includes evidence that has been published since March 2009.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;Further down this page you can find UK Guidelines that have been updated in the past year.&lt;/P&gt;
&lt;H2 style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;How the bibliographies are organised&lt;/H2&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;We found very few systematic reviews or randomised trials focused on this particular patient group.&amp;nbsp; This is partly because research tends to focus on specific clinical conditions rather than the general population of interest to this AEU.&amp;nbsp; For this reason, we included observational evidence such as cohort studies and qualitative research.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;The main pubication types are:&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Systematic reviews&lt;/STRONG&gt;&lt;BR&gt;Systematic reviews that have been published or updated in the last year.&amp;nbsp; Systematic reviews aim to find, assess and summarise all of the research that has been conducted on a specific topic.&amp;nbsp; We identify systematic reviews by checking the abstract for the key sections of a systematic review:&amp;nbsp; inclusion criteria, search strategy, study selection and evaluation, data extraction and statistical analysis.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Other reviews (or "non-systematic reviews")&lt;/STRONG&gt;&lt;BR&gt;This sub-section contains relevant reviews whose abstracts do not contain all of the key sections of a systematic review.&amp;nbsp; As such, some of these documents will be genuine systematic reviews, whilst others will be less rigorous overviews of the topic.&amp;nbsp; You should check the methods section to see if these reviews made sufficient efforts to find and include all of the relevant evidence.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Other important evidence&lt;/STRONG&gt;&lt;BR&gt;We use this category as a “catch-all” for studies, such as critical appraisals of individual trials, that are relevant but do not fit into either of the above two categories.&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;UK&amp;nbsp;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="nelh:338938:0" name=internalLink&gt;Improving care and saving money: learning the lessons on prevention and early intervention for older people&lt;/A&gt;. January 2010&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="nelh:305365:0" name=internalLink&gt;The Health and Social Care Act 2008: Code of Practice for health and adult social care on the prevention and control of infections and related guidance&lt;/A&gt;. December 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="nelh:321284:0" name=internalLink&gt;Prevention package for older people&lt;/A&gt;. July 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="nelh:319632:0" name=internalLink&gt;End of life care strategy: quality markers and measures for end of life care&lt;/A&gt;. June 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;NHS Primary Care Contracting&lt;/STRONG&gt;. &lt;A href="http://www.pcc.nhs.uk/uploads/pwsis/March%202009/updated_older_people.pdf" target="_blank"&gt;Guidance and competences for the provision of services using practitioners with special interests: older people (PDF).&lt;/A&gt; &amp;nbsp;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Centre for Public Scrutiny&lt;/STRONG&gt;. &lt;A href="nelh:330172:0" name=internalLink&gt;Walk a mile in my shoes: scrutiny of dignity and respect for individuals in health and social care services - a guide&lt;/A&gt;. November 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Nursing and Midwifery Council&lt;/STRONG&gt;. &lt;A href="nelh:313364:0" name=internalLink&gt;Guidance for the care of older people&lt;/A&gt;. March 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;Royal College of Physicians&lt;/STRONG&gt;. &lt;A href="nelh:313369:0" name=internalLink&gt;Advance Care Planning&lt;/A&gt;. February 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;SCIE&lt;/STRONG&gt;. &lt;A href="http://www.scie.org.uk/publications/guides/guide15/index.asp" target="_blank"&gt;Dignity in care&lt;/A&gt;. originally published in 2006 but new content added 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;The National Centre for Involvement&lt;/STRONG&gt;. &lt;A href="nelh:320302:1" name=internalLink&gt;A Guide to involving patients, carers and the public in palliative care and end of life care services&lt;/A&gt;. &lt;/DIV&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;NHS End of Life Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;This important policy framework contains many important resources for the care of older people who are having difficulty with independent living.&amp;nbsp; We link to each core document below:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.endoflifecare.nhs.uk/eolc/files/NHS-EoLC_Core_competences-Guide-Jul2009.pdf" target="_blank"&gt;Common core competences and principles for health and social care workers working with adults at the end of life&lt;/A&gt;&amp;nbsp;(PDF). June 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.endoflifecare.nhs.uk/eolc/files/NHS-EoLC_Developing_skills_pilot_schemes-Booklet-Jan2010.pdf" target="_blank"&gt;Developing skills: talking about end of life care – twelve pilot schemes in England&lt;/A&gt;&amp;nbsp;(PDF). January 2010&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.endoflifecare.nhs.uk/eolc/files/NHS-EoLC_Care_in_care_homes_report_Jan2009.pdf" target="_blank"&gt;The end of life care in nursing homes: understanding and mapping solutions- final report&lt;/A&gt;&amp;nbsp;(PDF). January 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.endoflifecare.nhs.uk/eolc/files/NHS-EoLC_Info_for_housing_care_staff-Resource_Pack-Jul2009.pdf" target="_blank"&gt;End of life care learning resource pack: information and resources for housing, care and support staff in extra care housing&lt;/A&gt;&amp;nbsp;(PDF). July 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.endoflifecare.nhs.uk/eolc/files/NHS-EoLC_Core_competences_framework_NOS-Jan2010.pdf" target="_blank"&gt;Framework of National Occupational standards to support common competencies and principles for health and social care work&lt;/A&gt;&amp;nbsp;(PDF). January 2010&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.endoflifecare.nhs.uk/eolc/files/NHS-EoLC_Planning_future_care-guide-Apr2009.pdf" target="_blank"&gt;Planning for your future care – a guide&lt;/A&gt;&amp;nbsp;(PDF). March 2009&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;A href="http://www.pcc.nhs.uk/uploads/pwsis/March%202009/updated_older_people.pdf" target="_blank"&gt;Guidance and competences for the provision of services using practitioners with special interests: older people&lt;/A&gt;&amp;nbsp;(PDF). 2009&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;International Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;
&lt;DIV style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&lt;STRONG&gt;European society for clinical nutrition and metabolism&lt;/STRONG&gt;. &lt;A href="http://www.espen.org/documents/0909/Home%20Parenteral%20Nutrition%20in%20adults.pdf" target="_blank"&gt;ESPEN guidelines on parental nutrition&lt;/A&gt;. September 2009&lt;/DIV&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;You can read and download the following documents below:&lt;/P&gt;
&lt;UL style="MARGIN-TOP: 10px"&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=372641" target="_blank"&gt;Methodology PDF&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=346692" target="_blank"&gt;Publicity Poster PDF&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=372640" target="_blank"&gt;Press Release PDF&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: arial, helvetica, sans-serif; COLOR: rgb(0,0,0); FONT-SIZE: 1.1em; PADDING-TOP: 5px"&gt;Please send us your feedback&lt;SPAN class=Apple-converted-space&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;A style="COLOR: rgb(0,102,204)" href="http://www.library.nhs.uk/LaterLife/ContactUs.aspx" target="_blank"&gt;here&lt;/A&gt;.&lt;/P&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346698</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346698]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Independent Living</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Independent Living&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:346692:1" name=internalLink&gt;Back to&amp;nbsp;Supporting People in Later Life&amp;nbsp;Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 hspace=20 vspace=120 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID346698/nelhImp_0000_iStock_000004488706Small.gif"&gt;&lt;BR&gt;&lt;BR&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P align=justify&gt;&lt;BR&gt;We use this category to identify studies of interventions that promote independence and prevent functional decline, but do not fall within any of the other categories.&amp;nbsp; This includes self-care interventions, exercise, quality of life and general aspects of how care is organised or delivered.&lt;BR&gt;&lt;BR&gt;Promisingly, Berzins et al’s review found that “self-care interventions have had positive effects for older participants but it remains unknown how best to support self-care in participants over 75, a group of people with long-term conditions who may have different needs”.&amp;nbsp; &lt;BR&gt;&lt;BR&gt;The importance of careful customising of interventions to individual patient needs is a theme in this section.&amp;nbsp; Findorff et al report from an RCT that “Individually tailored exercise interventions may be most amenable to older women”&lt;BR&gt;&lt;BR&gt;Birkeland &amp;amp; Natvig’s qualitative study contains interesting insights for professionals: “If the elderly tend to be passive and resigned, it can be necessary for the community nurses to have a more active problem-solving approach to these patients, in order to help them creating a daily rhythm with which they can feel comfortable.”&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;&lt;BR&gt;&lt;BR&gt;
&lt;H2&gt;Interventions to support independent living&lt;/H2&gt;&lt;BR&gt;&lt;U&gt;Systematic reviews&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Berzins K, Reilly S, Abell J, Hughes J, Challis D. UK self-care support initiatives for older patients with long-term conditions: A review. [References]. Chronic Illness. Vol.5(1), Mar 2009, Pp. 56-72.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19276226" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Non-systematic reviews&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Lui CW, Everingham JA, Warburton J, Cuthill M, Bartlett H. What makes a community age-friendly: A review of international literature. [Review] [50 refs]. Australasian Journal on Ageing 2009; 28(3):116-21.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19845650" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ryan AA, McCann S, McKenna H. Impact of community care in enabling older people with complex needs to remain at home. International Journal of Older People Nursing 2009; 4(1):22-33.&lt;BR&gt;[&lt;A href="http://www3.interscience.wiley.com/journal/121644498/abstract?CRETRY=1&amp;amp;SRETRY=0" target="_blank"&gt;Cochrane Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Experimental studies &lt;/U&gt;
&lt;OL&gt;
&lt;LI&gt;Findorff MJ, Wyman JF, Gross CR. Predictors of long-term exercise adherence in a community-based sample of older women. Journal of Women's Health (15409996) 2009; 18(11):1769-77.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19951210" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gitlin LN, Hauck WW, Dennis MP, Winter L, Hodgson N, Schinfeld S. Long-term effect on mortality of a home intervention that reduces functional difficulties in older adults: results from a randomized trial. J Am Geriatr Soc 2009; 57(3):476-82.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19187417" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Vass M, Avlund K, Siersma V, Hendriksen C. A feasible model for prevention of functional decline in older home-dwelling people--the GP role. A municipality-randomized intervention trial. Fam Pract 2009; 26(1):56-64.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19074756" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Feinglass J, Song J, Manheim LM, Semanik P, Chang RW, Dunlop DD. Correlates of improvement in walking ability in older persons in the United States. Am J Public Health 2009; 99(3):533-40.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19106418" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fujino Y, Matsuda S. Prospective study of living arrangement by the ability to receive informal care and survival among Japanese elderly. Prev Med 2009; 48(1):79-86.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19010348" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fujiwara Y, Chaves PHM, Yoshida H et al. Intellectual activity and likelihood of subsequently improving or maintaining instrumental activities of daily living functioning in community-dwelling older Japanese: a longitudinal study. Int J Geriatr Psychiatry 2009; 24(6):547-56.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19132642" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Karakaya MG, Bilgin SC, Ekici G, Kose N, Otman AS. Functional mobility, depressive symptoms, level of independence, and quality of life of the elderly living at home and in the nursing home. Journal of the American Medical Directors Association 2009; 10(9):662-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19883891" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Moone RP, Lightfoot E. Social marketing strategies for reaching older people with disabilities: findings from a survey of centers for independent living participants. Journal of Social Work in Disability &amp;amp; Rehabilitation 2009; 8(2):65-81.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19459127" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Pidgeon J. Whole system working in the promotion of independence and well-being for older people. Journal of Integrated Care 2009; 17(3):26-34.&lt;BR&gt;[&lt;A href="http://pierprofessional.metapress.com/content/q64t618j36vg4757/?p=1d91e237faef4bbb9251eea719a4ec74&amp;amp;pi=16" target="_blank"&gt;Pier Professional Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Sawada Y, Shinohara R, Sugisawa Y, Anme T. Maintenance of physical function and related factors for community dwelling elderly: a nine-year follow-up study. Journal of Physical Therapy Science 2009; 21(3):244-52.&lt;BR&gt;[&lt;A href="http://www.jstage.jst.go.jp/article/jpts/21/3/245/_pdf" target="_blank"&gt;Full Text PDF&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Young Y. Factors associated with permanent transition from independent living to nursing home in a continuing care retirement community. Journal of the American Medical Directors Association 2009; 10(7):491-7.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19716066" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Qualitative studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Birkeland A, Natvig GK. Coping with ageing and failing health: a qualitative study among elderly living alone. Int J Nurs Pract 2009; 15(4):257-65.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19703041" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Fange A, Ivanoff SD. The home is the hub of health in very old age: findings from the ENABLE-AGE Project. Archives of Gerontology &amp;amp; Geriatrics 2009; 48(3):340-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18423909" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jacelon CS. Maintaining the balance: older adults with chronic health problems manage life in the community. Rehabil Nurs 2010; 35(1):16-23.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20067206" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Jeon H, Dunkle RE. Stress and depression among the oldest-old: a longitudinal analysis. Res Aging 2009; 31(6):661-88.&lt;BR&gt;[&lt;A href="http://roa.sagepub.com/cgi/content/abstract/31/6/661" target="_blank"&gt;Sage Journals Online Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Seddon D, Harper G. What works well in community care: supporting older people in their own homes and community networks. Quality in Ageing 2009; 10(4):8-18.&lt;BR&gt;[&lt;A href="http://pierprofessional.metapress.com/content/qk44v17742617520/" target="_blank"&gt;Pier Professional&amp;nbsp;Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346695</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346695]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Primary and Community Care</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Primary and Community Care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:346692:1" name=internalLink&gt;Back to&amp;nbsp;Supporting People in Later Life&amp;nbsp;Annual Evidence Update Contents Page&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;&lt;BR&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage1 name=nelh_tempImage1 hspace=20 vspace=40 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID346695/nelhImp_0000_iStock_000005665659Small.gif"&gt;&lt;BR&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;&lt;BR&gt;
&lt;P align=justify&gt;This section of the AEU looks at older people experiencing difficulties with independent living who are living in the community and being cared for by primary care practitioners. Much of the evidence is focused on enabling early discharge from, or preventing re-admission to hospital.&lt;BR&gt;&lt;BR&gt;Eklund &amp;amp; Wilhelmson found that integrated interventions such as case management, when focused on frail elderly people living in the community, can reduce health utilisation and improve outcomes.&amp;nbsp; However, they note “the importance of using valid outcome measurements and describing both the content and implementation of the intervention”.&lt;BR&gt;&lt;BR&gt;In contrast, Sheppard et al found that their review “provides insufficient objective evidence of economic benefit or improved health outcomes” for hospital-at-home initiatives.&lt;BR&gt;&lt;BR&gt;Because of the complex context of this question, we also included individual trials, observational studies and qualitative studies.&lt;BR&gt;&lt;BR&gt;Amongst these, Vass et al found in an RCT that “A brief, practicable interdisciplinary educational programme for primary care professionals postponed functional decline in non-disabled 80-year-old home-dwelling persons”.&amp;nbsp; Hawley’s grounded theory qualitative study reports that “the key factor causing older people to carry out their home exercise programme is a determination to regain independence following illness and a fall.”&amp;nbsp; She also notes the importance of social interaction as a motivator. &lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;
&lt;H2&gt;Primary and community care&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;U&gt;Policy frameworks&lt;/U&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/DH_107305" target="_blank"&gt;Report on the Standing Commission on Carers 2001 to 2009&lt;/A&gt;. October 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="http://www.dh.gov.uk/en/SocialCare/Carers/DH_094301" target="_blank"&gt;Announcement of the Carers’ Strategy Demonstrator Sites&lt;/A&gt;. July 2009&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;U&gt;Policy reports from charities&lt;/U&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Age Concern&lt;/STRONG&gt;. &lt;A href="http://policy.helptheaged.org.uk/NR/rdonlyres/0C72CBF2-38BE-4E90-99AD-DFBAD20D3FB0/0/personalcareathome.pdf" target="_blank"&gt;Personal care at home – proposals for regulations and guidance&lt;/A&gt;. February 2010&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Counsel and Care&lt;/STRONG&gt;.&lt;A href="http://www.counselandcare.org.uk/assets/library/documents/Care_Concerns_2009__22.01.2010.pdf" target="_blank"&gt; Care Concerns 2009&lt;/A&gt;&amp;nbsp;(PDF). January 2010&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Counsel and Care&lt;/STRONG&gt;. &lt;A href="http://www.counselandcare.org.uk/assets/library/documents/Finding_and_financing_care_in_hard_times_-_14.01.09.pdf" target="_blank"&gt;Finding and financing care in hard times&lt;/A&gt; (PDF). January 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Counsel and Care&lt;/STRONG&gt;. &lt;A href="http://www.counselandcare.org.uk/assets/library/documents/Ceretas_discussion_paper_FINAL_October_09.pdf" target="_blank"&gt;The Future of Homecare: responding to older people's needs&lt;/A&gt;&amp;nbsp;(PDF). October 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Counsel and Care&lt;/STRONG&gt;. &lt;A href="http://www.counselandcare.org.uk/assets/library/documents/The_real_cost_of_quality_6.11.09.pdf" target="_blank"&gt;Published with National Care Forum. The real costs of quality are and support&lt;/A&gt;&amp;nbsp;(PDF). November 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;For Dementia&lt;/STRONG&gt;. &lt;A href="http://static.carers.org/files/no-breaks-for-carers-report-oct-09-4924.pdf" target="_blank"&gt;No breaks for carers (a report on primary care trusts and the carers strategy)&lt;/A&gt;&amp;nbsp;(PDF). October 2009&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&lt;U&gt;Systematic reviews&lt;/U&gt; &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Eklund K, Wilhelmson K. Outcomes of coordinated and integrated interventions targeting frail elderly people: a systematic review of randomised controlled trials. Health &amp;amp; Social Care in the Community 2009; 17(5): 447-58. &lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19245421" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Shepperd S, Doll H, Broad J et al. Early discharge hospital at home. [Review] [77 refs][Update of Cochrane Database Syst Rev. 2005;(3):CD000356; PMID: 16034853]. Cochrane Database of Systematic Reviews 2009; (1):CD000356.&lt;BR&gt;[&lt;A href="http://www2.cochrane.org/reviews/en/ab000356.html" target="_blank"&gt;Cochrane Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Non-systematic reviews&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Ryan AA, McCann S, McKenna H. Impact of community care in enabling older people with complex needs to remain at home. International Journal of Older People Nursing 2009; 4(1):22-33.&lt;BR&gt;[&lt;A href="http://www3.interscience.wiley.com/journal/121644498/abstract" target="_blank"&gt;Wiley InterScience Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Experimental studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Vass M, Avlund K, Siersma V, Hendriksen C. A feasible model for prevention of functional decline in older home-dwelling people--the GP role. A municipality-randomized intervention trial. Fam Pract 2009; 26(1):56-64.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19074756" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Wenger NS, Roth CP, Shekelle PG et al. A practice-based intervention to improve primary care for falls, urinary incontinence, and dementia. J Am Geriatr Soc 2009; 57(3):547-56.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19175441" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Observational studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Fusco D, Bochicchio GB, Onder G, Barillaro C, Bernabei R, Landi F. Predictors of rehabilitation outcome among frail elderly patients living in the community. Journal of the American Medical Directors Association 2009; 10(5):335-42.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19497546" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Heppenstall CP, Hanger HC, Wilkinson TJ. Predictors of discharge stability in the first year following hospital admission for a frail elderly population. Internal Medicine Journal 2009; 39(3):170-3.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18771437" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Nyweide DJ. Does continuity matter? Measuring the quality of ambulatory care among chronically ill elders in the United States. Dissertation Abstracts International: Section B: The Sciences and Engineering. Vol.70(5-B),2009, Pp. 2811.&lt;BR&gt;[&lt;A href="http://gradworks.umi.com/33/56/3356267.html" target="_blank"&gt;ProQuest Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;U&gt;Qualitative&amp;nbsp;studies&lt;/U&gt; 
&lt;OL&gt;
&lt;LI&gt;Graham CL, Ivey SL, Neuhauser L. From hospital to home: assessing the transitional care needs of vulnerable seniors. Gerontologist 2009; 49(1):23-33.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19363001" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hawley H. Older adults' perspectives on home exercise after falls rehabilitation: understanding the importance of promoting healthy, active ageing. Health Educ J 2009; 68(3):207-19.&lt;BR&gt;[&lt;A href="http://hej.sagepub.com/cgi/content/abstract/68/3/207" target="_blank"&gt;Sage Journals Online Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346694</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=346694]]&gt;</url>
    <title>Supporting People in Later Life Annual Evidence Update 2010: Residential and Supported Care</title>
    <publicationDate>2010-04-26T00:00:00</publicationDate>
    <publisher>NHS Evidence - later life</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Supporting People in Later Life Annual Evidence Update 2010: Residential and Supported Care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:346692:1" name=internalLink&gt;Back to Supporting People in Later Life Annual Evidence Update Contents Page&lt;/A&gt;&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;IMG style="FLOAT: right" id=nelh_tempImage0 name=nelh_tempImage0 hspace=20 src="https://rmsadmin.library.nhs.uk/libraryImages/Later%20Life/contentID346694/nelhImp_0001_iStock_000011259539Small.gif"&gt;&lt;/H2&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P align=justify&gt;&lt;BR&gt;This category includes studies based in a nursing home, residential care or supported care setting.&lt;BR&gt;&lt;BR&gt;We found no systematic reviews nor randomised trials on the management of older people experiencing difficulties with independent living that were focused on this care setting.&lt;BR&gt;&lt;BR&gt;We present an overview of observational studies reporting risk factors, functional outcomes and quality of life of older people in residential care.&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;
&lt;H2&gt;Residential and supported care&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;U&gt;Policy frameworks&lt;/U&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="nelh:344006:0" name=internalLink&gt;Response to the consultation on: The Health and Social Care Act 2008 code of practice for health and adult social care on the prevention and control of infection and related guidance, and prevention and control of infection in care homes&lt;/A&gt;. February 2010&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Department of Health&lt;/STRONG&gt;. &lt;A href="http://www.dh.gov.uk/en/Consultations/Liveconsultations/DH_111525" target="_blank"&gt;Charging arrangements for residential social care: consultation on issues concerning the current charging arrangements for residential social care&lt;/A&gt;. Launched January 2010&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;U&gt;Policy reports from charities&lt;/U&gt;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Counsel and Care&lt;/STRONG&gt;. &lt;A href="http://www.counselandcare.org.uk/assets/library/documents/Care_Home_Handbook_final.pdf" target="_blank"&gt;Care Home Handbook&lt;/A&gt;&amp;nbsp;(PDF). September 2009&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Help the Aged&lt;/STRONG&gt;. &lt;A href="http://www.helptheaged.org.uk/NR/rdonlyres/652BC405-AA9E-49CB-B7FE-E16A7B0D3A99/0/nobodys_listening.pdf" target="_blank"&gt;Nobody’s Listening&lt;/A&gt;&amp;nbsp;(PDF). 2009&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;&lt;U&gt;Observational studies&lt;/U&gt; &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Ahmed A, A,&amp;nbsp; HC et al. Predictors of In-Hospital Mortality Among Hospitalized Nursing Home Residents: An Analysis of the National Hospital Discharge Surveys 2005-2006. Journal of the American Medical Directors Association.&amp;nbsp; 11(1)(Pp 52-58), 2010. Date of Publication: January 2010.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20129215" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Belfrage MK, Chiminello C, Cooper D, Douglas S. Pushing the envelope: clinical handover from the aged-care home to the emergency department. Med J Aust 2009; 190(11 Suppl):S117-20.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19485858" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cai Q, Salmon J, Warren, Rodgers ME. Factors associated with long-stay nursing home admissions among the U.S. elderly population: Comparison of logistic regression and the cox proportional hazards model with policy implications for social work. [References]. Social Work in Health Care. Vol.48(2), Feb 2009, Pp. 154-168.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19197772" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Cole C, S,&amp;nbsp; RK et al. Relationships among disordered sleep and cognitive and functional status in nursing home residents. Research in Gerontological Nursing.&amp;nbsp; 2(3)(Pp 183-191), 2009. Date of Publication: Jul 2009.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20078008" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Connolly S, O'Reilly D. Variation in care home admission across areas of Northern Ireland. Age &amp;amp; Ageing 2009; 38(4):461-5.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19435758" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gaillat J, Chidiac C, Fagnani F et al. Morbidity and mortality associated with influenza exposure in long-term care facilities for dependent elderly people. European Journal of Clinical Microbiology &amp;amp; Infectious Diseases 2009; 28(9):1077-86.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19444493" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gill TM, Gahbauer EA, Han L, Allore HG. Factors associated with recovery of prehospital function among older persons admitted to a nursing home with disability after an acute hospitalization. Journals of Gerontology Series A-Biological Sciences &amp;amp; Medical Sciences 2009; 64(12):1296-303.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19661289" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Gill TM, Gahbauer EA, Han L, Allore HG. Functional trajectories in older persons admitted to a nursing home with disability after an acute hospitalization. J Am Geriatr Soc 2009; 57(2):195-201.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19170778" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Higgins L, Mansell J. Quality of life in group homes and older persons' homes. British Journal of Learning Disabilities 2009; 37(3):207-13.&lt;BR&gt;[&lt;A href="http://www3.interscience.wiley.com/journal/122413969/abstract" target="_blank"&gt;Wiley Interscience Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Hsu H, Ting Y, Jiang T, Chien M, Chien C. Autonomy and acceptance of long-term care. Educational Gerontology 2009; 35(11):949-63.&lt;BR&gt;[&lt;A href="http://www.informaworld.com/smpp/content~content=a915821375~db=all~jumptype=rss" target="_blank"&gt;Informaworld Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Karakaya MG, Bilgin SC, Ekici G, Kose N, Otman AS. Functional mobility, depressive symptoms, level of independence, and quality of life of the elderly living at home and in the nursing home. Journal of the American Medical Directors Association 2009; 10(9):662-6.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19883891" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Ouslander JG, Perloe M, Givens JH, Kluge L, Rutland T, Lamb G. Reducing potentially avoidable hospitalizations of nursing home residents: results of a pilot quality improvement project. Journal of the American Medical Directors Association 2009; 10(9):644-52.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19883888" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;
&lt;LI&gt;Walker JD, Teare GF, Hogan DB, Lewis S, Maxwell CJ. Identifying potentially avoidable hospital admissions from canadian long-term care facilities. Med Care 2009; 47(2):250-4.&lt;BR&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19169127" target="_blank"&gt;Pubmed Abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>282747</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sparc.ac.uk/media/downloads/executivesummaries/exec_summary_aldred.pdf]]&gt;</url>
    <title>Taking a Walk? Physical activity and the health of older people</title>
    <publicationDate>2008-04-07T00:00:00</publicationDate>
    <publisher>SPARC</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>An executive summary of a SPARC project by Sarah Aldred and Manjit Rohalu Singh.</description>
    <body>&lt;![CDATA[ &lt;P&gt;There are many benefits of exercise in later life, but the direct benefits of exercise on the biological ageing process are not fully understood. An experiment involving two groups of older people was carried out to investigate the effects of exercise on oxidative stress in older adults.&lt;/P&gt;
&lt;P&gt;Oxidative stress is something which can happen if reactive “free radicals” outbalance good “anti-oxidants” in our bodies. It is often thought that oxidative stress becomes more common as we grow older.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Volunteers, aged between 65 and 75 were split into two groups. The members of one group exercised as normal without changing their usual routines, and the others followed a modest walking regime of three 30 minute walks a week for 8 weeks. The volunteers assigned to the exercise group, lost weight over the 8 week period whilst those in the control group did not. As weight loss is associated with health benefits such as reduced risk of heart disease, the results suggest that regular walking is beneficial to healthy older adults. The exercise carried out in this study did not appear to increase oxidative stress. Some of the biological markers of oxidative stress which were measured were altered over the course of the study, but these changes were seen in both the control and the exercise groups. Oxidative stress in general is considered a risk factor for the development of diseases such as heart disease, arthritis, and some dementias. &lt;/P&gt;
&lt;P&gt;The results therefore suggest that exercise at this intensity and duration is not harmful to the health of older people.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>374913</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474442210700302/fulltext?rss=yes]]&gt;</url>
    <title>Tarenflurbil for Alzheimer's disease: a “shot on goal” that missed</title>
    <publicationDate>2010-02-15T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Currently available treatments for Alzheimer's disease (acetylcholinesterase inhibitors and memantine) improve cognitive function, but do not slow the long-term progression of this disorder. Despite several attempts with therapies aimed at reducing the brain amyloid load, or that target other pathological mechanisms, no treatment has been shown to slow the progression of Alzheimer's disease in a phase 3 trial.]]&gt;</body>
  </document>
  <document>
    <id>374914</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.thelancet.com/journals/laneur/article/PIIS1474442210700557/fulltext?rss=yes]]&gt;</url>
    <title>Testing the amyloid hypothesis of Alzheimer's disease in vivo</title>
    <publicationDate>2010-03-15T00:00:00</publicationDate>
    <publisher>The Lancet Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ In this issue of The Lancet Neurology , Rinne and colleagues 1 report something of a breakthrough by demonstrating the feasibility of eventually testing the so-called amyloid hypothesis of sporadic Alzheimer's disease in vivo. According to their analysis, a passive immunotherapy protocol with an anti-amyloid-ß monoclonal antibody (bapineuzumab) was associated with a decrease in the cerebral PET signal after administration of the amyloid plaque imaging compound carbon-11-labelled Pittsburgh compound]]&gt;</body>
  </document>
  <document>
    <id>94240</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;o=10956]]&gt;</url>
    <title>The assessment and prevention of falls in older people</title>
    <publicationDate>2004-07-04T00:00:00</publicationDate>
    <publisher>National Institute for Clinical Excellence (NICE)</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ PREVENTION,ASSESSING RISK,LATER LIFE,FALLS,CAUSES OF HARM,ENVIRONMENTAL,DETERMINANTS,ADULTS,OLDER PEOPLE,GUIDELINES,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,MANAGEMENT &amp; POLICY,FRAMES OF REFERENCE,MONTHLY ADDITIONS,2008-OCTOBER,AGE GROUPS,POPULATIONS,GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;The assessment and prevention of falls in older people&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;NICE and the National Collaborating Centre for Nursing and Supportive Care have published a guideline for the NHS in England and Wales on the assessment and prevention of falls in older people. &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.nice.org.uk/page.aspx?o=233391" target="_blank"&gt;Go to&amp;nbsp;further key documents for this guideline.&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>95413</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/SC89.asp]]&gt;</url>
    <title>The assessment process for older people leaving hospital</title>
    <publicationDate>1996-07-07T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SURVEILLANCE,SCREENING AND SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A new study suggests there are a number of problems with the current system of discharging older people requiring housing adaptations or special equipment from hospital. Looking particularly at the 'home visit' with hospital occupational therapists, when such needs are assessed, it found that pressure of resources means that safe discharge is taking precedence over consultation and enhancement of independence.]]&gt;</body>
  </document>
  <document>
    <id>374951</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/1/64?rss=1]]&gt;</url>
    <title>The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale</title>
    <publicationDate>2010-01-11T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objective&amp;nbsp; To determine the estimates of minimal, moderate, and large clinically important differences (CIDs) for the Unified Parkinson's Disease Rating Scale (UPDRS).]]&gt;</body>
  </document>
  <document>
    <id>281333</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.cot.org.uk/specialist/olderpeople/links/intro.php]]&gt;</url>
    <title>The College of Occupational Therapists Specialist Section: Older People</title>
    <publicationDate>2008-03-04T00:00:00</publicationDate>
    <publisher>The College of Occupational Therapists</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Useful links for occupational therapists working with older people.</description>
    <body>&lt;![CDATA[ &lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;Mental Health&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;Professional Links&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;Government / Health / Legislation&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;Specialist organisations&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;Physical Health&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;Gateways&lt;/H2&gt;
&lt;LI&gt;
&lt;H2&gt;Other useful links&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>94193</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/cgi/reprint/139/10/835.pdf]]&gt;</url>
    <title>The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Ann Intern Med</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,CANCER,BREAST,SCREENING,SCREENING AND SURVEILLANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objectives:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;There are few data on the effects of disease biology and competing mortality on the effectiveness of screening women for breast cancer after age 65 years. The authors performed a review to determine the costs and benefits of mammography screening after age 65 years.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Conclusions:&lt;/P&gt;
&lt;P&gt;Current estimates suggest that biennial breast cancer screening after age 65 years reduces mortality at reasonable costs for women without clinically significant comorbid conditions. More data are needed on disease biology and preferences for benefits and harms in older women.&amp;nbsp;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>291076</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.pssru.ac.uk/pdf/dp2538.pdf]]&gt;</url>
    <title>The Costs of Addressing Age Discrimination in Social Care</title>
    <publicationDate>2008-07-25T00:00:00</publicationDate>
    <publisher>Personal Social Services Research Unit</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,THE WHY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Personal Social Services Research Unit Discussion paper April 2008.</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Introduction&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Historically PSS expenditure per head on older people using social care services has been lower than for other adult client groups. Along with a number of investigations (e.g. Age Concern England 2008), this difference is taken as a possible indicator of age discrimination in the deployment of services. The UK government is proceeding with the introduction of a Single Equality Bill during this Parliament. One of the proposals is to outlaw age discrimination in the provision of public services. This report seeks to gauge the extent of age discrimination in council-funded social care services for adults (people 18 or over). It draws on a quantitative analysis of the level of support provided to service users. Lower expenditure per head on services may indicate age discrimination, but there are also a range of ‘legitimate’ reasons for this pattern of spending. The analysis aims to determine whether people in different age groups are treated differently after these ‘legitimate’ differences are removed.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>262100</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzscot.org/pages/policy/dementiaepidemic.htm]]&gt;</url>
    <title>'The Dementia Epidemic' Report</title>
    <publicationDate>2007-06-06T00:00:00</publicationDate>
    <publisher>Alzheimer Scotland</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,LATER LIFE,PATHOLOGY,DEFINITION AND TYPES,DEMENTIA,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The report highlights the large and rapidly-growing numbers of people with dementia in Scotland and the economic impact now and in the future. It provides detailed figures on numbers of people with dementia and on services, both nationally and by local authority and health board. The report sets out what strategies need to be put in place to manage or reduce the increase.&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;Summary&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Dementia is a key health issue facing Scotland over the coming decades. As our population ages there is projected to be a 75% increase in the number of people with dementia.&lt;/LI&gt;
&lt;LI&gt;The 'Dementia Epidemic' report aims to give a picture of current and future numbers of people with dementia based on the best current evidence, to outline current service provision and issues of quality and adequacy, to look at the economic impact of dementia and to set out what strategies need to be put in place to manage or mitigate the increase in numbers.&lt;/LI&gt;
&lt;LI&gt;Dementia is a major cause of disability in people aged over 60. It contributes 11.2% of all years lived with disability, more than stroke (9%), musculoskeletal disorders (8.9%), cardiovascular disease (5%) and all forms of cancer (2.4%).&lt;/LI&gt;
&lt;LI&gt;In order to cope effectively with the projected increase in the numbers of people with dementia and the associated cost, it is essential that Scotland has a forward-looking strategy for dementia that seeks to minimise the numbers of people developing dementia, invests in anticipatory care and support for self management, provides sufficient good quality and cost-effective services, increases resources in line with demographic growth and supports research into the causes, treatment and care of people with dementia.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>332517</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/sites/files/jrf/care-and-well-being-full.pdf]]&gt;</url>
    <title>The development of social well-being in new extra care housing schemes</title>
    <publicationDate>2009-11-19T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ HEALTH &amp; WELLBEING,LATER LIFE,ENVIRONMENTAL,ENVIRONMENT,ADULTS,OLDER PEOPLE,MONTHLY ADDITIONS,COMMUNITY DEVELOPMENT,POPULATION BASED &amp; PREVENTATIVE SERVICES,DETERMINANTS,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,BUILDINGS,SHELTERED ACCOMMODATION,SERVICES,GROUPS,AGE GROUPS,POPULATIONS,SETTINGS,HOUSING,APRIL 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Extra care schemes help older people remain independent. But they also aim to provide social opportunities that prevent residents feeling isolated. &lt;/P&gt;
&lt;P&gt;This research, which examined how social well-being developed in 15 new-build housing schemes, revealed the following: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Communal facilities and a diverse range of organised activities need to be available when schemes open as they help residents interact&lt;/LI&gt;
&lt;LI&gt;Residents involved in running social activities found it gave them ownership of their social lives, supported their independence and encouraged others to join in&lt;/LI&gt;
&lt;LI&gt;Adequate staff time and resources to support social activities are crucial at the start of a scheme but also over time as some residents become frailer&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>280470</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ageuk.org.uk/get-involved/make-a-donation/the-disconnected-mind/?paging=false]]&gt;</url>
    <title>The Disconnected Mind</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;H2&gt;&amp;nbsp;The Disconnected Mind research programme aims to:&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;determine the risk factors for healthy mental ageing; 
&lt;LI&gt;define the changes taking place in the brain during mental decline; 
&lt;LI&gt;provide health advice for preventing mental decline; and 
&lt;LI&gt;test new treatments to help combat dementia and age related illnesses&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>95408</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/SCR478.asp]]&gt;</url>
    <title>The effect on carers of a frail older person's admission to a care home</title>
    <publicationDate>1998-07-05T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This study found that many family caregivers found the process of choosing a suitable care home for a frail elderly relative intimidating and would have welcomed more advice and support. There was also much confusion about the financial arrangements.]]&gt;</body>
  </document>
  <document>
    <id>95397</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialpolicy/7112.asp]]&gt;</url>
    <title>The experiences of working carers of older adults</title>
    <publicationDate>2002-07-07T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This investigation of two large public sector organisations looked at how staff and managers dealt with workers’ caring responsibilities for older adults.]]&gt;</body>
  </document>
  <document>
    <id>395033</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.cpa.org.uk/information/reviews/thefutureageingoftheethnicminoritypopulationofenglandandwales.pdf]]&gt;</url>
    <title>The future ageing of the ethnic minority population of England and Wales</title>
    <publicationDate>2010-11-01T00:00:00</publicationDate>
    <publisher>Centre for Policy on Ageing</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,WHAT IS AGEISM?,HOW DOES AGEISM OCCUR?,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Centre for Policy on Ageing (CPA) is highlighting its recent report for the Runnymede Trust, The future ageing of the ethnic minority population of England and Wales. By 2051, in England and Wales, there will be 3.8 million black and minority ethnic older people aged 65 and over and 2.8 million aged 70 and over. The ageing of individual ethnic minority communities will have an impact not only on the need for services but also on the communities themselves. For example, it is estimated that between 2001 and 2051 there will be a 45-fold increase in the number of people with dementia in the Black African ethnic minority community.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>277032</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.caringchoices.org.uk/wp-content/uploads/the-future-of-care-funding-final-report-jan08.pdf]]&gt;</url>
    <title>The Future of Care Funding: Time for a change</title>
    <publicationDate>2008-01-08T00:00:00</publicationDate>
    <publisher>Caring Choices</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SECONDARY CARE,SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The future of care funding: time for a change  was published by Caring Choices, a collaboration of 15 organisations representing all aspects of the long-term care system.  Caring Choices: Who will pay for long-term care?’ was a nationwide initiative throughout 2007 to help shape future policy on long-term care for older people.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Caring Choices, a coalition of 15 organisations from across the long-term care system, sought to gather the views of older people, carers and others with direct experience of the system on how care should best be funded in the future. It was born out of widespread and growing concern that the current long-term care funding system is not fit for purpose. Throughout 2007, it has engaged with more than 700 individuals at events across England and Scotland and through an interactive website. The initiative – and this final report in particular – provides insights into potential areas of consensus as well as some of the difficult choices and trade-offs that will need to be made in order to create a funding system that is fair, effective and sustainable.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;The findings reported below came from the discussions at the Caring Choices events and from a survey of those attending the events, web visitors and a number of partner organisation contacts.&lt;BR&gt;&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;Caring Choices found:&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;There was almost no support for the current funding system. Ninety per cent of participants at the events rejected the use of a means test to determine whether or not an individual receives any state-funded care. In other words, they supported a stronger ‘universal’ element, determined by care need rather than by people’s income or wealth. 
&lt;LI&gt;The vast majority of Caring Choices participants wanted a simpler system, in which entitlements are clearer and people are able to plan ahead with greater understanding of what will be on offer. 
&lt;LI&gt;Almost all Caring Choices participants (99 per cent of those who completed the questionnaire) believed that more money needs to be spent on long-term care – regardless of what kind of funding system we have in place or where that money comes from. 
&lt;LI&gt;Just under three-quarters of all participants believed that the costs of long-term care should be shared between the government and the individual, although there was a range of views on how that could be organised and what the balance should be. 
&lt;LI&gt;Although Caring Choices participants demonstrated strong support for a system that gave a much clearer sense of entitlement to some level of state support, there were many calls for older people and their families to have control over the services they obtain with the help of this support. 
&lt;LI&gt;There were many calls for a wider range of care needs beyond those narrowly defined as ‘personal care’ (help with washing and dressing etc), such as shopping or help with gardening, to be better supported. 
&lt;LI&gt;There was a recurrent but unresolved debate about whether and to what extent existing general and nonmeans- tested disability&amp;nbsp;benefits, such as Attendance Allowance, should be brought in to any reform of long-term care funding. 
&lt;LI&gt;Most participants were in favour of the idea that the state should support schemes, such as equity release, that help to unlock private resources or encourage private contributions towards the cost of care. But there were mixed views on specific schemes and a clear sense that participants felt a variety of options should be encouraged rather than a single ‘solution’. 
&lt;LI&gt;There was an overwhelming view, often strongly expressed, that the current levels of support, financial and otherwise, for unpaid carers is totally inadequate. Participants emphasised that this is an important issue, and that any settlement will fail if it neglects carers’ needs.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>293435</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.publications.parliament.uk/pa/jt200607/jtselect/jtrights/156/156i.pdf]]&gt;</url>
    <title>The Human Rights of Older People in Healthcare: Eighteenth Report of Session 2006-07</title>
    <publicationDate>2007-07-16T00:00:00</publicationDate>
    <publisher>House of Lords</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Volume I - Report and Formal Minutes.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Summary&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;In addition to its scrutiny of parliamentary Bills and policy documents for human rights implications, the Committee examines areas where human rights concerns arise, such as the treatment of older persons in health care.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;In this Report the Committee examines how human rights principles can be applied to ensure that older people in hospitals and care homes are treated with greater dignity and respect (paragraphs 1 - 8).&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;The Committee heard that, while some older people receive excellent care, there are concerns about poor treatment, neglect, abuse, discrimination and ill-considered discharge. It considers that an entire culture change is needed. It also recommends legislative changes&lt;BR&gt;and a role for the new Commission for Equality and Human Rights (paragraphs 9 - 65).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;In the Committee’s view there is a significant distinction between a “duty to provide” under care standards legislation and a “right to receive” under human rights legislation. It recommends that the Government and other public bodies should champion understanding of how human rights principles can help transform health and social care services (paragraphs 66 - 95).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;While welcoming the recent acceptance at senior levels in the&amp;nbsp;Department of Health of the importance of human rights in healthcare, the Committee recommends adoption of a strategy to make the Human Rights Act integral to policy-making and social care across the Department (paragraphs 96 - 124).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;The Committee regrets the failure of the Department of Health and the Ministry of Justice to give proper leadership and guidance to providers of health and residential care on the implications of the Human Rights Act. It recommends measures to strengthen human rights obligations and duties and to bring private and voluntary care homes within the scope of the Human Rights Act (paragraphs 125 - 161).&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;The Committee recommends improved guidance and standards on human rights compliance in healthcare and that the forthcoming merged inspectorate for health, social care and mental health should adopt a human rights framework for all its work. It also recommends that the National Institute for Health and Clinical Excellence should take clearer account of the Convention rights of any patients affected by its decisions on clinical practice (paragraphs 162 - 198).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;The Committee advocates better staff training in human rights principles and their inclusion in health professionals’ qualifications as well as a duty to blow the whistle on abuse (paragraphs 199 - 232).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;The Committee makes recommendations relating to protection against eviction for care home residents, improved defence of their human rights and more robust complaints procedures. It also recommends promotional work to improve the image of human rights and spread awareness of older people’s rights (paragraphs 233 - 288).&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95406</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/SCR768.asp]]&gt;</url>
    <title>The importance of 'low level' preventive services to older people</title>
    <publicationDate>1998-07-05T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This study suggests that ‘low level’ services, like help with housework, gardening, laundry and home maintenance, both enhance quality of life for older people and help them maintain their independence.]]&gt;</body>
  </document>
  <document>
    <id>33771</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.assoc-optometrists.org/uploaded_files/pdf/fallscollegegeriatricnov_03.pdf]]&gt;</url>
    <title>The importance of vision in preventing falls</title>
    <publicationDate>2003-02-12T00:00:00</publicationDate>
    <publisher>College of Optometrists &amp; British Geriatrics Society</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ FALLS,LATER LIFE,PREVENTION,NSF FOR OLDER PEOPLE,LIVING WITH VISUAL IMPAIRMENT,LOW VISION,ENVIRONMENTAL,CAUSES OF HARM,DETERMINANTS,OUTCOMES,ADULTS,EYE DISORDERS,OLDER PEOPLE,EYES AND VISION,PUBLIC HEALTH,MONTHLY ADDITIONS,2008-OCTOBER,CONDITIONS,AGE GROUPS,GROUPS,POPULATIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The document states that visual impairment is strongly associated with falls and hip fractures and that adding treatment of poor vision to exercise and hazard management in the home, produced an additional 14% reduction in the annual fall rate. “Older people and their supporting health care professionals should be aware of the importance of regular eye examinations. It is vital that people identified as suffering from visual impairment, such as the many that are in residential care or nursing homes who are at an increased risk of falls, have full and regular eye examinations by optometrists,” said Frank Munro, President of the College of Optometrists.]]&gt;</body>
  </document>
  <document>
    <id>374918</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/5/631?rss=1]]&gt;</url>
    <title>The N141I Mutation in PSEN2: Implications for the Quintessential Case of Alzheimer Disease</title>
    <publicationDate>2010-05-10T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Objective&amp;nbsp; To connect a new family with early-onset Alzheimer disease (EOAD) in Germany to the American Volga German pedigrees.&lt;/P&gt;
&lt;P&gt;Design&amp;nbsp; Pedigree molecular genetic analysis.&lt;/P&gt;
&lt;P&gt;Setting&amp;nbsp; University Medical Centers in Fulda and Giessen, Germany, and in Seattle, Washington.&lt;/P&gt;
&lt;P&gt;Results&amp;nbsp; The families from Fulda, Germany, and the American Volga German families with EOAD share the same N141I PSEN2 mutation on an identical haplotypic background. This establishes that the N141I mutation occurred prior to emigration of the families from the Hesse region to Russia in the 1760s, and documents that relatives of the original immigrant families are presently living in Germany with the mutation and the disease.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>287482</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_084579]]&gt;</url>
    <title>The National Service Framework for Long-term Neurological Conditions: national support for local implementation 2008</title>
    <publicationDate>2008-05-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,PARKINSON'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document is the product of collaboration between DH, Care Service Improvement Partnership (CSIP) and the Third sector, and gives an overview of  resources, tools and initiatives that are/will be available to support local implementation of the NSF.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This document is the product of collaboration between DH, Care Service Improvement Partnership (CSIP) and the Third sector, and gives an overview of&amp;nbsp; resources, tools and initiatives that are/will be available to support local implementation of the NSF.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>346413</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/reprint/303/3/258]]&gt;</url>
    <title>The Patient Who Falls</title>
    <publicationDate>2010-01-20T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>OBSERVATIONAL STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,ASSESSING RISK,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;Falls are common health events that cause discomfort and disability&lt;SUP&gt; &lt;/SUP&gt;for older adults and stress for caregivers. Using the case of&lt;SUP&gt; &lt;/SUP&gt;an older man who has experienced multiple falls and a hip fracture,&lt;SUP&gt; &lt;/SUP&gt;this article, which focuses on community-living older adults,&lt;SUP&gt; &lt;/SUP&gt;addresses the consequences and etiology of falls; summarizes&lt;SUP&gt; &lt;/SUP&gt;the evidence on predisposing factors and effective interventions;&lt;SUP&gt; &lt;/SUP&gt;and discusses how to translate this evidence into patient care.&lt;SUP&gt; &lt;/SUP&gt;Previous falls; strength, gait, and balance impairments; and&lt;SUP&gt; &lt;/SUP&gt;medications are the strongest risk factors for falling. &lt;/FONT&gt;&lt;FONT size=2 face="verdana, arial, helvetica, sans-serif"&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93883</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9892451&amp;query_hl=36]]&gt;</url>
    <title>The protective effect of moderate alcohol consumption on ischemic stroke</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ STROKE,CAUSES AND PRIMARY PREVENTION,LATER LIFE,OUTCOMES,CIRCULATORY DISEASES,STROKE &amp; TIA,ETHNIC GROUPS,DETERMINANTS,PUBLIC HEALTH,INDIVIDUAL BEHAVIOUR,ALCOHOL CONSUMPTION,LIFESTYLE,SOCIAL DETERMINANTS,GROUPS,POPULATIONS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This case-control study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/alcisstro.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"This case-control study found that moderate drinking, up to two drinks a day, reduced the risk of ischaemic stroke by 49% in a multiethnic, elderly population. Not surprisingly, heavier drinking, seven or more drinks a day, was associated with an increased risk of ischaemic stroke. However, it is possible that past heavier drinkers may not maintain an increased risk if they reduce their consumption to a moderate level"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>260394</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://whqlibdoc.who.int/hq/1998/WHO_HPR_AHE_98.2.pdf]]&gt;</url>
    <title>The Role of Physical Activity in Healthy Ageing</title>
    <publicationDate>1998-12-21T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Prepared by Dr Riitta-Liisa Heikkinen, from the Finnish Centre for Interdisciplinary Gerontology, under the guidance of the World Health Organization Ageing and Health Programme.</description>
    <body>&lt;![CDATA[ A 24-page review of the role of physical activity in health ageing, with a particular focus on the research evidence on the benefits of exercise for mobility, cardiovascular disease, osteoporosis, falls, and glucose metabolism, as well as mental health.]]&gt;</body>
  </document>
  <document>
    <id>278220</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.csci.org.uk/about_us/news/state_of_social_care_2007_ne-1.aspx]]&gt;</url>
    <title>The state of social care in England 2006-07: CSCI's third annual report to Parliament on the state of social care</title>
    <publicationDate>2008-01-30T00:00:00</publicationDate>
    <publisher>Commission for Social Care Inspection (CSCI)</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,SECONDARY CARE,PRIMARY CARE,SURVEILLANCE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>CSCI's third annual report to Parliament on the state of social care shows that people who are not receiving support from councils are struggling with a poor quality of life.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Sharp divide between people who do and do not qualify for social care&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;CSCI's third annual report to Parliament on the state of social care shows that people who are not receiving support from councils are struggling with a poor quality of life. It gives a comprehensive overview of the social care sector in England.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Download the report:&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/PDF/20080128_SOSC_Summary_2007.pdf" target="_blank"&gt;Summary version&lt;/A&gt; (PDF, 721 KB, opens in a new window) 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/PDF/20080128_SOSC_2006_07_Foreword_Overview.pdf" target="_blank"&gt;State of social care - foreword &amp;amp; overview&lt;/A&gt; (PDF, 268 KB, opens in a new window) 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/PDF/20080128_SOSC_2006_07_Context.pdf" target="_blank"&gt;State of social care - context and focus&lt;/A&gt; (PDF, 248 KB, opens in a new window) 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/PDF/20080128_SOSC_2006_07_Part1.pdf" target="_blank"&gt;State of social care - part 1&lt;/A&gt; (PDF, 3.85 MB, opens in a new window) 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/PDF/20080128_SOSC_2006_07_Part2.pdf" target="_blank"&gt;State of social care - part 2&lt;/A&gt; (PDF, 874 KB, opens in a new window) 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/PDF/20080128_SOSC_2006_07_Appendices.pdf" target="_blank"&gt;State of social care - appendices&lt;/A&gt; (PDF, 426 KB, opens in a new window) 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/about_us/publications/state_of_social_care_07/state_of_social_care_07_alt.aspx" target="_blank"&gt;Alternative formats&lt;/A&gt;: includes large print, easy to read and audio versions&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;CSCI's&amp;nbsp;chair Dame Denise Platt said: "Our report is in two parts."&lt;/P&gt;
&lt;P&gt;"On the one hand we show that those who qualify for council support are having a better experience than before."&lt;/P&gt;
&lt;P&gt;"On the other hand those people who fall outside the system, including self funders, have a poor quality experience that can leave them struggling to cope. People who only five years ago qualified for council-arranged help are today excluded by the system and left to fend for themselves. The poor experiences of people and their carers trying and failing to get sufficient help contrast starkly with those people who do qualify for council arranged care."&lt;/P&gt;
&lt;P&gt;Following concerns raised by the Commission last year, the third State of Social Care in England report for the first time explores the experiences of people not deemed eligible for state-supported social care. It shows that many younger disabled people and frail older people are being ‘signposted’ to voluntary services. Many are forced to rely on help from family and informal arrangements which can break down at short notice. People unable to rely on families or friends and unable to pay for care services themselves are simply left to cope with everyday life, while some become virtually trapped in their own home.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Fair Access to Care Services&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Local councils increasingly only help those with ‘substantial’ or ‘critical’ needs. Although councils use a national set of rules (called Fair Access to Care Services - FACS ) to decide who is eligible for support.&lt;/P&gt;
&lt;P&gt;The report includes new research which shows that who does or doesn’t get help varies not only between but also within the same council. In practice the criteria can be interpreted in different ways by local staff.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/about_us/publications/state_of_social_care_07/state_of_social_care_07_bg.aspx" target="_blank"&gt;Read the background research papers that contributed to the State of social care report&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Find out more&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/about_us/news/state_of_social_care_2007_fact.aspx" target="_blank"&gt;Read some key facts from the report&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/about_us/press_releases/state_of_social_care_2007.aspx" target="_blank"&gt;Read a press release about the report&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.csci.org.uk/about_us/press_releases/state_of_social_care_2007/state_of_social_care_07_video.aspx" target="_blank"&gt;Watch our video news release and listen to audio clips about the report&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Presented to Parliament under section 129 (1)(b) of the Health and Social Care (Community Health and Standards) Act 2003&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>235825</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/bookshop/eBooks/1954-older-people-services.pdf]]&gt;</url>
    <title>The support older people want and the services they need</title>
    <publicationDate></publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE,NSF FOR OLDER PEOPLE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This report looks at the services older people want to support them in
their life at home.</description>
    <body>&lt;![CDATA[ This report looks at the services older people want to support them in their life at home. It presents research carried out by a team of researchers, practitioners and older people, looks at the barriers that prevent access to practical every-day services, and highlights ways in which improvements can be made in assessing people’s needs and providing services.]]&gt;</body>
  </document>
  <document>
    <id>319609</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://jama.ama-assn.org/cgi/content/extract/301/23/2430?etoc]]&gt;</url>
    <title>Therapeutic environmental design aims to help patients with alzheimer's disease</title>
    <publicationDate>2009-06-17T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;FONT face="verdana, arial, helvetica, sans-serif" size=2&gt;By the time Alzheimer disease (AD) has reached its end stage,&lt;SUP&gt; &lt;/SUP&gt;the brain is riddled with plaques, tangles, cavities, and fissures&lt;SUP&gt; &lt;/SUP&gt;and has lost a substantial percentage of its weight. However,&lt;SUP&gt; &lt;/SUP&gt;most people living with AD are not yet at this stage and still&lt;SUP&gt; &lt;/SUP&gt;have a good portion of working neurons with which they can learn,&lt;SUP&gt; &lt;/SUP&gt;be creative, and enjoy life, said John Zeisel, PhD, a sociologist&lt;SUP&gt; &lt;/SUP&gt;who focuses on the therapeutic effects of residential environment&lt;SUP&gt; &lt;/SUP&gt;design among patients with the disorder (Zeisel J et al. &lt;I&gt;Gerontologist&lt;/I&gt;.&lt;SUP&gt; &lt;/SUP&gt;2003;43[5]:697-711).&lt;SUP&gt; &lt;/SUP&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT face="verdana, arial, helvetica, sans-serif" size=2&gt;Therapeutic environmental design seeks to tap into the areas&lt;SUP&gt; &lt;/SUP&gt;of the brain that are still functioning rather than focusing&lt;SUP&gt; &lt;/SUP&gt;on the parts of the brain that do not work, said Zeisel, who&lt;SUP&gt; &lt;/SUP&gt;presented his approach to designing residences for people with&lt;SUP&gt; &lt;/SUP&gt;AD at a recent meeting on environments for aging. Applying insights&lt;SUP&gt; &lt;/SUP&gt;from neuroscience to the design of &lt;NOBR&gt;&lt;EM&gt;. . .&lt;/EM&gt;[this article has been abstracted]&lt;/NOBR&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>321687</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/reprint/14/3/76]]&gt;</url>
    <title>Therapeutics - Review: exercise programmes prevent falls in elderly people</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;QUESTIONS&lt;BR&gt;&lt;/STRONG&gt;Do exercise programmes prevent falls in elderly people? What are the most important components of effective exercise interventions?&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;REVIEW SCOPE&lt;/STRONG&gt;&lt;BR&gt;Included studies evaluated exercise interventions for falls prevention in elderly people. Studies in which the control group received exercise or the intervention group received additional non-exercise interventions for &amp;gt;25% of the time were excluded. Outcome was the pooled incidence rate ratio (IRR), which allows for multiple falls per person.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;REVIEW METHODS&lt;/STRONG&gt;&lt;BR&gt;Medline, CINAHL, EMBASE/Excerpta Medica, PubMed, Physiotherapy Evidence Database, SafetyLit, Prevention of Falls Network Europe, and the Cochrane Bone, Joint, and Muscle Trauma Group’s trial register (May 2007); and references were searched for published randomised controlled trials (RCTs). 44 RCTs (49 comparisons, n = 9603) met the selection criteria. Mean age was &amp;gt;=75 years in 65% of comparisons. 16 trials reported allocation concealment, and 22 used intention-to-treat analysis. Most trials involved community-dwelling elderly people who were at increased risk of falling. Most exercise programmes . . (Abstracted)&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94091</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://stroke.ahajournals.org/cgi/content/full/34/6/1437]]&gt;</url>
    <title>Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke. Where do we go from here: a cumulative meta-analysis</title>
    <publicationDate>2003-07-06T00:00:00</publicationDate>
    <publisher>Stroke</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,ACUTE MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This meta analysis has been appraised by the &lt;A href="http://144.32.150.197/scripts/WEBC.EXE/nhscrd/expand?saan=0000295903" target="_blank"&gt;Centre for Reviews and Dissemination (CRD).&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;CRD summary:&lt;/P&gt;
&lt;P&gt;"&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;Despite the volume of data having doubled since 1995, the magnitude of the risks and benefits of rtPA remains imprecise. New trials are needed to fill this gap in knowledge, which may be hindering the clinical use of rtPA.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;&lt;FONT color=blue&gt;&lt;FONT color=black&gt;This was a well-conducted systematic review and the authors' conclusions are supported by their findings".&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>319608</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=1&amp;id=232]]&gt;</url>
    <title>Top scientists warn of dementia threat to NHS</title>
    <publicationDate>2009-06-18T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists slammed the government’s underinvestment in dementia research amid warnings of “catastrophic” economic consequences.]]&gt;</body>
  </document>
  <document>
    <id>260397</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://whqlibdoc.who.int/publications/2004/9241592184.pdf]]&gt;</url>
    <title>Towards Age-friendly Primary Health Care</title>
    <publicationDate>2004-05-03T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A 40-page report on the need for age-friendly primary health care.]]&gt;</body>
  </document>
  <document>
    <id>260400</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.who.int/ageing/publications/alc_fs_ageing_policy.pdf]]&gt;</url>
    <title>Towards policy for health and ageing: fact sheet</title>
    <publicationDate></publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A one-page fact sheet on the challenge for health care systems of a rapidly ageing population.]]&gt;</body>
  </document>
  <document>
    <id>329999</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/sites/files/jrf/training-in-use-of-talking-mats-summary.pdf]]&gt;</url>
    <title>Training care home staff to use Talking Mats® with people who have dementia</title>
    <publicationDate>2009-10-27T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,TREATMENT AND CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;It can be difficult for carers and people with dementia to communicate.In recognition of this, JRF funded the development and delivery of a project in 2008/2009 that would train care home staff across the UK to use Talking Mats. This system, complete with a textured mat and visual symbols, helps people with communications difficulties to interact.&lt;/P&gt;
&lt;P&gt;This paper highlights key findings from the project, including:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Confident staff who had management support were more likely to do well in training and implement new practice&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Training of this kind is more effective when delivered to a group of staff in one care home&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Talking Mats can benefit people at all stages of dementia, but it is still especially difficult to interact with residents in the later stages of the disease&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>268803</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ageuk.org.uk/travel-lifestyle/travel-tips/?paging=false]]&gt;</url>
    <title>Travel tips</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>Age UK</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,AGEISM,THE WHY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;One year on from its 2005 report 'In the Right Place', which made a series of recommendations to transport planners to improve access and local services for older people, Help the Aged reviews progress. Despite some encouraging signs, and improved awareness of the issues, the research reveals a depressing lack of action to address the problems.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317299</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.endoflifecareforadults.nhs.uk/publications/eolccarehomesreport]]&gt;</url>
    <title>Understanding and mapping innovative solutions PDF</title>
    <publicationDate>2009-05-05T00:00:00</publicationDate>
    <publisher>NHS End of Life Care Programme</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=3&gt;&lt;FONT size=3&gt;
&lt;P&gt;This document reports a study commissioned by the National End of Life Care Programme to examine these issues in relation to the care of older people in nursing homes2. The study was conducted by staff from the Sue Ryder Care Centre for Palliative and End of Life Studies at the University of Nottingham and from the International Observatory on End of Life Care at Lancaster University between September 2007 and November 2008.&lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT size=3&gt;&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>282751</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sparc.ac.uk/media/downloads/executivesummaries/exec_summary_gibb.pdf]]&gt;</url>
    <title>Understanding the Older Worker in Construction</title>
    <publicationDate>2008-01-07T00:00:00</publicationDate>
    <publisher>SPARC</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>An executive summary of a SPARC project by Joanna Leaviss, Alistair Gibb &amp; Phil Bust.</description>
    <body>&lt;![CDATA[ The primary aim of this project is to better understand the abilities and needs of older workers, through surveying them, to see how they fit within the changing workplaces of the construction industry. It should also establish the parameters of equipment design to see how new equipment, being introduced to assist construction workers generally, addresses the special needs of older workers. The need for this work has resulted from the construction industry's skills shortage – the early retirement of workers from the physically demanding workloads present in the construction industry being compounded by school leavers and graduates seeing the industry as 'dirty and dangerous' and seeking more appealing forms of employment.]]&gt;</body>
  </document>
  <document>
    <id>395039</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_121934]]&gt;</url>
    <title>Uptake of the seasonal influenza vaccine</title>
    <publicationDate>2010-11-19T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This letter to the NHS highlights the importance of achieving high seasonal flu vaccination coverage in:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;People aged 65 years and over;&lt;/LI&gt;
&lt;LI&gt;People aged under 65 in the clinical risk groups; and &lt;/LI&gt;
&lt;LI&gt;Frontline healthcare professionals.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>374910</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/content/15/2/59.short?rss=1]]&gt;</url>
    <title>Use of sedatives and hypnotics, antidepressants and benzodiazepines in older people significantly increases their risk of falls</title>
    <publicationDate>2010-05-01T00:00:00</publicationDate>
    <publisher>EBM BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,FALLS,PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Falls are a common geriatric syndrome. They are highly prevalent in older people, their impact on quality of life and disability is substantial, and multiple factors contribute to the risk.1 Age-related changes in pharmacokinetics and pharmacodynamics and declining health make older people particularly vulnerable to adverse drug events, including falls. Risk factors are of most importance in clinical practice if they are easily identifiable, modifiable and, at best, avoidable. Medication use often meets these criteria.]]&gt;</body>
  </document>
  <document>
    <id>273189</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jrf.org.uk/knowledge/findings/socialcare/2159.asp]]&gt;</url>
    <title>Using 'Talking Mats' to help people with dementia to communicate</title>
    <publicationDate>2007-10-31T00:00:00</publicationDate>
    <publisher>Joseph Rowntree Foundation</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,ADULT CONDITIONS,LATER LIFE,MENTAL HEALTH,TREATMENT AND CARE,DEMENTIA,DEMENTIA,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The deterioration of communication between people with dementia and their carers is one of the most distressing aspects of the illness. This project aimed to establish whether Talking Mats (www.talkingmats.com), a low-tech communication framework, help people with dementia to communicate, and to examine how effective they are for people at different stages of dementia.</description>
    <body>&lt;![CDATA[ &lt;P&gt;The deterioration of communication between people with dementia and their carers is one of the most distressing aspects of the illness. This project aimed to establish whether Talking Mats (&lt;A href="http://www.talkingmats.com/" target="_blank"&gt;www.talkingmats.com&lt;/A&gt;), a low-tech communication framework, help people with dementia to communicate, and to examine how effective they are for people at different stages of dementia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;Key points&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Conversations using Talking Mats were more effective for people with dementia than both unstructured (ordinary) or structured conversations. Improvements were evident in the participants' understanding, engagement, and ability to keep on track and make their views understood. 
&lt;LI&gt;Talking Mats enhanced the reliability of information provided by people with dementia. 
&lt;LI&gt;The amount of time spent 'on-task' – e.g. making eye contact and engaging actively in conversation – increased when using Talking Mats, and participants were less frequently distracted. 
&lt;LI&gt;Talking Mats reduced instances of repetitive behaviour, such as repeating words, phrases, ideas or actions. 
&lt;LI&gt;Conversations using Talking Mats lasted longer than ordinary conversations. 
&lt;LI&gt;People with early and middle-stage dementia could use Talking Mats effectively. People with late-stage dementia showed improvements when communicating with Talking Mats, but not everyone with late-stage dementia could use Talking Mats effectively. 
&lt;LI&gt;The researchers conclude that Talking Mats can be used by many people at all stages of dementia and that the framework improves their ability to communicate. Talking Mats may therefore play an important role in improving the quality of care by helping family and staff to engage with people with dementia and help them express their views about a range of topics.&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>93863</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11401607&amp;query_hl=23]]&gt;</url>
    <title>Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation</title>
    <publicationDate>2001-07-01T00:00:00</publicationDate>
    <publisher>JAMA</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study has been reviewed by &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band89/b89-3.html" target="_blank"&gt;Bandolier&lt;/A&gt;:&lt;/P&gt;
&lt;P&gt;"This is another example of a clinical scoring system being tested and showing how useful they can be. Here the very system, being an acronym, is helpful in bringing to mind important risk factors for stroke with non-rheumatic atrial fibrillation. The annual risk of stroke rose from under 2% a year with no risk factors to over 10% a year for five or six. At some point the balance tips to the use of anticoagulants. &lt;BR&gt;&lt;BR&gt;It would be terrific to see this scoring system tested on a separate data set, but for now we have a useful way of targeting warfarin treatment at patients who will benefit most, those with a high baseline risk. Patients with a lower risk can be offered aspirin".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>317306</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.alzheimers-research.org.uk/news/article.php?type=News&amp;archive=0&amp;id=412]]&gt;</url>
    <title>Vitamin D improves brain performance</title>
    <publicationDate>2009-05-21T00:00:00</publicationDate>
    <publisher>Alzheimer's Research Trust</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ University of Manchester scientists, in collaboration with colleagues from other European centres, have shown that higher levels of vitamin D are associated with improved cognitive function in middle-aged and older men.]]&gt;</body>
  </document>
  <document>
    <id>390681</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.bbc.co.uk/news/health-11537068]]&gt;</url>
    <title>Walking 'could ward off dementia and mental decline'</title>
    <publicationDate>2010-10-14T00:00:00</publicationDate>
    <publisher>BBC</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,CAUSES AND PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Elderly people who get about by walking are less likely to suffer mental decline or even dementia, a study says.&lt;/P&gt;
&lt;P&gt;Brain scans revealed that older people walking between six and nine miles a week appeared to have more brain tissue in key areas.&lt;/P&gt;
&lt;P&gt;The Pittsburgh University study of 299 people suggested they had less "brain shrinkage", which is linked to memory problems.&lt;/P&gt;
&lt;P&gt;The research was reported in the journal Neurology.&lt;/P&gt;
&lt;P&gt;The volunteers, who had an average age of 78, were checked for signs of "cognitive impairment" or even dementia.&lt;/P&gt;
&lt;P&gt;The Pittsburgh team also had access to brain scan results from four years previously which measured the amount of "grey matter" in their brains.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>34087</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//laterlife/ViewResource.aspx?resID=34087]]&gt;</url>
    <title>What is ageism?</title>
    <publicationDate></publicationDate>
    <publisher>Grimley Evans J</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ AGEISM,LATER LIFE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>An introduction to Ageism by Professor Sir John Grimley Evans</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;What is ageism?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;AGEISM&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;Ageism is discrimination against individuals because of their age.&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;It is a prejudice morally similar to sexism and racism in that it disadvantages people on account of characteristics over which they have no control.&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;It is also similar to sexism and racism in that it disadvantages people through attributing to them characteristics they may not have.&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;On average a group of older people will differ from a group of younger people. For example a higher proportion of the younger people will have acne. But knowing that someone is seventeen will not tell you that he or she suffers from acne. A person’s age tells us nothing about him or her as an individual. &lt;/FONT&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;As citizens of a democratic country we all have the right to be treated as individuals not just as members of a group.&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;Other things being equal avoidance of ageism would mean that the age pattern of the use of a treatment for a disease would match the age pattern of the incidence of the disease. “Other things” are not necessarily equal however because with increasing age there is also an increase in the prevalence of other illnesses or disability that might make treatment hazardous or futile. But the patient has the right to decide what risks he or she is prepared to undergo to obtain benefit from a treatment and also to decide what benefits would be “futile”.&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;Avoidance of ageism therefore requires that reasons for not providing treatment for a person with a disease should be:&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;A] Explicit&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;B] Evidence-based&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;C] Explained to and agreed by the patient.&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face="Times New Roman" color=#000000 size=3&gt;As medical science and technology advance, treatments and investigations become less challenging. Examples include safer anaesthetics, “keyhole” surgery and magnetic resonance imaging in the investigation of neurological disorders. Many people, including health care workers, overestimate the risks and underestimate the benefits for older people from modern treatments. &lt;/FONT&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 12pt 27pt; TEXT-INDENT: -27pt; tab-stops: right 18.0pt left 27.0pt; mso-layout-grid-align: none"&gt;&lt;SPAN lang=EN-US style="mso-bidi-font-size: 10.0pt; mso-ansi-language: EN-US"&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;&lt;FONT face="Times New Roman"&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>374923</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://archneur.ama-assn.org/cgi/content/short/67/4/483?rss=1]]&gt;</url>
    <title>What Is Semantic Dementia?: A Cohort Study of Diagnostic Features and Clinical Boundaries</title>
    <publicationDate>2010-04-12T00:00:00</publicationDate>
    <publisher>JAMA Neurology</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,DEMENTIA,DEFINITION AND TYPES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Objectives&amp;nbsp; To describe a large, clinically defined cohort of patients with semantic dementia (SD) that highlights important, sometimes overlooked features and to compare it with similar entities.]]&gt;</body>
  </document>
  <document>
    <id>93892</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/hliving/nutstroke.html]]&gt;</url>
    <title>Which nutrients reduce the risk of stroke?</title>
    <publicationDate>1999-07-04T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,STROKE,CAUSES AND PRIMARY PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This Bandolier article reviews the following studies:&lt;/P&gt;
&lt;P&gt;1. A Ascherio et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998 98: 1198-1204.&lt;/P&gt;
&lt;P&gt;2. H Iso et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 1999 30: 1772-1779.&lt;/P&gt;
&lt;P&gt;Clinical bottom line:&lt;/P&gt;
&lt;P&gt;A high potassium intake is associated with a reduced risk of ischaemic stroke. The best way to increase dietary potassium is to eat more fruit and vegetables. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>287561</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.who.int/ageing/publications/Falls_prevention7March.pdf]]&gt;</url>
    <title>WHO Global Report on Falls Prevention in Older Age 2008</title>
    <publicationDate>2008-05-30T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ FALLS,LATER LIFE,PREVENTION,ASSESSING RISK,REHABILITATION,OUTCOMES,ENVIRONMENTAL,CAUSES OF HARM,ADULTS,INJURIES,POPULATION BASED &amp; PREVENTATIVE SERVICES,OLDER PEOPLE,MONTHLY ADDITIONS,PUBLIC HEALTH,DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,SERVICES,INTERNATIONAL ISSUES,GEOGRAPHY,2008-SEPTEMBER,2008,GROUPS,SETTINGS,POPULATIONS,AGE GROUPS,ACCIDENTS,FALLS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document pulls together recent evidence and presents a strategy for health promotion to prevent falls.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;Contents&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Chapter I: Magnitude of falls - a worldwide overview 
&lt;LI&gt;Chapter II: Active ageing: A framework for the global strategy for the prevention of falls in older age 
&lt;LI&gt;Chapter III: Determinants of Active Ageing as they relate to falls in older age 
&lt;LI&gt;Chapter IV: Challenges for prevention of falls in older age 
&lt;LI&gt;Chapter V: Examples of effective policies and interventions 
&lt;LI&gt;Chapter VI: WHO falls prevention model within the Active Ageing framework&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>281657</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.who.int/chp/topics/Osteoporosis.pdf]]&gt;</url>
    <title>WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level</title>
    <publicationDate>2008-03-07T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ BONE DISORDERS,CONDITIONS,MUSCULOSKELETAL,OSTEOPOROSIS,TRAUMA AND ORTHOPAEDICS,PREVENTION,FALLS,ASSESSING RISK,LATER LIFE,TRAUMA,METABOLIC BONE DISEASE,FRACTURE,REHABILITATION,FRAGILITY FRACTURES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Summary Meeting report, Brussels, Belgium, 5-7 May 2004, published 2007.</description>
    <body>&lt;![CDATA[ &lt;H2&gt;CONTENTS&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Overview 1 
&lt;LI&gt;Background 1 
&lt;LI&gt;Risk factors 4 
&lt;LI&gt;Model synthesis 4 
&lt;LI&gt;Possibilities for the future 5 
&lt;LI&gt;Summary, conclusions and recommendations for research 7 
&lt;LI&gt;Consequences of osteoporosis 7 
&lt;LI&gt;Bone mineral measurements and diagnosis of osteoporosis 8 
&lt;LI&gt;Clinical risk factors for fracture 8 
&lt;LI&gt;Assessment tools for case-finding 9 
&lt;LI&gt;Assessment and the formulation of therapeutic strategy 10 
&lt;LI&gt;Recommendations for research 10 
&lt;LI&gt;References 11 
&lt;LI&gt;Acknowledgements 12 
&lt;LI&gt;List of participants 13&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;OVERVIEW&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;A WHO Scientific Group on the Assessment of Osteoporosis at the Primary Health Care Level met in Brussels from 5 to 7 May 2004. The meeting was opened by Dr N. Khaltaev, Responsible Officer for Chronic Respiratory Diseases and Arthritis, who welcomed the participants on behalf of the Director-General of the World Health Organization (WHO).&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;Background&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;Following the publication of the report of a WHO Study Group meeting on Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, osteoporosis has been recognized as an established and well-defined disease that affects more than 75 million people in the United States, Europe and Japan. Osteoporosis causes more than 8.9 million fractures annually worldwide, of which more than 4.5 million occur in the Americas and Europe. The lifetime risk for a wrist, hip or vertebral fracture has been estimated to be in the order of 30% to 40% in developed countries – in other words, very close to that for coronary heart disease. Osteoporosis is not only a major cause of fractures, it also ranks high among diseases that cause people to become bedridden with serious complications. These complications may be lifethreatening in elderly people. In the Americas and Europe osteoporotic fractures account for 2.8 million disability-adjusted life years (DALYs) annually, somewhat more than accounted for by hypertension and rheumatoid arthritis, but less than diabetes mellitus or chronic obstructive pulmonary diseases. Collectively, osteoporotic fractures account for approximately 1% of the DALYs attributable to noncommunicable diseases.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Because of the morbid consequences of osteoporosis, the prevention of this disease and its associated fractures is considered essential to the maintenance of health, quality of life, and independence in the elderly population. In May 1998, the Fifty-first World Health Assembly, having considered The world health report 1997: conquering suffering, enriching humanity, which described the high rates of mortality, morbidity and disability from major noncommunicable diseases – including osteoporosis, adopted a resolution requesting the Director-General to formulate a global strategy for the prevention and control of noncommunicable diseases. A scientific group meeting subsequently reported on the prevention and management of osteoporosis. The report of the present Scientific Group on Assessment of Osteoporosis at the Primary Health Care Level is a further step in the development of cohesive strategies for tackling osteoporosis in response to the World Health Assembly resolution. It is expected that the report of this meeting will lead to improvements in the assessment of osteoporosis patients throughout the world, and make a valuable contribution to the development of effective global strategies for the control of this important disease.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>282750</id>
    <name>&lt;![CDATA[ Later Life]]&gt;</name>
    <rootDirectory>/laterlife</rootDirectory>
    <url>&lt;![CDATA[http://www.sparc.ac.uk/media/downloads/executivesummaries/exec_summary_buckle.pdf]]&gt;</url>
    <title>Workplace Design for the Older Worker</title>
    <publicationDate>2008-04-07T00:00:00</publicationDate>
    <publisher>SPARC</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>An executive summary of a SPARC project by Peter Buckle, Valerie Woods, Ozhan Oztug &amp; David Stubbs.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Few workplaces are designed for older workers (65 years +) who want and need to continue working. There is little knowledge of what this workforce sector requires, how organisations view these issues or what help they need to accommodate older workers. &lt;/P&gt;
&lt;P&gt;This study will explore the match between older workers' capacities, abilities and expectations, and organisational requirements and strategies in the office and manual sectors. It will highlight the user perspective of being an older worker and the management perspective of employing an older workforce through discussion with managers, currently employed workers, those who retired at the traditional age, and those who retired early. T&lt;/P&gt;
&lt;P&gt;his ergonomics study will explore strengths and weaknesses of workplace design by looking at individual (e.g. physical aspects of workplace, job scheduling, training) and organisational factors (e.g. team working, support, policies) and will highlight adjustments/ procedures/ policies/ support networks that organisations should adopt to ensure a healthy working environment for all, and to extend productive working lives.&lt;/P&gt;]]&gt;</body>
  </document>
</documents>